knightlabID	sample_name	run_prefix	experimental_strategy	cgc_base_name	filename	analyte_amount	analyte_A260A280Ratio	aliquot_concentration	cgc_id	cgc_filename	vital_status	gender	race	ethnicity	disease_type	data_subtype	tcga_sample_id	cgc_case_uuid	sample_type	cgc_platform	gdc_file_uuid	primary_site	age_at_diagnosis	cgc_sample_uuid	cgc_aliquot_uuid	tcga_aliquot_id	reference_genome	tcga_case_id	investigation	days_to_death	data_submitting_center_label	tissue_source_site_label	country_of_sample_procurement	portion_is_ffpe	pathologic_t_label	pathologic_n_label	histological_diagnosis_label	pathologic_stage_label
s15482	58cfa82ee4b0c9d6adf6aa32	G23081.TCGA_CV_6961_11A_01D_2268_08.2.filtered.	WGS	G23081.TCGA_CV_6961_11A_01D_2268_08.2	G23081.TCGA_CV_6961_11A_01D_2268_08.2.bam	52.7	1.9	0.16	58cfa82ee4b0c9d6adf6aa32	G23081.TCGA_CV_6961_11A_01D_2268_08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6961-11A	4075717B-2240-4842-A00A-0C4DBCB910C4	Solid Tissue Normal	Illumina HiSeq	f4233ca2-6eae-497e-8d71-234f85182d06	Head and Neck	61.0	2F64AB02-D9B5-4EF3-9CBA-7534DC0735D5	26F6321F-F079-430F-8B87-5F06B92C07AF	TCGA-CV-6961-11A-01D-2268-08	HG19_Broad_variant	TCGA-CV-6961	TCGA-HNSC	76.0	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15483	58cfa82ee4b0c9d6adf6a7d5	G23062.TCGA_BA_4077_10A_01D_2268_08.2.filtered.	WGS	G23062.TCGA_BA_4077_10A_01D_2268_08.2	G23062.TCGA_BA_4077_10A_01D_2268_08.2.bam	58.03	1.9	0.14	58cfa82ee4b0c9d6adf6a7d5	G23062.TCGA_BA_4077_10A_01D_2268_08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4077-10A	4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A	Blood Derived Normal	Illumina HiSeq	82ff50a2-3252-4ce5-a0ad-979cce2ec4cb	Head and Neck	45.0	8C074534-49B5-4D4A-A9C8-59BFEF52A800	C955ACC5-3717-4CCA-A394-004E3C8A0686	TCGA-BA-4077-10A-01D-2268-08	HG19_Broad_variant	TCGA-BA-4077	TCGA-HNSC	1134.0	Broad Institute of MIT and Harvard	UNC	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15484	58cfa82ee4b0c9d6adf6a7ea	G23065.TCGA_BA_5153_01A_01D_2268_08.1.filtered.	WGS	G23065.TCGA_BA_5153_01A_01D_2268_08.1	G23065.TCGA_BA_5153_01A_01D_2268_08.1.bam	422.7	1.9	0.15	58cfa82ee4b0c9d6adf6a7ea	G23065.TCGA_BA_5153_01A_01D_2268_08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5153-01A	B3631718-9E0A-454C-BEE1-8F36EBC509D8	Primary Tumor	Illumina HiSeq	29740348-2de4-44e6-bdb0-05a2fb2fd9eb	Head and Neck	51.0	2DC7070A-9C70-4BB1-9634-8C934BB9C8D1	24D2B176-B1AB-4789-B394-616B722E63DF	TCGA-BA-5153-01A-01D-2268-08	HG19_Broad_variant	TCGA-BA-5153	TCGA-HNSC	1762.0	Broad Institute of MIT and Harvard	UNC	None	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15485	58cfa82ee4b0c9d6adf6ab5a	G23071.TCGA_CV_7100_10A_01D_2268_08.1.filtered.	WGS	G23071.TCGA_CV_7100_10A_01D_2268_08.1	G23071.TCGA_CV_7100_10A_01D_2268_08.1.bam	21.0		0.14	58cfa82ee4b0c9d6adf6ab5a	G23071.TCGA_CV_7100_10A_01D_2268_08.1.bam	Dead	MALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7100-10A	90A8D2CB-1F31-45F9-8575-EED3CB9A7798	Blood Derived Normal	Illumina HiSeq	1a0d4aab-84fc-453c-a92a-e4af5474a74a	Head and Neck	66.0	82FF7CAA-BC9B-408E-9106-D76BCEC69665	AC85E832-92B2-45A2-8A0B-3FC4A9E83661	TCGA-CV-7100-10A-01D-2268-08	HG19_Broad_variant	TCGA-CV-7100	TCGA-HNSC	274.0	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15487	58cfa830e4b0c9d6adf6c15c	TCGA-BA-4075-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BA-4075-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_4_rg.sorted	TCGA-BA-4075-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_4_rg.sorted.bam	80.03	1.9	0.14	58cfa830e4b0c9d6adf6c15c	TCGA-BA-4075-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_4_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4075-10A	6FA62461-E721-415A-8B0F-363B84292B82	Blood Derived Normal	Illumina HiSeq	5481b0b3-1652-4735-9746-fbf7bfb454a9	Head and Neck	49.0	4A5BA6E2-C47A-4CF4-A657-5FD0E962E49C	515D017E-D7A6-4CFF-AC82-F58E5A47005D	TCGA-BA-4075-10A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4075	TCGA-HNSC	283.0	Harvard Medical School	UNC	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15488	58cfa830e4b0c9d6adf6c164	TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted	TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted.bam	227.7	1.9	0.15	58cfa830e4b0c9d6adf6c164	TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5151-01A	A55FB87D-F606-48A5-82F5-09EACBACF41B	Primary Tumor	Illumina HiSeq	d1067ce4-863a-49f4-9061-d2e677695382	Head and Neck	72.0	63384A6A-9686-44EE-8C8F-22923968C9DE	5B29B8E2-23E6-4E6E-815C-B8D0EF534B14	TCGA-BA-5151-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-5151	TCGA-HNSC		Harvard Medical School	UNC	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15490	58cfa830e4b0c9d6adf6bd8f	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.bam	11.7	2.0	0.14	58cfa830e4b0c9d6adf6bd8f	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4223-01A	05F01280-BF77-4682-A7A8-20DD0EAC77BD	Primary Tumor	Illumina HiSeq	e8bc6546-004a-4702-9289-b5c90582298e	Head and Neck	48.0	82DB742D-885D-4788-B509-474715AE183B	007F0F41-C370-45F9-8053-2C774ADDED49	TCGA-BB-4223-01A-01D-1431-02	HG19_Broad_variant	TCGA-BB-4223	TCGA-HNSC		Harvard Medical School	Johns Hopkins	United States	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15491	58cfa830e4b0c9d6adf6c1a4	TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted	TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted.bam	94.4	1.9	0.15	58cfa830e4b0c9d6adf6c1a4	TCGA-BA-5559-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5559-10A	17B17D91-C3DF-4B89-9C10-4DB069AFF656	Blood Derived Normal	Illumina HiSeq	e4331399-eb06-4ee0-a375-64ffa929d8e7	Head and Neck	71.0	43FBB037-8BA4-4BA3-8458-71A027EDA822	673B6C98-3F56-42D2-BFF8-2E68992864F4	TCGA-BA-5559-10A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5559	TCGA-HNSC		Harvard Medical School	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15492	58cfa830e4b0c9d6adf6c1b0	TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina	TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina.bam	385.4	1.9	0.08	58cfa830e4b0c9d6adf6c1b0	TCGA-BA-5556-10A-01D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5556-10A	70741B73-9683-42BD-87FC-6A021A70103B	Blood Derived Normal	Illumina HiSeq	a2799f35-a768-4cac-a6e3-80c77052b7f9	Head and Neck	58.0	F57EB501-88BB-446B-9F7E-85FCCD0A828F	31220135-1318-4D47-8D69-49CABF4D087F	TCGA-BA-5556-10A-01D-A32X-10	GRCh37-lite	TCGA-BA-5556	TCGA-HNSC		Baylor College of Medicine	UNC	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15494	58cfa831e4b0c9d6adf6c459	TCGA-CN-4727-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-4727-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_8_rg.sorted	TCGA-CN-4727-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_8_rg.sorted.bam	1116.4	1.9	0.15	58cfa831e4b0c9d6adf6c459	TCGA-CN-4727-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4727-10A	12D05E8F-8D13-47C1-B713-2250F6ABCEF9	Blood Derived Normal	Illumina HiSeq	03edf3dd-9b2f-4ef6-8846-5a0154eacc1e	Head and Neck	56.0	CC2D6CFA-7640-44DD-A200-68FD9F9EE69C	28CF8227-EDE2-470C-81C1-A11462070E9A	TCGA-CN-4727-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4727	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15495	58cfa831e4b0c9d6adf6c426	TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted	TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted.bam	81.7	1.9	0.14	58cfa831e4b0c9d6adf6c426	TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4727-01A	12D05E8F-8D13-47C1-B713-2250F6ABCEF9	Primary Tumor	Illumina HiSeq	f26c4909-b285-4ca0-ac40-fe65ad4a6a1a	Head and Neck	56.0	F102AEF0-94B8-4D26-8055-35B76DA9DD5F	E42C764C-98DB-4E55-A625-B1443E6C4B3A	TCGA-CN-4727-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4727	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15496	58cfa831e4b0c9d6adf6c54a	TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted	TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted.bam	23.7	1.9	0.14	58cfa831e4b0c9d6adf6c54a	TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4730-01A	35C1F2C6-771C-4533-82DF-F8E2EC7107D7	Primary Tumor	Illumina HiSeq	56942e06-fb67-4bf4-993e-16cb67f52239	Head and Neck	62.0	8270C53E-F2CF-4F57-A1AC-A8BA978CC1C8	094C2014-ABA2-4C11-B076-27EA61C7A48E	TCGA-CN-4730-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4730	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15497	58cfa831e4b0c9d6adf6c698	TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted	TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted.bam	313.7	1.9	0.16	58cfa831e4b0c9d6adf6c698	TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5366-01A	30EB06A5-8E88-4C46-BEBB-FB93CA07F108	Primary Tumor	Illumina HiSeq	0a7fb0ab-3302-4187-a567-58bc19979dc5	Head and Neck	51.0	62FDF8F3-A028-453F-B27C-C2506BE68CBE	AE791AB1-78E2-4E8B-AB05-4435D9C67AA3	TCGA-CN-5366-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5366	TCGA-HNSC	360.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15498	58cfa831e4b0c9d6adf6c801	TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted	TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted.bam	96.0	1.9	0.14	58cfa831e4b0c9d6adf6c801	TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6018-01A	55838E1F-07E8-49CA-89D6-46216BABC6F7	Primary Tumor	Illumina HiSeq	ce9ca233-92c4-44b8-b97f-b56f1f73cb5a	Head and Neck	85.0	1A3E8C8B-9E99-499A-9BA7-4CDFC11B106D	7F0998E4-AF05-42C5-962C-5EA4D8993EB0	TCGA-CN-6018-01A-11D-1681-02	HG19_Broad_variant	TCGA-CN-6018	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15499	58cfa831e4b0c9d6adf6c8f6	TCGA-CN-6994-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CN-6994-10A-01D-A32X-10_wgs_Illumina	TCGA-CN-6994-10A-01D-A32X-10_wgs_Illumina.bam	893.0		0.09	58cfa831e4b0c9d6adf6c8f6	TCGA-CN-6994-10A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6994-10A	6909302D-358A-46CD-8052-EEDB09C83C83	Blood Derived Normal	Illumina HiSeq	48292910-3d60-4328-adc3-59a101b81ce8	Head and Neck	67.0	18FBC6DE-9DF1-4D95-9619-EF92C3BF4C91	62D512B9-D138-4C6B-90AF-D29634F0084E	TCGA-CN-6994-10A-01D-A32X-10	GRCh37-lite	TCGA-CN-6994	TCGA-HNSC		Baylor College of Medicine	University of Pittsburgh	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15500	58cfa831e4b0c9d6adf6c7ba	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.bam	193.0	1.9	0.08	58cfa831e4b0c9d6adf6c7ba	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6011-01A	E7D49212-E9CB-4CD7-923A-BDFC82A4A150	Primary Tumor	Illumina HiSeq	33680362-5ef1-477f-9dbc-64dc2ed0d5a8	Head and Neck	57.0	AFBF3020-1715-4E74-8224-05E316796999	21205681-A0C7-48D0-81D4-0B7EF31158CF	TCGA-CN-6011-01A-11D-A32X-10	GRCh37-lite	TCGA-CN-6011	TCGA-HNSC		Baylor College of Medicine	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15501	58cfa831e4b0c9d6adf6c5f5	TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted	TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted.bam	322.7	1.9	0.16	58cfa831e4b0c9d6adf6c5f5	TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5355-01A	45A10908-19E6-421A-8903-1440BFA57C9D	Primary Tumor	Illumina HiSeq	083daa5f-0e79-4402-94b2-48a892a5a4f1	Head and Neck	64.0	63535469-D402-4BA2-9AB5-986E6ED80F55	180BC055-9C10-4B84-80C4-3DF00742719D	TCGA-CN-5355-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5355	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15502	58cfa831e4b0c9d6adf6c7c0	TCGA-CN-5369-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-5369-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_7_rg.sorted	TCGA-CN-5369-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_7_rg.sorted.bam	64.4	1.9	0.16	58cfa831e4b0c9d6adf6c7c0	TCGA-CN-5369-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5369-10A	B98867D7-7D5A-4C58-8878-37BEE6F2F4FA	Blood Derived Normal	Illumina HiSeq	054b3120-d8ab-44a6-93c2-a8a5ae1f7855	Head and Neck	90.0	8D31F35C-9178-447D-9A2B-ACC305FAB407	A8FA8446-39EF-4B2C-B42B-A6FFD39139E1	TCGA-CN-5369-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5369	TCGA-HNSC	380.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15503	58cfa831e4b0c9d6adf6c6b9	TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina	TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina.bam	191.7	1.9	0.08	58cfa831e4b0c9d6adf6c6b9	TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6225-01A	90F44998-3C05-44B2-9501-BBD0F43C5147	Primary Tumor	Illumina HiSeq	4bedf81d-7024-4c95-8d97-32aa6de7578e	Head and Neck	65.0	E907D8D4-C4C6-441F-9F19-FF3746E5D13E	AFA4344E-2252-4EF9-8B8A-14AAE14ACC9C	TCGA-CQ-6225-01A-11D-A32X-10	GRCh37-lite	TCGA-CQ-6225	TCGA-HNSC	403.0	Baylor College of Medicine	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15504	58cfa831e4b0c9d6adf6c6b0	TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina	TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina.bam	78.7	1.9	0.08	58cfa831e4b0c9d6adf6c6b0	TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6491-01A	5FCE954C-11B9-41F4-9471-4B5BDC0EFA7F	Primary Tumor	Illumina HiSeq	85a87fce-1144-4d78-8495-597c211a5312	Head and Neck	60.0	E23D2F8B-ACA4-43C2-876E-F8C6E1CA2D93	A315B798-F037-48D5-91ED-E733E3BBD6EE	TCGA-CR-6491-01A-11D-A32X-10	GRCh37-lite	TCGA-CR-6491	TCGA-HNSC		Baylor College of Medicine	Vanderbilt University	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15505	58cfa831e4b0c9d6adf6c924	TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted	TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted.bam	579.0		0.15	58cfa831e4b0c9d6adf6c924	TCGA-CN-6996-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6996-10A	49B94421-FE82-4F24-8EF2-820674142418	Blood Derived Normal	Illumina HiSeq	ca0120d2-68ba-4605-a647-eb86ed714611	Head and Neck	58.0	91A53555-ECB3-4FF6-B56F-8AC5021BB5A8	F268F2F5-1BE4-454B-809B-C509F1454D8E	TCGA-CN-6996-10A-01D-1911-02	HG19_Broad_variant	TCGA-CN-6996	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15506	58cfa831e4b0c9d6adf6c772	TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted	TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted.bam	637.73		0.15	58cfa831e4b0c9d6adf6c772	TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-7068-01A	8EBE8C25-5EF9-42D4-9414-8313227B673F	Primary Tumor	Illumina HiSeq	77b40e7d-41a7-4e5d-a3e9-ce1e2d077c98	Head and Neck	80.0	1C86E4AF-03CE-477C-BE08-0CFA565861B7	F0B87929-92F5-4AB9-849F-00F970E56577	TCGA-CQ-7068-01A-11D-2317-26	HG19_Broad_variant	TCGA-CQ-7068	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15507	58cfa831e4b0c9d6adf6c6ec	TCGA-CQ-6228-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CQ-6228-10A-01D-A32X-10_wgs_Illumina	TCGA-CQ-6228-10A-01D-A32X-10_wgs_Illumina.bam	67.0		0.07	58cfa831e4b0c9d6adf6c6ec	TCGA-CQ-6228-10A-01D-A32X-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6228-10A	E303B8C4-6428-4134-BB9D-A95DC1D8E35E	Blood Derived Normal	Illumina HiSeq	5d6324c4-f5bf-4a4f-bc7b-c12e4c489709	Head and Neck	71.0	E7D92B6E-9717-43C9-AD7D-0BFFE48C4C1A	07C948F4-4BEF-47D8-87D6-990DF62B541B	TCGA-CQ-6228-10A-01D-A32X-10	GRCh37-lite	TCGA-CQ-6228	TCGA-HNSC	456.0	Baylor College of Medicine	University Health Network, Toronto	Canada	NO	T1	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15508	58cfa831e4b0c9d6adf6c7f8	TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted	TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted.bam	955.03		0.14	58cfa831e4b0c9d6adf6c7f8	TCGA-CN-6998-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6998-10A	039788EC-1364-40C7-9E9D-13DC305674E9	Blood Derived Normal	Illumina HiSeq	3bcec620-bcec-4025-afe3-25731e0db2a4	Head and Neck	53.0	5938BBFB-E390-437D-BC1F-BFC0FD6A9497	81C32657-4CBF-41AA-BFD9-7F4D50D33275	TCGA-CN-6998-10A-01D-2317-26	HG19_Broad_variant	TCGA-CN-6998	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15509	58cfa831e4b0c9d6adf6c6ad	TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted	TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted.bam	115.0	1.9	0.15	58cfa831e4b0c9d6adf6c6ad	TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5970-01A	1F6167D9-C99D-4873-8D6E-E62A1C964135	Primary Tumor	Illumina HiSeq	e7fcc1c5-e66d-4024-adb8-45def5252f1a	Head and Neck	59.0	4DF92618-5E63-46D7-8526-846932BCE3C2	7EBDEF16-0A0E-4DB2-AB6A-7B6115A7B739	TCGA-CV-5970-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5970	TCGA-HNSC	406.0	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15510	58cfa831e4b0c9d6adf6c792	TCGA-CV-6003-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-6003-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_8_rg.sorted	TCGA-CV-6003-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_8_rg.sorted.bam	35.0	1.8	0.14	58cfa831e4b0c9d6adf6c792	TCGA-CV-6003-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6003-11A	417B357E-C90E-4B63-AE7A-4B782038FFD3	Solid Tissue Normal	Illumina HiSeq	ee070c27-f11a-4e98-9b45-ccc7d38c8241	Head and Neck	50.0	2B487266-919F-45DF-B7DD-1E60E063FF80	921977EE-19C0-4DEF-BF18-3493D6054677	TCGA-CV-6003-11A-01D-1681-02	HG19_Broad_variant	TCGA-CV-6003	TCGA-HNSC		Harvard Medical School	MD Anderson Cancer Center	None	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15511	58cfa831e4b0c9d6adf6c81d	TCGA-CV-6433-01A-11D-2276-10_Illumina.filtered.	WGS	TCGA-CV-6433-01A-11D-2276-10_Illumina	TCGA-CV-6433-01A-11D-2276-10_Illumina.bam	207.03	1.9	0.05	58cfa831e4b0c9d6adf6c81d	TCGA-CV-6433-01A-11D-2276-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6433-01A	D5EEDFB5-4FA3-4A1E-AD0D-EA550B22A5BA	Primary Tumor	Illumina HiSeq	0fc542ae-619e-45f5-9496-dcf6f31f4c32	Head and Neck	57.0	47EC5010-4353-493B-AB28-C95BC2CB026C	0E6CA8DC-0F31-4675-95B1-5920576DAEFF	TCGA-CV-6433-01A-11D-2276-10	GRCh37-lite	TCGA-CV-6433	TCGA-HNSC		Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15513	58cfa831e4b0c9d6adf6c6f0	TCGA-CV-5439-11B-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CV-5439-11B-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_5_rg.sorted	TCGA-CV-5439-11B-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_5_rg.sorted.bam	32.0	1.8	0.14	58cfa831e4b0c9d6adf6c6f0	TCGA-CV-5439-11B-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5439-11B	3EE863DA-7991-414F-82D8-2B6502D4C061	Solid Tissue Normal	Illumina HiSeq	f81e667a-9c30-4093-8e59-c8fa7f8b772c	Head and Neck	62.0	23F2A9BF-D544-407E-A074-AD7CA9614D7D	82E05280-64DC-4926-931F-B24196B966AF	TCGA-CV-5439-11B-01D-1681-02	HG19_Broad_variant	TCGA-CV-5439	TCGA-HNSC	546.0	Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15514	58cfa831e4b0c9d6adf6c713	TCGA-CV-7090-10A-01D-2276-10_Illumina.filtered.	WGS	TCGA-CV-7090-10A-01D-2276-10_Illumina	TCGA-CV-7090-10A-01D-2276-10_Illumina.bam	18.33		0.05	58cfa831e4b0c9d6adf6c713	TCGA-CV-7090-10A-01D-2276-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7090-10A	05FBD98C-28BD-41BC-AE60-16AC0C16C723	Blood Derived Normal	Illumina HiSeq	ba2b472d-b185-4c74-8e0f-8ff0e82db9de	Head and Neck	39.0	1DEC9BE0-AAEA-4CD9-AE2E-7CAD47E112E0	0822164C-236B-48A7-A50A-2C3FD45C3E36	TCGA-CV-7090-10A-01D-2276-10	GRCh37-lite	TCGA-CV-7090	TCGA-HNSC		Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s15515	58cfa831e4b0c9d6adf6c752	TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted	TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted.bam	193.7	1.9	0.14	58cfa831e4b0c9d6adf6c752	TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6939-01A	E7D1F0DD-EEC0-4670-A2BA-00FFE38C6382	Primary Tumor	Illumina HiSeq	28dc7c63-6d80-4648-a356-07e8f846bc80	Head and Neck	60.0	1ED822F5-FEA5-46DE-9681-EC484DE734D8	8BB4510A-C148-4A9E-8ECF-6F8C8E9309CA	TCGA-CV-6939-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6939	TCGA-HNSC	666.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15516	58cfa831e4b0c9d6adf6c7dd	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.bam	361.7	1.9	0.15	58cfa831e4b0c9d6adf6c7dd	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6933-01A	2A749317-0156-4213-8482-B2C2D6E52E9B	Primary Tumor	Illumina HiSeq	76d94513-c228-445e-91f7-474a75422b69	Head and Neck	53.0	8C57C9E6-75BD-442C-984D-3709D2AC4CEC	662EA9EC-86E3-46EE-91C9-6972DA5B5CA1	TCGA-CV-6933-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6933	TCGA-HNSC	2741.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15517	58cfa831e4b0c9d6adf6c863	TCGA-CV-6960-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-6960-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_2_rg.sorted	TCGA-CV-6960-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_2_rg.sorted.bam	19.03		0.14	58cfa831e4b0c9d6adf6c863	TCGA-CV-6960-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_2_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6960-10A	2C985B30-0F8F-4C8F-A924-CC6AAD7EBF0D	Blood Derived Normal	Illumina HiSeq	48a5d368-878b-4e4a-9232-501b2c2dfbfe	Head and Neck	49.0	923CD247-B6A7-4FBA-8867-59BEC8641A05	8865D60E-A053-4471-862D-B1B90BCBC99E	TCGA-CV-6960-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-6960	TCGA-HNSC	862.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15518	58cfa831e4b0c9d6adf6c815	TCGA-CV-6951-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-6951-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_8_rg.sorted	TCGA-CV-6951-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_8_rg.sorted.bam	6.0	1.9	0.16	58cfa831e4b0c9d6adf6c815	TCGA-CV-6951-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6951-10A	91728CD6-ED91-49DC-9279-FAEDBE211A9D	Blood Derived Normal	Illumina HiSeq	c7e5f6bc-d595-433f-89cc-cfd1cc99ff25	Head and Neck	57.0	16ECE3C5-7709-481C-A4BD-49ED6E6BDDA6	851E3F8F-6F52-4B1F-A439-7D08B7457276	TCGA-CV-6951-10A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6951	TCGA-HNSC	915.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15519	58cfa831e4b0c9d6adf6c761	TCGA-CV-6952-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CV-6952-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_5_rg.sorted	TCGA-CV-6952-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_5_rg.sorted.bam	13.0	1.9	0.14	58cfa831e4b0c9d6adf6c761	TCGA-CV-6952-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6952-10A	7ED006E8-461F-4664-BFFF-55FA6812743C	Blood Derived Normal	Illumina HiSeq	0e2d0224-15cc-4ffb-b42d-300f4f08688a	Head and Neck	65.0	AA8A2097-2F73-4176-81C9-782F2C068DB9	B0D99166-225D-4BCA-910F-48754CE443A2	TCGA-CV-6952-10A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6952	TCGA-HNSC	185.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15520	58cfa831e4b0c9d6adf6c828	TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted	TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted.bam	143.73		0.14	58cfa831e4b0c9d6adf6c828	TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7238-01A	78FCC813-D0A8-44AA-B004-62810DCA9D12	Primary Tumor	Illumina HiSeq	3eb627a6-bbcf-4699-ad23-e52a26cd4453	Head and Neck	69.0	831808D5-1883-4F6F-B252-1BB397FBD62A	D051D2CB-F8DE-4E42-B9CF-E7CBE43861A0	TCGA-CV-7238-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7238	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15521	58cfa831e4b0c9d6adf6c71a	TCGA-CV-6954-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-6954-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_7_rg.sorted	TCGA-CV-6954-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_7_rg.sorted.bam	99.7	1.9	0.14	58cfa831e4b0c9d6adf6c71a	TCGA-CV-6954-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_7_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6954-11A	402FD96C-76D3-4AC2-9F64-77BD34BE0ADB	Solid Tissue Normal	Illumina HiSeq	fa689d79-bedd-452e-935f-21bd4866b9d0	Head and Neck	59.0	9695FCED-AEF4-43ED-B1BE-026072DC4DDD	BDAFAD43-C3AE-4356-8B6F-DB08ACA4EDD1	TCGA-CV-6954-11A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6954	TCGA-HNSC	2002.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	NX	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15522	58cfa831e4b0c9d6adf6c797	TCGA-CV-7178-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-7178-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_3_rg.sorted	TCGA-CV-7178-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_3_rg.sorted.bam	36.03		0.17	58cfa831e4b0c9d6adf6c797	TCGA-CV-7178-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7178-10A	8F044599-3FBE-4B69-B67D-49AEE9168545	Blood Derived Normal	Illumina HiSeq	428da9ec-1409-4479-843a-6d2ecff5f7b8	Head and Neck	64.0	16ED7D38-69BB-4D8B-B150-44AC80CE4FCB	CBC1F4A7-5FFD-46D7-835D-40EDB0336C5C	TCGA-CV-7178-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7178	TCGA-HNSC	2166.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15523	58cfa831e4b0c9d6adf6c87c	TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted	TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted.bam	79.73		0.16	58cfa831e4b0c9d6adf6c87c	TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7414-01A	C3B2C38D-81A3-42FD-A41E-6F6DE3934007	Primary Tumor	Illumina HiSeq	d2264558-e25d-4169-9e22-8f3c23b50ad9	Head and Neck	78.0	7BE274D5-D5A0-4EF9-A65A-4127ED864F0C	A78CD28C-EDAF-4439-905B-44B4616DF078	TCGA-CV-7414-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7414	TCGA-HNSC	14.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15524	58cfa831e4b0c9d6adf6c79f	TCGA-CX-7086-10D-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CX-7086-10D-01D-A32X-10_wgs_Illumina	TCGA-CX-7086-10D-01D-A32X-10_wgs_Illumina.bam	76.0		0.09	58cfa831e4b0c9d6adf6c79f	TCGA-CX-7086-10D-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CX-7086-10D	AD6C9D09-2C03-4786-A72D-DD2AA5F603D4	Blood Derived Normal	Illumina HiSeq	62f53214-e1e5-42fe-821b-a2a656206e1f	Head and Neck	53.0	E94BDE7C-1A9E-4D1C-B681-C996E5BC01C5	4568C503-4D0D-4B5A-84ED-CF7984B3A722	TCGA-CX-7086-10D-01D-A32X-10	GRCh37-lite	TCGA-CX-7086	TCGA-HNSC		Baylor College of Medicine	Medical College of Georgia	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15525	58cfa831e4b0c9d6adf6c807	TCGA-CV-7432-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-7432-10A-01D-A32X-10_wgs_Illumina	TCGA-CV-7432-10A-01D-A32X-10_wgs_Illumina.bam	95.03		0.07	58cfa831e4b0c9d6adf6c807	TCGA-CV-7432-10A-01D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7432-10A	EAF674DD-9909-4879-B9A3-74253169EDDD	Blood Derived Normal	Illumina HiSeq	c7df3c71-767b-466e-a301-731b8071e632	Head and Neck	79.0	53470D1A-5DF1-40C4-9758-DDB52A50099F	DBF50D0D-D4E6-46EA-B1A6-90CDA6969C2B	TCGA-CV-7432-10A-01D-A32X-10	GRCh37-lite	TCGA-CV-7432	TCGA-HNSC	2570.0	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15526	58cfa831e4b0c9d6adf6c8ea	TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted	TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted.bam	80.73		0.16	58cfa831e4b0c9d6adf6c8ea	TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7411-01A	600FC87B-A177-4BF9-9084-457F7E7E102C	Primary Tumor	Illumina HiSeq	7db9b308-952d-4c12-98c4-9de1f4b9fbd2	Head and Neck	64.0	24876E1A-E07E-4F74-86BF-3395A88CE4A1	221E7B51-6E05-45A9-99AC-EB705D3B2AD8	TCGA-CV-7411-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7411	TCGA-HNSC	2717.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15527	58cfa831e4b0c9d6adf6c946	TCGA-CV-7432-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-7432-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_2_rg.sorted	TCGA-CV-7432-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_2_rg.sorted.bam	95.03		0.14	58cfa831e4b0c9d6adf6c946	TCGA-CV-7432-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7432-10A	EAF674DD-9909-4879-B9A3-74253169EDDD	Blood Derived Normal	Illumina HiSeq	7698153d-ef10-4787-a1d6-4b0022b02236	Head and Neck	79.0	53470D1A-5DF1-40C4-9758-DDB52A50099F	F1189AE7-3633-4FCD-8659-FA9E8BCCA663	TCGA-CV-7432-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7432	TCGA-HNSC	2570.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15528	58cfa831e4b0c9d6adf6c7ce	TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted	TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted.bam	274.73		0.14	58cfa831e4b0c9d6adf6c7ce	TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7434-01A	63B50E1C-7948-464F-BFF1-8E0E5DAAFCC5	Primary Tumor	Illumina HiSeq	c645c62d-79d3-478c-a9c4-16294daad71c	Head and Neck	64.0	2CB75C6E-CA4F-4A88-9679-812A51C7B832	4A4BF5E3-272F-492C-9755-BBFE14D3BEE1	TCGA-CV-7434-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7434	TCGA-HNSC	218.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15529	58cfa831e4b0c9d6adf6c726	TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted	TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted.bam	288.7	1.9	0.14	58cfa831e4b0c9d6adf6c726	TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6825-01A	42BC2336-2408-441A-83B9-AADC9700F750	Primary Tumor	Illumina HiSeq	e785062a-dcec-4a1d-aa67-6089980c9e35	Head and Neck	73.0	D9E2F5AA-A6E2-491A-9DBC-E5D10B4ABA58	8B36C904-50A1-4B17-94A2-F9331A5FED1E	TCGA-D6-6825-01A-21D-1911-02	HG19_Broad_variant	TCGA-D6-6825	TCGA-HNSC		Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15530	58cfa831e4b0c9d6adf6c85f	TCGA-D6-6517-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_4_rg.sorted.filtered.	WGS	TCGA-D6-6517-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_4_rg.sorted	TCGA-D6-6517-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_4_rg.sorted.bam	367.0	1.8	0.15	58cfa831e4b0c9d6adf6c85f	TCGA-D6-6517-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6517-10A	EBE99910-E9F2-43DC-AD57-AC2F610B60C8	Blood Derived Normal	Illumina HiSeq	019b158f-ce54-4f1b-9db2-b82383657121	Head and Neck	59.0	A2DD87A8-E0D1-47C1-A8D1-70B9730AA4BA	81C11B09-5291-4389-977F-904F11E62597	TCGA-D6-6517-10A-01D-1868-02	HG19_Broad_variant	TCGA-D6-6517	TCGA-HNSC		Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15531	58cfa831e4b0c9d6adf6c866	TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted	TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted.bam	384.7	1.9	0.14	58cfa831e4b0c9d6adf6c866	TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6823-01A	FBDAB01C-191C-4AEF-9451-CA3AFEC55FA1	Primary Tumor	Illumina HiSeq	250e5855-f3af-4c16-9efe-918be02bf754	Head and Neck	50.0	2DA83450-04C2-44D0-AB8A-9CC876242D5A	FE15C318-C3B1-4541-A0DA-4E41D7E99FBB	TCGA-D6-6823-01A-11D-1911-02	HG19_Broad_variant	TCGA-D6-6823	TCGA-HNSC		Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15532	58cfa831e4b0c9d6adf6ca92	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.bam	98.7	1.9	0.15	58cfa831e4b0c9d6adf6ca92	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5624-01A	B4A41682-4ACA-4F1D-BACD-66F5E6EC7466	Primary Tumor	Illumina HiSeq	72ea153a-e312-4f8e-8fa6-bd705df2b106	Head and Neck	43.0	39A74037-6C20-4713-A6AA-E972218EFF90	45F819EB-F6B5-4B82-9E47-060B2E111851	TCGA-DQ-5624-01A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5624	TCGA-HNSC		Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15533	58cfa831e4b0c9d6adf6c9e2	TCGA-DQ-5631-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_4_rg.sorted.filtered.	WGS	TCGA-DQ-5631-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_4_rg.sorted	TCGA-DQ-5631-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_4_rg.sorted.bam	135.0	1.9	0.15	58cfa831e4b0c9d6adf6c9e2	TCGA-DQ-5631-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5631-10A	10B3F56A-E61E-486B-8D3C-176668D5DC34	Blood Derived Normal	Illumina HiSeq	f614c1a4-6710-4035-bf2b-23679a3c3fd0	Head and Neck	52.0	730E5BDB-1E07-47A4-B708-3CC08C603017	5833C7BB-9FEE-4244-A533-36712BCF2444	TCGA-DQ-5631-10A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5631	TCGA-HNSC	548.0	Harvard Medical School	University Of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15534	58cfa832e4b0c9d6adf6d17e	TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina	TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina.bam	103.73		0.07	58cfa832e4b0c9d6adf6d17e	TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-HD-7753-01A	E8AC39E6-377A-412C-B18D-F6C4FC654EC6	Primary Tumor	Illumina HiSeq	393b4af8-b44d-4c3f-b5ca-f7032b687a16	Head and Neck	62.0	E723F1BB-73A3-4D65-BD25-DE76138515E9	54E78DE0-D357-4125-A904-AB35E461572B	TCGA-HD-7753-01A-11D-A32X-10	GRCh37-lite	TCGA-HD-7753	TCGA-HNSC		Baylor College of Medicine	International Genomics Consortium	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15602	58cfa82ee4b0c9d6adf6aa44	G25251.TCGA-CR-7404-01A-11D-2334-08.1.filtered.	WGS	G25251.TCGA-CR-7404-01A-11D-2334-08.1	G25251.TCGA-CR-7404-01A-11D-2334-08.1.bam	181.7		0.05	58cfa82ee4b0c9d6adf6aa44	G25251.TCGA-CR-7404-01A-11D-2334-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7404-01A	D189A6C6-210F-4957-B500-457D5CE3F867	Primary Tumor	Illumina HiSeq	f8742c2f-2e32-467e-9347-f0dd0959da6b	Head and Neck	53.0	A39131B9-E7C7-4385-A1B9-D8A0A0950337	83ECA7B5-45BB-44C0-8AFE-36F8988D0078	TCGA-CR-7404-01A-11D-2334-08	HG19_Broad_variant	TCGA-CR-7404	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15603	58cfa82ee4b0c9d6adf6a7d6	G23064.TCGA_CR_6472_01A_11D_2268_08.1.filtered.	WGS	G23064.TCGA_CR_6472_01A_11D_2268_08.1	G23064.TCGA_CR_6472_01A_11D_2268_08.1.bam	118.0	1.9	0.15	58cfa82ee4b0c9d6adf6a7d6	G23064.TCGA_CR_6472_01A_11D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6472-01A	0956BC67-DD55-4C54-A56A-F22F2856662A	Primary Tumor	Illumina HiSeq	8bf4b442-c0d0-4794-b87d-990df38dfce7	Head and Neck	59.0	76095F05-CD2B-4973-800A-10FE58EE1609	5193A482-6ED9-4504-BD7C-C8B9E4103577	TCGA-CR-6472-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6472	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available
s15604	58cfa82ee4b0c9d6adf6a9d8	G25252.TCGA-CV-7416-01A-11D-2334-08.1.filtered.	WGS	G25252.TCGA-CV-7416-01A-11D-2334-08.1	G25252.TCGA-CV-7416-01A-11D-2334-08.1.bam	242.7		0.05	58cfa82ee4b0c9d6adf6a9d8	G25252.TCGA-CV-7416-01A-11D-2334-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7416-01A	96415324-6859-41EB-8D07-BE4E6F7D9781	Primary Tumor	Illumina HiSeq	1374c517-8c54-4a22-80e6-0f48eb1d4de6	Head and Neck	29.0	2E08CFFB-DA11-40A5-81AB-3B1BFFA5E2CE	2738B06F-155B-4CB8-983B-AD61D451E5AE	TCGA-CV-7416-01A-11D-2334-08	HG19_Broad_variant	TCGA-CV-7416	TCGA-HNSC	763.0	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T4a	Not available	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15605	58cfa82ee4b0c9d6adf6a95a	G23063.TCGA_CR_7385_01A_11D_2268_08.1.filtered.	WGS	G23063.TCGA_CR_7385_01A_11D_2268_08.1	G23063.TCGA_CR_7385_01A_11D_2268_08.1.bam	289.7		0.15	58cfa82ee4b0c9d6adf6a95a	G23063.TCGA_CR_7385_01A_11D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7385-01A	9F89510C-ED07-471F-B35E-7C87C237B9FE	Primary Tumor	Illumina HiSeq	0d321573-5651-4eb3-9f8c-a11f802e5e92	Head and Neck	42.0	4C4A6867-BABE-4032-A639-A9B31CDDDC6C	6BBD66DD-EFEE-4D6E-B02F-F88E98526B82	TCGA-CR-7385-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-7385	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15606	58cfa82ee4b0c9d6adf6aa01	G23078.TCGA_CR_6487_01A_11D_2268_08.2.filtered.	WGS	G23078.TCGA_CR_6487_01A_11D_2268_08.2	G23078.TCGA_CR_6487_01A_11D_2268_08.2.bam	287.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa01	G23078.TCGA_CR_6487_01A_11D_2268_08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6487-01A	9AE5101B-6031-4AB1-BFCA-198C41AF3184	Primary Tumor	Illumina HiSeq	5efcbe11-0d48-4b66-abce-d78199fe8fd8	Head and Neck	50.0	027DEDD3-BD53-420E-B7F2-EB5B8C26BCDC	1DB83E80-BDF7-4D8D-8008-BD8406D641FC	TCGA-CR-6487-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6487	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15608	58cfa830e4b0c9d6adf6c146	TCGA-BA-4074-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BA-4074-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_2_rg.sorted	TCGA-BA-4074-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_2_rg.sorted.bam	61.03	1.9	0.14	58cfa830e4b0c9d6adf6c146	TCGA-BA-4074-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4074-10A	A63CA97D-EF31-4118-9547-A6730967290F	Blood Derived Normal	Illumina HiSeq	669ebf5f-7222-410b-b76e-2551f11e014f	Head and Neck	69.0	BCB3B1E4-AD0E-44B7-9143-E6B642BC7F72	9DAE3CA2-1F5A-458E-98EF-7451D5F41EBC	TCGA-BA-4074-10A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4074	TCGA-HNSC	462.0	Harvard Medical School	UNC	None	NO	T2	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15609	58cfa830e4b0c9d6adf6c1aa	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.bam	213.7	1.9	0.16	58cfa830e4b0c9d6adf6c1aa	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5555-01A	8970F713-4A7A-4125-892C-6A34139371D8	Primary Tumor	Illumina HiSeq	cd7725ec-bc8e-4c93-aba5-19dbdeb78b0d	Head and Neck	54.0	2920CA1C-6035-4350-ADA4-C60D485DBFFF	4AB42DF9-A215-4965-A125-CC0C4122FF06	TCGA-BA-5555-01A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5555	TCGA-HNSC		Harvard Medical School	UNC	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15610	58cfa830e4b0c9d6adf6c208	TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted	TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted.bam	252.7	1.9	0.15	58cfa830e4b0c9d6adf6c208	TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5558-01A	6A1AA50C-097C-4E04-8DDD-12D50F8A5AC2	Primary Tumor	Illumina HiSeq	4116c10d-23f4-49f2-bd5a-9b9466f08bfb	Head and Neck	65.0	EB749281-B3DC-43E4-812E-F5F5004A21ED	41737268-345A-4F87-B2DB-E184247E1396	TCGA-BA-5558-01A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5558	TCGA-HNSC		Harvard Medical School	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15611	58cfa830e4b0c9d6adf6c202	TCGA-BA-5558-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BA-5558-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_8_rg.sorted	TCGA-BA-5558-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_8_rg.sorted.bam	317.4	1.9	0.15	58cfa830e4b0c9d6adf6c202	TCGA-BA-5558-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5558-10A	6A1AA50C-097C-4E04-8DDD-12D50F8A5AC2	Blood Derived Normal	Illumina HiSeq	da16b0c3-9934-4caa-b4ca-5e4c5d9a4494	Head and Neck	65.0	160DD4E9-A8C0-42B3-BF9B-747D5AC25922	730EC759-9CC9-4F3A-96D1-C11101CBE3B3	TCGA-BA-5558-10A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5558	TCGA-HNSC		Harvard Medical School	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15612	58cfa830e4b0c9d6adf6c174	TCGA-BA-4076-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BA-4076-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_6_rg.sorted	TCGA-BA-4076-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_6_rg.sorted.bam	51.03	1.9	0.14	58cfa830e4b0c9d6adf6c174	TCGA-BA-4076-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4076-10A	7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70	Blood Derived Normal	Illumina HiSeq	ebc1363c-072a-468d-abba-3a9ac03513bf	Head and Neck	39.0	D6F48BB2-379A-448D-B13D-2DFC5DA91D0C	01549853-3132-42A7-A2ED-5AD365EAA63F	TCGA-BA-4076-10A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4076	TCGA-HNSC	415.0	Harvard Medical School	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15613	58cfa830e4b0c9d6adf6c1ce	TCGA-BB-4224-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BB-4224-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_2_rg.sorted	TCGA-BB-4224-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_2_rg.sorted.bam	100.4	1.9	0.13	58cfa830e4b0c9d6adf6c1ce	TCGA-BB-4224-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4224-10A	58574E35-8A30-4207-B127-59FFF7C87A43	Blood Derived Normal	Illumina HiSeq	5fadfb17-7c88-4357-a519-b6c61ea4dc49	Head and Neck	52.0	2C21CAA5-DD9B-43E1-807A-4A145D3AA192	A4ECE80F-3F1F-4930-817D-6F8F1606DE5B	TCGA-BB-4224-10A-01D-1431-02	HG19_Broad_variant	TCGA-BB-4224	TCGA-HNSC		Harvard Medical School	Johns Hopkins	United States	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15614	58cfa830e4b0c9d6adf6c1d8	TCGA-BA-6873-10A-01D-2266-10_Illumina.filtered.	WGS	TCGA-BA-6873-10A-01D-2266-10_Illumina	TCGA-BA-6873-10A-01D-2266-10_Illumina.bam	76.0	1.9	0.05	58cfa830e4b0c9d6adf6c1d8	TCGA-BA-6873-10A-01D-2266-10_Illumina.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-6873-10A	BF6B931E-CB2E-4CC0-B603-E9FC71FDC509	Blood Derived Normal	Illumina HiSeq	462b2014-7710-44e6-a8da-32e584676737	Head and Neck	28.0	B2A9D46A-2627-49ED-B82E-8154833A4808	E26A2E12-6203-4F6E-B494-8128BEF26323	TCGA-BA-6873-10A-01D-2266-10	GRCh37-lite	TCGA-BA-6873	TCGA-HNSC		Baylor College of Medicine	UNC	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15615	58cfa830e4b0c9d6adf6c15e	TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina	TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina.bam	379.7	1.9	0.07	58cfa830e4b0c9d6adf6c15e	TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-6869-01A	FAFD6F5B-1D76-4537-BD1C-E0BD7B4E2166	Primary Tumor	Illumina HiSeq	e35c380b-a1ee-47e3-b382-139ed8640d98	Head and Neck	62.0	F4ED2C84-39F8-4AB3-8762-A9920ACC2432	3E604A1C-B95F-44FF-9723-E2FAC845DA3B	TCGA-BA-6869-01A-11D-A32X-10	GRCh37-lite	TCGA-BA-6869	TCGA-HNSC		Baylor College of Medicine	UNC	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15616	58cfa830e4b0c9d6adf6c192	TCGA-BA-5149-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BA-5149-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_1_rg.sorted	TCGA-BA-5149-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_1_rg.sorted.bam	277.7	1.9	0.15	58cfa830e4b0c9d6adf6c192	TCGA-BA-5149-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5149-01A	CB99FB14-641C-4FB3-BF1D-17EFB8CD982A	Primary Tumor	Illumina HiSeq	88e71e4f-d4a5-4136-844d-883107af63b9	Head and Neck	47.0	E5A9FE30-E292-47DC-8EF5-565894B02A62	0F1EEC01-B772-47F6-8A14-0F651FC2F84E	TCGA-BA-5149-01A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5149	TCGA-HNSC		Harvard Medical School	UNC	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15618	58cfa830e4b0c9d6adf6c222	TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted	TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted.bam	63.03	1.9	0.14	58cfa830e4b0c9d6adf6c222	TCGA-BA-4078-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4078-10A	C7353D6A-82A2-4A0D-8CD4-8C8957943EDB	Blood Derived Normal	Illumina HiSeq	9f383e84-52bd-4beb-b916-e1c652c45e27	Head and Neck	83.0	25B0AE1D-2ADD-49B9-A5AE-99702A5C48F4	FA6F21FF-7667-491C-9A99-31B473C9D683	TCGA-BA-4078-10A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4078	TCGA-HNSC	276.0	Harvard Medical School	UNC	None	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available
s15619	58cfa831e4b0c9d6adf6c572	TCGA-CN-4736-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-4736-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_3_rg.sorted	TCGA-CN-4736-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_3_rg.sorted.bam	557.4	1.9	0.14	58cfa831e4b0c9d6adf6c572	TCGA-CN-4736-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4736-10A	0FB3E5FF-54F0-43C5-9322-541BB7825E7F	Blood Derived Normal	Illumina HiSeq	c96f69ef-daa9-46cf-b34f-d7c328956edd	Head and Neck	70.0	206FA54C-7FB3-442A-9A50-09C5CEA8A6C7	10D1A9FE-CB75-426B-9D1D-55F21CD1A5F1	TCGA-CN-4736-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4736	TCGA-HNSC	395.0	Harvard Medical School	University of Pittsburgh	None	NO	T1	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15620	58cfa831e4b0c9d6adf6c57e	TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted	TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted.bam	99.7	1.9	0.15	58cfa831e4b0c9d6adf6c57e	TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4729-01A	2FC960BD-01B0-422D-AD33-34520FA3DF0E	Primary Tumor	Illumina HiSeq	8b48a937-18eb-4e54-95d1-680ce9284b60	Head and Neck	73.0	1DA8FE25-AEE2-45FD-A1F3-3239A42E54B2	A49670C2-95A6-4DEB-BFC5-59B0FF37389E	TCGA-CN-4729-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4729	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15621	58cfa831e4b0c9d6adf6c518	TCGA-CN-4729-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-4729-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_4_rg.sorted	TCGA-CN-4729-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_4_rg.sorted.bam	948.4	1.9	0.14	58cfa831e4b0c9d6adf6c518	TCGA-CN-4729-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4729-10A	2FC960BD-01B0-422D-AD33-34520FA3DF0E	Blood Derived Normal	Illumina HiSeq	a038764a-307f-4a6f-8fd0-5ad2d2e2c05e	Head and Neck	73.0	818173B3-BD9D-44DD-B1C0-6CBF552C51D7	21E11B04-9295-48DE-A5C2-2796A44698EE	TCGA-CN-4729-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4729	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15622	58cfa831e4b0c9d6adf6c576	TCGA-CN-4725-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-4725-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_4_rg.sorted	TCGA-CN-4725-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_4_rg.sorted.bam	274.4	1.9	0.14	58cfa831e4b0c9d6adf6c576	TCGA-CN-4725-10A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4725-10A	3BE2ACE5-1C2A-49E9-8DA9-CEED6119530B	Blood Derived Normal	Illumina HiSeq	bf165379-dbd3-45a0-b736-21fb5757d11a	Head and Neck	60.0	53B7BCFC-B007-436C-A375-4CBA7DE5BA1E	CCEF4FE6-7FAB-4F31-914D-44F1D42AAE7D	TCGA-CN-4725-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4725	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15624	58cfa831e4b0c9d6adf6c62e	TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted	TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted.bam	112.4	1.9	0.13	58cfa831e4b0c9d6adf6c62e	TCGA-CN-5361-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5361-10A	044579EF-16A6-4F00-B951-EDC423D8A14F	Blood Derived Normal	Illumina HiSeq	34ee605a-e704-413f-91ff-81dbaef22fb7	Head and Neck	80.0	5B2581D8-C087-4CAA-B9CE-BC0168FBFEFA	2B747573-FEA7-4404-937E-5D7D74772776	TCGA-CN-5361-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5361	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2a	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15625	58cfa831e4b0c9d6adf6c8fc	TCGA-CN-6018-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-6018-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_7_rg.sorted	TCGA-CN-6018-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_7_rg.sorted.bam	523.7	1.9	0.16	58cfa831e4b0c9d6adf6c8fc	TCGA-CN-6018-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6018-10A	55838E1F-07E8-49CA-89D6-46216BABC6F7	Blood Derived Normal	Illumina HiSeq	c73af9fc-fb38-4307-955a-8e275bdab29f	Head and Neck	85.0	DD41FBB4-0AB7-469D-BF71-44017FEB05E1	CEB9ED62-B029-4AFD-8D10-EA5EA35F24F5	TCGA-CN-6018-10A-01D-1681-02	HG19_Broad_variant	TCGA-CN-6018	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15626	58cfa831e4b0c9d6adf6c63c	TCGA-CN-4741-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-4741-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_6_rg.sorted	TCGA-CN-4741-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_6_rg.sorted.bam	84.4	1.9	0.15	58cfa831e4b0c9d6adf6c63c	TCGA-CN-4741-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4741-10A	277B02E9-DED5-4980-845D-AF53690000AC	Blood Derived Normal	Illumina HiSeq	ada75f19-f08c-4bbe-a617-4f070b55e658	Head and Neck	75.0	8D8DDCA2-6461-4A8B-A696-DA0906661B9E	CAA37FFF-7EA8-4980-A7FF-FF228F2B432A	TCGA-CN-4741-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4741	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15627	58cfa831e4b0c9d6adf6c917	TCGA-CN-6011-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CN-6011-10A-01D-A32X-10_wgs_Illumina	TCGA-CN-6011-10A-01D-A32X-10_wgs_Illumina.bam	396.7	1.9	0.08	58cfa831e4b0c9d6adf6c917	TCGA-CN-6011-10A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6011-10A	E7D49212-E9CB-4CD7-923A-BDFC82A4A150	Blood Derived Normal	Illumina HiSeq	76964677-277a-41bf-8cd5-1d52cbc10e60	Head and Neck	57.0	4D620A8E-517E-43B2-AD44-D9A8467E73A7	E2F90B88-0469-4CE8-846F-90FAB387903E	TCGA-CN-6011-10A-01D-A32X-10	GRCh37-lite	TCGA-CN-6011	TCGA-HNSC		Baylor College of Medicine	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15628	58cfa831e4b0c9d6adf6c5a4	TCGA-CN-4739-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-4739-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_3_rg.sorted	TCGA-CN-4739-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_3_rg.sorted.bam	10.4	1.9	0.15	58cfa831e4b0c9d6adf6c5a4	TCGA-CN-4739-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4739-10A	7E3B90C1-8772-4E12-8050-A156558BEB82	Blood Derived Normal	Illumina HiSeq	1f5e9479-345d-4dc7-a9c5-24dbf2e32405	Head and Neck	71.0	B916FA4A-1D15-4619-9D6C-1000E96B7E0D	86D66FCC-56C5-491A-95A9-B57E40F6C380	TCGA-CN-4739-10A-01D-1509-02	HG19_Broad_variant	TCGA-CN-4739	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15629	58cfa831e4b0c9d6adf6ca60	TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted	TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted.bam	354.0	1.9	0.15	58cfa831e4b0c9d6adf6ca60	TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6013-01A	714496C5-D221-4397-9C5A-CD2D22603E6F	Primary Tumor	Illumina HiSeq	2ca5ef3f-76f6-4db9-85e7-d32249cd642f	Head and Neck	56.0	D018CD44-6B01-44F2-9181-81153225AAB8	2DE7DBC6-2A3E-4E67-BB96-552E27137618	TCGA-CN-6013-01A-11D-1681-02	HG19_Broad_variant	TCGA-CN-6013	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15630	58cfa831e4b0c9d6adf6c6ac	TCGA-CQ-6223-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CQ-6223-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_7_rg.sorted	TCGA-CQ-6223-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_7_rg.sorted.bam	55.0		0.14	58cfa831e4b0c9d6adf6c6ac	TCGA-CQ-6223-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6223-10A	D9E8C707-E61A-4813-8DC0-2472E9CCF12B	Blood Derived Normal	Illumina HiSeq	e392e96d-65fa-489f-829d-9a222f0ff650	Head and Neck	69.0	2AE7FBDA-7434-4105-9FED-C5F650BF10DB	4189A43B-649F-4495-B4FB-3B452E53BCFC	TCGA-CQ-6223-10A-01D-1911-02	HG19_Broad_variant	TCGA-CQ-6223	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15631	58cfa831e4b0c9d6adf6c69c	TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted	TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted.bam	60.7	1.9	0.17	58cfa831e4b0c9d6adf6c69c	TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6229-01A	A091822C-447A-49A5-8C20-E329DF79599C	Primary Tumor	Illumina HiSeq	c3f7b43b-25d2-4df3-a85c-231a6708bf8c	Head and Neck	61.0	F01165B0-911A-45B0-BA7D-7CD0E723A2E4	4AF0777A-6FE3-49AE-B3B9-4AB077DDB007	TCGA-CQ-6229-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6229	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15632	58cfa831e4b0c9d6adf6c60e	TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted	TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted.bam	187.7	1.9	0.16	58cfa831e4b0c9d6adf6c60e	TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6219-01A	0CA3D25A-22E9-4E40-834B-65F402535005	Primary Tumor	Illumina HiSeq	e1a5a3ec-64d9-4348-8104-4f08021e914e	Head and Neck	50.0	2AAD293C-B3ED-4BD7-971D-EA8A5EFC66AD	215B7B8C-E4D0-4CD2-B2B8-9CDC222EBF25	TCGA-CQ-6219-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6219	TCGA-HNSC	479.0	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N2a	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15633	58cfa831e4b0c9d6adf6c6a0	TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted	TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted.bam	40.7	2.0	0.16	58cfa831e4b0c9d6adf6c6a0	TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6224-01A	D86FD392-FA5C-4142-A647-440E6C32D478	Primary Tumor	Illumina HiSeq	e8b32a2c-944e-4b3e-a302-ffe9e9f8a3ea	Head and Neck	52.0	AD242EAC-A5AE-42B7-85CE-3E4D0DD308D6	3FAD44AE-89FC-4BB4-BA86-15A0EF7E2C3A	TCGA-CQ-6224-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6224	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15634	58cfa831e4b0c9d6adf6c612	TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina	TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina.bam	338.7	1.9	0.07	58cfa831e4b0c9d6adf6c612	TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6228-01A	E303B8C4-6428-4134-BB9D-A95DC1D8E35E	Primary Tumor	Illumina HiSeq	c8e6d97c-8cc3-45f6-99a2-d20b8bc3b2d6	Head and Neck	71.0	62E8F535-CF5E-4F90-AFCD-1E0136066820	C2124BB2-30E1-4093-9A8A-3A188A6DC0A9	TCGA-CQ-6228-01A-11D-A32X-10	GRCh37-lite	TCGA-CQ-6228	TCGA-HNSC	456.0	Baylor College of Medicine	University Health Network, Toronto	Canada	NO	T1	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15635	58cfa831e4b0c9d6adf6c6dc	TCGA-CR-7382-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CR-7382-10A-01D-A32X-10_wgs_Illumina	TCGA-CR-7382-10A-01D-A32X-10_wgs_Illumina.bam	60.0		0.07	58cfa831e4b0c9d6adf6c6dc	TCGA-CR-7382-10A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7382-10A	F030E410-2585-461E-AD23-9FDF026AC06C	Blood Derived Normal	Illumina HiSeq	eac78b10-617e-41af-8cf9-dd55919bc5c7	Head and Neck	49.0	27DB87BD-FF36-4ADC-AD1C-066C6AE80122	CEC794FA-BD1E-4502-AC47-6D94059B33EB	TCGA-CR-7382-10A-01D-A32X-10	GRCh37-lite	TCGA-CR-7382	TCGA-HNSC		Baylor College of Medicine	Vanderbilt University	United States	NO	T2	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15636	58cfa831e4b0c9d6adf6c6f6	TCGA-CR-5250-10A-01D-2276-10_Illumina.filtered.	WGS	TCGA-CR-5250-10A-01D-2276-10_Illumina	TCGA-CR-5250-10A-01D-2276-10_Illumina.bam	23.73	1.9	0.05	58cfa831e4b0c9d6adf6c6f6	TCGA-CR-5250-10A-01D-2276-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-5250-10A	9E178D80-FE90-4998-9DAE-726C4BECEEF7	Blood Derived Normal	Illumina HiSeq	ff59a531-3bb9-4afc-ad7c-dfd839bcfa0e	Head and Neck	71.0	66C00888-C048-441E-BFFC-13EB0F299D97	D88E8F94-C624-4618-8D2F-DCE4436140BE	TCGA-CR-5250-10A-01D-2276-10	GRCh37-lite	TCGA-CR-5250	TCGA-HNSC		Baylor College of Medicine	Vanderbilt University	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15637	58cfa831e4b0c9d6adf6c610	TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted	TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted.bam	12.33		0.15	58cfa831e4b0c9d6adf6c610	TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6221-01A	839B660C-98FE-4468-A2B3-408594350250	Primary Tumor	Illumina HiSeq	16de682b-970e-4857-821f-5a32d6b74f71	Head and Neck	79.0	65BAAE80-7FD5-40B1-B5FB-BDD013B70931	C90134BD-6F38-45B9-B82D-E84ACEB2E90F	TCGA-CQ-6221-01A-11D-2317-26	HG19_Broad_variant	TCGA-CQ-6221	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	University Health Network, Toronto	Canada	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15638	58cfa831e4b0c9d6adf6c646	TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted	TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted.bam	234.0	1.9	0.15	58cfa831e4b0c9d6adf6c646	TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5327-01A	5A03E2B6-4C8B-479A-9036-9859AF031DA4	Primary Tumor	Illumina HiSeq	3482a15d-acdc-4fcf-86a5-b015e57faefd	Head and Neck	61.0	93D283A7-E866-4F23-81F7-942DEE5009B8	55F0F300-E472-4254-9BDA-76AD94EA8C13	TCGA-CQ-5327-01A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5327	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15639	58cfa831e4b0c9d6adf6c6f8	TCGA-CR-6491-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CR-6491-10A-01D-A32X-10_wgs_Illumina	TCGA-CR-6491-10A-01D-A32X-10_wgs_Illumina.bam	237.0	1.8	0.08	58cfa831e4b0c9d6adf6c6f8	TCGA-CR-6491-10A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6491-10A	5FCE954C-11B9-41F4-9471-4B5BDC0EFA7F	Blood Derived Normal	Illumina HiSeq	1ff34fd0-0329-461b-a74f-409c6590c6a7	Head and Neck	60.0	7F539E65-6E3A-4EB3-8711-33A7F2DED0E8	A5449995-33F9-43CB-A439-9284E4F2EFD7	TCGA-CR-6491-10A-01D-A32X-10	GRCh37-lite	TCGA-CR-6491	TCGA-HNSC		Baylor College of Medicine	Vanderbilt University	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15640	58cfa831e4b0c9d6adf6c604	TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted	TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted.bam	258.0	1.9	0.14	58cfa831e4b0c9d6adf6c604	TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5330-01A	9FFA79FA-D2D8-48E1-8FD6-4B020ECF357C	Primary Tumor	Illumina HiSeq	a37f15ec-e0df-4bcd-8275-88312d0a1566	Head and Neck	69.0	A70301B0-F66D-49B7-B420-C1F56B90002D	AB6DC814-ECE0-497C-BC58-5FECE5D3DCE6	TCGA-CQ-5330-01A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5330	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15642	58cfa831e4b0c9d6adf6c6f2	TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted	TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted.bam	37.0	1.9	0.14	58cfa831e4b0c9d6adf6c6f2	TCGA-CV-5976-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5976-11A	23062172-7361-4E61-8EE6-B0A613D72A24	Solid Tissue Normal	Illumina HiSeq	f5c4e8eb-c5ca-4eb2-b92d-a5a054c4a0c6	Head and Neck	50.0	B721E292-1D8D-451C-BB08-77BC2A61A1B0	662DE6A8-5889-4EB1-86D6-7C5E4012F914	TCGA-CV-5976-11A-01D-1681-02	HG19_Broad_variant	TCGA-CV-5976	TCGA-HNSC		Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15643	58cfa831e4b0c9d6adf6c7e8	TCGA-CV-7255-11A-01D-2276-10_Illumina.filtered.	WGS	TCGA-CV-7255-11A-01D-2276-10_Illumina	TCGA-CV-7255-11A-01D-2276-10_Illumina.bam	28.03		0.05	58cfa831e4b0c9d6adf6c7e8	TCGA-CV-7255-11A-01D-2276-10_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7255-11A	534F85F2-B9EB-45BE-87D5-C3DFFD13D541	Solid Tissue Normal	Illumina HiSeq	e24cfdc8-ec05-41ac-aa61-3339c1769152	Head and Neck	32.0	2B4DBC74-4623-4746-BC29-8F33CE84A05B	1F285865-6A20-42AE-AF55-AAA0E0AB0E8C	TCGA-CV-7255-11A-01D-2276-10	GRCh37-lite	TCGA-CV-7255	TCGA-HNSC	64.0	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15644	58cfa831e4b0c9d6adf6c920	TCGA-CV-7091-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7091-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_7_rg.sorted	TCGA-CV-7091-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_7_rg.sorted.bam	61.03		0.13	58cfa831e4b0c9d6adf6c920	TCGA-CV-7091-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7091-10A	2A192049-6435-49AB-8444-DDEB2B9EE774	Blood Derived Normal	Illumina HiSeq	fd03b019-209c-4744-9f18-0fdd68024ed6	Head and Neck	54.0	2957E13D-6A6D-40FF-852C-E30690F9D758	28B008FF-7892-4193-B1DF-575D09BD6D7F	TCGA-CV-7091-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7091	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15645	58cfa831e4b0c9d6adf6c722	TCGA-CV-6938-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-6938-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_2_rg.sorted	TCGA-CV-6938-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_2_rg.sorted.bam	127.7	1.9	0.14	58cfa831e4b0c9d6adf6c722	TCGA-CV-6938-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6938-11A	FF9DB03D-F81C-4079-8B05-F5A8C05B8CFE	Solid Tissue Normal	Illumina HiSeq	f15c68cb-d7b4-4f77-9154-f6beb21ff1f1	Head and Neck	87.0	CF972FFA-A8F4-4DDF-AE83-F80E7C24DE3F	EF1B3760-3B55-4C1B-9952-4AD151738604	TCGA-CV-6938-11A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6938	TCGA-HNSC	144.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s15646	58cfa831e4b0c9d6adf6c7e1	TCGA-CV-7090-01A-11D-2276-10_Illumina.filtered.	WGS	TCGA-CV-7090-01A-11D-2276-10_Illumina	TCGA-CV-7090-01A-11D-2276-10_Illumina.bam	158.73		0.05	58cfa831e4b0c9d6adf6c7e1	TCGA-CV-7090-01A-11D-2276-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7090-01A	05FBD98C-28BD-41BC-AE60-16AC0C16C723	Primary Tumor	Illumina HiSeq	30e23a3f-f6eb-45e4-9d14-bddafc4fab6d	Head and Neck	39.0	E8BD9DCB-A9C7-4361-9724-24922A5E613B	A8041E86-071E-46CD-8FB5-7ECDC1AB0553	TCGA-CV-7090-01A-11D-2276-10	GRCh37-lite	TCGA-CV-7090	TCGA-HNSC		Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s15647	58cfa831e4b0c9d6adf6c8c8	TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted	TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted.bam	111.7	1.9	0.15	58cfa831e4b0c9d6adf6c8c8	TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6952-01A	7ED006E8-461F-4664-BFFF-55FA6812743C	Primary Tumor	Illumina HiSeq	7145e1a2-e609-45d9-a111-efe59656286d	Head and Neck	65.0	18E70193-5D78-41DD-9FCA-AF5E54594AD3	EAA6BAF6-1D90-471D-BBFF-2230B87339E4	TCGA-CV-6952-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6952	TCGA-HNSC	185.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15648	58cfa831e4b0c9d6adf6c83b	TCGA-CV-7180-01A-11D-2266-10_Illumina.filtered.	WGS	TCGA-CV-7180-01A-11D-2266-10_Illumina	TCGA-CV-7180-01A-11D-2266-10_Illumina.bam	52.7		0.05	58cfa831e4b0c9d6adf6c83b	TCGA-CV-7180-01A-11D-2266-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7180-01A	D2CA9A4D-C14C-40C0-871C-88794A02E4AA	Primary Tumor	Illumina HiSeq	b66083b7-e0ae-4f6e-ab6a-76caf55a13bc	Head and Neck	34.0	551B5AC7-41E8-42BC-B64D-20E7E156DBBC	1727E88B-DF0A-4AF2-9191-8C6061D98AD0	TCGA-CV-7180-01A-11D-2266-10	GRCh37-lite	TCGA-CV-7180	TCGA-HNSC	327.0	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s15649	58cfa831e4b0c9d6adf6c8f0	TCGA-CV-7180-10A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CV-7180-10A-01D-2266-10_Illumina	TCGA-CV-7180-10A-01D-2266-10_Illumina.bam	36.0		0.05	58cfa831e4b0c9d6adf6c8f0	TCGA-CV-7180-10A-01D-2266-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7180-10A	D2CA9A4D-C14C-40C0-871C-88794A02E4AA	Blood Derived Normal	Illumina HiSeq	7a1bc885-10c7-42e5-9024-c742bde8c9cc	Head and Neck	34.0	406255B7-F269-4DC2-9EC2-E68809B66787	87255DF3-4E17-4CC4-A3CF-EA121E937D8F	TCGA-CV-7180-10A-01D-2266-10	GRCh37-lite	TCGA-CV-7180	TCGA-HNSC	327.0	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s15650	58cfa831e4b0c9d6adf6c850	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.bam	263.7	1.9	0.15	58cfa831e4b0c9d6adf6c850	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6948-01A	FCF0DC48-B889-4593-A15B-AA715AAE7BF5	Primary Tumor	Illumina HiSeq	87c6cf32-e113-471b-86b3-cca360f47616	Head and Neck	79.0	21844F33-DD12-4940-B42D-2F9FABB2F7BA	8FEEA708-D971-4FD0-8542-1E31A9DFF8EA	TCGA-CV-6948-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6948	TCGA-HNSC	1289.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N3	Head and Neck Squamous Cell Carcinoma	Stage IVB
s15652	58cfa831e4b0c9d6adf6c757	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.bam	7.43		0.14	58cfa831e4b0c9d6adf6c757	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7183-01A	DE206681-3E27-4D4F-8669-AEFB12B5B1E3	Primary Tumor	Illumina HiSeq	f449ea84-f7cf-4a26-bc43-707ac56f0038	Head and Neck	53.0	0BFD11FD-B227-41EF-BD54-7BE877BCE5A2	C2030338-EFEF-48CD-B893-BBDB8D85456E	TCGA-CV-7183-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7183	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15653	58cfa831e4b0c9d6adf6c867	TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted	TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted.bam	876.0	1.9	0.14	58cfa831e4b0c9d6adf6c867	TCGA-D6-6827-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6827-10A	3C5BC678-41E9-46B3-9686-5CD95659AB71	Blood Derived Normal	Illumina HiSeq	aef80235-e93d-436c-8a32-888344249391	Head and Neck	55.0	2EF80E58-961D-45D6-AC3A-A520BE3728C9	E38F279E-881E-4A80-806E-50B316E0741D	TCGA-D6-6827-10A-01D-1911-02	HG19_Broad_variant	TCGA-D6-6827	TCGA-HNSC		Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15654	58cfa831e4b0c9d6adf6c848	TCGA-D6-6823-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-D6-6823-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_5_rg.sorted	TCGA-D6-6823-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_5_rg.sorted.bam	658.0	1.9	0.15	58cfa831e4b0c9d6adf6c848	TCGA-D6-6823-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6823-10A	FBDAB01C-191C-4AEF-9451-CA3AFEC55FA1	Blood Derived Normal	Illumina HiSeq	60900e52-222a-400c-9981-8ea2dfba4553	Head and Neck	50.0	3CA51C87-28F6-4269-A387-D9D89E8FBA56	0B3ABCE7-4747-4354-8481-EEB667C705EE	TCGA-D6-6823-10A-01D-1911-02	HG19_Broad_variant	TCGA-D6-6823	TCGA-HNSC		Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15655	58cfa831e4b0c9d6adf6c858	TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted	TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted.bam	209.7	1.9	0.15	58cfa831e4b0c9d6adf6c858	TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6517-01A	EBE99910-E9F2-43DC-AD57-AC2F610B60C8	Primary Tumor	Illumina HiSeq	e84f34a5-8df7-4824-92d7-4f53b4bace58	Head and Neck	59.0	8C099F45-3FD6-4966-8CDB-CA4B9288B1A2	97962F6C-B2FB-4618-A5A4-7B376714EC62	TCGA-D6-6517-01A-11D-1868-02	HG19_Broad_variant	TCGA-D6-6517	TCGA-HNSC		Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15656	58cfa831e4b0c9d6adf6c85a	TCGA-D6-6825-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-D6-6825-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_6_rg.sorted	TCGA-D6-6825-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_6_rg.sorted.bam	530.0	1.9	0.15	58cfa831e4b0c9d6adf6c85a	TCGA-D6-6825-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6825-10A	42BC2336-2408-441A-83B9-AADC9700F750	Blood Derived Normal	Illumina HiSeq	dac94d31-7c1f-4e4b-98af-a3a585b86fae	Head and Neck	73.0	2D4DD757-4C4F-49E4-B5BA-84BCAE21C5FD	222663D9-DF98-4A0B-88EB-83FCB81BCB0A	TCGA-D6-6825-10A-01D-1911-02	HG19_Broad_variant	TCGA-D6-6825	TCGA-HNSC		Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15657	58cfa832e4b0c9d6adf6d20a	TCGA-HD-7753-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-HD-7753-10A-01D-A32X-10_wgs_Illumina	TCGA-HD-7753-10A-01D-A32X-10_wgs_Illumina.bam	115.0		0.07	58cfa832e4b0c9d6adf6d20a	TCGA-HD-7753-10A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-HD-7753-10A	E8AC39E6-377A-412C-B18D-F6C4FC654EC6	Blood Derived Normal	Illumina HiSeq	ddb75587-4d2e-4c11-bd83-f7a0accb8120	Head and Neck	62.0	7FB56F25-873D-475C-9DB6-F0BE3945D926	60D15C0C-A12E-4FE5-8D76-CAD096F2C248	TCGA-HD-7753-10A-01D-A32X-10	GRCh37-lite	TCGA-HD-7753	TCGA-HNSC		Baylor College of Medicine	International Genomics Consortium	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15742	58cfa82ee4b0c9d6adf6a9c4	G23076.TCGA_CV_5443_01A_01D_2268_08.1.filtered.	WGS	G23076.TCGA_CV_5443_01A_01D_2268_08.1	G23076.TCGA_CV_5443_01A_01D_2268_08.1.bam	385.0	1.9	0.15	58cfa82ee4b0c9d6adf6a9c4	G23076.TCGA_CV_5443_01A_01D_2268_08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5443-01A	180036A2-3B56-405E-A1FE-D5932517B6C7	Primary Tumor	Illumina HiSeq	9e76f187-2863-42f5-9540-da82b815d6c0	Head and Neck	63.0	746322C7-FE75-4B9F-9309-93E9CFA4CB5A	D4B80307-ABBD-48BB-B52C-6DCD409699A2	TCGA-CV-5443-01A-01D-2268-08	HG19_Broad_variant	TCGA-CV-5443	TCGA-HNSC		Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15743	58cfa82ee4b0c9d6adf6a7be	G23076.TCGA_CV_5443_11A_01D_2268_08.1.filtered.	WGS	G23076.TCGA_CV_5443_11A_01D_2268_08.1	G23076.TCGA_CV_5443_11A_01D_2268_08.1.bam	62.0	1.9	0.15	58cfa82ee4b0c9d6adf6a7be	G23076.TCGA_CV_5443_11A_01D_2268_08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5443-11A	180036A2-3B56-405E-A1FE-D5932517B6C7	Solid Tissue Normal	Illumina HiSeq	f744f137-822a-4f3c-960b-aa2f4ab9ebb8	Head and Neck	63.0	4863312A-043E-418E-812D-2AE2A1F66F29	1CE3915A-B077-41AF-9AD0-B8A81CD1199B	TCGA-CV-5443-11A-01D-2268-08	HG19_Broad_variant	TCGA-CV-5443	TCGA-HNSC		Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15744	58cfa82ee4b0c9d6adf6aa3c	G23081.TCGA_CV_6961_01A_21D_2268_08.2.filtered.	WGS	G23081.TCGA_CV_6961_01A_21D_2268_08.2	G23081.TCGA_CV_6961_01A_21D_2268_08.2.bam	52.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa3c	G23081.TCGA_CV_6961_01A_21D_2268_08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6961-01A	4075717B-2240-4842-A00A-0C4DBCB910C4	Primary Tumor	Illumina HiSeq	4b9344a0-a7c6-453a-b184-87e94c97920a	Head and Neck	61.0	BE0A6A2B-A306-4AC6-8BF8-EA6AF16EAA5A	DFA20D2D-1BA3-476A-B4B9-21D21470BEE2	TCGA-CV-6961-01A-21D-2268-08	HG19_Broad_variant	TCGA-CV-6961	TCGA-HNSC	76.0	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15745	58cfa82ee4b0c9d6adf6aa06	G23074.TCGA_CN_4741_01A_01D_2268_08.1.filtered.	WGS	G23074.TCGA_CN_4741_01A_01D_2268_08.1	G23074.TCGA_CN_4741_01A_01D_2268_08.1.bam	215.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa06	G23074.TCGA_CN_4741_01A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4741-01A	277B02E9-DED5-4980-845D-AF53690000AC	Primary Tumor	Illumina HiSeq	b508fa53-d86f-4e56-9703-6cdb7095ed0b	Head and Neck	75.0	03C9108A-5139-4BAC-9641-C7DBBEDEF420	F652367A-D6C9-4A0A-AADE-1AB988BE3BE6	TCGA-CN-4741-01A-01D-2268-08	HG19_Broad_variant	TCGA-CN-4741	TCGA-HNSC		Broad Institute of MIT and Harvard	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15746	58cfa82ee4b0c9d6adf6aa2e	G25252.TCGA-CV-7416-11A-01D-2334-08.1.filtered.	WGS	G25252.TCGA-CV-7416-11A-01D-2334-08.1	G25252.TCGA-CV-7416-11A-01D-2334-08.1.bam	208.0		0.05	58cfa82ee4b0c9d6adf6aa2e	G25252.TCGA-CV-7416-11A-01D-2334-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7416-11A	96415324-6859-41EB-8D07-BE4E6F7D9781	Solid Tissue Normal	Illumina HiSeq	6650adf8-2533-476f-a2ae-1471135763a3	Head and Neck	29.0	D390D3E6-9516-4485-AF75-955B1A1B76CA	BC890854-512D-4118-B5A5-954F774D0C36	TCGA-CV-7416-11A-01D-2334-08	HG19_Broad_variant	TCGA-CV-7416	TCGA-HNSC	763.0	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T4a	Not available	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15747	58cfa82ee4b0c9d6adf6ab86	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.filtered.	WGS	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.bam	39.39		0.07	58cfa82ee4b0c9d6adf6ab86	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-A4IH-01A	BD75D8EE-916B-4ABC-BF33-BCE6A4217076	Primary Tumor	Illumina HiSeq	dc2ac994-c455-4e1f-9319-2865614853ba	Head and Neck	57.0	F87EFB5E-24F5-4D2B-B6B3-987BBDA30E03	B537BC07-9998-49F4-BBBE-5B617152BFD9	TCGA-BA-A4IH-01A-11D-A25T-08	HG19_Broad_variant	TCGA-BA-A4IH	TCGA-HNSC		Broad Institute of MIT and Harvard	UNC	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma Basaloid Type	Stage IVA
s15748	58cfa82ee4b0c9d6adf6ab12	G35155.TCGA-CQ-6220-01A-11D-1912-08.2.filtered.	WGS	G35155.TCGA-CQ-6220-01A-11D-1912-08.2	G35155.TCGA-CQ-6220-01A-11D-1912-08.2.bam	342.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab12	G35155.TCGA-CQ-6220-01A-11D-1912-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6220-01A	96D0CEFE-7949-4736-A7DC-1E4FA94765EC	Primary Tumor	Illumina HiSeq	34bb201c-76f4-432d-b2d3-a46d882b205d	Head and Neck	69.0	E0E75203-3982-40B2-A057-FAA8433DFB7A	65E67EDA-16A4-4DFD-94A9-546C76D94A02	TCGA-CQ-6220-01A-11D-1912-08	HG19_Broad_variant	TCGA-CQ-6220	TCGA-HNSC	985.0	Broad Institute of MIT and Harvard	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15749	58cfa830e4b0c9d6adf6c1b6	TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted	TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted.bam	333.33	1.9	0.15	58cfa830e4b0c9d6adf6c1b6	TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4076-01A	7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70	Primary Tumor	Illumina HiSeq	f67d413c-c33d-4d97-9853-0b00f93f2304	Head and Neck	39.0	FD99FD83-4040-4738-8A5A-E42D36ECFE0E	54F77A3E-290A-4073-8012-4873579E95E9	TCGA-BA-4076-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4076	TCGA-HNSC	415.0	Harvard Medical School	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15750	58cfa830e4b0c9d6adf6c1e0	TCGA-BA-5151-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BA-5151-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_4_rg.sorted	TCGA-BA-5151-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_4_rg.sorted.bam	73.4	1.9	0.14	58cfa830e4b0c9d6adf6c1e0	TCGA-BA-5151-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5151-10A	A55FB87D-F606-48A5-82F5-09EACBACF41B	Blood Derived Normal	Illumina HiSeq	fe120e7f-b67b-43e6-9502-3878c982d056	Head and Neck	72.0	18B31768-284F-4B52-9BED-D0ACE9B8D4FE	5B6DC28D-F368-4A15-8CAE-781081317AB9	TCGA-BA-5151-10A-01D-1431-02	HG19_Broad_variant	TCGA-BA-5151	TCGA-HNSC		Harvard Medical School	UNC	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15751	58cfa830e4b0c9d6adf6c18e	TCGA-BA-6869-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-6869-10A-01D-A32X-10_wgs_Illumina	TCGA-BA-6869-10A-01D-A32X-10_wgs_Illumina.bam	48.0	1.9	0.07	58cfa830e4b0c9d6adf6c18e	TCGA-BA-6869-10A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-6869-10A	FAFD6F5B-1D76-4537-BD1C-E0BD7B4E2166	Blood Derived Normal	Illumina HiSeq	609c293a-3273-47e0-b4d1-9fd98e1163db	Head and Neck	62.0	0AAA8BBA-F4A5-4158-B9B4-A02244B5F6F7	C051B998-1CEC-4FFB-A1AA-32A3C05DD30A	TCGA-BA-6869-10A-01D-A32X-10	GRCh37-lite	TCGA-BA-6869	TCGA-HNSC		Baylor College of Medicine	UNC	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15752	58cfa830e4b0c9d6adf6c22e	TCGA-BA-5149-01A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-5149-01A-01D-A32X-10_wgs_Illumina	TCGA-BA-5149-01A-01D-A32X-10_wgs_Illumina.bam	277.7	1.9	0.08	58cfa830e4b0c9d6adf6c22e	TCGA-BA-5149-01A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5149-01A	CB99FB14-641C-4FB3-BF1D-17EFB8CD982A	Primary Tumor	Illumina HiSeq	e69377da-ccc2-447e-9c7f-b7a7743575d8	Head and Neck	47.0	E5A9FE30-E292-47DC-8EF5-565894B02A62	1FFF8B62-534B-4D71-A65F-E5F93B8B50ED	TCGA-BA-5149-01A-01D-A32X-10	GRCh37-lite	TCGA-BA-5149	TCGA-HNSC		Baylor College of Medicine	UNC	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15753	58cfa831e4b0c9d6adf6c522	TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted	TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted.bam	31.7	1.9	0.14	58cfa831e4b0c9d6adf6c522	TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4731-01A	50E25A4B-2EB2-4770-9A2D-8922A1E0AB56	Primary Tumor	Illumina HiSeq	50e66965-d2d5-49dd-a113-8b1751d6f7b7	Head and Neck	63.0	CD4E9D8C-B1F9-486A-ADCD-BD4B77A50326	981D992B-B92F-4E42-AA43-FC48068648A8	TCGA-CN-4731-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4731	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15754	58cfa831e4b0c9d6adf6c59a	TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted	TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted.bam	142.0	1.9	0.15	58cfa831e4b0c9d6adf6c59a	TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4737-01A	1F744ADA-6DE1-446D-B62C-76A7FC8B40AF	Primary Tumor	Illumina HiSeq	db7d0f46-b4eb-4cad-8324-08d0a5781624	Head and Neck	19.0	BA5D40F5-56A2-438B-92B8-6EB7DB6D6AFA	43003723-9C58-4B5E-8F47-56B4BDA476A0	TCGA-CN-4737-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4737	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15755	58cfa831e4b0c9d6adf6c424	TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted	TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted.bam	52.7	1.9	0.17	58cfa831e4b0c9d6adf6c424	TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4725-01A	3BE2ACE5-1C2A-49E9-8DA9-CEED6119530B	Primary Tumor	Illumina HiSeq	7ddc2537-f164-4a40-befe-6e0a3deed186	Head and Neck	60.0	DD42AB2F-E936-4ACE-93D8-60375E03F2FE	C8B71532-685F-47AC-B019-B898A8D1670D	TCGA-CN-4725-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4725	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15756	58cfa831e4b0c9d6adf6c5a8	TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted	TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted.bam	550.4	1.9	0.15	58cfa831e4b0c9d6adf6c5a8	TCGA-CN-4731-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4731-10A	50E25A4B-2EB2-4770-9A2D-8922A1E0AB56	Blood Derived Normal	Illumina HiSeq	bb50f6f4-9a32-49a6-a81f-dca3c16699cd	Head and Neck	63.0	C01EE9F4-05A4-438A-BA60-0F5A92864398	C54FB259-8BCF-495A-B96B-40266CAD460F	TCGA-CN-4731-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4731	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15757	58cfa831e4b0c9d6adf6c63e	TCGA-CN-4733-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-4733-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_6_rg.sorted	TCGA-CN-4733-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_6_rg.sorted.bam	195.0	1.9	0.16	58cfa831e4b0c9d6adf6c63e	TCGA-CN-4733-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4733-10A	DEDD71B4-8537-4947-839E-90ACEDDD0893	Blood Derived Normal	Illumina HiSeq	42c2db46-32f6-476f-8c0a-eef25c7b64db	Head and Neck	61.0	7554FBBB-837F-4F9E-B7FE-B05AA1D76831	C4E4D614-B608-435A-B715-F2115D20AB3A	TCGA-CN-4733-10A-01D-1868-02	HG19_Broad_variant	TCGA-CN-4733	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T1	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15758	58cfa831e4b0c9d6adf6c498	TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted	TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted.bam	52.7	1.9	0.16	58cfa831e4b0c9d6adf6c498	TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4722-01A	B64BFCA1-033C-4501-A900-103AC105C084	Primary Tumor	Illumina HiSeq	3723e20c-1e27-4158-8bc5-1768c49ee5e5	Head and Neck	61.0	6E767FC9-0F5A-49EC-999A-CDA2DAEBA6FF	0CA196A7-5A71-4E70-8FA6-9506E1883032	TCGA-CN-4722-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4722	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15759	58cfa831e4b0c9d6adf6c642	TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted	TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted.bam	72.7	1.9	0.15	58cfa831e4b0c9d6adf6c642	TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4734-01A	B80FDC9A-341D-4277-9664-8E8F770D9DDD	Primary Tumor	Illumina HiSeq	4b3be461-622d-492e-8465-1d0d1167701c	Head and Neck	70.0	20614787-1E55-40F0-88DE-080640EB8A03	EA9125C8-3F3B-47CE-AD79-802692B1FB4A	TCGA-CN-4734-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4734	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15760	58cfa831e4b0c9d6adf6c64e	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.bam	215.7	1.9	0.14	58cfa831e4b0c9d6adf6c64e	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4741-01A	277B02E9-DED5-4980-845D-AF53690000AC	Primary Tumor	Illumina HiSeq	cd19ee2f-be9d-446a-9045-e7bfcafb49aa	Head and Neck	75.0	03C9108A-5139-4BAC-9641-C7DBBEDEF420	FAA30C0B-E008-4313-A2AB-1D641F98E2B9	TCGA-CN-4741-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4741	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15761	58cfa831e4b0c9d6adf6c79e	TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted	TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted.bam	473.7	1.9	0.17	58cfa831e4b0c9d6adf6c79e	TCGA-CN-6019-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6019-10A	EE3061EC-273C-4BEF-A325-35E9C469BF01	Blood Derived Normal	Illumina HiSeq	7b49ae2c-674f-4f8f-b99b-fd2884c78a1b	Head and Neck	61.0	71ABA174-1006-4B0E-96FA-EF1BF171314B	2138A253-33D1-4402-8F65-BBE6F609AB58	TCGA-CN-6019-10A-01D-1681-02	HG19_Broad_variant	TCGA-CN-6019	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15762	58cfa831e4b0c9d6adf6c5e7	TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted	TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted.bam	214.7	1.9	0.15	58cfa831e4b0c9d6adf6c5e7	TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5367-01A	61D0709C-D148-413B-A7B5-C0C82ED2F32F	Primary Tumor	Illumina HiSeq	9ab4b634-5191-4a97-b9df-f75528b90bae	Head and Neck	60.0	379F9E65-54F3-4566-B018-3F3EEE6A4DF4	1380173D-316F-4821-8B98-654AD1050A38	TCGA-CN-5367-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5367	TCGA-HNSC	352.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15763	58cfa831e4b0c9d6adf6c5a6	TCGA-CN-4737-10A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CN-4737-10A-01D-2266-10_Illumina	TCGA-CN-4737-10A-01D-2266-10_Illumina.bam	702.7	1.9	0.05	58cfa831e4b0c9d6adf6c5a6	TCGA-CN-4737-10A-01D-2266-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4737-10A	1F744ADA-6DE1-446D-B62C-76A7FC8B40AF	Blood Derived Normal	Illumina HiSeq	afe2b5ea-bb70-4f3b-a489-38b303667626	Head and Neck	19.0	E0D710B0-E301-4441-BF1C-44AE39CB3239	97060C75-AD9A-4C28-926A-15354F608FF9	TCGA-CN-4737-10A-01D-2266-10	GRCh37-lite	TCGA-CN-4737	TCGA-HNSC		Baylor College of Medicine	University of Pittsburgh	None	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15764	58cfa831e4b0c9d6adf6c6e2	TCGA-CN-5355-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-5355-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_7_rg.sorted	TCGA-CN-5355-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_7_rg.sorted.bam	15.4	1.9	0.14	58cfa831e4b0c9d6adf6c6e2	TCGA-CN-5355-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_7_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5355-10A	45A10908-19E6-421A-8903-1440BFA57C9D	Blood Derived Normal	Illumina HiSeq	b41ec820-7463-4bef-84a1-09d5c40fc499	Head and Neck	64.0	C2EF7833-C2FA-446C-A12E-F353C744B1E4	75ACDB7E-80B8-41DA-B105-F57F4BE1E9F0	TCGA-CN-5355-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5355	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15765	58cfa831e4b0c9d6adf6c8f8	TCGA-CN-5373-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-5373-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_8_rg.sorted	TCGA-CN-5373-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_8_rg.sorted.bam	50.4	1.9	0.15	58cfa831e4b0c9d6adf6c8f8	TCGA-CN-5373-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5373-10A	546F01D5-AED5-4FB8-91C0-0FD5E0FDE935	Blood Derived Normal	Illumina HiSeq	166276f6-82c3-4536-bce5-6e520be8554c	Head and Neck	55.0	629A4D66-6FD4-4619-B949-362860B276CB	08C37803-59E9-44B8-BC72-C4D512312537	TCGA-CN-5373-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5373	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15766	58cfa831e4b0c9d6adf6c933	TCGA-CN-6989-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CN-6989-10A-01D-A32X-10_wgs_Illumina	TCGA-CN-6989-10A-01D-A32X-10_wgs_Illumina.bam	845.0		0.08	58cfa831e4b0c9d6adf6c933	TCGA-CN-6989-10A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6989-10A	F33AA93F-B32D-4C4F-9A71-1E5AB69C6899	Blood Derived Normal	Illumina HiSeq	a59dd8f5-b54d-4460-ac1e-f3f5831ec920	Head and Neck	64.0	3570AC4B-B585-4262-B54B-137A2515C689	07B97B7C-C88E-4769-B302-F50D1176BD2D	TCGA-CN-6989-10A-01D-A32X-10	GRCh37-lite	TCGA-CN-6989	TCGA-HNSC		Baylor College of Medicine	University of Pittsburgh	United States	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15767	58cfa831e4b0c9d6adf6c5de	TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted	TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted.bam	172.7	1.9	0.14	58cfa831e4b0c9d6adf6c5de	TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5364-01A	13F63218-0949-41E6-A661-C844414C45B5	Primary Tumor	Illumina HiSeq	c408c80c-a712-46f0-8945-22511233d2bf	Head and Neck	55.0	38A4AC42-BE08-4187-98C2-AF861218C3DB	6CE3D597-51F1-4807-A28F-271F25F95ED4	TCGA-CN-5364-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5364	TCGA-HNSC	493.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15768	58cfa831e4b0c9d6adf6c966	TCGA-CN-5374-01A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CN-5374-01A-01D-2266-10_Illumina	TCGA-CN-5374-01A-01D-2266-10_Illumina.bam	384.7	1.9	0.05	58cfa831e4b0c9d6adf6c966	TCGA-CN-5374-01A-01D-2266-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5374-01A	D7641CA1-A062-4DD2-9414-447AF7311A84	Primary Tumor	Illumina HiSeq	3713f8c9-23d7-490a-bec2-99cb7ab55eac	Head and Neck	56.0	617DF1E0-B075-4610-B6D5-8850786FEA70	AB923DB7-54E8-4A50-B7FD-C2B4B300041E	TCGA-CN-5374-01A-01D-2266-10	GRCh37-lite	TCGA-CN-5374	TCGA-HNSC		Baylor College of Medicine	University of Pittsburgh	None	NO	T2	N2	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15769	58cfa831e4b0c9d6adf6c6ee	TCGA-CR-6467-01A-11D-2266-10_Illumina.filtered.	WGS	TCGA-CR-6467-01A-11D-2266-10_Illumina	TCGA-CR-6467-01A-11D-2266-10_Illumina.bam	319.7	1.9	0.05	58cfa831e4b0c9d6adf6c6ee	TCGA-CR-6467-01A-11D-2266-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6467-01A	89F91E36-FED8-4DA3-8A35-C761D6F65285	Primary Tumor	Illumina HiSeq	27f00d9e-af52-4af4-b29b-a75a506754a8	Head and Neck	59.0	5EF4D047-5A84-4E03-ACF5-02029D8A4CF2	EE963667-56B1-49BD-8896-E07B536D3014	TCGA-CR-6467-01A-11D-2266-10	GRCh37-lite	TCGA-CR-6467	TCGA-HNSC		Baylor College of Medicine	Vanderbilt University	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15770	58cfa831e4b0c9d6adf6c629	TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted	TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted.bam	54.0		0.16	58cfa831e4b0c9d6adf6c629	TCGA-CQ-6219-10A-01D-1911_120504_SN1222_0101_AC0UMDACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6219-10A	0CA3D25A-22E9-4E40-834B-65F402535005	Blood Derived Normal	Illumina HiSeq	24f2b999-b137-4cd9-8d46-948ef995485d	Head and Neck	50.0	A10F3B24-FF67-48FB-9EB3-AFB10B3D36FB	008B9151-B9C9-42D8-AC2A-E2F3C4A62ABC	TCGA-CQ-6219-10A-01D-1911-02	HG19_Broad_variant	TCGA-CQ-6219	TCGA-HNSC	479.0	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N2a	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15771	58cfa831e4b0c9d6adf6c69e	TCGA-CQ-6220-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CQ-6220-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_5_rg.sorted	TCGA-CQ-6220-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_5_rg.sorted.bam	93.0		0.14	58cfa831e4b0c9d6adf6c69e	TCGA-CQ-6220-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6220-10A	96D0CEFE-7949-4736-A7DC-1E4FA94765EC	Blood Derived Normal	Illumina HiSeq	7a4c76f2-7fac-4e3d-8651-0c74feb12abb	Head and Neck	69.0	67AD295F-426F-4761-90C3-448623D8EF37	59E0535C-BC9C-4584-A559-331C216EF4C9	TCGA-CQ-6220-10A-01D-1911-02	HG19_Broad_variant	TCGA-CQ-6220	TCGA-HNSC	985.0	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15772	58cfa831e4b0c9d6adf6c605	TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted	TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted.bam	687.0	1.9	0.14	58cfa831e4b0c9d6adf6c605	TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5329-01A	02DCC11F-4F0E-4C9E-8D96-D22D47BEEF5D	Primary Tumor	Illumina HiSeq	b54a3eac-9c58-453d-9db1-395601ae82ea	Head and Neck	46.0	D22E9B65-495B-4D42-926A-01BF2C436D76	63CE8A9C-2CC5-41D9-B24D-3FB88343B693	TCGA-CQ-5329-01A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5329	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15773	58cfa831e4b0c9d6adf6c5fe	TCGA-CQ-5330-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CQ-5330-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_8_rg.sorted	TCGA-CQ-5330-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_8_rg.sorted.bam	55.7	1.9	0.14	58cfa831e4b0c9d6adf6c5fe	TCGA-CQ-5330-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5330-10A	9FFA79FA-D2D8-48E1-8FD6-4B020ECF357C	Blood Derived Normal	Illumina HiSeq	583ffff7-e647-470a-ac1d-3d6bab206e8a	Head and Neck	69.0	B3D8B1A6-DCC5-434F-B17A-BCC2D1D9CA2D	3BF2FBFA-2B1F-423B-9FB5-84C16EF882DE	TCGA-CQ-5330-10A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5330	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15774	58cfa831e4b0c9d6adf6c6a6	TCGA-CV-5431-11A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-5431-11A-01D-A32X-10_wgs_Illumina	TCGA-CV-5431-11A-01D-A32X-10_wgs_Illumina.bam	25.7	1.8	0.07	58cfa831e4b0c9d6adf6c6a6	TCGA-CV-5431-11A-01D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5431-11A	64BB5550-2735-4401-A0DB-58EC1020A32D	Solid Tissue Normal	Illumina HiSeq	878f4d9b-a3fb-4517-9331-fe3b4590447e	Head and Neck	73.0	39E3FACF-6D13-4611-BCFA-90EF0350814D	A909F28C-EE65-4859-BB65-B07D77F0BA75	TCGA-CV-5431-11A-01D-A32X-10	GRCh37-lite	TCGA-CV-5431	TCGA-HNSC	522.0	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15775	58cfa831e4b0c9d6adf6c7d0	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.bam	155.7	1.9	0.14	58cfa831e4b0c9d6adf6c7d0	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6945-01A	15714E69-E075-4688-8F51-C7102FE4CA07	Primary Tumor	Illumina HiSeq	50a2b9f7-d572-47c4-bf4b-3d6255512094	Head and Neck	41.0	55849997-67DE-4FC6-B7BF-9D02D15920C9	FC2ACD2E-751C-4252-85A1-6C5A8E980964	TCGA-CV-6945-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6945	TCGA-HNSC	366.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15776	58cfa831e4b0c9d6adf6c737	TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted	TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted.bam	170.73		0.14	58cfa831e4b0c9d6adf6c737	TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7263-01A	93B742EB-5FC3-4CE2-B7F6-C89F97E0DCC9	Primary Tumor	Illumina HiSeq	d8d79518-dd53-49b5-850c-3af45043e30c	Head and Neck	64.0	54DCB9AC-FD35-49C2-A790-B1F016160183	32435F1B-5D36-4335-B25E-43B89202F1B2	TCGA-CV-7263-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7263	TCGA-HNSC	560.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s15777	58cfa831e4b0c9d6adf6c818	TCGA-CV-6948-10A-01D-1911_120816_SN1222_0144_AD16PUACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-6948-10A-01D-1911_120816_SN1222_0144_AD16PUACXX_s_8_rg.sorted	TCGA-CV-6948-10A-01D-1911_120816_SN1222_0144_AD16PUACXX_s_8_rg.sorted.bam	23.0	1.8	0.13	58cfa831e4b0c9d6adf6c818	TCGA-CV-6948-10A-01D-1911_120816_SN1222_0144_AD16PUACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6948-10A	FCF0DC48-B889-4593-A15B-AA715AAE7BF5	Blood Derived Normal	Illumina HiSeq	44d87ab1-c19b-4411-8774-2f888600c978	Head and Neck	79.0	86696AE2-B67D-43B3-929B-C4BAB7417852	4291C3F6-447E-482F-ADB3-304D59F87F82	TCGA-CV-6948-10A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6948	TCGA-HNSC	1289.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N3	Head and Neck Squamous Cell Carcinoma	Stage IVB
s15778	58cfa831e4b0c9d6adf6c788	TCGA-CV-7183-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-7183-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_1_rg.sorted	TCGA-CV-7183-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_1_rg.sorted.bam	42.03		0.13	58cfa831e4b0c9d6adf6c788	TCGA-CV-7183-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7183-10A	DE206681-3E27-4D4F-8669-AEFB12B5B1E3	Blood Derived Normal	Illumina HiSeq	f7f69891-d84b-4137-92ba-59f738bbc299	Head and Neck	53.0	E9101C16-E19C-46E7-99F4-2851FF7DA89E	E13D1C47-E67F-403E-984F-19721890E7A8	TCGA-CV-7183-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7183	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15779	58cfa831e4b0c9d6adf6c8e8	TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted	TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted.bam	46.0	1.9	0.14	58cfa831e4b0c9d6adf6c8e8	TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6441-01A	59398D50-45CF-4812-A24E-0C00C0199971	Primary Tumor	Illumina HiSeq	4df6f8df-9255-4e46-8936-baeab0ed20c2	Head and Neck	60.0	192C9F36-08EC-4F7F-8137-1A9BD0282D98	FE879D88-4817-4ED8-9FB2-EE92AF1A582F	TCGA-CV-6441-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-6441	TCGA-HNSC	292.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15780	58cfa831e4b0c9d6adf6c86c	TCGA-CV-6952-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CV-6952-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_5_rg.sorted	TCGA-CV-6952-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_5_rg.sorted.bam	203.7	1.9	0.15	58cfa831e4b0c9d6adf6c86c	TCGA-CV-6952-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6952-11A	7ED006E8-461F-4664-BFFF-55FA6812743C	Solid Tissue Normal	Illumina HiSeq	48cd5e34-4d2c-4cb0-802c-1b4c2e7a44e1	Head and Neck	65.0	FE486AA7-B37A-4016-A71C-56D97BD73208	11CB737F-78D0-42B4-9800-C4D38EADAC88	TCGA-CV-6952-11A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6952	TCGA-HNSC	185.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15781	58cfa831e4b0c9d6adf6c882	TCGA-CV-6939-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-6939-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_3_rg.sorted	TCGA-CV-6939-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_3_rg.sorted.bam	16.7	1.9	0.13	58cfa831e4b0c9d6adf6c882	TCGA-CV-6939-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6939-11A	E7D1F0DD-EEC0-4670-A2BA-00FFE38C6382	Solid Tissue Normal	Illumina HiSeq	c0371496-b9f6-4925-bbcf-e8a5de80d00d	Head and Neck	60.0	B7635DF8-644C-473D-8B07-F586693A1F3E	28B55601-835D-4281-828D-37363F5D7EAF	TCGA-CV-6939-11A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6939	TCGA-HNSC	666.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15782	58cfa831e4b0c9d6adf6c7f0	TCGA-CV-7429-10A-01D-2317_120622_SN1120_0156_BD123WACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7429-10A-01D-2317_120622_SN1120_0156_BD123WACXX_s_7_rg.sorted	TCGA-CV-7429-10A-01D-2317_120622_SN1120_0156_BD123WACXX_s_7_rg.sorted.bam	9.33		0.17	58cfa831e4b0c9d6adf6c7f0	TCGA-CV-7429-10A-01D-2317_120622_SN1120_0156_BD123WACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7429-10A	44D99F11-EF5B-45D7-B7DF-B5C5893D878F	Blood Derived Normal	Illumina HiSeq	6998b65f-568a-4636-a6cb-07fb23e984a7	Head and Neck	55.0	349E31CA-41F2-4617-A20D-98B2277A4374	38F01A0A-8FF8-44D0-9982-C8281DF02F18	TCGA-CV-7429-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7429	TCGA-HNSC	107.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15783	58cfa831e4b0c9d6adf6c8b0	TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted	TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted.bam	222.73		0.15	58cfa831e4b0c9d6adf6c8b0	TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7432-01A	EAF674DD-9909-4879-B9A3-74253169EDDD	Primary Tumor	Illumina HiSeq	d1f8d81a-4553-4c26-9d59-534aa2475dca	Head and Neck	79.0	9213AB13-AFC6-40B9-B278-98DD05C92934	541FB07A-7568-4CFC-9FCD-C5B403C619BA	TCGA-CV-7432-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7432	TCGA-HNSC	2570.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15784	58cfa831e4b0c9d6adf6c710	TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted	TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted.bam	325.73		0.16	58cfa831e4b0c9d6adf6c710	TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7428-01A	90D3C240-5CB6-4601-A852-B5CDFBCD6483	Primary Tumor	Illumina HiSeq	234197c5-8479-49c1-9f04-5e9171364a3d	Head and Neck	47.0	F3CFC60B-ADA9-4549-8CDB-6CEBABB1E6B3	BA021325-B1CC-4C81-99B7-7B7349CFFFB6	TCGA-CV-7428-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7428	TCGA-HNSC	1671.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15785	58cfa831e4b0c9d6adf6c8f4	TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina	TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina.bam	222.73		0.08	58cfa831e4b0c9d6adf6c8f4	TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7432-01A	EAF674DD-9909-4879-B9A3-74253169EDDD	Primary Tumor	Illumina HiSeq	b0ae59a2-ff3b-4c06-a046-3138e659d051	Head and Neck	79.0	9213AB13-AFC6-40B9-B278-98DD05C92934	D25A4C65-9CB4-4611-909E-E68F93408D84	TCGA-CV-7432-01A-11D-A32X-10	GRCh37-lite	TCGA-CV-7432	TCGA-HNSC	2570.0	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15786	58cfa831e4b0c9d6adf6c931	TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted	TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted.bam	33.0	1.9	0.15	58cfa831e4b0c9d6adf6c931	TCGA-DQ-5624-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5624-10A	B4A41682-4ACA-4F1D-BACD-66F5E6EC7466	Blood Derived Normal	Illumina HiSeq	72bf54c2-0056-4578-8448-34fb30ed8b3a	Head and Neck	43.0	A782129D-F444-45AB-AFEC-0F45B369B258	55E14906-C54C-495E-B360-0384B230200D	TCGA-DQ-5624-10A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5624	TCGA-HNSC		Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15861	58cfa82ee4b0c9d6adf6aa3a	G23069.TCGA_CR_6480_10A_01D_2268_08.1.filtered.	WGS	G23069.TCGA_CR_6480_10A_01D_2268_08.1	G23069.TCGA_CR_6480_10A_01D_2268_08.1.bam	144.0	1.9	0.14	58cfa82ee4b0c9d6adf6aa3a	G23069.TCGA_CR_6480_10A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6480-10A	BA9D4568-71A8-41FC-A2BE-0BF784E36D6A	Blood Derived Normal	Illumina HiSeq	745de1a1-46c6-45d4-b70a-c06d2a9cef3e	Head and Neck	53.0	E49031DD-14F3-4F2C-8457-D0249C491AE9	BFB164E0-33C8-4163-A60D-11742A922E52	TCGA-CR-6480-10A-01D-2268-08	HG19_Broad_variant	TCGA-CR-6480	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available
s15862	58cfa82ee4b0c9d6adf6a7cf	G25249.TCGA-CR-7391-01A-11D-2334-08.1.filtered.	WGS	G25249.TCGA-CR-7391-01A-11D-2334-08.1	G25249.TCGA-CR-7391-01A-11D-2334-08.1.bam	85.7		0.05	58cfa82ee4b0c9d6adf6a7cf	G25249.TCGA-CR-7391-01A-11D-2334-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7391-01A	832316EE-08AB-412B-9E4D-8A57FF84BC11	Primary Tumor	Illumina HiSeq	ef4db578-e4b8-4047-b761-df26ecf7a41e	Head and Neck	36.0	54B7DB2E-F0DD-469D-81BB-4E2A86EBEA9D	C121DE15-78F7-4698-91BF-FD0485C466C2	TCGA-CR-7391-01A-11D-2334-08	HG19_Broad_variant	TCGA-CR-7391	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15863	58cfa82ee4b0c9d6adf6a90c	G23064.TCGA_CR_6472_10A_01D_2268_08.1.filtered.	WGS	G23064.TCGA_CR_6472_10A_01D_2268_08.1	G23064.TCGA_CR_6472_10A_01D_2268_08.1.bam	222.3	1.8	0.16	58cfa82ee4b0c9d6adf6a90c	G23064.TCGA_CR_6472_10A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6472-10A	0956BC67-DD55-4C54-A56A-F22F2856662A	Blood Derived Normal	Illumina HiSeq	d2f9239e-7f1c-4f81-9d85-3690f7dd3412	Head and Neck	59.0	212A8E4C-31AB-4A72-9E78-D8076FEF8FFF	C2CD77C0-44D7-47DB-84D0-E9B030C2F9D4	TCGA-CR-6472-10A-01D-2268-08	HG19_Broad_variant	TCGA-CR-6472	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available
s15864	58cfa82ee4b0c9d6adf6a7d9	G25249.TCGA-CR-7391-10A-01D-2334-08.1.filtered.	WGS	G25249.TCGA-CR-7391-10A-01D-2334-08.1	G25249.TCGA-CR-7391-10A-01D-2334-08.1.bam	82.0		0.05	58cfa82ee4b0c9d6adf6a7d9	G25249.TCGA-CR-7391-10A-01D-2334-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7391-10A	832316EE-08AB-412B-9E4D-8A57FF84BC11	Blood Derived Normal	Illumina HiSeq	1013b4f5-cc60-41aa-9ed4-32c66ca645b8	Head and Neck	36.0	EFCF402C-AD35-433A-B285-DB8C8CBD9552	EEBC2429-9186-49DE-9911-35FEAA58187B	TCGA-CR-7391-10A-01D-2334-08	HG19_Broad_variant	TCGA-CR-7391	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15865	58cfa82ee4b0c9d6adf6a995	G23063.TCGA_CR_7385_10A_01D_2268_08.1.filtered.	WGS	G23063.TCGA_CR_7385_10A_01D_2268_08.1	G23063.TCGA_CR_7385_10A_01D_2268_08.1.bam	25.0		0.13	58cfa82ee4b0c9d6adf6a995	G23063.TCGA_CR_7385_10A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7385-10A	9F89510C-ED07-471F-B35E-7C87C237B9FE	Blood Derived Normal	Illumina HiSeq	c5913c28-c0b8-4239-a121-017446bde4c3	Head and Neck	42.0	D1553B1A-BC1E-4DCF-A273-B3EFFABE380B	3A27A8C3-E060-4251-A0D5-D4AF2032391D	TCGA-CR-7385-10A-01D-2268-08	HG19_Broad_variant	TCGA-CR-7385	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15866	58cfa82ee4b0c9d6adf6aab8	G23079.TCGA_CR_6482_01A_11D_2268_08.2.filtered.	WGS	G23079.TCGA_CR_6482_01A_11D_2268_08.2	G23079.TCGA_CR_6482_01A_11D_2268_08.2.bam	68.7	1.9	0.14	58cfa82ee4b0c9d6adf6aab8	G23079.TCGA_CR_6482_01A_11D_2268_08.2.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6482-01A	468649E7-1525-4B8A-8AB5-DDB27DB5F022	Primary Tumor	Illumina HiSeq	47cd6984-3399-4fc7-a843-09a97b33bf4b	Head and Neck	62.0	92173F97-B46A-4950-8CD8-6729AB9522C5	7158C9FD-A633-4FEF-AA23-BD285F2A87A8	TCGA-CR-6482-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6482	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available
s15867	58cfa82ee4b0c9d6adf6a9c8	G23072.TCGA_BB_4225_10A_01D_2268_08.1.filtered.	WGS	G23072.TCGA_BB_4225_10A_01D_2268_08.1	G23072.TCGA_BB_4225_10A_01D_2268_08.1.bam	71.4	1.4	0.13	58cfa82ee4b0c9d6adf6a9c8	G23072.TCGA_BB_4225_10A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4225-10A	C1F50A22-38DF-41CC-A1F4-F7985504A7AC	Blood Derived Normal	Illumina HiSeq	ed3a6fa5-eed2-4b41-836b-658c39d33602	Head and Neck	73.0	F50A9185-7AF4-4EB7-8866-AA3FBBBC3BAB	7E57A5CF-3D3E-4CDF-BDE5-7C030944DBDD	TCGA-BB-4225-10A-01D-2268-08	HG19_Broad_variant	TCGA-BB-4225	TCGA-HNSC		Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15868	58cfa82ee4b0c9d6adf6a936	G35153.TCGA-BA-A4IH-10A-01D-A25T-08.4.filtered.	WGS	G35153.TCGA-BA-A4IH-10A-01D-A25T-08.4	G35153.TCGA-BA-A4IH-10A-01D-A25T-08.4.bam	7.99		0.08	58cfa82ee4b0c9d6adf6a936	G35153.TCGA-BA-A4IH-10A-01D-A25T-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-A4IH-10A	BD75D8EE-916B-4ABC-BF33-BCE6A4217076	Blood Derived Normal	Illumina HiSeq	e4a8ada8-a509-41eb-87a1-c2bc06960125	Head and Neck	57.0	EFF60F0D-E3C1-4A93-9026-C0764C70BA9F	F518AD7C-0500-48C4-81D5-8A424B91BD35	TCGA-BA-A4IH-10A-01D-A25T-08	HG19_Broad_variant	TCGA-BA-A4IH	TCGA-HNSC		Broad Institute of MIT and Harvard	UNC	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma Basaloid Type	Stage IVA
s15872	58cfa82ee4b0c9d6adf6aa64	G35155.TCGA-CN-5373-01A-01D-1434-08.2.filtered.	WGS	G35155.TCGA-CN-5373-01A-01D-1434-08.2	G35155.TCGA-CN-5373-01A-01D-1434-08.2.bam	165.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa64	G35155.TCGA-CN-5373-01A-01D-1434-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5373-01A	546F01D5-AED5-4FB8-91C0-0FD5E0FDE935	Primary Tumor	Illumina HiSeq	25d55985-95b6-4558-b42e-5c32684d89b0	Head and Neck	55.0	9D73D061-F1E1-47BA-929D-FEEB6C191279	00988676-1E9B-4E00-B4AA-A8F86C21B206	TCGA-CN-5373-01A-01D-1434-08	HG19_Broad_variant	TCGA-CN-5373	TCGA-HNSC		Broad Institute of MIT and Harvard	University of Pittsburgh	None	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15874	58cfa82ee4b0c9d6adf6ab7e	G35155.TCGA-CQ-5323-01A-01D-1683-08.2.filtered.	WGS	G35155.TCGA-CQ-5323-01A-01D-1683-08.2	G35155.TCGA-CQ-5323-01A-01D-1683-08.2.bam	481.0	1.9	0.05	58cfa82ee4b0c9d6adf6ab7e	G35155.TCGA-CQ-5323-01A-01D-1683-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5323-01A	DEEFDD62-4D35-40C9-AD4C-0B593F35CFF7	Primary Tumor	Illumina HiSeq	a8f7b17a-acda-474e-be1c-c3a584542451	Head and Neck	82.0	3AC5396D-B92F-41D5-A3F0-603AA52AAFA3	892067EF-C465-46EA-8F91-10636DD0081B	TCGA-CQ-5323-01A-01D-1683-08	HG19_Broad_variant	TCGA-CQ-5323	TCGA-HNSC		Broad Institute of MIT and Harvard	University Health Network, Toronto	Canada	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15876	58cfa830e4b0c9d6adf6c1db	TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted	TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted.bam	16.7	1.9	0.13	58cfa830e4b0c9d6adf6c1db	TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4224-01A	58574E35-8A30-4207-B127-59FFF7C87A43	Primary Tumor	Illumina HiSeq	44a7ef3f-57df-49e2-80b9-1f0dca51067f	Head and Neck	52.0	077ACD68-8C30-41A6-BB7E-5B014866B807	E2FF93EB-AE22-4C6B-B4D5-181B9393BC64	TCGA-BB-4224-01A-01D-1431-02	HG19_Broad_variant	TCGA-BB-4224	TCGA-HNSC		Harvard Medical School	Johns Hopkins	United States	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15877	58cfa830e4b0c9d6adf6c246	TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted	TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted.bam	747.33	1.9	0.16	58cfa830e4b0c9d6adf6c246	TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4078-01A	C7353D6A-82A2-4A0D-8CD4-8C8957943EDB	Primary Tumor	Illumina HiSeq	cf3b040a-b4be-41ce-a172-1a295ebd79b2	Head and Neck	83.0	2027EDE3-13F5-40F6-BEF6-16704981D676	66A9CFF2-397E-415E-BF54-9A75CCC80BDE	TCGA-BA-4078-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4078	TCGA-HNSC	276.0	Harvard Medical School	UNC	None	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available
s15879	58cfa830e4b0c9d6adf6c210	TCGA-BA-4077-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BA-4077-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_8_rg.sorted	TCGA-BA-4077-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_8_rg.sorted.bam	58.03	1.9	0.14	58cfa830e4b0c9d6adf6c210	TCGA-BA-4077-10A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4077-10A	4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A	Blood Derived Normal	Illumina HiSeq	b95aebf7-d49b-41bd-86d3-66e2ef172c88	Head and Neck	45.0	8C074534-49B5-4D4A-A9C8-59BFEF52A800	0687CAE5-A756-4B2F-9DA4-FD4E9C4B91B2	TCGA-BA-4077-10A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4077	TCGA-HNSC	1134.0	Harvard Medical School	UNC	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15880	58cfa831e4b0c9d6adf6c558	TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted	TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted.bam	7.7	1.9	0.14	58cfa831e4b0c9d6adf6c558	TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4733-01A	DEDD71B4-8537-4947-839E-90ACEDDD0893	Primary Tumor	Illumina HiSeq	c1887d1c-970a-4e8d-80df-a16844daef9f	Head and Neck	61.0	A1FD1C9D-C763-488A-8649-FF069F56D2BE	1CB41C9B-FB04-438D-A9FB-89D6186E0D37	TCGA-CN-4733-01A-02D-1868-02	HG19_Broad_variant	TCGA-CN-4733	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T1	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15881	58cfa831e4b0c9d6adf6c651	TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted	TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted.bam	52.7	1.9	0.15	58cfa831e4b0c9d6adf6c651	TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4736-01A	0FB3E5FF-54F0-43C5-9322-541BB7825E7F	Primary Tumor	Illumina HiSeq	45c5cea2-56a4-43af-9c53-19302867f2d9	Head and Neck	70.0	6DB0B6EE-23B3-43BF-8AA9-FDF641AFC673	8141905F-DE66-4DB2-A9F9-5819C953A465	TCGA-CN-4736-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4736	TCGA-HNSC	395.0	Harvard Medical School	University of Pittsburgh	None	NO	T1	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15882	58cfa831e4b0c9d6adf6c796	TCGA-CN-5374-10A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CN-5374-10A-01D-2266-10_Illumina	TCGA-CN-5374-10A-01D-2266-10_Illumina.bam	73.4	1.9	0.05	58cfa831e4b0c9d6adf6c796	TCGA-CN-5374-10A-01D-2266-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5374-10A	D7641CA1-A062-4DD2-9414-447AF7311A84	Blood Derived Normal	Illumina HiSeq	ed899124-7dec-45d3-a9f2-79402efa65bb	Head and Neck	56.0	27FB0AE5-D8A1-46AC-AD3E-2464C52D9CFD	F9416343-E559-49FD-80CE-D6E7607B5B58	TCGA-CN-5374-10A-01D-2266-10	GRCh37-lite	TCGA-CN-5374	TCGA-HNSC		Baylor College of Medicine	University of Pittsburgh	None	NO	T2	N2	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15883	58cfa831e4b0c9d6adf6c60c	TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted	TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted.bam	449.7	1.9	0.15	58cfa831e4b0c9d6adf6c60c	TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5360-01A	5793879B-F663-4A10-9BD9-1ACD2E189650	Primary Tumor	Illumina HiSeq	56414402-7420-42b7-a93d-3d1f88308155	Head and Neck	68.0	0C00768E-8B13-4B8E-80FC-B344740845F1	7EE362C2-86AD-462C-B478-21255D96ED90	TCGA-CN-5360-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5360	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15884	58cfa831e4b0c9d6adf6c6c2	TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted	TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted.bam	78.7	1.9	0.14	58cfa831e4b0c9d6adf6c6c2	TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4740-01A	E37C83DC-C2C4-4E5F-A57B-39FFCF9AA3CF	Primary Tumor	Illumina HiSeq	c1580763-a5d9-4753-b80c-f8d5498a7494	Head and Neck	79.0	2311DEEC-8DBC-4449-BE09-FCD4E3BAFD87	9DD678DF-BCE7-46C2-8454-3DE815FB85ED	TCGA-CN-4740-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4740	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15885	58cfa831e4b0c9d6adf6c619	TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted	TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted.bam	301.7	1.9	0.15	58cfa831e4b0c9d6adf6c619	TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5356-01A	E1FED7AA-2BCE-45AE-B0C6-7F50EF97E425	Primary Tumor	Illumina HiSeq	c8e59618-fd16-4e8e-abe2-e3d5d674390c	Head and Neck	56.0	BCB5DA85-78D6-4519-9740-378587B1BD37	199B42E1-301A-49AD-A364-BBF4FAD8B049	TCGA-CN-5356-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5356	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15886	58cfa831e4b0c9d6adf6c61d	TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted	TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted.bam	38.4	1.9	0.13	58cfa831e4b0c9d6adf6c61d	TCGA-CN-4740-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4740-10A	E37C83DC-C2C4-4E5F-A57B-39FFCF9AA3CF	Blood Derived Normal	Illumina HiSeq	d36d8c79-6394-457e-a92f-c582f98097a0	Head and Neck	79.0	533B0EC7-41DD-405E-A6B5-6E82CB689CDE	A820807E-4D6F-4481-BD39-C29522B3C3FE	TCGA-CN-4740-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4740	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15887	58cfa831e4b0c9d6adf6c5d4	TCGA-CN-5367-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-5367-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_6_rg.sorted	TCGA-CN-5367-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_6_rg.sorted.bam	28.4	1.9	0.15	58cfa831e4b0c9d6adf6c5d4	TCGA-CN-5367-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_6_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5367-10A	61D0709C-D148-413B-A7B5-C0C82ED2F32F	Blood Derived Normal	Illumina HiSeq	b73d2b70-fbf3-440b-bf21-7a3ea5ebcdbd	Head and Neck	60.0	DA2FE372-D082-40B6-81AF-F895050AF58D	BA3EF724-B5F4-4DDF-BFD9-8928FB36BE7F	TCGA-CN-5367-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5367	TCGA-HNSC	352.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15888	58cfa831e4b0c9d6adf6c67c	TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted	TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted.bam	187.7	1.9	0.14	58cfa831e4b0c9d6adf6c67c	TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4739-01A	7E3B90C1-8772-4E12-8050-A156558BEB82	Primary Tumor	Illumina HiSeq	796943be-2aa7-419f-801f-22c78459cc72	Head and Neck	71.0	F450DBE6-4972-4C49-AF97-963BCD0D0DA0	3B0BED92-ED76-451D-B605-A79FAE296DDE	TCGA-CN-4739-01A-02D-1509-02	HG19_Broad_variant	TCGA-CN-4739	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15889	58cfa831e4b0c9d6adf6c784	TCGA-CN-6013-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-6013-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_5_rg.sorted	TCGA-CN-6013-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_5_rg.sorted.bam	492.7	1.9	0.15	58cfa831e4b0c9d6adf6c784	TCGA-CN-6013-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6013-10A	714496C5-D221-4397-9C5A-CD2D22603E6F	Blood Derived Normal	Illumina HiSeq	6b051d97-36f0-4a18-80f9-60c27c73c081	Head and Neck	56.0	8B510BC8-7B3C-4861-9A40-C2C30B7099E0	762CA7DA-6D6E-4709-B1AA-13621D962D35	TCGA-CN-6013-10A-01D-1681-02	HG19_Broad_variant	TCGA-CN-6013	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15890	58cfa831e4b0c9d6adf6c5b8	TCGA-CN-5360-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-5360-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_5_rg.sorted	TCGA-CN-5360-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_5_rg.sorted.bam	98.4	1.9	0.14	58cfa831e4b0c9d6adf6c5b8	TCGA-CN-5360-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5360-10A	5793879B-F663-4A10-9BD9-1ACD2E189650	Blood Derived Normal	Illumina HiSeq	e5e36209-eb45-4a7f-b70a-547a36daace6	Head and Neck	68.0	9439BC03-9D26-454A-BA80-A0F5A4585656	E8A06D37-CC48-46E7-B1DA-C9B8A9B2A462	TCGA-CN-5360-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5360	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15891	58cfa831e4b0c9d6adf6c5d8	TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted	TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted.bam	197.7	1.9	0.15	58cfa831e4b0c9d6adf6c5d8	TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5363-01A	291B069C-9DDE-4E1E-8430-85146BC94338	Primary Tumor	Illumina HiSeq	624b1e50-b5bd-4a3f-98fd-4514bff3244d	Head and Neck	48.0	5E4E1E21-8016-4E27-8F72-2411714203E8	BEB17091-BD47-4666-8E3A-7A397977EA41	TCGA-CN-5363-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5363	TCGA-HNSC	253.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N3	Head and Neck Squamous Cell Carcinoma	Stage IVB
s15892	58cfa831e4b0c9d6adf6c6be	TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted	TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted.bam	52.7	1.9	0.16	58cfa831e4b0c9d6adf6c6be	TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4742-01A	444E5BFC-D4E5-4B0D-B96D-88ECEA8873E9	Primary Tumor	Illumina HiSeq	e655fe0a-a859-4967-b69c-4c8d36a8a7e0	Head and Neck	48.0	507B9A1D-BFBF-43F8-86D2-665A488441AF	A9768535-FE1C-4B4F-B709-DED0809BA592	TCGA-CN-4742-01A-02D-1509-02	HG19_Broad_variant	TCGA-CN-4742	TCGA-HNSC	397.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15893	58cfa831e4b0c9d6adf6c614	TCGA-CQ-6221-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CQ-6221-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_5_rg.sorted	TCGA-CQ-6221-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_5_rg.sorted.bam	9.53		0.14	58cfa831e4b0c9d6adf6c614	TCGA-CQ-6221-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6221-10A	839B660C-98FE-4468-A2B3-408594350250	Blood Derived Normal	Illumina HiSeq	74dfb1a3-cdd5-4360-923f-2c18cd7e6044	Head and Neck	79.0	12BACDFA-4252-405C-B49A-361438036A52	573C20DD-4DC1-4404-BE48-6E3AA7E6475A	TCGA-CQ-6221-10A-01D-2317-26	HG19_Broad_variant	TCGA-CQ-6221	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	University Health Network, Toronto	Canada	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15894	58cfa831e4b0c9d6adf6c6b2	TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina.filtered.	WGS	TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina	TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina.bam	213.73	1.9	0.05	58cfa831e4b0c9d6adf6c6b2	TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-5249-01A	C7DF3466-B9A7-4818-883B-D0CD08483570	Primary Tumor	Illumina HiSeq	cef48339-6b24-4da9-b25d-55a64c71d0dc	Head and Neck	35.0	6697DD71-5A58-4862-B26E-EA16DCC383F2	C0812962-A345-48B7-AEC0-01336C2D1EED	TCGA-CR-5249-01A-01D-2276-10	GRCh37-lite	TCGA-CR-5249	TCGA-HNSC		Baylor College of Medicine	Vanderbilt University	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15895	58cfa831e4b0c9d6adf6c6fa	TCGA-CQ-7068-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CQ-7068-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_5_rg.sorted	TCGA-CQ-7068-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_5_rg.sorted.bam	6.83		0.16	58cfa831e4b0c9d6adf6c6fa	TCGA-CQ-7068-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-7068-10A	8EBE8C25-5EF9-42D4-9414-8313227B673F	Blood Derived Normal	Illumina HiSeq	ab245773-e618-4653-9bbd-066158ce2131	Head and Neck	80.0	B3F3A97A-FE74-4F1B-AB76-64EBD4F6518E	19652FBF-B3BC-4900-9CF5-67BAF165D19F	TCGA-CQ-7068-10A-01D-2317-26	HG19_Broad_variant	TCGA-CQ-7068	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15896	58cfa831e4b0c9d6adf6c6f4	TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted	TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted.bam	307.0	1.9	0.15	58cfa831e4b0c9d6adf6c6f4	TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5977-01A	50239D1D-B3A4-4240-AB83-B24BA67B1299	Primary Tumor	Illumina HiSeq	ccdab134-2f40-4e7a-8b7c-ac1269321d3e	Head and Neck	66.0	84756AB5-9CB6-4DBD-848C-A85804F22AA1	140E6B2E-7EDD-417D-B720-58BEAB50AEA5	TCGA-CV-5977-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5977	TCGA-HNSC		Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15897	58cfa831e4b0c9d6adf6c7e3	TCGA-CV-5973-11A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-5973-11A-01D-A32X-10_wgs_Illumina	TCGA-CV-5973-11A-01D-A32X-10_wgs_Illumina.bam	17.0	1.8	0.07	58cfa831e4b0c9d6adf6c7e3	TCGA-CV-5973-11A-01D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5973-11A	8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB	Solid Tissue Normal	Illumina HiSeq	f0e1f7a9-618e-4dfa-91db-019ab3386912	Head and Neck	62.0	8ED1F8FB-095A-4E76-88A3-15CEE4B5B4BB	038BDC6A-3A8D-41D8-855B-35C8EDCC97B6	TCGA-CV-5973-11A-01D-A32X-10	GRCh37-lite	TCGA-CV-5973	TCGA-HNSC		Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15898	58cfa831e4b0c9d6adf6c7b5	TCGA-CV-5973-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CV-5973-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_5_rg.sorted	TCGA-CV-5973-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_5_rg.sorted.bam	17.0	1.8	0.14	58cfa831e4b0c9d6adf6c7b5	TCGA-CV-5973-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5973-11A	8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB	Solid Tissue Normal	Illumina HiSeq	195bab19-b8a4-467b-b019-332843975246	Head and Neck	62.0	8ED1F8FB-095A-4E76-88A3-15CEE4B5B4BB	FE312A26-D94E-4AE0-962A-2372E061EECC	TCGA-CV-5973-11A-01D-1681-02	HG19_Broad_variant	TCGA-CV-5973	TCGA-HNSC		Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15899	58cfa831e4b0c9d6adf6c81c	TCGA-CV-6933-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-6933-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_7_rg.sorted	TCGA-CV-6933-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_7_rg.sorted.bam	34.0	1.9	0.16	58cfa831e4b0c9d6adf6c81c	TCGA-CV-6933-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6933-10A	2A749317-0156-4213-8482-B2C2D6E52E9B	Blood Derived Normal	Illumina HiSeq	983b388d-7527-45b1-bcc8-375b7f38e128	Head and Neck	53.0	6D7E5088-B49D-4182-90C2-79DF36F96E35	C74C03E1-2876-41E9-950D-6CB081DF559C	TCGA-CV-6933-10A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6933	TCGA-HNSC	2741.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s15900	58cfa831e4b0c9d6adf6c76c	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.bam	199.73		0.16	58cfa831e4b0c9d6adf6c76c	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7178-01A	8F044599-3FBE-4B69-B67D-49AEE9168545	Primary Tumor	Illumina HiSeq	f76f830b-a361-4cf5-a60f-69d4d574723f	Head and Neck	64.0	CAAB8E84-3225-4543-949E-7B7EB11244A2	A139820A-0B76-4A95-A3EE-DDDDF514A9C3	TCGA-CV-7178-01A-21D-2317-26	HG19_Broad_variant	TCGA-CV-7178	TCGA-HNSC	2166.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15901	58cfa831e4b0c9d6adf6c8d2	TCGA-CV-6939-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CV-6939-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_5_rg.sorted	TCGA-CV-6939-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_5_rg.sorted.bam	60.0	1.8	0.13	58cfa831e4b0c9d6adf6c8d2	TCGA-CV-6939-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6939-10A	E7D1F0DD-EEC0-4670-A2BA-00FFE38C6382	Blood Derived Normal	Illumina HiSeq	309581c5-c366-45cd-8989-49eb97775978	Head and Neck	60.0	65C69882-7AD5-4EA8-B8F6-CA17A0EA8E73	F5E8B5DB-1814-4D08-9D7D-3AD879EFD522	TCGA-CV-6939-10A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6939	TCGA-HNSC	666.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15902	58cfa831e4b0c9d6adf6c8e6	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.bam	52.73		0.13	58cfa831e4b0c9d6adf6c8e6	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6960-01A	2C985B30-0F8F-4C8F-A924-CC6AAD7EBF0D	Primary Tumor	Illumina HiSeq	5fdfb781-64fd-48dd-9d26-3de7bfdf5908	Head and Neck	49.0	967F6CC9-95D2-4666-A20A-717D768613A4	F41864FE-49FA-4037-AF02-E3F8E2515614	TCGA-CV-6960-01A-41D-2317-26	HG19_Broad_variant	TCGA-CV-6960	TCGA-HNSC	862.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15903	58cfa831e4b0c9d6adf6c748	TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted	TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted.bam	264.7	1.9	0.13	58cfa831e4b0c9d6adf6c748	TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6959-01A	EF3CE0E5-D2E8-4616-8B1A-A78C591CF235	Primary Tumor	Illumina HiSeq	ff9553cc-07a7-497f-be70-1ad5b8e09130	Head and Neck	48.0	07FB167A-3F61-4517-A79E-BA2042F10A3A	E1D21CB1-4329-447E-AC5B-EC31BF045495	TCGA-CV-6959-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6959	TCGA-HNSC	256.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15904	58cfa831e4b0c9d6adf6c741	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.bam	52.73		0.13	58cfa831e4b0c9d6adf6c741	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7247-01A	5E25AB76-A8AB-4779-AA03-8DE658F18DA1	Primary Tumor	Illumina HiSeq	0b4ae8f3-7acd-4d37-a39f-cb4fc2b537b4	Head and Neck	55.0	F84AE44B-4BB7-4841-AEE0-139CD79B9680	A5BA905A-C959-4118-B1C9-F6466CB5541A	TCGA-CV-7247-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7247	TCGA-HNSC	577.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s15905	58cfa831e4b0c9d6adf6c8d8	TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted	TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted.bam	62.7	1.9	0.14	58cfa831e4b0c9d6adf6c8d8	TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6951-01A	91728CD6-ED91-49DC-9279-FAEDBE211A9D	Primary Tumor	Illumina HiSeq	ec458668-da73-4d3e-8ac6-08a0e974b879	Head and Neck	57.0	9EE0F161-0976-4697-BF69-7E42E7149FEB	90F9C6C1-B7E9-48E4-9A02-C5FAB56AFD95	TCGA-CV-6951-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6951	TCGA-HNSC	915.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15906	58cfa831e4b0c9d6adf6c85e	TCGA-CV-6938-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-6938-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_8_rg.sorted	TCGA-CV-6938-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_8_rg.sorted.bam	75.0	1.8	0.13	58cfa831e4b0c9d6adf6c85e	TCGA-CV-6938-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6938-10A	FF9DB03D-F81C-4079-8B05-F5A8C05B8CFE	Blood Derived Normal	Illumina HiSeq	2bf8f074-cca1-41f9-88b4-32ba64d7990c	Head and Neck	87.0	1F925F99-1D41-4BDF-99AE-CA7B4D16A567	3A63D568-0924-4D11-BCA0-86DAB2D8C889	TCGA-CV-6938-10A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6938	TCGA-HNSC	144.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s15907	58cfa831e4b0c9d6adf6c7d2	TCGA-CV-6951-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-6951-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_4_rg.sorted	TCGA-CV-6951-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_4_rg.sorted.bam	99.7	1.9	0.14	58cfa831e4b0c9d6adf6c7d2	TCGA-CV-6951-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6951-11A	91728CD6-ED91-49DC-9279-FAEDBE211A9D	Solid Tissue Normal	Illumina HiSeq	a087903d-fb41-4d87-9500-6b62de815139	Head and Neck	57.0	E5D22220-4951-42F5-80E5-4510AC3E99C2	73E856AD-F850-4433-AF90-1D7EF628FBB8	TCGA-CV-6951-11A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6951	TCGA-HNSC	915.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15908	58cfa831e4b0c9d6adf6c8de	TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted	TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted.bam	262.73		0.15	58cfa831e4b0c9d6adf6c8de	TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7429-01A	44D99F11-EF5B-45D7-B7DF-B5C5893D878F	Primary Tumor	Illumina HiSeq	4860e1b8-251e-4894-91f2-c9416a9b7f28	Head and Neck	55.0	A8A03639-FAD0-4B1B-9802-E3882BBFC7B8	18E1FCE0-D678-48D9-AD23-432E23C9077D	TCGA-CV-7429-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7429	TCGA-HNSC	107.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15909	58cfa831e4b0c9d6adf6c830	TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted	TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted.bam	131.73		0.16	58cfa831e4b0c9d6adf6c830	TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7407-01A	8B63BE59-9CE6-45A0-80D9-4D20F4918CB9	Primary Tumor	Illumina HiSeq	e5709830-4141-4354-94f0-94f576fe84c9	Head and Neck	67.0	6ABAF81A-B228-4AFE-B931-BC1FC39CD265	4CC9AD85-2F84-4657-8F3E-6C5DD69F1B30	TCGA-CV-7407-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7407	TCGA-HNSC	1081.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s15910	58cfa831e4b0c9d6adf6c71c	TCGA-CV-7414-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7414-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_7_rg.sorted	TCGA-CV-7414-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_7_rg.sorted.bam	4.33		0.15	58cfa831e4b0c9d6adf6c71c	TCGA-CV-7414-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7414-10A	C3B2C38D-81A3-42FD-A41E-6F6DE3934007	Blood Derived Normal	Illumina HiSeq	2f7acc14-13c2-4d7a-8ba8-6f6e9d6e12b6	Head and Neck	78.0	328F4499-00A9-410A-A458-F18BA8CE3AC8	3D6C1E58-7D9C-436C-8CF8-BD98C9821255	TCGA-CV-7414-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7414	TCGA-HNSC	14.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15911	58cfa831e4b0c9d6adf6c7ca	TCGA-CX-7085-10A-01D-2317_120730_SN1222_0140_AC11GKACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CX-7085-10A-01D-2317_120730_SN1222_0140_AC11GKACXX_s_3_rg.sorted	TCGA-CX-7085-10A-01D-2317_120730_SN1222_0140_AC11GKACXX_s_3_rg.sorted.bam	8.03		0.14	58cfa831e4b0c9d6adf6c7ca	TCGA-CX-7085-10A-01D-2317_120730_SN1222_0140_AC11GKACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CX-7085-10A	2A7B4613-F908-4E78-98ED-857DCD7ED774	Blood Derived Normal	Illumina HiSeq	2187824f-bc90-441a-8180-5f1524daf954	Head and Neck	77.0	9B665276-9D15-4B3B-B201-FB0A8C7C54B2	97FE8A31-73BB-4EC1-A07E-C7D8A6B7059F	TCGA-CX-7085-10A-01D-2317-26	HG19_Broad_variant	TCGA-CX-7085	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	Medical College of Georgia	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s15912	58cfa831e4b0c9d6adf6c876	TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted	TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted.bam	275.7	1.9	0.14	58cfa831e4b0c9d6adf6c876	TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6826-01A	31243867-8E9F-46E9-A213-B83544EB8028	Primary Tumor	Illumina HiSeq	377f848a-3e59-4eee-bd9d-87fdc1a898bb	Head and Neck	64.0	1737989D-8463-4761-B111-53E4FD396375	07759CEA-B923-4D20-96DB-7952D50314C7	TCGA-D6-6826-01A-11D-1911-02	HG19_Broad_variant	TCGA-D6-6826	TCGA-HNSC		Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15913	58cfa831e4b0c9d6adf6c82e	TCGA-D6-6826-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-D6-6826-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_7_rg.sorted	TCGA-D6-6826-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_7_rg.sorted.bam	405.0	1.9	0.16	58cfa831e4b0c9d6adf6c82e	TCGA-D6-6826-10A-01D-1911_120518_SN1120_0143_BC0VN6ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6826-10A	31243867-8E9F-46E9-A213-B83544EB8028	Blood Derived Normal	Illumina HiSeq	cb6e32f1-cfa4-4387-a53f-e7a562ac45d9	Head and Neck	64.0	7AA13049-917A-4D7A-BCEB-3C718EC8FB7A	A6B7AC7D-425D-4741-BE71-3E3FA167AEE8	TCGA-D6-6826-10A-01D-1911-02	HG19_Broad_variant	TCGA-D6-6826	TCGA-HNSC		Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15914	58cfa831e4b0c9d6adf6c75a	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.bam	127.7	1.9	0.15	58cfa831e4b0c9d6adf6c75a	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6515-01A	8E0E456E-85EE-4DE5-8F0B-72393D6ACDE0	Primary Tumor	Illumina HiSeq	5a79073a-b6a0-41df-b26b-247649784d4d	Head and Neck	82.0	4453D224-F846-4CEE-972F-8438C964913B	D6E287D9-D7C4-496C-829F-F7D7980D77A2	TCGA-D6-6515-01A-21D-1868-02	HG19_Broad_variant	TCGA-D6-6515	TCGA-HNSC	403.0	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15915	58cfa831e4b0c9d6adf6c72e	TCGA-D6-6515-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_8_rg.sorted.filtered.	WGS	TCGA-D6-6515-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_8_rg.sorted	TCGA-D6-6515-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_8_rg.sorted.bam	566.0	1.9	0.14	58cfa831e4b0c9d6adf6c72e	TCGA-D6-6515-10A-01D-1868_120530_SN1222_0110_AC0VLAACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6515-10A	8E0E456E-85EE-4DE5-8F0B-72393D6ACDE0	Blood Derived Normal	Illumina HiSeq	9162c3e1-cccb-4dbd-8584-1ed07c67a6ae	Head and Neck	82.0	30F64CB6-602E-442B-A49C-AD7BA013582F	E0792BA6-84EE-48A7-8965-3EA79DED53A3	TCGA-D6-6515-10A-01D-1868-02	HG19_Broad_variant	TCGA-D6-6515	TCGA-HNSC	403.0	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s15916	58cfa831e4b0c9d6adf6c8a2	TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted.filtered.	WGS	TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted	TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted.bam	207.7	1.9	0.14	58cfa831e4b0c9d6adf6c8a2	TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5631-01A	10B3F56A-E61E-486B-8D3C-176668D5DC34	Primary Tumor	Illumina HiSeq	9aae2925-69ec-44f9-bc1d-bfefd16ce242	Head and Neck	52.0	2E4AA773-6094-46BD-A97F-9694E80C71CF	5B9E894B-444B-4DCF-9E6C-C1F398A52A81	TCGA-DQ-5631-01A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5631	TCGA-HNSC	548.0	Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s15917	58cfa832e4b0c9d6adf6cf12	TCGA-H7-7774-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_3_rg.sorted.filtered.	WGS	TCGA-H7-7774-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_3_rg.sorted	TCGA-H7-7774-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_3_rg.sorted.bam	85.03		0.15	58cfa832e4b0c9d6adf6cf12	TCGA-H7-7774-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-H7-7774-10A	EEAE67AC-C9E0-468D-AAD6-052501F7B982	Blood Derived Normal	Illumina HiSeq	4b8c5d66-16c6-43b0-8204-3a12b6a6394b	Head and Neck	75.0	51C3E2E6-E44A-4259-9F28-3DA984FE0664	F7E34DFA-8785-43E9-904B-1C7AFD2AFDC2	TCGA-H7-7774-10A-01D-2317-26	HG19_Broad_variant	TCGA-H7-7774	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s15918	58cfa832e4b0c9d6adf6d22a	TCGA-IQ-7632-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-IQ-7632-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_3_rg.sorted	TCGA-IQ-7632-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_3_rg.sorted.bam	197.03		0.13	58cfa832e4b0c9d6adf6d22a	TCGA-IQ-7632-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-IQ-7632-10A	601A4146-8093-4F20-9A0A-A97916C9E7F6	Blood Derived Normal	Illumina HiSeq	dd7b51dc-f3ec-450a-91b7-909ceb81e85e	Head and Neck	68.0	28D815A5-CAB2-4F9C-A6BD-EE17FCA4488F	25BE07AE-D5E7-4B3C-B855-CC6843F21BFB	TCGA-IQ-7632-10A-01D-2317-26	HG19_Broad_variant	TCGA-IQ-7632	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	University of Miami	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16017	58cfa82ee4b0c9d6adf6a81a	G23062.TCGA_BA_4077_01B_01D_2268_08.2.filtered.	WGS	G23062.TCGA_BA_4077_01B_01D_2268_08.2	G23062.TCGA_BA_4077_01B_01D_2268_08.2.bam	246.33	1.9	0.15	58cfa82ee4b0c9d6adf6a81a	G23062.TCGA_BA_4077_01B_01D_2268_08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4077-01B	4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A	Primary Tumor	Illumina HiSeq	6533e56c-b5b8-4c85-862b-a5526c5c2e0a	Head and Neck	45.0	327BBCA7-FA25-4A92-BE27-21A4C184C760	268D9CDB-CCCF-491A-A9BB-2E3D6B85951F	TCGA-BA-4077-01B-01D-2268-08	HG19_Broad_variant	TCGA-BA-4077	TCGA-HNSC	1134.0	Broad Institute of MIT and Harvard	UNC	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16018	58cfa82ee4b0c9d6adf6a7cb	G23079.TCGA_CR_6482_10A_01D_2268_08.2.filtered.	WGS	G23079.TCGA_CR_6482_10A_01D_2268_08.2	G23079.TCGA_CR_6482_10A_01D_2268_08.2.bam	88.0	1.8	0.13	58cfa82ee4b0c9d6adf6a7cb	G23079.TCGA_CR_6482_10A_01D_2268_08.2.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6482-10A	468649E7-1525-4B8A-8AB5-DDB27DB5F022	Blood Derived Normal	Illumina HiSeq	313a6b3c-974e-4fd2-8f12-6cddbb546254	Head and Neck	62.0	3A24AAEB-37CE-4508-81D5-E531AAC8A167	1345478B-17B3-46A0-A78B-F4461A6651FF	TCGA-CR-6482-10A-01D-2268-08	HG19_Broad_variant	TCGA-CR-6482	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available
s16019	58cfa82ee4b0c9d6adf6aa04	G25250.TCGA-CR-6470-01A-11D-2334-08.1.filtered.	WGS	G25250.TCGA-CR-6470-01A-11D-2334-08.1	G25250.TCGA-CR-6470-01A-11D-2334-08.1.bam	137.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa04	G25250.TCGA-CR-6470-01A-11D-2334-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6470-01A	CD032DDB-55F2-4C77-8DCF-E4E630F7DE6F	Primary Tumor	Illumina HiSeq	1a71c849-3daa-48f9-b309-4c340a01def2	Head and Neck	38.0	AFB7EA63-2959-4E53-95EA-7A032DCB5A8B	02C6A893-49C5-49D1-8EB1-195021E70D52	TCGA-CR-6470-01A-11D-2334-08	HG19_Broad_variant	TCGA-CR-6470	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16020	58cfa82ee4b0c9d6adf6ab78	G23065.TCGA_BA_5153_10A_01D_2268_08.1.filtered.	WGS	G23065.TCGA_BA_5153_10A_01D_2268_08.1	G23065.TCGA_BA_5153_10A_01D_2268_08.1.bam	61.4	1.9	0.14	58cfa82ee4b0c9d6adf6ab78	G23065.TCGA_BA_5153_10A_01D_2268_08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5153-10A	B3631718-9E0A-454C-BEE1-8F36EBC509D8	Blood Derived Normal	Illumina HiSeq	2908ea28-7831-4ed0-9a9e-fab525fefab6	Head and Neck	51.0	F079E825-160A-40D5-97CC-1931F11C4E2E	FF47B947-C437-4692-AB18-733411C22ABF	TCGA-BA-5153-10A-01D-2268-08	HG19_Broad_variant	TCGA-BA-5153	TCGA-HNSC	1762.0	Broad Institute of MIT and Harvard	UNC	None	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16021	58cfa82ee4b0c9d6adf6abac	G25250.TCGA-CR-6470-10A-01D-2334-08.1.filtered.	WGS	G25250.TCGA-CR-6470-10A-01D-2334-08.1	G25250.TCGA-CR-6470-10A-01D-2334-08.1.bam	142.0	1.9	0.05	58cfa82ee4b0c9d6adf6abac	G25250.TCGA-CR-6470-10A-01D-2334-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6470-10A	CD032DDB-55F2-4C77-8DCF-E4E630F7DE6F	Blood Derived Normal	Illumina HiSeq	08705672-13bb-497c-8d31-11c561bfe1a4	Head and Neck	38.0	AA121605-A2C9-43FC-A836-8EC6C42B99DE	6CCAA1AA-3906-41B8-AC89-C35ADC6DFDCC	TCGA-CR-6470-10A-01D-2334-08	HG19_Broad_variant	TCGA-CR-6470	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16024	58cfa830e4b0c9d6adf6c1c0	TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted	TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted.bam	56.7	1.9	0.15	58cfa830e4b0c9d6adf6c1c0	TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4225-01A	C1F50A22-38DF-41CC-A1F4-F7985504A7AC	Primary Tumor	Illumina HiSeq	4903ac5e-6fa0-41de-b272-c4139a3c0632	Head and Neck	73.0	AC42070B-F4D6-47BE-96AA-A713D66A0072	F7E6BD4D-3E7C-427E-8618-FAFB3731E597	TCGA-BB-4225-01A-01D-1431-02	HG19_Broad_variant	TCGA-BB-4225	TCGA-HNSC		Harvard Medical School	Johns Hopkins	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16025	58cfa830e4b0c9d6adf6c1b4	TCGA-BA-6872-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-6872-10A-01D-A32X-10_wgs_Illumina	TCGA-BA-6872-10A-01D-A32X-10_wgs_Illumina.bam	64.0	1.9	0.07	58cfa830e4b0c9d6adf6c1b4	TCGA-BA-6872-10A-01D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-6872-10A	3E5F451A-5882-4914-AE1A-95C898C2BCCA	Blood Derived Normal	Illumina HiSeq	71a05657-fd70-495f-9249-703bffe96173	Head and Neck	47.0	96307963-4A11-45A6-8886-954848E309E5	3BC3B470-DDE6-4A89-A9D5-B2051BB13793	TCGA-BA-6872-10A-01D-A32X-10	GRCh37-lite	TCGA-BA-6872	TCGA-HNSC	384.0	Baylor College of Medicine	UNC	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16026	58cfa830e4b0c9d6adf6c220	TCGA-BA-4076-10A-01D-2266-10_Illumina.filtered.	WGS	TCGA-BA-4076-10A-01D-2266-10_Illumina	TCGA-BA-4076-10A-01D-2266-10_Illumina.bam	51.03	1.9	0.05	58cfa830e4b0c9d6adf6c220	TCGA-BA-4076-10A-01D-2266-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4076-10A	7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70	Blood Derived Normal	Illumina HiSeq	57de9078-5a6a-4185-846e-9c81add66025	Head and Neck	39.0	D6F48BB2-379A-448D-B13D-2DFC5DA91D0C	9249EB3D-5186-489E-B7FD-5FFF554E4B6E	TCGA-BA-4076-10A-01D-2266-10	GRCh37-lite	TCGA-BA-4076	TCGA-HNSC	415.0	Baylor College of Medicine	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16027	58cfa830e4b0c9d6adf6c160	TCGA-BA-5149-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BA-5149-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_4_rg.sorted	TCGA-BA-5149-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_4_rg.sorted.bam	65.4	1.9	0.15	58cfa830e4b0c9d6adf6c160	TCGA-BA-5149-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5149-10A	CB99FB14-641C-4FB3-BF1D-17EFB8CD982A	Blood Derived Normal	Illumina HiSeq	4b0f007d-eb09-44cc-be19-114f76f43c09	Head and Neck	47.0	C991BC28-AB65-4D05-931A-676BE035B94C	9668CD24-0B23-4749-8C84-B12203236DA4	TCGA-BA-5149-10A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5149	TCGA-HNSC		Harvard Medical School	UNC	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16028	58cfa830e4b0c9d6adf6c140	TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina	TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina.bam	89.7	1.9	0.07	58cfa830e4b0c9d6adf6c140	TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-6872-01A	3E5F451A-5882-4914-AE1A-95C898C2BCCA	Primary Tumor	Illumina HiSeq	28a6e3a3-207f-4df1-bdb3-c63373ce9ba2	Head and Neck	47.0	04107A58-667D-4712-B972-61837EFF6029	C76F7FCC-2748-4B6D-805E-D21652DD5E3A	TCGA-BA-6872-01A-11D-A32X-10	GRCh37-lite	TCGA-BA-6872	TCGA-HNSC	384.0	Baylor College of Medicine	UNC	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16029	58cfa831e4b0c9d6adf6c598	TCGA-CN-4735-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CN-4735-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_2_rg.sorted	TCGA-CN-4735-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_2_rg.sorted.bam	543.4	1.9	0.16	58cfa831e4b0c9d6adf6c598	TCGA-CN-4735-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4735-10A	FE844945-3EA9-449E-993C-DF392FABCFD0	Blood Derived Normal	Illumina HiSeq	430a1e6e-314d-47f4-82fe-d5976cdc409d	Head and Neck	52.0	A2CAEAB5-55A4-412F-A647-0112F48BBBE7	9E74974B-EE15-4452-801B-770B4D7F9FD3	TCGA-CN-4735-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4735	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16030	58cfa831e4b0c9d6adf6c630	TCGA-CN-4737-01A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CN-4737-01A-01D-2266-10_Illumina	TCGA-CN-4737-01A-01D-2266-10_Illumina.bam	142.0	1.9	0.05	58cfa831e4b0c9d6adf6c630	TCGA-CN-4737-01A-01D-2266-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4737-01A	1F744ADA-6DE1-446D-B62C-76A7FC8B40AF	Primary Tumor	Illumina HiSeq	cd1138ab-45a7-4da9-a78d-142e2e75f255	Head and Neck	19.0	BA5D40F5-56A2-438B-92B8-6EB7DB6D6AFA	878A7FE7-20FF-4651-9587-B4D6FD42E929	TCGA-CN-4737-01A-01D-2266-10	GRCh37-lite	TCGA-CN-4737	TCGA-HNSC		Baylor College of Medicine	University of Pittsburgh	None	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16031	58cfa831e4b0c9d6adf6c686	TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted	TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted.bam	702.7	1.9	0.16	58cfa831e4b0c9d6adf6c686	TCGA-CN-4737-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4737-10A	1F744ADA-6DE1-446D-B62C-76A7FC8B40AF	Blood Derived Normal	Illumina HiSeq	fdf0a7f2-3007-49fa-b8f8-88f75e9f9396	Head and Neck	19.0	E0D710B0-E301-4441-BF1C-44AE39CB3239	76742CF6-8394-4B19-A4A8-59C305F21DC4	TCGA-CN-4737-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4737	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16032	58cfa831e4b0c9d6adf6c514	TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted	TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted.bam	52.7	1.9	0.13	58cfa831e4b0c9d6adf6c514	TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4735-01A	FE844945-3EA9-449E-993C-DF392FABCFD0	Primary Tumor	Illumina HiSeq	b8913a67-9dd4-41f9-8888-c998df0a0a23	Head and Neck	52.0	FBB300FA-8793-42DA-A68E-4570AE2E5186	F759672A-62CA-49DC-BC4F-643E8A885787	TCGA-CN-4735-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4735	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16033	58cfa831e4b0c9d6adf6c608	TCGA-CN-5365-01A-01D-2276-10_Illumina.filtered.	WGS	TCGA-CN-5365-01A-01D-2276-10_Illumina	TCGA-CN-5365-01A-01D-2276-10_Illumina.bam	305.73	1.9	0.05	58cfa831e4b0c9d6adf6c608	TCGA-CN-5365-01A-01D-2276-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5365-01A	4CFFEA0B-90A7-4C86-A73F-BB8FECA3ADA7	Primary Tumor	Illumina HiSeq	84352351-1bc3-4c62-93be-29c899ff9811	Head and Neck	38.0	665D4BFF-603C-497B-816F-C98784665D0F	A0FE80E0-E3AC-485B-8A1A-4C80C101B874	TCGA-CN-5365-01A-01D-2276-10	GRCh37-lite	TCGA-CN-5365	TCGA-HNSC	351.0	Baylor College of Medicine	University of Pittsburgh	None	NO	T2	N3	Head and Neck Squamous Cell Carcinoma	Stage IVB
s16034	58cfa831e4b0c9d6adf6c92a	TCGA-CN-6017-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-6017-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_6_rg.sorted	TCGA-CN-6017-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_6_rg.sorted.bam	384.7	1.9	0.16	58cfa831e4b0c9d6adf6c92a	TCGA-CN-6017-10A-01D-1681_120425_SN1222_0099_AC0JCEACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6017-10A	23C4E2EB-142B-4FCC-A974-9A248AEC3F37	Blood Derived Normal	Illumina HiSeq	553eeabf-a561-46bd-8f08-ad29986c1766	Head and Neck	55.0	EE520EE4-84F7-4CA2-B513-67C76368991E	088B8668-613A-4864-8C03-EA150C4E5AAE	TCGA-CN-6017-10A-01D-1681-02	HG19_Broad_variant	TCGA-CN-6017	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16035	58cfa831e4b0c9d6adf6c8c4	TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted	TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted.bam	165.7	1.9	0.14	58cfa831e4b0c9d6adf6c8c4	TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5373-01A	546F01D5-AED5-4FB8-91C0-0FD5E0FDE935	Primary Tumor	Illumina HiSeq	22213a76-97e9-4565-8074-c3046269b70a	Head and Neck	55.0	9D73D061-F1E1-47BA-929D-FEEB6C191279	3FE7F18F-8AA4-4AFE-8AF0-256876F7E86E	TCGA-CN-5373-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5373	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s16036	58cfa831e4b0c9d6adf6c6bc	TCGA-CQ-7065-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CQ-7065-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_4_rg.sorted	TCGA-CQ-7065-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_4_rg.sorted.bam	9.83		0.14	58cfa831e4b0c9d6adf6c6bc	TCGA-CQ-7065-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_4_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-7065-10A	20ECE2CA-8601-4CCA-AEC5-0A5C0B92594D	Blood Derived Normal	Illumina HiSeq	2b184042-0329-4d3e-866c-14da9baa50d2	Head and Neck	40.0	DF6098B9-A45D-4EF8-A29B-B4B3F271D335	378F921F-A78B-4094-A8C4-D41ECCDB94F9	TCGA-CQ-7065-10A-01D-2317-26	HG19_Broad_variant	TCGA-CQ-7065	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16037	58cfa831e4b0c9d6adf6c60a	TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted	TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted.bam	342.7	1.9	0.15	58cfa831e4b0c9d6adf6c60a	TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6220-01A	96D0CEFE-7949-4736-A7DC-1E4FA94765EC	Primary Tumor	Illumina HiSeq	d86390d3-24c6-4e56-9b8a-d6b3ec75c989	Head and Neck	69.0	E0E75203-3982-40B2-A057-FAA8433DFB7A	C7EABDCF-81F2-4C87-946A-B5BA42056B04	TCGA-CQ-6220-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6220	TCGA-HNSC	985.0	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16038	58cfa831e4b0c9d6adf6c6a2	TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted	TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted.bam	325.7	1.9	0.15	58cfa831e4b0c9d6adf6c6a2	TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6223-01A	D9E8C707-E61A-4813-8DC0-2472E9CCF12B	Primary Tumor	Illumina HiSeq	d12d744d-5a58-4e30-bcb7-b8c033a8255d	Head and Neck	69.0	775DB365-3533-41D9-B635-582292B22700	6CE8A7EC-2730-49E4-81F0-47B03A54EA1A	TCGA-CQ-6223-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6223	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16039	58cfa831e4b0c9d6adf6c682	TCGA-CR-5250-01A-01D-2276-10_Illumina.filtered.	WGS	TCGA-CR-5250-01A-01D-2276-10_Illumina	TCGA-CR-5250-01A-01D-2276-10_Illumina.bam	261.73	1.9	0.05	58cfa831e4b0c9d6adf6c682	TCGA-CR-5250-01A-01D-2276-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-5250-01A	9E178D80-FE90-4998-9DAE-726C4BECEEF7	Primary Tumor	Illumina HiSeq	486d7653-48d6-47cc-b04b-362d1b0e485b	Head and Neck	71.0	13AE9411-E63F-4093-A80E-8B64837C001D	29FC38AA-F367-46A3-A14D-A5F657AD0CAA	TCGA-CR-5250-01A-01D-2276-10	GRCh37-lite	TCGA-CR-5250	TCGA-HNSC		Baylor College of Medicine	Vanderbilt University	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16040	58cfa831e4b0c9d6adf6c6b6	TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted	TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted.bam	15.93		0.13	58cfa831e4b0c9d6adf6c6b6	TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-7065-01A	20ECE2CA-8601-4CCA-AEC5-0A5C0B92594D	Primary Tumor	Illumina HiSeq	a7ab0507-8b7a-45aa-9e07-21bfc50fddd0	Head and Neck	40.0	65B44EBF-F817-4B29-8FB6-01B07BC2E7D1	DFB72780-B485-403B-997C-6F6FD0EF0E75	TCGA-CQ-7065-01A-11D-2317-26	HG19_Broad_variant	TCGA-CQ-7065	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16041	58cfa831e4b0c9d6adf6c8f2	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.bam	135.0	1.9	0.15	58cfa831e4b0c9d6adf6c8f2	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5976-01A	23062172-7361-4E61-8EE6-B0A613D72A24	Primary Tumor	Illumina HiSeq	ef7745ae-17be-41bc-a3a5-c24eeda89075	Head and Neck	50.0	EEF68956-D624-4CD0-9C48-28FAF052C5F9	2581BC16-0DEF-40BC-8A97-54A1AE577E26	TCGA-CV-5976-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5976	TCGA-HNSC		Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16042	58cfa831e4b0c9d6adf6c8ca	TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina	TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina.bam	115.0	1.9	0.08	58cfa831e4b0c9d6adf6c8ca	TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5973-01A	8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB	Primary Tumor	Illumina HiSeq	91b47661-f43d-4fb8-a616-e40ed72329d3	Head and Neck	62.0	5078222F-B257-4286-A29A-BC1E395149BC	7E584FF6-0B81-4F85-81DA-B8117AFEE326	TCGA-CV-5973-01A-11D-A32X-10	GRCh37-lite	TCGA-CV-5973	TCGA-HNSC		Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s16043	58cfa831e4b0c9d6adf6c6a8	TCGA-CV-5432-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-5432-10A-01D-A32X-10_wgs_Illumina	TCGA-CV-5432-10A-01D-A32X-10_wgs_Illumina.bam	46.0	1.8	0.07	58cfa831e4b0c9d6adf6c6a8	TCGA-CV-5432-10A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5432-10A	D89B1FD6-BEF4-4803-8ED3-3B442BE600B6	Blood Derived Normal	Illumina HiSeq	39f4a08d-69ba-4e67-b8a9-4983f17e14f6	Head and Neck	68.0	3A13692E-CB77-464A-8ACE-CBA47F99247F	3205A312-3259-4E13-8B12-3E612E7A2400	TCGA-CV-5432-10A-01D-A32X-10	GRCh37-lite	TCGA-CV-5432	TCGA-HNSC		Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16044	58cfa831e4b0c9d6adf6c6b8	TCGA-CV-5431-11A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-5431-11A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_6_rg.sorted	TCGA-CV-5431-11A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_6_rg.sorted.bam	25.7	1.8	0.14	58cfa831e4b0c9d6adf6c6b8	TCGA-CV-5431-11A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5431-11A	64BB5550-2735-4401-A0DB-58EC1020A32D	Solid Tissue Normal	Illumina HiSeq	d7c39448-b5a1-49bb-8ff7-249509a8ffaf	Head and Neck	73.0	39E3FACF-6D13-4611-BCFA-90EF0350814D	2DD2EAD7-B8E3-4FEB-B03A-C799C73BEF17	TCGA-CV-5431-11A-01D-1509-02	HG19_Broad_variant	TCGA-CV-5431	TCGA-HNSC	522.0	Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16045	58cfa831e4b0c9d6adf6c6aa	TCGA-CV-5966-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-5966-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_6_rg.sorted	TCGA-CV-5966-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_6_rg.sorted.bam	31.0	1.9	0.14	58cfa831e4b0c9d6adf6c6aa	TCGA-CV-5966-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_6_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5966-11A	0D0731E2-8D82-4B6D-9258-2896A770A868	Solid Tissue Normal	Illumina HiSeq	41d152b5-0e3b-4db4-a2b0-0f2a5276d6e8	Head and Neck	63.0	53D3B388-6F20-40E1-BA4B-B969F3E52E09	32059756-2F60-4B75-BDBC-72BE2CEE7259	TCGA-CV-5966-11A-01D-1681-02	HG19_Broad_variant	TCGA-CV-5966	TCGA-HNSC	545.0	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16046	58cfa831e4b0c9d6adf6c7a2	TCGA-CV-5971-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-5971-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_8_rg.sorted	TCGA-CV-5971-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_8_rg.sorted.bam	30.0	1.9	0.15	58cfa831e4b0c9d6adf6c7a2	TCGA-CV-5971-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5971-11A	1465B7EC-8D2B-47DD-8387-977EED44CC86	Solid Tissue Normal	Illumina HiSeq	1ceeef7f-0aec-40ec-b515-3b369cde02e2	Head and Neck	60.0	925E85CB-0CEB-44B7-A745-7B7C21427DF8	27495DD9-B50E-4C66-AFF3-C910D0DCC72D	TCGA-CV-5971-11A-01D-1681-02	HG19_Broad_variant	TCGA-CV-5971	TCGA-HNSC		Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2a	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16047	58cfa831e4b0c9d6adf6c8dc	TCGA-CV-6945-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-6945-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_6_rg.sorted	TCGA-CV-6945-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_6_rg.sorted.bam	14.0	1.8	0.14	58cfa831e4b0c9d6adf6c8dc	TCGA-CV-6945-10A-01D-1911_120504_SN208_0297_BC0VJEACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6945-10A	15714E69-E075-4688-8F51-C7102FE4CA07	Blood Derived Normal	Illumina HiSeq	881094bd-54eb-4839-a62c-4abb208130cb	Head and Neck	41.0	974F0AEE-5BB9-4840-B141-A02B6A2FB65B	4DF4A64E-3543-4FF7-969F-49F5EB5EF877	TCGA-CV-6945-10A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6945	TCGA-HNSC	366.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16048	58cfa831e4b0c9d6adf6c78e	TCGA-CV-6956-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-6956-10A-01D-A32X-10_wgs_Illumina	TCGA-CV-6956-10A-01D-A32X-10_wgs_Illumina.bam	22.03	1.8	0.07	58cfa831e4b0c9d6adf6c78e	TCGA-CV-6956-10A-01D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6956-10A	8C238D30-DF8E-4E6B-98FC-21696269A294	Blood Derived Normal	Illumina HiSeq	c03352c8-542b-4ea8-b982-ff61e0723b16	Head and Neck	67.0	BA086EB2-DE97-4D74-9F92-05874932C25E	F6CA8BBE-25BF-4557-A4F6-8DAC8AC3B47E	TCGA-CV-6956-10A-01D-A32X-10	GRCh37-lite	TCGA-CV-6956	TCGA-HNSC	217.0	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s16049	58cfa831e4b0c9d6adf6c942	TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted	TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted.bam	8.43		0.16	58cfa831e4b0c9d6adf6c942	TCGA-CV-7247-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7247-10A	5E25AB76-A8AB-4779-AA03-8DE658F18DA1	Blood Derived Normal	Illumina HiSeq	eda6d221-38ba-4187-8a10-2c0217d09e31	Head and Neck	55.0	2E9CDAD5-53EC-4B5E-8A1E-4F8ABEE04149	16906F53-CCD9-4D19-8DBF-8DD6A59D392F	TCGA-CV-7247-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7247	TCGA-HNSC	577.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16050	58cfa831e4b0c9d6adf6c80f	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.bam	62.7	2.0	0.16	58cfa831e4b0c9d6adf6c80f	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6938-01A	FF9DB03D-F81C-4079-8B05-F5A8C05B8CFE	Primary Tumor	Illumina HiSeq	a328ffc7-c5cd-4726-a75a-e625d33859a8	Head and Neck	87.0	9EB292E6-AE4D-4613-98EE-0197FD97B633	87E1BCCB-5B03-40AF-A262-0B2B5E6A08D2	TCGA-CV-6938-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6938	TCGA-HNSC	144.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s16051	58cfa831e4b0c9d6adf6c79a	TCGA-CV-7255-01A-11D-2276-10_Illumina.filtered.	WGS	TCGA-CV-7255-01A-11D-2276-10_Illumina	TCGA-CV-7255-01A-11D-2276-10_Illumina.bam	143.73		0.05	58cfa831e4b0c9d6adf6c79a	TCGA-CV-7255-01A-11D-2276-10_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7255-01A	534F85F2-B9EB-45BE-87D5-C3DFFD13D541	Primary Tumor	Illumina HiSeq	7f307e2b-3164-4bb0-aa04-90c538b8bb46	Head and Neck	32.0	45A42060-1F1C-45FF-9717-9BE2F7FDF3F7	1AFF91A6-1B0F-4575-8F4B-4E064A50B886	TCGA-CV-7255-01A-11D-2276-10	GRCh37-lite	TCGA-CV-7255	TCGA-HNSC	64.0	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16053	58cfa831e4b0c9d6adf6c7ec	TCGA-CV-7263-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-7263-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_4_rg.sorted	TCGA-CV-7263-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_4_rg.sorted.bam	2.73		0.14	58cfa831e4b0c9d6adf6c7ec	TCGA-CV-7263-10A-01D-2317_120623_SN1222_0118_AD13T1ACXX_s_4_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7263-10A	93B742EB-5FC3-4CE2-B7F6-C89F97E0DCC9	Blood Derived Normal	Illumina HiSeq	64a6f3f5-8b60-439f-86f8-603118060103	Head and Neck	64.0	E57B3C9C-5BF5-432C-B7D1-4C1D37F22510	AD8791C4-E40B-46F7-88D8-6E514243F970	TCGA-CV-7263-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7263	TCGA-HNSC	560.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s16054	58cfa831e4b0c9d6adf6c72c	TCGA-CV-7434-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-7434-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_8_rg.sorted	TCGA-CV-7434-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_8_rg.sorted.bam	28.03		0.14	58cfa831e4b0c9d6adf6c72c	TCGA-CV-7434-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7434-10A	63B50E1C-7948-464F-BFF1-8E0E5DAAFCC5	Blood Derived Normal	Illumina HiSeq	61309435-9e3d-4fc8-989e-63773d630677	Head and Neck	64.0	B59039EF-7711-40AE-B87F-D8B566365F1F	615AE823-25D8-4409-91DD-78E14339312B	TCGA-CV-7434-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7434	TCGA-HNSC	218.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16055	58cfa831e4b0c9d6adf6c749	TCGA-CV-7407-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-7407-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_2_rg.sorted	TCGA-CV-7407-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_2_rg.sorted.bam	8.33		0.14	58cfa831e4b0c9d6adf6c749	TCGA-CV-7407-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7407-10A	8B63BE59-9CE6-45A0-80D9-4D20F4918CB9	Blood Derived Normal	Illumina HiSeq	324e0ca4-45b2-4348-bcc6-969674ada4bc	Head and Neck	67.0	2B996D86-64A5-4721-85F2-C75DBBAD5B81	7C8D7D6B-52A3-4766-AE2E-B70E938E0F6B	TCGA-CV-7407-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7407	TCGA-HNSC	1081.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II
s16056	58cfa831e4b0c9d6adf6c7cb	TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted	TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted.bam	262.73		0.15	58cfa831e4b0c9d6adf6c7cb	TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CX-7085-01A	2A7B4613-F908-4E78-98ED-857DCD7ED774	Primary Tumor	Illumina HiSeq	2a118e3e-c8f9-43b4-b1d7-4659e37a96ce	Head and Neck	77.0	A07E086C-1D2D-4D92-A663-ECD7EA4DBD73	57FA3BBB-D571-475C-95A2-AAEDFF4835FC	TCGA-CX-7085-01A-21D-2317-26	HG19_Broad_variant	TCGA-CX-7085	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	Medical College of Georgia	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s16057	58cfa831e4b0c9d6adf6c7ac	TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted	TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted.bam	262.7	1.9	0.14	58cfa831e4b0c9d6adf6c7ac	TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6827-01A	3C5BC678-41E9-46B3-9686-5CD95659AB71	Primary Tumor	Illumina HiSeq	849f41d7-0557-40ce-bca0-8a54c496fef2	Head and Neck	55.0	C53D6135-C614-45F4-8F41-49B20ED4A549	E2CDC496-8A62-4501-98C0-2AF2CCF48988	TCGA-D6-6827-01A-11D-1911-02	HG19_Broad_variant	TCGA-D6-6827	TCGA-HNSC		Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s16058	58cfa831e4b0c9d6adf6ca01	TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted	TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted.bam	154.7	1.9	0.15	58cfa831e4b0c9d6adf6ca01	TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5625-01A	53D9A130-4A3A-4491-85CD-9A44415A1632	Primary Tumor	Illumina HiSeq	33b84364-a81e-48fd-89d6-552802c7ff18	Head and Neck	52.0	74856E66-109F-4A68-A496-8FA66729FE1F	9641D13E-BE95-46BB-8330-6128EE15D47C	TCGA-DQ-5625-01A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5625	TCGA-HNSC		Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16059	58cfa831e4b0c9d6adf6c97e	TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina	TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina.bam	31.0	1.9	0.08	58cfa831e4b0c9d6adf6c97e	TCGA-DQ-5625-10A-01D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5625-10A	53D9A130-4A3A-4491-85CD-9A44415A1632	Blood Derived Normal	Illumina HiSeq	8525b9e2-c05e-4524-ba11-f1673ffc575e	Head and Neck	52.0	F3AD5B44-87B1-41AE-8CC1-42E158BC174C	FDE15753-1874-45DB-9CCF-7C1BD4238D59	TCGA-DQ-5625-10A-01D-A32X-10	GRCh37-lite	TCGA-DQ-5625	TCGA-HNSC		Baylor College of Medicine	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16060	58cfa831e4b0c9d6adf6ca66	TCGA-DQ-5629-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-DQ-5629-10A-01D-A32X-10_wgs_Illumina	TCGA-DQ-5629-10A-01D-A32X-10_wgs_Illumina.bam	130.0	1.9	0.08	58cfa831e4b0c9d6adf6ca66	TCGA-DQ-5629-10A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5629-10A	E95E9E7D-A1ED-46EB-9CF8-1D355BF0577F	Blood Derived Normal	Illumina HiSeq	a61bf907-f580-4de5-8210-8c01ede3d802	Head and Neck	64.0	769F3C1C-323E-4F04-9AE7-E41F484A964C	1DBB8816-5B42-4A9F-A8DA-960281C93AE4	TCGA-DQ-5629-10A-01D-A32X-10	GRCh37-lite	TCGA-DQ-5629	TCGA-HNSC		Baylor College of Medicine	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16061	58cfa831e4b0c9d6adf6cae4	TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina	TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina.bam	154.7	1.9	0.08	58cfa831e4b0c9d6adf6cae4	TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5625-01A	53D9A130-4A3A-4491-85CD-9A44415A1632	Primary Tumor	Illumina HiSeq	cb931cae-83da-428c-86f1-59df36c9af80	Head and Neck	52.0	74856E66-109F-4A68-A496-8FA66729FE1F	D3709EEA-CA2A-49AC-B79C-871A5473D450	TCGA-DQ-5625-01A-01D-A32X-10	GRCh37-lite	TCGA-DQ-5625	TCGA-HNSC		Baylor College of Medicine	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16163	58cfa82ee4b0c9d6adf6a8d6	G23072.TCGA_BB_4225_01A_01D_2268_08.1.filtered.	WGS	G23072.TCGA_BB_4225_01A_01D_2268_08.1	G23072.TCGA_BB_4225_01A_01D_2268_08.1.bam	56.7	1.9	0.15	58cfa82ee4b0c9d6adf6a8d6	G23072.TCGA_BB_4225_01A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4225-01A	C1F50A22-38DF-41CC-A1F4-F7985504A7AC	Primary Tumor	Illumina HiSeq	e43130ec-f2f3-4984-8ba9-8f0e641acce9	Head and Neck	73.0	AC42070B-F4D6-47BE-96AA-A713D66A0072	81598359-24D5-4A8B-A6E6-7A6F94289119	TCGA-BB-4225-01A-01D-2268-08	HG19_Broad_variant	TCGA-BB-4225	TCGA-HNSC		Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16164	58cfa82ee4b0c9d6adf6a7cd	G23078.TCGA_CR_6487_10A_01D_2268_08.1.filtered.	WGS	G23078.TCGA_CR_6487_10A_01D_2268_08.1	G23078.TCGA_CR_6487_10A_01D_2268_08.1.bam	141.0	1.8	0.13	58cfa82ee4b0c9d6adf6a7cd	G23078.TCGA_CR_6487_10A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6487-10A	9AE5101B-6031-4AB1-BFCA-198C41AF3184	Blood Derived Normal	Illumina HiSeq	8874033e-39fc-438d-96cb-baabcb41a1f7	Head and Neck	50.0	FF63290D-0644-4387-99BB-697150A7FB6B	BC26BAA4-0F4D-4B8C-95F4-B8F9FB2BD328	TCGA-CR-6487-10A-01D-2268-08	HG19_Broad_variant	TCGA-CR-6487	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s16165	58cfa82ee4b0c9d6adf6aa5c	G23074.TCGA_CN_4741_10A_01D_2268_08.3.filtered.	WGS	G23074.TCGA_CN_4741_10A_01D_2268_08.3	G23074.TCGA_CN_4741_10A_01D_2268_08.3.bam	84.4	1.9	0.15	58cfa82ee4b0c9d6adf6aa5c	G23074.TCGA_CN_4741_10A_01D_2268_08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4741-10A	277B02E9-DED5-4980-845D-AF53690000AC	Blood Derived Normal	Illumina HiSeq	19da4d3c-e43b-4310-9e3b-2fa09a8049c6	Head and Neck	75.0	8D8DDCA2-6461-4A8B-A696-DA0906661B9E	1C444414-1DFA-4FCD-AA31-68D17A35F898	TCGA-CN-4741-10A-01D-2268-08	HG19_Broad_variant	TCGA-CN-4741	TCGA-HNSC		Broad Institute of MIT and Harvard	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16166	58cfa82ee4b0c9d6adf6aa50	G23069.TCGA_CR_6480_01A_11D_2268_08.2.filtered.	WGS	G23069.TCGA_CR_6480_01A_11D_2268_08.2	G23069.TCGA_CR_6480_01A_11D_2268_08.2.bam	158.7	1.9	0.15	58cfa82ee4b0c9d6adf6aa50	G23069.TCGA_CR_6480_01A_11D_2268_08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6480-01A	BA9D4568-71A8-41FC-A2BE-0BF784E36D6A	Primary Tumor	Illumina HiSeq	cf0a07e0-8d0a-4c16-8d48-7efb9bf38f8a	Head and Neck	53.0	0C6B4631-381E-4B73-AC9E-62BBC1849FF4	EF673D3D-2031-4036-BA25-4BC7EF04075B	TCGA-CR-6480-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6480	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available
s16168	58cfa830e4b0c9d6adf6c17e	TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted	TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted.bam	598.33	1.9	0.16	58cfa830e4b0c9d6adf6c17e	TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4074-01A	A63CA97D-EF31-4118-9547-A6730967290F	Primary Tumor	Illumina HiSeq	da78e5e3-ea94-4ac2-8b21-69809cabb0c7	Head and Neck	69.0	7BC6B159-19B4-4711-961D-830BC9E56493	4786A24C-D127-43FB-9D9C-FF59622B7B24	TCGA-BA-4074-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4074	TCGA-HNSC	462.0	Harvard Medical School	UNC	None	NO	T2	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16169	58cfa830e4b0c9d6adf6c184	TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted	TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted.bam	430.33	1.9	0.16	58cfa830e4b0c9d6adf6c184	TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4075-01A	6FA62461-E721-415A-8B0F-363B84292B82	Primary Tumor	Illumina HiSeq	85bcc36c-7376-4108-ac13-c495a75d3e00	Head and Neck	49.0	4DC36C31-35D8-4263-B141-C734545540A9	4B0B38F4-AC21-4F3E-8A8E-A69FBA619629	TCGA-BA-4075-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4075	TCGA-HNSC	283.0	Harvard Medical School	UNC	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16170	58cfa830e4b0c9d6adf6c1a7	TCGA-BA-5153-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BA-5153-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_6_rg.sorted	TCGA-BA-5153-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_6_rg.sorted.bam	61.4	1.9	0.14	58cfa830e4b0c9d6adf6c1a7	TCGA-BA-5153-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5153-10A	B3631718-9E0A-454C-BEE1-8F36EBC509D8	Blood Derived Normal	Illumina HiSeq	246bc4c7-cd66-439e-b78e-15222d1efba7	Head and Neck	51.0	F079E825-160A-40D5-97CC-1931F11C4E2E	88631234-EDDF-4B86-BAAD-6450C21ED2CC	TCGA-BA-5153-10A-01D-1431-02	HG19_Broad_variant	TCGA-BA-5153	TCGA-HNSC	1762.0	Harvard Medical School	UNC	None	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16171	58cfa830e4b0c9d6adf6c149	TCGA-BA-4076-01A-01D-2266-10_Illumina.filtered.	WGS	TCGA-BA-4076-01A-01D-2266-10_Illumina	TCGA-BA-4076-01A-01D-2266-10_Illumina.bam	333.33	1.9	0.05	58cfa830e4b0c9d6adf6c149	TCGA-BA-4076-01A-01D-2266-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4076-01A	7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70	Primary Tumor	Illumina HiSeq	62857418-5247-4ae1-8064-d900ef856428	Head and Neck	39.0	FD99FD83-4040-4738-8A5A-E42D36ECFE0E	E2B5C926-491D-430D-8D9C-5C73D7752D1B	TCGA-BA-4076-01A-01D-2266-10	GRCh37-lite	TCGA-BA-4076	TCGA-HNSC	415.0	Baylor College of Medicine	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16172	58cfa830e4b0c9d6adf6c242	TCGA-BB-4223-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BB-4223-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_8_rg.sorted	TCGA-BB-4223-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_8_rg.sorted.bam	341.4	1.6	0.15	58cfa830e4b0c9d6adf6c242	TCGA-BB-4223-10A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4223-10A	05F01280-BF77-4682-A7A8-20DD0EAC77BD	Blood Derived Normal	Illumina HiSeq	a8c97047-ef56-4439-be7b-19e789bde2bf	Head and Neck	48.0	75430612-09BB-4D6F-9304-62A5B517D424	139A8577-EC63-4AAF-9796-200173B6DE91	TCGA-BB-4223-10A-01D-1431-02	HG19_Broad_variant	TCGA-BB-4223	TCGA-HNSC		Harvard Medical School	Johns Hopkins	United States	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16174	58cfa831e4b0c9d6adf6c538	TCGA-CN-4730-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-4730-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_6_rg.sorted	TCGA-CN-4730-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_6_rg.sorted.bam	928.4	1.9	0.16	58cfa831e4b0c9d6adf6c538	TCGA-CN-4730-10A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4730-10A	35C1F2C6-771C-4533-82DF-F8E2EC7107D7	Blood Derived Normal	Illumina HiSeq	2fecd58a-13da-4b74-ae07-237756d10f5c	Head and Neck	62.0	3D7DC830-42C8-4746-AA06-C5A58E6AD510	D7DBCD9B-1AF6-41AE-8C6F-420E6041E346	TCGA-CN-4730-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4730	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16175	58cfa831e4b0c9d6adf6c6e7	TCGA-CN-4742-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-4742-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_4_rg.sorted	TCGA-CN-4742-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_4_rg.sorted.bam	41.4	1.9	0.16	58cfa831e4b0c9d6adf6c6e7	TCGA-CN-4742-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_4_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4742-10A	444E5BFC-D4E5-4B0D-B96D-88ECEA8873E9	Blood Derived Normal	Illumina HiSeq	2f928254-a183-425a-b4d0-4a9317c432fd	Head and Neck	48.0	580D4B59-8FB5-49BC-8030-56524652DDC3	80CAB596-28EA-43F4-BFEB-98599A3494CF	TCGA-CN-4742-10A-01D-1509-02	HG19_Broad_variant	TCGA-CN-4742	TCGA-HNSC	397.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16176	58cfa831e4b0c9d6adf6c684	TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted	TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted.bam	122.7	1.9	0.15	58cfa831e4b0c9d6adf6c684	TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4738-01A	97640EF0-0259-4244-95BA-48D28C60B372	Primary Tumor	Illumina HiSeq	142fc981-c09b-4d94-96d3-b0d48b4d59f2	Head and Neck	53.0	8277E744-0508-47D5-9CEA-11DCF7F56D35	0EABE3ED-367B-4055-8700-0036E6A0FB1D	TCGA-CN-4738-01A-02D-1509-02	HG19_Broad_variant	TCGA-CN-4738	TCGA-HNSC	436.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16177	58cfa831e4b0c9d6adf6ca63	TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina	TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina.bam	182.7		0.08	58cfa831e4b0c9d6adf6ca63	TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6989-01A	F33AA93F-B32D-4C4F-9A71-1E5AB69C6899	Primary Tumor	Illumina HiSeq	190e57a0-694b-46ca-a944-0bf0e9d732c2	Head and Neck	64.0	7AC8FB22-0A09-4B16-AF8C-B5C2E90A968A	08227616-02A5-46E8-9DB1-F2D1D691AB23	TCGA-CN-6989-01A-11D-A32X-10	GRCh37-lite	TCGA-CN-6989	TCGA-HNSC		Baylor College of Medicine	University of Pittsburgh	United States	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16178	58cfa831e4b0c9d6adf6c7bc	TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted	TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted.bam	172.0	1.9	0.15	58cfa831e4b0c9d6adf6c7bc	TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6019-01A	EE3061EC-273C-4BEF-A325-35E9C469BF01	Primary Tumor	Illumina HiSeq	e7b9cb7d-0a1a-4461-ab89-108d02821762	Head and Neck	61.0	AC349695-2219-4A67-ADD5-A94FF85794E1	2C509E96-12D7-4DBB-A02F-DCDCC6F76952	TCGA-CN-6019-01A-11D-1681-02	HG19_Broad_variant	TCGA-CN-6019	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16179	58cfa831e4b0c9d6adf6c5d2	TCGA-CN-5365-10A-01D-2276-10_Illumina.filtered.	WGS	TCGA-CN-5365-10A-01D-2276-10_Illumina	TCGA-CN-5365-10A-01D-2276-10_Illumina.bam	0.0	1.9	0.05	58cfa831e4b0c9d6adf6c5d2	TCGA-CN-5365-10A-01D-2276-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5365-10A	4CFFEA0B-90A7-4C86-A73F-BB8FECA3ADA7	Blood Derived Normal	Illumina HiSeq	65cf1dc0-039b-4fc7-85e5-efe031070b06	Head and Neck	38.0	665D66AD-54EE-478E-BDD0-85D77980FB3E	D8367C6F-52E6-430F-A9AC-CA6FAB7222F4	TCGA-CN-5365-10A-01D-2276-10	GRCh37-lite	TCGA-CN-5365	TCGA-HNSC	351.0	Baylor College of Medicine	University of Pittsburgh	None	NO	T2	N3	Head and Neck Squamous Cell Carcinoma	Stage IVB
s16180	58cfa831e4b0c9d6adf6c7b1	TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted	TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted.bam	155.7		0.15	58cfa831e4b0c9d6adf6c7b1	TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6996-01A	49B94421-FE82-4F24-8EF2-820674142418	Primary Tumor	Illumina HiSeq	533cea76-ea79-4b37-8e72-5626bc894990	Head and Neck	58.0	2C3790CE-A54D-431B-B76C-FA25441AA41C	5367CF72-E404-4203-AD7D-CF7663072EA7	TCGA-CN-6996-01A-11D-1911-02	HG19_Broad_variant	TCGA-CN-6996	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16181	58cfa831e4b0c9d6adf6c794	TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted	TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted.bam	69.0	1.9	0.15	58cfa831e4b0c9d6adf6c794	TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6017-01A	23C4E2EB-142B-4FCC-A974-9A248AEC3F37	Primary Tumor	Illumina HiSeq	e0dae8a5-f74f-4e25-98c2-238e28c54863	Head and Neck	55.0	6C07CD48-2269-4D42-9879-309EA4CD3A74	48A22F9A-2A18-4FCA-8271-44B3F7C3A628	TCGA-CN-6017-01A-11D-1681-02	HG19_Broad_variant	TCGA-CN-6017	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16182	58cfa831e4b0c9d6adf6c574	TCGA-CN-4738-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CN-4738-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_2_rg.sorted	TCGA-CN-4738-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_2_rg.sorted.bam	52.4	1.9	0.15	58cfa831e4b0c9d6adf6c574	TCGA-CN-4738-10A-01D-1509_120420_SN208_0286_BD0T87ACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4738-10A	97640EF0-0259-4244-95BA-48D28C60B372	Blood Derived Normal	Illumina HiSeq	6420a19a-13dc-4a15-9792-d6c02672c4c8	Head and Neck	53.0	51622170-A903-43CB-BC38-4D40C7EA170F	0487F393-1CF0-4CB4-864F-FA2C895E2E07	TCGA-CN-4738-10A-01D-1509-02	HG19_Broad_variant	TCGA-CN-4738	TCGA-HNSC	436.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16183	58cfa831e4b0c9d6adf6c5bf	TCGA-CN-5356-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-5356-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_8_rg.sorted	TCGA-CN-5356-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_8_rg.sorted.bam	231.4	1.9	0.16	58cfa831e4b0c9d6adf6c5bf	TCGA-CN-5356-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5356-10A	E1FED7AA-2BCE-45AE-B0C6-7F50EF97E425	Blood Derived Normal	Illumina HiSeq	057502ad-201c-4e2a-967a-1ed9dbf9245b	Head and Neck	56.0	CF684788-D8E6-49DA-8421-B2DBF040A529	9DCEEF82-8725-48B3-8728-4D48B3033796	TCGA-CN-5356-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5356	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16184	58cfa831e4b0c9d6adf6c634	TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted	TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted.bam	225.7	1.9	0.15	58cfa831e4b0c9d6adf6c634	TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5361-01A	044579EF-16A6-4F00-B951-EDC423D8A14F	Primary Tumor	Illumina HiSeq	490cddf8-816a-45f5-acbf-3fd898eb3479	Head and Neck	80.0	C807171A-4433-4246-A454-C5CF768DA8AA	A4E6D494-865F-4F60-B9C6-13C9C0CEA6AB	TCGA-CN-5361-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5361	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2a	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16185	58cfa831e4b0c9d6adf6c5dc	TCGA-CN-5364-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-5364-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_8_rg.sorted	TCGA-CN-5364-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_8_rg.sorted.bam	38.4	1.9	0.14	58cfa831e4b0c9d6adf6c5dc	TCGA-CN-5364-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5364-10A	13F63218-0949-41E6-A661-C844414C45B5	Blood Derived Normal	Illumina HiSeq	2dc9d158-11f1-4d04-a6e6-8075121def2e	Head and Neck	55.0	7CFD419C-8485-4080-BDB3-18B33964FBDF	31CB16D7-5896-4895-AE00-46DD28092923	TCGA-CN-5364-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5364	TCGA-HNSC	493.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16186	58cfa831e4b0c9d6adf6c602	TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted	TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted.bam	191.7	1.9	0.15	58cfa831e4b0c9d6adf6c602	TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6225-01A	90F44998-3C05-44B2-9501-BBD0F43C5147	Primary Tumor	Illumina HiSeq	a96392ab-a0d3-4c22-a2e2-08b58bb3e61b	Head and Neck	65.0	E907D8D4-C4C6-441F-9F19-FF3746E5D13E	40BFD664-E699-4F0D-9670-30D0F5CC8728	TCGA-CQ-6225-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6225	TCGA-HNSC	403.0	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16187	58cfa831e4b0c9d6adf6c68e	TCGA-CQ-6225-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CQ-6225-10A-01D-A32X-10_wgs_Illumina	TCGA-CQ-6225-10A-01D-A32X-10_wgs_Illumina.bam	38.0		0.07	58cfa831e4b0c9d6adf6c68e	TCGA-CQ-6225-10A-01D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6225-10A	90F44998-3C05-44B2-9501-BBD0F43C5147	Blood Derived Normal	Illumina HiSeq	16279dce-4563-4617-8c4e-0d1aca77f910	Head and Neck	65.0	D30CD5CB-D0DE-446A-8A57-4F8B69AB25FE	5B19CDD0-20C5-4FBD-ABF3-B88B95085A11	TCGA-CQ-6225-10A-01D-A32X-10	GRCh37-lite	TCGA-CQ-6225	TCGA-HNSC	403.0	Baylor College of Medicine	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16188	58cfa831e4b0c9d6adf6c6a3	TCGA-CR-6467-10A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CR-6467-10A-01D-2266-10_Illumina	TCGA-CR-6467-10A-01D-2266-10_Illumina.bam	145.0	1.8	0.05	58cfa831e4b0c9d6adf6c6a3	TCGA-CR-6467-10A-01D-2266-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6467-10A	89F91E36-FED8-4DA3-8A35-C761D6F65285	Blood Derived Normal	Illumina HiSeq	7bb031ed-5edc-4778-a891-4fe286111566	Head and Neck	59.0	2D9AD43C-F177-455E-9B63-1B9FFDC672D9	0075C3F3-A8FE-486F-AA97-B05FC8EF9375	TCGA-CR-6467-10A-01D-2266-10	GRCh37-lite	TCGA-CR-6467	TCGA-HNSC		Baylor College of Medicine	Vanderbilt University	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s16189	58cfa831e4b0c9d6adf6c92f	TCGA-CQ-6229-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CQ-6229-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_6_rg.sorted	TCGA-CQ-6229-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_6_rg.sorted.bam	57.0		0.14	58cfa831e4b0c9d6adf6c92f	TCGA-CQ-6229-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6229-10A	A091822C-447A-49A5-8C20-E329DF79599C	Blood Derived Normal	Illumina HiSeq	16ed6dc6-b3ef-4721-a79d-db228afd20c2	Head and Neck	61.0	6C33C6D3-A5B8-47D2-8A20-66A54E46E272	7CA9E363-A5A7-4458-8015-6A72FB563F79	TCGA-CQ-6229-10A-01D-1911-02	HG19_Broad_variant	TCGA-CQ-6229	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16190	58cfa831e4b0c9d6adf6c6c9	TCGA-CQ-6224-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CQ-6224-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_8_rg.sorted	TCGA-CQ-6224-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_8_rg.sorted.bam	67.0		0.16	58cfa831e4b0c9d6adf6c6c9	TCGA-CQ-6224-10A-01D-1911_120504_SN1222_0102_BC0VHDACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6224-10A	D86FD392-FA5C-4142-A647-440E6C32D478	Blood Derived Normal	Illumina HiSeq	532aa1c3-e7a0-4117-9718-2accf1ab0fd5	Head and Neck	52.0	737605E7-E6DC-4A82-A244-61B6AEFE392B	DC395D99-027E-4997-B75B-6E17E066FB3E	TCGA-CQ-6224-10A-01D-1911-02	HG19_Broad_variant	TCGA-CQ-6224	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16191	58cfa831e4b0c9d6adf6c79b	TCGA-CV-6433-11A-01D-2276-10_Illumina.filtered.	WGS	TCGA-CV-6433-11A-01D-2276-10_Illumina	TCGA-CV-6433-11A-01D-2276-10_Illumina.bam	16.33	1.7	0.05	58cfa831e4b0c9d6adf6c79b	TCGA-CV-6433-11A-01D-2276-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6433-11A	D5EEDFB5-4FA3-4A1E-AD0D-EA550B22A5BA	Solid Tissue Normal	Illumina HiSeq	3d294c7d-40cc-48ed-a436-c0a0b44ef8b9	Head and Neck	57.0	5E2DC8CE-9F72-4AAB-BFDB-C2C09EEE1AEE	EACADA84-BC54-4C03-879B-B290B7F6AA78	TCGA-CV-6433-11A-01D-2276-10	GRCh37-lite	TCGA-CV-6433	TCGA-HNSC		Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16192	58cfa831e4b0c9d6adf6c706	TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina	TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina.bam	464.7	1.8	0.08	58cfa831e4b0c9d6adf6c706	TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5431-01A	64BB5550-2735-4401-A0DB-58EC1020A32D	Primary Tumor	Illumina HiSeq	cbfa9144-8087-42ab-9497-71bfeddc55ae	Head and Neck	73.0	BE567C0A-3833-45D7-B846-D229A8E16E16	DE8EF60B-4DBE-4AA8-ADEF-6F58CDFADA29	TCGA-CV-5431-01A-01D-A32X-10	GRCh37-lite	TCGA-CV-5431	TCGA-HNSC	522.0	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16193	58cfa831e4b0c9d6adf6c70c	TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted	TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted.bam	115.0	1.9	0.15	58cfa831e4b0c9d6adf6c70c	TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5973-01A	8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB	Primary Tumor	Illumina HiSeq	4965236e-7173-4701-bd61-0550f3451b03	Head and Neck	62.0	5078222F-B257-4286-A29A-BC1E395149BC	55E8AEAC-4C0E-49DF-8F57-605E7C820B89	TCGA-CV-5973-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5973	TCGA-HNSC		Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s16194	58cfa831e4b0c9d6adf6c78a	TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted	TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted.bam	262.0	1.9	0.17	58cfa831e4b0c9d6adf6c78a	TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5439-01A	3EE863DA-7991-414F-82D8-2B6502D4C061	Primary Tumor	Illumina HiSeq	e10c02de-cabd-4311-baab-3bb90e13717f	Head and Neck	62.0	C94D8E61-8A15-4702-90EF-37616F1C015B	A1170138-A1B1-4D13-B66B-0507D3DE897B	TCGA-CV-5439-01A-01D-1681-02	HG19_Broad_variant	TCGA-CV-5439	TCGA-HNSC	546.0	Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16195	58cfa831e4b0c9d6adf6c6b3	TCGA-CV-5966-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-5966-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_7_rg.sorted	TCGA-CV-5966-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_7_rg.sorted.bam	62.0	1.8	0.14	58cfa831e4b0c9d6adf6c6b3	TCGA-CV-5966-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5966-10A	0D0731E2-8D82-4B6D-9258-2896A770A868	Blood Derived Normal	Illumina HiSeq	29536ca9-0a82-43fd-869c-1663c534daee	Head and Neck	63.0	BAD68BB8-4147-4981-959E-440AFC642F6E	154101FF-F8CF-4D61-BE7E-1DC04317799B	TCGA-CV-5966-10A-01D-1868-02	HG19_Broad_variant	TCGA-CV-5966	TCGA-HNSC	545.0	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16196	58cfa831e4b0c9d6adf6c6c6	TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina	TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina.bam	341.0	1.9	0.08	58cfa831e4b0c9d6adf6c6c6	TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5432-01A	D89B1FD6-BEF4-4803-8ED3-3B442BE600B6	Primary Tumor	Illumina HiSeq	6d564719-34a3-4b79-bf57-a5c8f73d7436	Head and Neck	68.0	B4A36114-80D3-4F28-B85A-077DC31EB485	9988EB07-01F6-4F83-8699-BB63E0525F08	TCGA-CV-5432-01A-02D-A32X-10	GRCh37-lite	TCGA-CV-5432	TCGA-HNSC		Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16197	58cfa831e4b0c9d6adf6c86a	TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted	TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted.bam	223.0	1.9	0.14	58cfa831e4b0c9d6adf6c86a	TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6003-01A	417B357E-C90E-4B63-AE7A-4B782038FFD3	Primary Tumor	Illumina HiSeq	b314312e-2a3f-45dd-a813-870344654395	Head and Neck	50.0	6892F7E3-630E-45B5-8C30-139161461A85	9DF426C5-E45E-428B-A63C-11D4C1BEB4B2	TCGA-CV-6003-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-6003	TCGA-HNSC		Harvard Medical School	MD Anderson Cancer Center	None	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s16198	58cfa831e4b0c9d6adf6c8c0	TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted	TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted.bam	22.0	1.9	0.16	58cfa831e4b0c9d6adf6c8c0	TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5971-01A	1465B7EC-8D2B-47DD-8387-977EED44CC86	Primary Tumor	Illumina HiSeq	03c22e39-15a9-4b8a-8db1-cf41d618b7fc	Head and Neck	60.0	82589B3F-BD41-4ABE-9469-7DD48447DDDC	5739D7DE-98D4-4591-B8B1-E0E9AA9B05DF	TCGA-CV-5971-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5971	TCGA-HNSC		Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2a	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16199	58cfa831e4b0c9d6adf6c7e7	TCGA-CV-5977-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-5977-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_7_rg.sorted	TCGA-CV-5977-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_7_rg.sorted.bam	22.0	1.9	0.17	58cfa831e4b0c9d6adf6c7e7	TCGA-CV-5977-11A-01D-1681_120427_SN1120_0137_BD0T3FACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5977-11A	50239D1D-B3A4-4240-AB83-B24BA67B1299	Solid Tissue Normal	Illumina HiSeq	e6770560-36ba-42ca-bdc1-8a715a864c51	Head and Neck	66.0	7DB4F0EF-5756-42F6-8D3B-68F68BCB7B8B	C4BE77A1-3AE3-4D82-B53B-7FAA22A796BD	TCGA-CV-5977-11A-01D-1681-02	HG19_Broad_variant	TCGA-CV-5977	TCGA-HNSC		Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16200	58cfa831e4b0c9d6adf6c786	TCGA-CV-5970-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-5970-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_8_rg.sorted	TCGA-CV-5970-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_8_rg.sorted.bam	4.0	1.8	0.15	58cfa831e4b0c9d6adf6c786	TCGA-CV-5970-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5970-10A	1F6167D9-C99D-4873-8D6E-E62A1C964135	Blood Derived Normal	Illumina HiSeq	509b8904-dfc6-4184-9e6c-1248a6280d9e	Head and Neck	59.0	156CC44B-397D-46D0-AF8C-2ECCF6F6CDC2	3222362E-0351-470B-82F3-EDEFBFA5B399	TCGA-CV-5970-10A-01D-1868-02	HG19_Broad_variant	TCGA-CV-5970	TCGA-HNSC	406.0	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16201	58cfa831e4b0c9d6adf6c7be	TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina	TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina.bam	124.43		0.07	58cfa831e4b0c9d6adf6c7be	TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6956-01A	8C238D30-DF8E-4E6B-98FC-21696269A294	Primary Tumor	Illumina HiSeq	f9762350-aee5-49d2-a5de-165317ff2bd3	Head and Neck	67.0	8B9F33FA-04EF-4767-93D1-98F6E420D037	5046F1B4-9D95-4841-BA30-691FA44719A2	TCGA-CV-6956-01A-21D-A32X-10	GRCh37-lite	TCGA-CV-6956	TCGA-HNSC	217.0	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s16202	58cfa831e4b0c9d6adf6c832	TCGA-CV-6954-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-6954-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_7_rg.sorted	TCGA-CV-6954-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_7_rg.sorted.bam	16.0	1.8	0.14	58cfa831e4b0c9d6adf6c832	TCGA-CV-6954-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_7_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6954-10A	402FD96C-76D3-4AC2-9F64-77BD34BE0ADB	Blood Derived Normal	Illumina HiSeq	90995f22-7f27-483b-9410-bfd068cdbc20	Head and Neck	59.0	EAA7EA4D-7F53-4107-B147-EA87EFA8B954	2B5419A2-9E0E-40AF-9FC7-EA3A56780E87	TCGA-CV-6954-10A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6954	TCGA-HNSC	2002.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	NX	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16203	58cfa831e4b0c9d6adf6c7fc	TCGA-CV-6959-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-6959-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_8_rg.sorted	TCGA-CV-6959-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_8_rg.sorted.bam	79.7	1.9	0.14	58cfa831e4b0c9d6adf6c7fc	TCGA-CV-6959-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6959-11A	EF3CE0E5-D2E8-4616-8B1A-A78C591CF235	Solid Tissue Normal	Illumina HiSeq	e12b73cf-efab-4371-8449-776e46f7949c	Head and Neck	48.0	C6706A96-631D-43D0-9A08-0BBE9D6295FB	556078E9-11DC-4089-9520-D5D5C49E42E0	TCGA-CV-6959-11A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6959	TCGA-HNSC	256.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16204	58cfa831e4b0c9d6adf6c813	TCGA-CV-7238-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-7238-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_6_rg.sorted	TCGA-CV-7238-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_6_rg.sorted.bam	1.83		0.15	58cfa831e4b0c9d6adf6c813	TCGA-CV-7238-10A-01D-2317_120710_SN590_0166_AC0VNFACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7238-10A	78FCC813-D0A8-44AA-B004-62810DCA9D12	Blood Derived Normal	Illumina HiSeq	70f8bf18-8050-4dad-9029-c90972a9bfb4	Head and Neck	69.0	CB099E57-06AC-4139-8B3D-45F1E395B3C5	AEEBFA8B-F1A2-41DA-905D-FC10B87E87EC	TCGA-CV-7238-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7238	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16206	58cfa831e4b0c9d6adf6c716	TCGA-CV-7428-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-7428-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_1_rg.sorted	TCGA-CV-7428-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_1_rg.sorted.bam	6.13		0.15	58cfa831e4b0c9d6adf6c716	TCGA-CV-7428-10A-01D-2317_120623_SN1222_0119_BC0WLLACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7428-10A	90D3C240-5CB6-4601-A852-B5CDFBCD6483	Blood Derived Normal	Illumina HiSeq	ff322aea-a4fd-4377-81b7-e8cac37aa770	Head and Neck	47.0	52BAF3E9-1C5A-4DA5-81B9-729F84C2B36B	7E12A56F-C3E7-4AA4-BD55-D6A572587F98	TCGA-CV-7428-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7428	TCGA-HNSC	1671.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16207	58cfa831e4b0c9d6adf6c8b3	TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted	TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted.bam	10.03		0.14	58cfa831e4b0c9d6adf6c8b3	TCGA-CV-7411-10A-01D-2317_120710_SN590_0165_BC0VU7ACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7411-10A	600FC87B-A177-4BF9-9084-457F7E7E102C	Blood Derived Normal	Illumina HiSeq	9ad035d2-035c-4447-a744-24409cfeb23e	Head and Neck	64.0	3F69EF25-0751-46B5-934D-9501DA864535	2A1972F4-F2EE-40C5-BF2F-22F4C26237D7	TCGA-CV-7411-10A-01D-2317-26	HG19_Broad_variant	TCGA-CV-7411	TCGA-HNSC	2717.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16208	58cfa831e4b0c9d6adf6c9d2	TCGA-DQ-5630-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DQ-5630-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_3_rg.sorted	TCGA-DQ-5630-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_3_rg.sorted.bam	134.0	1.9	0.15	58cfa831e4b0c9d6adf6c9d2	TCGA-DQ-5630-10A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5630-10A	91A712B5-A724-48D0-BA06-4F6857683463	Blood Derived Normal	Illumina HiSeq	1c95b304-0beb-462d-bb72-fe1946dfbc5f	Head and Neck	73.0	06BDB35A-E44C-4D86-AD0E-3BF74F567609	08A5D543-6FF9-402B-B86D-1A5ED0F0D75E	TCGA-DQ-5630-10A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5630	TCGA-HNSC		Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16209	58cfa832e4b0c9d6adf6cf1a	TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted.filtered.	WGS	TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted	TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted.bam	52.73		0.15	58cfa832e4b0c9d6adf6cf1a	TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-H7-7774-01A	EEAE67AC-C9E0-468D-AAD6-052501F7B982	Primary Tumor	Illumina HiSeq	ab347312-e135-4dd6-9be3-fa5fdebbcd68	Head and Neck	75.0	50F6615A-49CC-4E14-B5DD-54784B66C27B	B9B2B6F5-57EB-4DD6-8FE2-1E8669840DAB	TCGA-H7-7774-01A-21D-2317-26	HG19_Broad_variant	TCGA-H7-7774	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16311	58cfa82ee4b0c9d6adf6aad0	G25251.TCGA-CR-7404-10A-01D-2334-08.1.filtered.	WGS	G25251.TCGA-CR-7404-10A-01D-2334-08.1	G25251.TCGA-CR-7404-10A-01D-2334-08.1.bam	210.0		0.05	58cfa82ee4b0c9d6adf6aad0	G25251.TCGA-CR-7404-10A-01D-2334-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7404-10A	D189A6C6-210F-4957-B500-457D5CE3F867	Blood Derived Normal	Illumina HiSeq	ee383040-a4f3-4618-8286-715b2d1fa381	Head and Neck	53.0	A0723862-62F9-4770-B415-E8F52C447E7A	8BEF3E1F-1C5D-4770-9FDE-25B760B4C235	TCGA-CR-7404-10A-01D-2334-08	HG19_Broad_variant	TCGA-CR-7404	TCGA-HNSC		Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16312	58cfa82ee4b0c9d6adf6ab02	G23071.TCGA_CV_7100_01A_11D_2268_08.1.filtered.	WGS	G23071.TCGA_CV_7100_01A_11D_2268_08.1	G23071.TCGA_CV_7100_01A_11D_2268_08.1.bam	335.7		0.14	58cfa82ee4b0c9d6adf6ab02	G23071.TCGA_CV_7100_01A_11D_2268_08.1.bam	Dead	MALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7100-01A	90A8D2CB-1F31-45F9-8575-EED3CB9A7798	Primary Tumor	Illumina HiSeq	4e9d6eec-9af8-4de3-b449-1d56dd8ba30f	Head and Neck	66.0	08C3093D-4100-4BFC-92FC-A11F1393868F	FECCC27E-5C2E-4339-8746-0945FEE93C1E	TCGA-CV-7100-01A-11D-2268-08	HG19_Broad_variant	TCGA-CV-7100	TCGA-HNSC	274.0	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s16314	58cfa830e4b0c9d6adf6c214	TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted	TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted.bam	246.33	1.9	0.15	58cfa830e4b0c9d6adf6c214	TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4077-01B	4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A	Primary Tumor	Illumina HiSeq	4f243210-88ea-4d9f-88fd-faf45b45d38e	Head and Neck	45.0	327BBCA7-FA25-4A92-BE27-21A4C184C760	8428602A-5EEC-4D09-B187-02B1CFF24EB5	TCGA-BA-4077-01B-01D-1431-02	HG19_Broad_variant	TCGA-BA-4077	TCGA-HNSC	1134.0	Harvard Medical School	UNC	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16315	58cfa830e4b0c9d6adf6c1d4	TCGA-BB-4225-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BB-4225-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_4_rg.sorted	TCGA-BB-4225-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_4_rg.sorted.bam	71.4	1.4	0.13	58cfa830e4b0c9d6adf6c1d4	TCGA-BB-4225-10A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4225-10A	C1F50A22-38DF-41CC-A1F4-F7985504A7AC	Blood Derived Normal	Illumina HiSeq	4d810623-2a13-4ed1-ac3c-9582a8e96048	Head and Neck	73.0	F50A9185-7AF4-4EB7-8866-AA3FBBBC3BAB	27BEDA53-5C52-4515-9125-702366FE2B4A	TCGA-BB-4225-10A-01D-1431-02	HG19_Broad_variant	TCGA-BB-4225	TCGA-HNSC		Harvard Medical School	Johns Hopkins	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16316	58cfa830e4b0c9d6adf6c21a	TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted	TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted.bam	422.7	1.9	0.15	58cfa830e4b0c9d6adf6c21a	TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5153-01A	B3631718-9E0A-454C-BEE1-8F36EBC509D8	Primary Tumor	Illumina HiSeq	3bd56918-8f2b-4486-86ea-e479c2cab413	Head and Neck	51.0	2DC7070A-9C70-4BB1-9634-8C934BB9C8D1	F14D0AA8-E7BB-4E0E-B887-DA7B6FA0BC86	TCGA-BA-5153-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-5153	TCGA-HNSC	1762.0	Harvard Medical School	UNC	None	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16317	58cfa830e4b0c9d6adf6c193	TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted	TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted.bam	64.4	1.9	0.14	58cfa830e4b0c9d6adf6c193	TCGA-BA-5555-10A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_5_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5555-10A	8970F713-4A7A-4125-892C-6A34139371D8	Blood Derived Normal	Illumina HiSeq	cb082daa-fb68-4836-bd36-abeed40b581c	Head and Neck	54.0	99CA3C12-0D63-428F-8B1B-03E4A3E8E233	8837A50C-34E3-471D-89FE-D9444255804B	TCGA-BA-5555-10A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5555	TCGA-HNSC		Harvard Medical School	UNC	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16318	58cfa830e4b0c9d6adf6c162	TCGA-BA-5149-10A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-5149-10A-01D-A32X-10_wgs_Illumina	TCGA-BA-5149-10A-01D-A32X-10_wgs_Illumina.bam	65.4	1.9	0.08	58cfa830e4b0c9d6adf6c162	TCGA-BA-5149-10A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5149-10A	CB99FB14-641C-4FB3-BF1D-17EFB8CD982A	Blood Derived Normal	Illumina HiSeq	8626b587-5c7a-4a53-8c31-903465f3ce40	Head and Neck	47.0	C991BC28-AB65-4D05-931A-676BE035B94C	B39B682A-56FE-4EAC-87DC-8A13411C1976	TCGA-BA-5149-10A-01D-A32X-10	GRCh37-lite	TCGA-BA-5149	TCGA-HNSC		Baylor College of Medicine	UNC	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16319	58cfa830e4b0c9d6adf6c14d	TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina	TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina.bam	116.7	1.9	0.08	58cfa830e4b0c9d6adf6c14d	TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5556-01A	70741B73-9683-42BD-87FC-6A021A70103B	Primary Tumor	Illumina HiSeq	e855f092-899d-469a-981c-5094b07c31ac	Head and Neck	58.0	C00EEDDB-6AE2-48BA-8677-C174E579A724	8294A969-59A1-4D3B-895B-F07E96BF9F7A	TCGA-BA-5556-01A-01D-A32X-10	GRCh37-lite	TCGA-BA-5556	TCGA-HNSC		Baylor College of Medicine	UNC	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16320	58cfa830e4b0c9d6adf6c1fa	TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted	TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted.bam	476.7	1.9	0.16	58cfa830e4b0c9d6adf6c1fa	TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5559-01A	17B17D91-C3DF-4B89-9C10-4DB069AFF656	Primary Tumor	Illumina HiSeq	a6749339-8b87-4219-84dd-8045857cbe79	Head and Neck	71.0	FBEA64F9-B46B-4AF1-BFB2-1791D93977B6	61532C84-EDD9-492D-AF89-99086F87381E	TCGA-BA-5559-01A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5559	TCGA-HNSC		Harvard Medical School	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16321	58cfa831e4b0c9d6adf6c6e6	TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted	TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted.bam	850.4	1.9	0.15	58cfa831e4b0c9d6adf6c6e6	TCGA-CN-4734-10A-01D-1431_120412_SN208_0284_BD0T51ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4734-10A	B80FDC9A-341D-4277-9664-8E8F770D9DDD	Blood Derived Normal	Illumina HiSeq	dc55020c-4480-41b1-ad6f-0295abea2b6c	Head and Neck	70.0	782C9013-4F6F-461B-AA33-5E60D38BFCCC	67C9A43F-0254-47C0-9AE7-B3328D75CBFA	TCGA-CN-4734-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4734	TCGA-HNSC		Harvard Medical School	University of Pittsburgh	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16322	58cfa831e4b0c9d6adf6c5da	TCGA-CN-5366-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-5366-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_5_rg.sorted	TCGA-CN-5366-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_5_rg.sorted.bam	31.4	1.9	0.15	58cfa831e4b0c9d6adf6c5da	TCGA-CN-5366-10A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5366-10A	30EB06A5-8E88-4C46-BEBB-FB93CA07F108	Blood Derived Normal	Illumina HiSeq	8d6d4c85-46e4-449c-9bc1-f75a4af110a6	Head and Neck	51.0	111AD944-F78E-4EC6-967B-F05C49B49B1C	1683419A-F9D7-4484-A65B-B5A1DE47D1EB	TCGA-CN-5366-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5366	TCGA-HNSC	360.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16323	58cfa831e4b0c9d6adf6c5fc	TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted	TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted.bam	345.7	1.9	0.15	58cfa831e4b0c9d6adf6c5fc	TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5369-01A	B98867D7-7D5A-4C58-8878-37BEE6F2F4FA	Primary Tumor	Illumina HiSeq	bd85b141-d240-412f-9b74-379c4e3797d2	Head and Neck	90.0	B4C02606-0F86-46E4-9DAF-DC7DBCD60D78	1A532CA9-E72F-4906-867B-272A18CFEC79	TCGA-CN-5369-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5369	TCGA-HNSC	380.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16324	58cfa831e4b0c9d6adf6c671	TCGA-CN-5363-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-5363-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_7_rg.sorted	TCGA-CN-5363-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_7_rg.sorted.bam	15.4	1.9	0.14	58cfa831e4b0c9d6adf6c671	TCGA-CN-5363-10A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_7_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5363-10A	291B069C-9DDE-4E1E-8430-85146BC94338	Blood Derived Normal	Illumina HiSeq	97348237-93c4-44d0-9bb6-3c2ee7ac10a1	Head and Neck	48.0	591E99EC-46F9-442D-AC20-745DCCC8A52B	559D615C-BE5B-4AD1-8860-B633A0B361B6	TCGA-CN-5363-10A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5363	TCGA-HNSC	253.0	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N3	Head and Neck Squamous Cell Carcinoma	Stage IVB
s16325	58cfa831e4b0c9d6adf6c8fe	TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina	TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina.bam	267.7		0.07	58cfa831e4b0c9d6adf6c8fe	TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6994-01A	6909302D-358A-46CD-8052-EEDB09C83C83	Primary Tumor	Illumina HiSeq	165171a0-a11e-4c82-b718-897ca9741478	Head and Neck	67.0	1A5AF8E2-61B4-4A04-B4B6-EA41FC34C89A	190EB791-383D-4E27-870D-E470630843E7	TCGA-CN-6994-01A-11D-A32X-10	GRCh37-lite	TCGA-CN-6994	TCGA-HNSC		Baylor College of Medicine	University of Pittsburgh	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16326	58cfa831e4b0c9d6adf6c665	TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted	TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted.bam	38.0		0.14	58cfa831e4b0c9d6adf6c665	TCGA-CQ-6225-10A-01D-1911_120504_SN208_0296_AC0V09ACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6225-10A	90F44998-3C05-44B2-9501-BBD0F43C5147	Blood Derived Normal	Illumina HiSeq	82431af8-972a-4db7-b424-bac44c375bc2	Head and Neck	65.0	D30CD5CB-D0DE-446A-8A57-4F8B69AB25FE	7F65174A-1AB8-492D-91B6-0C39F14243AF	TCGA-CQ-6225-10A-01D-1911-02	HG19_Broad_variant	TCGA-CQ-6225	TCGA-HNSC	403.0	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16327	58cfa831e4b0c9d6adf6c69a	TCGA-CQ-5329-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CQ-5329-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_7_rg.sorted	TCGA-CQ-5329-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_7_rg.sorted.bam	77.7	1.9	0.14	58cfa831e4b0c9d6adf6c69a	TCGA-CQ-5329-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5329-10A	02DCC11F-4F0E-4C9E-8D96-D22D47BEEF5D	Blood Derived Normal	Illumina HiSeq	9f0c3cb3-500d-46d1-8abc-1b4492354050	Head and Neck	46.0	03BF8F50-0D93-4656-A625-4D4BBF3A876F	E3943EA3-6B2E-402E-BB8D-B226FADF1038	TCGA-CQ-5329-10A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5329	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16328	58cfa831e4b0c9d6adf6c66a	TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina	TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina.bam	170.7		0.08	58cfa831e4b0c9d6adf6c66a	TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7382-01A	F030E410-2585-461E-AD23-9FDF026AC06C	Primary Tumor	Illumina HiSeq	ab5f1c0e-d07d-49b4-9fc2-b74f3c4928a6	Head and Neck	49.0	A8D8886B-B422-4C66-B0B4-4C9F0546B1B3	B86E88E7-0D5F-4B32-A35F-DC97251AB990	TCGA-CR-7382-01A-11D-A32X-10	GRCh37-lite	TCGA-CR-7382	TCGA-HNSC		Baylor College of Medicine	Vanderbilt University	United States	NO	T2	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16329	58cfa831e4b0c9d6adf6c65f	TCGA-CQ-5325-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CQ-5325-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_5_rg.sorted	TCGA-CQ-5325-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_5_rg.sorted.bam	35.7	1.9	0.14	58cfa831e4b0c9d6adf6c65f	TCGA-CQ-5325-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5325-10A	408C5D54-7888-4955-8386-BF8819B48A6C	Blood Derived Normal	Illumina HiSeq	3fe557f8-8ca8-4e87-b083-a50b0c942824	Head and Neck	65.0	4F23D06D-E97A-44A6-A485-635E64FDFAB0	FDF04252-7092-4C2A-937F-A7ED2E15CED7	TCGA-CQ-5325-10A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5325	TCGA-HNSC	654.0	Harvard Medical School	University Health Network, Toronto	Canada	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s16330	58cfa831e4b0c9d6adf6c6d4	TCGA-CQ-5327-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CQ-5327-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_6_rg.sorted	TCGA-CQ-5327-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_6_rg.sorted.bam	87.7	1.9	0.14	58cfa831e4b0c9d6adf6c6d4	TCGA-CQ-5327-10A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_6_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5327-10A	5A03E2B6-4C8B-479A-9036-9859AF031DA4	Blood Derived Normal	Illumina HiSeq	f13990a7-88ec-44b6-b54c-82cd223ab0e2	Head and Neck	61.0	1C3A8D45-573F-49F3-AF6C-F5686B6F21C5	B39DC256-152A-4592-B7BC-6859E46D1F8E	TCGA-CQ-5327-10A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5327	TCGA-HNSC		Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16331	58cfa831e4b0c9d6adf6c678	TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted	TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted.bam	166.0	1.9	0.14	58cfa831e4b0c9d6adf6c678	TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5325-01A	408C5D54-7888-4955-8386-BF8819B48A6C	Primary Tumor	Illumina HiSeq	a7440672-d797-4ad6-979a-c0835f0c2768	Head and Neck	65.0	8394A7F6-1BF6-473E-A155-3DA1A3DE244F	FFB4F8E1-B683-4A35-A5E7-15DBF610AE47	TCGA-CQ-5325-01A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5325	TCGA-HNSC	654.0	Harvard Medical School	University Health Network, Toronto	Canada	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s16332	58cfa831e4b0c9d6adf6c658	TCGA-CR-5249-10A-01D-2276-10_Illumina.filtered.	WGS	TCGA-CR-5249-10A-01D-2276-10_Illumina	TCGA-CR-5249-10A-01D-2276-10_Illumina.bam	12.73	1.9	0.05	58cfa831e4b0c9d6adf6c658	TCGA-CR-5249-10A-01D-2276-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-5249-10A	C7DF3466-B9A7-4818-883B-D0CD08483570	Blood Derived Normal	Illumina HiSeq	6a1956ba-8f1c-4504-86e4-1395788b83ff	Head and Neck	35.0	B72390D2-F19E-493D-9A30-CD81DD232188	4070818B-1918-4D2A-BEB7-98B752D51A8D	TCGA-CR-5249-10A-01D-2276-10	GRCh37-lite	TCGA-CR-5249	TCGA-HNSC		Baylor College of Medicine	Vanderbilt University	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II
s16333	58cfa831e4b0c9d6adf6c819	TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted	TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted.bam	9.03		0.13	58cfa831e4b0c9d6adf6c819	TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6998-01A	039788EC-1364-40C7-9E9D-13DC305674E9	Primary Tumor	Illumina HiSeq	d281a462-58dd-4303-9419-617fec3fcf35	Head and Neck	53.0	64C8DB8B-5D5C-4FBE-8996-4A7CB161D4A0	88B8B48D-51B8-4D46-9C36-E565A2582D94	TCGA-CN-6998-01A-23D-2317-26	HG19_Broad_variant	TCGA-CN-6998	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16334	58cfa831e4b0c9d6adf6c6fc	TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted	TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted.bam	464.7	1.8	0.15	58cfa831e4b0c9d6adf6c6fc	TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5431-01A	64BB5550-2735-4401-A0DB-58EC1020A32D	Primary Tumor	Illumina HiSeq	0cba1ad9-9899-40b0-9fa7-dc39030c04e7	Head and Neck	73.0	BE567C0A-3833-45D7-B846-D229A8E16E16	D751368D-5948-42EF-8C61-D24595CAC1E9	TCGA-CV-5431-01A-01D-1509-02	HG19_Broad_variant	TCGA-CV-5431	TCGA-HNSC	522.0	Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16335	58cfa831e4b0c9d6adf6c702	TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted	TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted.bam	99.0	1.9	0.14	58cfa831e4b0c9d6adf6c702	TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5966-01A	0D0731E2-8D82-4B6D-9258-2896A770A868	Primary Tumor	Illumina HiSeq	a774b0c6-39f6-4601-9c2a-5a81369b9f87	Head and Neck	63.0	E71C33E9-1F74-4CF6-B6BF-985D0C96F71E	84D0CA61-132A-4B85-A343-0C55DE088B0C	TCGA-CV-5966-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5966	TCGA-HNSC	545.0	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16336	58cfa831e4b0c9d6adf6c845	TCGA-CV-5442-01A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CV-5442-01A-01D-2266-10_Illumina	TCGA-CV-5442-01A-01D-2266-10_Illumina.bam	323.7	1.9	0.05	58cfa831e4b0c9d6adf6c845	TCGA-CV-5442-01A-01D-2266-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5442-01A	3C975B68-4A6E-4C97-A8D1-B9A427D4957C	Primary Tumor	Illumina HiSeq	53f0ce53-95fe-4d6c-930d-f8427c0c46ec	Head and Neck	76.0	698208BB-7272-4AD5-9CC0-909CB669BDAF	46D35B82-E1B7-4D35-BE5E-3A70FD47E421	TCGA-CV-5442-01A-01D-2266-10	GRCh37-lite	TCGA-CV-5442	TCGA-HNSC		Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16337	58cfa831e4b0c9d6adf6c6fe	TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted	TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted.bam	37.0	1.9	0.13	58cfa831e4b0c9d6adf6c6fe	TCGA-CV-5970-11A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5970-11A	1F6167D9-C99D-4873-8D6E-E62A1C964135	Solid Tissue Normal	Illumina HiSeq	004bd2ad-a03c-45c2-9e51-6051014fe91b	Head and Neck	59.0	EF1AEFD1-1B8F-4840-9037-282DE48ED7F7	B31C32DB-0966-4A8A-AD18-0F5EDAFBBCCB	TCGA-CV-5970-11A-01D-1681-02	HG19_Broad_variant	TCGA-CV-5970	TCGA-HNSC	406.0	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16338	58cfa831e4b0c9d6adf6c70a	TCGA-CV-5442-11A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CV-5442-11A-01D-2266-10_Illumina	TCGA-CV-5442-11A-01D-2266-10_Illumina.bam	36.7	1.8	0.05	58cfa831e4b0c9d6adf6c70a	TCGA-CV-5442-11A-01D-2266-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5442-11A	3C975B68-4A6E-4C97-A8D1-B9A427D4957C	Solid Tissue Normal	Illumina HiSeq	40685f5a-d0e0-4f57-be78-25032bb1a9f2	Head and Neck	76.0	EC885AF4-3513-4790-AB1F-6ECC94B6115D	6527E1BE-0D25-4846-89B7-6C6B407E25E9	TCGA-CV-5442-11A-01D-2266-10	GRCh37-lite	TCGA-CV-5442	TCGA-HNSC		Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16339	58cfa831e4b0c9d6adf6c874	TCGA-CV-6933-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-6933-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_1_rg.sorted	TCGA-CV-6933-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_1_rg.sorted.bam	215.7	1.9	0.16	58cfa831e4b0c9d6adf6c874	TCGA-CV-6933-11A-01D-1911_120526_SN208_0303_BD12PWACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6933-11A	2A749317-0156-4213-8482-B2C2D6E52E9B	Solid Tissue Normal	Illumina HiSeq	8d4274cf-c829-4e6a-abf1-e3380c63ab8f	Head and Neck	53.0	EDD36B53-EB43-4ED6-9509-53A56CDCF80D	2E0F5A01-B6BF-4A04-9F70-05CAECA30B83	TCGA-CV-6933-11A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6933	TCGA-HNSC	2741.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s16340	58cfa831e4b0c9d6adf6c782	TCGA-CV-6959-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-6959-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_8_rg.sorted	TCGA-CV-6959-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_8_rg.sorted.bam	16.0	1.9	0.15	58cfa831e4b0c9d6adf6c782	TCGA-CV-6959-10A-01D-1911_120505_SN1120_0138_AD11NHACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6959-10A	EF3CE0E5-D2E8-4616-8B1A-A78C591CF235	Blood Derived Normal	Illumina HiSeq	4eee28c3-7d03-46c8-99b8-b3b17fce88d8	Head and Neck	48.0	854B6BC0-3318-4D35-A6F5-6F598E47870C	8862CE4E-8AA5-4542-8750-67B26759B7D1	TCGA-CV-6959-10A-01D-1911-02	HG19_Broad_variant	TCGA-CV-6959	TCGA-HNSC	256.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III
s16341	58cfa831e4b0c9d6adf6c7a3	TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted	TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted.bam	62.7	1.9	0.15	58cfa831e4b0c9d6adf6c7a3	TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6954-01A	402FD96C-76D3-4AC2-9F64-77BD34BE0ADB	Primary Tumor	Illumina HiSeq	115469a6-3c3e-4a3b-adf9-ed831266829c	Head and Neck	59.0	F72D39EA-7DB5-47C6-9428-3E26454C9A9A	7FA6660F-0B18-4F4D-AEA1-17C22A9DBAA6	TCGA-CV-6954-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6954	TCGA-HNSC	2002.0	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	NX	Head and Neck Squamous Cell Carcinoma	Stage IVA
s16342	58cfa831e4b0c9d6adf6c7da	TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted	TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted.bam	289.73		0.15	58cfa831e4b0c9d6adf6c7da	TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7091-01A	2A192049-6435-49AB-8444-DDEB2B9EE774	Primary Tumor	Illumina HiSeq	8a0170b3-9cda-4426-be4b-9e488f6244c2	Head and Neck	54.0	3AB78DC4-682E-4B5A-ADDA-223ACF0FBB6A	78998DCE-A468-416B-9F81-D64E43B52883	TCGA-CV-7091-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7091	TCGA-HNSC		MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I
s16343	58cfa831e4b0c9d6adf6c8e4	TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina	TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina.bam	464.7		0.08	58cfa831e4b0c9d6adf6c8e4	TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CX-7086-01A	AD6C9D09-2C03-4786-A72D-DD2AA5F603D4	Primary Tumor	Illumina HiSeq	2c64cb1b-6ae4-4191-9b2c-e5c13e267e83	Head and Neck	53.0	B293A736-9A82-4AD9-BF7E-9E2CEA09DDBC	E52FFA79-557A-4024-81F3-F3826C227EC5	TCGA-CX-7086-01A-11D-A32X-10	GRCh37-lite	TCGA-CX-7086	TCGA-HNSC		Baylor College of Medicine	Medical College of Georgia	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III
s16344	58cfa831e4b0c9d6adf6ca62	TCGA-DQ-5625-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_2_rg.sorted.filtered.	WGS	TCGA-DQ-5625-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_2_rg.sorted	TCGA-DQ-5625-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_2_rg.sorted.bam	31.0	1.9	0.16	58cfa831e4b0c9d6adf6ca62	TCGA-DQ-5625-10A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5625-10A	53D9A130-4A3A-4491-85CD-9A44415A1632	Blood Derived Normal	Illumina HiSeq	faef45e3-26d8-4053-a1ff-b62774815392	Head and Neck	52.0	F3AD5B44-87B1-41AE-8CC1-42E158BC174C	EB9FB8DF-AD96-4EFF-8673-4D3DDB4BD6AB	TCGA-DQ-5625-10A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5625	TCGA-HNSC		Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16345	58cfa831e4b0c9d6adf6c954	TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina	TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina.bam	233.7	1.9	0.08	58cfa831e4b0c9d6adf6c954	TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5629-01A	E95E9E7D-A1ED-46EB-9CF8-1D355BF0577F	Primary Tumor	Illumina HiSeq	3fb0505f-e847-4658-93f1-0af7d8617e66	Head and Neck	64.0	57EA3EED-F8E2-4310-90C0-50D89F818A12	2AFB198A-D4AA-4544-BDCE-85695E185869	TCGA-DQ-5629-01A-01D-A32X-10	GRCh37-lite	TCGA-DQ-5629	TCGA-HNSC		Baylor College of Medicine	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s16346	58cfa831e4b0c9d6adf6c9c7	TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted	TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted.bam	374.7	1.9	0.15	58cfa831e4b0c9d6adf6c9c7	TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5630-01A	91A712B5-A724-48D0-BA06-4F6857683463	Primary Tumor	Illumina HiSeq	865b23ff-32b6-41bf-8316-cde4e80d7873	Head and Neck	73.0	A0CDB208-E66F-4AD7-86FA-5077145A4A68	4C2960DA-103B-4620-ABCD-0EE586F39E0D	TCGA-DQ-5630-01A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5630	TCGA-HNSC		Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available
s2674	58cfa82ee4b0c9d6adf6aa78	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.filtered.	WGS	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.bam	59.68	2.07	0.09	58cfa82ee4b0c9d6adf6aa78	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20T-01A	096B4F32-10C1-4737-A0DD-CAE04C54EE33	Primary Tumor	Illumina HiSeq	7d40d139-a746-424d-9f90-d5d3da5e98cb	Bladder	63.0	52F538EF-B05D-4C76-9976-CE6D49158016	301D6CE3-4099-4C1D-8E50-C04B7CE91450	TCGA-BT-A20T-01A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20T	TCGA-BLCA	453.0	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2677	58cfa82ee4b0c9d6adf6aab6	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.filtered.	WGS	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.bam	30.45		0.08	58cfa82ee4b0c9d6adf6aab6	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N5-01A	A658BECF-3934-49F2-9E74-291DCA61D4BB	Primary Tumor	Illumina HiSeq	3519f8d9-0eab-45e8-b398-5ddc469243cd	Bladder	69.0	66559B5F-AB2F-406B-9EDB-0F5085EEC7C5	418A3DEC-96FF-4719-BECB-E1A8260CCE2F	TCGA-FD-A3N5-01A-11D-A21A-08	HG19_Broad_variant	TCGA-FD-A3N5	TCGA-BLCA		Broad Institute of MIT and Harvard	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2678	58cfa82ee4b0c9d6adf6aae8	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.filtered.	WGS	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.bam	67.64	2.28	0.09	58cfa82ee4b0c9d6adf6aae8	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A27C-01A	7FEE9D6F-C0EA-43C2-89C2-66D965A077A8	Primary Tumor	Illumina HiSeq	456bc333-4951-4b6e-845e-2af77b0a86d7	Bladder	52.0	EAD6792B-4E52-4C28-891C-6D8696873A13	ACC629CB-AD03-4CEC-9B21-922E4932EF3E	TCGA-CF-A27C-01A-11D-A16O-08	HG19_Broad_variant	TCGA-CF-A27C	TCGA-BLCA		Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2687	58cfa82ee4b0c9d6adf6a8d2	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.filtered.	WGS	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.bam	70.38	1.89	0.08	58cfa82ee4b0c9d6adf6a8d2	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AG-01A	F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5	Primary Tumor	Illumina HiSeq	af228568-1064-4709-8bc8-435278c73ca0	Bladder	65.0	64668AA0-DDE5-4534-8CD0-378881E4A4E4	7D2A22EB-7344-4CBA-AD7D-94C3F9EF3D7C	TCGA-DK-A1AG-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1AG	TCGA-BLCA		Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2688	58cfa82ee4b0c9d6adf6ad0e	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.filtered.	WGS	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.bam	76.27	1.91	0.08	58cfa82ee4b0c9d6adf6ad0e	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AE-01A	493A4FF2-37A5-4B79-928D-83DBFE534556	Primary Tumor	Illumina HiSeq	2722f260-d3b4-4088-860d-7a5070921255	Bladder	84.0	67865453-D515-4D63-84E8-CFB2686A211D	ABD2D959-D5ED-4EB3-9759-67EB1AA23325	TCGA-DK-A1AE-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1AE	TCGA-BLCA		Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2689	58cfa830e4b0c9d6adf6be90	TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted	TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted.bam	92.87	2.0	0.15	58cfa830e4b0c9d6adf6be90	TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A13I-01A	EBC094A6-CDC9-4C02-B8EC-A181B25A364D	Primary Tumor	Illumina HiSeq	b7cfe609-703a-4750-b9e7-5bda8e948cc4	Bladder	57.0	62C2BA8F-02E3-4100-86BC-5958038B4983	7C09CFF3-3162-4952-93AD-8A7D89F07266	TCGA-BL-A13I-01A-11D-A13U-02	HG19_Broad_variant	TCGA-BL-A13I	TCGA-BLCA	223.0	Harvard Medical School	Christiana Healthcare	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2690	58cfa830e4b0c9d6adf6be82	TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted	TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted.bam	69.7	2.0	0.17	58cfa830e4b0c9d6adf6be82	TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A0C8-01A	A6003B1C-56A9-430A-A5E2-B70AF3F81BDB	Primary Tumor	Illumina HiSeq	19df03d2-75d2-408e-86e2-482ddeed9736	Bladder	73.0	5FEED572-07C0-4DA0-8649-CA8F8682657A	AB020F79-BA66-457C-9D77-DDD87C799538	TCGA-BL-A0C8-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BL-A0C8	TCGA-BLCA		Harvard Medical School	Christiana Healthcare	United States	NO	T1	NX	Not available	Stage I
s2691	58cfa830e4b0c9d6adf6be78	TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted	TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted.bam	24.07		0.16	58cfa830e4b0c9d6adf6be78	TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A3JM-01A	0F4FB205-B13C-4A85-97B3-779429E6CCDD	Primary Tumor	Illumina HiSeq	5cd881b7-caa0-43ad-9ba8-f9696fdf7403	Bladder	62.0	110ACEE1-915F-43A2-B382-5D0AF1FC167F	6ABBBA00-C322-4EDE-91A4-85D0D3E886F9	TCGA-BL-A3JM-01A-12D-A21C-26	HG19_Broad_variant	TCGA-BL-A3JM	TCGA-BLCA	205.0	MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2692	58cfa830e4b0c9d6adf6c228	TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted	TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted.bam	38.54	1.64	0.16	58cfa830e4b0c9d6adf6c228	TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20X-01A	BE8B3F36-AAA1-4302-B28E-DE1996FACEAF	Primary Tumor	Illumina HiSeq	256c8b67-1fea-4666-b42c-21e8860946e3	Bladder	56.0	4D7D3354-6588-4E02-9354-AB5044BA1AB3	B9EE2E33-FF09-41FE-901C-453588041DCE	TCGA-BT-A20X-01A-11D-A16N-02	HG19_Broad_variant	TCGA-BT-A20X	TCGA-BLCA	251.0	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2694	58cfa830e4b0c9d6adf6c238	TCGA-BT-A20Q-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BT-A20Q-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_6_rg.sorted	TCGA-BT-A20Q-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_6_rg.sorted.bam	7.0	1.89	0.14	58cfa830e4b0c9d6adf6c238	TCGA-BT-A20Q-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20Q-11A	419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F	Solid Tissue Normal	Illumina HiSeq	6669a6f9-a976-4716-a57d-7b08ef6afd14	Bladder	73.0	DF346965-B972-445D-9AAC-35605B908F4D	51F7BC24-EEEB-407E-BCB0-531A5092067A	TCGA-BT-A20Q-11A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20Q	TCGA-BLCA	593.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2695	58cfa831e4b0c9d6adf6c428	TCGA-BT-A20W-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BT-A20W-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_6_rg.sorted	TCGA-BT-A20W-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_6_rg.sorted.bam	21.45	2.03	0.15	58cfa831e4b0c9d6adf6c428	TCGA-BT-A20W-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20W-11A	4DC5CFFE-ED8C-47AB-B5FC-F9615B5414F7	Solid Tissue Normal	Illumina HiSeq	f3f37b3b-3755-4102-b654-abea4d035ed1	Bladder	71.0	5FF660D2-10DE-4D72-BDE0-93840309B5E5	47F326E8-52A3-43C8-BF5E-43358E0D13B9	TCGA-BT-A20W-11A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20W	TCGA-BLCA	254.0	Harvard Medical School	University of Pittsburgh	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2696	58cfa830e4b0c9d6adf6c23a	TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted	TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted.bam	26.04	1.91	0.17	58cfa830e4b0c9d6adf6c23a	TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20R-01A	F8780A4B-7F55-41D1-BF92-8513955D150E	Primary Tumor	Illumina HiSeq	e997f623-927f-4dae-8fe9-590eef9a9f59	Bladder	79.0	20231B7F-CB6A-4CD0-9C46-10D4E959D483	78460059-E3A1-40F1-89B5-2F69C6E2E0F1	TCGA-BT-A20R-01A-12D-A16N-02	HG19_Broad_variant	TCGA-BT-A20R	TCGA-BLCA	154.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2698	58cfa831e4b0c9d6adf6c4d0	TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted	TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted.bam	55.89		0.15	58cfa831e4b0c9d6adf6c4d0	TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PJ-01A	CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A	Primary Tumor	Illumina HiSeq	cac436d2-b3cb-4351-953e-084c7a431f0f	Bladder	76.0	29D79B83-FA80-490E-A8A1-C51C9AD061FE	4BAD319F-9A5F-4257-863A-BCD8ED983EFE	TCGA-BT-A3PJ-01A-21D-A221-26	HG19_Broad_variant	TCGA-BT-A3PJ	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2699	58cfa830e4b0c9d6adf6c2d8	TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted	TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted.bam	56.18		0.16	58cfa830e4b0c9d6adf6c2d8	TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PH-01A	932BCDD4-5145-49E8-9A95-8A546396F572	Primary Tumor	Illumina HiSeq	9096dde9-2391-4c22-b816-2057b8adb483	Bladder	76.0	33A83E54-3BE5-4A68-8AB0-D31D0BCD3B67	4C010558-360B-44AF-A980-A1CCDF3AB9C7	TCGA-BT-A3PH-01A-11D-A221-26	HG19_Broad_variant	TCGA-BT-A3PH	TCGA-BLCA	142.0	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2703	58cfa831e4b0c9d6adf6ca1b	TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted	TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted.bam	57.02		0.16	58cfa831e4b0c9d6adf6ca1b	TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A2I6-01A	DE810AF0-4C18-4E8F-9836-F8ABC425E3EB	Primary Tumor	Illumina HiSeq	6567cd2d-a1e5-4226-9239-77c48c09c55e	Bladder	81.0	A536F8F9-3A68-4792-880D-387D78FD0C66	B791021D-173E-4B08-8769-A9F289818D11	TCGA-DK-A2I6-01A-12D-A18D-02	HG19_Broad_variant	TCGA-DK-A2I6	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2704	58cfa831e4b0c9d6adf6c91b	TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted	TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted.bam	37.09		0.15	58cfa831e4b0c9d6adf6c91b	TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A2I1-01A	036B9681-AB58-4734-A8FD-E0D5D078BF5A	Primary Tumor	Illumina HiSeq	724308ea-3fa9-4762-9800-445a044e94f2	Bladder	73.0	F9BD70B2-6CDE-48E5-9F0D-55D86CCFEBA8	010259EE-2667-4B8E-BB20-0F75F53A64BA	TCGA-DK-A2I1-01A-11D-A17R-02	HG19_Broad_variant	TCGA-DK-A2I1	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2707	58cfa831e4b0c9d6adf6c91f	TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted	TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted.bam	43.47	2.0	0.18	58cfa831e4b0c9d6adf6c91f	TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AB-01A	F027D254-EC01-4882-A8A7-964AE90B7D49	Primary Tumor	Illumina HiSeq	a5005e15-2ada-4bf4-9a61-0febc81a99ca	Bladder	74.0	253F84AB-FCE2-4E2D-955B-0B8D13A9E4F0	D1F85B58-EBF8-4A73-A5E0-8DFE62CF1164	TCGA-DK-A1AB-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AB	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2708	58cfa831e4b0c9d6adf6c912	TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted	TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted.bam	49.35		0.16	58cfa831e4b0c9d6adf6c912	TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A2I2-01A	234086DD-5A74-4FF1-94AB-BAD43EE69D5C	Primary Tumor	Illumina HiSeq	99517da2-f39e-4005-8efc-4487b92c0dcc	Bladder	63.0	45F8E4B6-5D36-47D7-A77D-E5E4C15848B3	767D7AA5-093D-48AB-BCDA-92729F4B95B7	TCGA-DK-A2I2-01A-11D-A17R-02	HG19_Broad_variant	TCGA-DK-A2I2	TCGA-BLCA	237.0	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2711	58cfa831e4b0c9d6adf6ca0d	TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted	TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted.bam	55.51	1.93	0.17	58cfa831e4b0c9d6adf6ca0d	TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AD-01A	88A521CE-A5E9-4C6F-83D4-EC36A62FEDB6	Primary Tumor	Illumina HiSeq	26694fc3-c6e4-45f9-82f0-57b6f4955b4b	Bladder	69.0	C79F4327-675D-4651-994D-E683096DF9C3	86DF29FD-B5F6-4316-BC89-DC9386D177C6	TCGA-DK-A1AD-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AD	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2712	58cfa831e4b0c9d6adf6c90c	TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted	TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted.bam	16.46		0.14	58cfa831e4b0c9d6adf6c90c	TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A2HX-01A	C728FAC9-5452-4759-A4ED-A366E0F757CB	Primary Tumor	Illumina HiSeq	17e4edb9-ac80-43de-a7c1-66edf1201ac0	Bladder	80.0	537F3FE6-4E8E-4570-827A-0F5CAB193BE0	4BAFEFB4-28D5-4126-B6B7-AE5B0D03F05D	TCGA-DK-A2HX-01A-12D-A18D-02	HG19_Broad_variant	TCGA-DK-A2HX	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2715	58cfa831e4b0c9d6adf6c8bc	TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted	TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted.bam	24.31		0.16	58cfa831e4b0c9d6adf6c8bc	TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IT-01A	58520C66-7688-435A-B09F-653B18768C41	Primary Tumor	Illumina HiSeq	276fd52d-8d51-4e03-85a5-a7f02ee03b71	Bladder	62.0	6B48DAE5-B757-450A-8248-65C2434A7AFC	CDBAE634-52F3-4165-A214-BB60BEC5D6C4	TCGA-DK-A3IT-01A-31D-A210-26	HG19_Broad_variant	TCGA-DK-A3IT	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2716	58cfa831e4b0c9d6adf6ca0f	TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted	TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted.bam	51.32		0.15	58cfa831e4b0c9d6adf6ca0f	TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3X2-01A	40551D53-388B-4067-9341-76E94D023703	Primary Tumor	Illumina HiSeq	a8b7a158-32d0-421e-82bd-edb6a44d69e0	Bladder	85.0	3B816277-91CB-413E-BC7C-BA33CD72B67D	5D13DEBC-82D6-45EA-A9EA-A85B85CF659F	TCGA-DK-A3X2-01A-11D-A233-26	HG19_Broad_variant	TCGA-DK-A3X2	TCGA-BLCA	547.0	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2719	58cfa832e4b0c9d6adf6cdfc	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.bam	33.16		0.15	58cfa832e4b0c9d6adf6cdfc	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SN-01A	0FB043D3-D86B-4CD8-8C01-9E2B3E965BB0	Primary Tumor	Illumina HiSeq	2281a267-dad6-42d6-9df2-8d37a696c507	Bladder	79.0	127892ED-8A7A-41CB-8ABE-353E09E6D327	B0AD1373-0C51-41A3-9F8B-BDE28C67CFB8	TCGA-FD-A3SN-01A-12D-A233-26	HG19_Broad_variant	TCGA-FD-A3SN	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2720	58cfa831e4b0c9d6adf6cd16	TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted	TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted.bam	18.6		0.16	58cfa831e4b0c9d6adf6cd16	TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SL-01A	4570B6E2-D430-41CA-AAB1-CE4D14C36463	Primary Tumor	Illumina HiSeq	764ae567-a7b6-4d13-bef1-8cc55afb4524	Bladder	60.0	0A1E88E0-3593-40BA-86E5-751074885578	2BF89FED-C215-4893-BA35-2FE0C7DD5DD0	TCGA-FD-A3SL-01A-21D-A233-26	HG19_Broad_variant	TCGA-FD-A3SL	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2721	58cfa832e4b0c9d6adf6ce18	TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted	TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted.bam	33.2		0.17	58cfa832e4b0c9d6adf6ce18	TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B5-01A	462D5A6B-9F39-4AAE-A35B-D06A7811D053	Primary Tumor	Illumina HiSeq	d7af6a65-2c95-4a83-8e6f-756aef5309bd	Bladder	86.0	F9DEDC8C-327D-456A-9C0B-E1EC58AE3169	0D51FF4C-41D7-4296-BDDC-F9DB7F41276A	TCGA-FD-A3B5-01A-11D-A210-26	HG19_Broad_variant	TCGA-FD-A3B5	TCGA-BLCA	272.0	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2725	58cfa832e4b0c9d6adf6d12c	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.bam	16.85		0.18	58cfa832e4b0c9d6adf6d12c	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EK-01A	5DA1CB68-C438-4DDC-999F-90AED0C4BD7A	Primary Tumor	Illumina HiSeq	f98c8702-90e5-4e7a-ad12-d11a9af57bf5	Bladder	57.0	FF1691F2-DF11-4068-8D8D-A778F384EC60	8A75CF19-7645-489D-AAEC-5D9AD293C4B1	TCGA-G2-A2EK-01A-22D-A18D-02	HG19_Broad_variant	TCGA-G2-A2EK	TCGA-BLCA		Harvard Medical School	MD Anderson	United States	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2726	58cfa832e4b0c9d6adf6d12e	TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted	TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted.bam	39.31		0.15	58cfa832e4b0c9d6adf6d12e	TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A3IB-01A	AF53D51E-0B5C-437F-A1C0-EC5F55C49364	Primary Tumor	Illumina HiSeq	f78443a3-8c1b-429a-93c3-fcd93f3c6d55	Bladder	66.0	791E4058-E872-4AF8-A431-F5782811F02A	80F634F1-C34C-40CD-9F9B-BBFC18E9DE6E	TCGA-G2-A3IB-01A-11D-A210-26	HG19_Broad_variant	TCGA-G2-A3IB	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	MD Anderson	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2731	58cfa832e4b0c9d6adf6d034	TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted.filtered.	WGS	TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted	TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted.bam	46.83		0.16	58cfa832e4b0c9d6adf6d034	TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3RD-01A	6A2155B3-915C-41B1-B730-32E55E0C1FBD	Primary Tumor	Illumina HiSeq	27573bf6-b72d-47e6-93f7-38d2887d8b32	Bladder	83.0	1C60F60E-A3C6-43A1-A56E-BA68801D2D90	C9E9DC46-2917-47BE-92DA-9C40C6F13500	TCGA-GC-A3RD-01A-12D-A233-26	HG19_Broad_variant	TCGA-GC-A3RD	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2733	58cfa832e4b0c9d6adf6cfb8	TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted	TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted.bam	65.0		0.16	58cfa832e4b0c9d6adf6cfb8	TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3I6-01A	74CBB078-9AAE-422A-A7AF-DD29EBCA949E	Primary Tumor	Illumina HiSeq	ec0a1f1d-c6e7-4b4a-a296-02087e0b6586	Bladder	45.0	DB9442F6-38F2-4092-9E85-F5EC0C924025	8B23B777-2BF2-422A-8AB3-1DF94EE61690	TCGA-GC-A3I6-01A-11D-A210-26	HG19_Broad_variant	TCGA-GC-A3I6	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2735	58cfa832e4b0c9d6adf6cefc	TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted.filtered.	WGS	TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted	TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted.bam	54.46		0.15	58cfa832e4b0c9d6adf6cefc	TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-H4-A2HQ-01A	CEDE5274-279D-4021-8ACA-5ECC4BF94D66	Primary Tumor	Illumina HiSeq	46adb3c9-ac82-4284-b0d1-f95b10435695	Bladder	64.0	CBEDC0DB-39FD-4661-9531-CC24D422FAC4	CD60EBC2-EF2A-4B47-8D42-C864AA095B8D	TCGA-H4-A2HQ-01A-11D-A17R-02	HG19_Broad_variant	TCGA-H4-A2HQ	TCGA-BLCA		Harvard Medical School	Medical College of Georgia	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2736	58cfa832e4b0c9d6adf6cfe8	TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted.filtered.	WGS	TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted	TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted.bam	67.04		0.15	58cfa832e4b0c9d6adf6cfe8	TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JX-01A	D9DCBB57-F6C2-4465-8A60-AFE876E113CA	Primary Tumor	Illumina HiSeq	317cc3f0-7a98-402b-bb1f-81a0437fbaf8	Bladder	59.0	CE32612D-F504-4164-AE50-04C4AC2999FB	A8636E11-C752-46F4-A6A8-42D5B7DCBD02	TCGA-GV-A3JX-01A-11D-A210-26	HG19_Broad_variant	TCGA-GV-A3JX	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2737	58cfa832e4b0c9d6adf6d1fa	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.bam	45.77		0.15	58cfa832e4b0c9d6adf6d1fa	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JW-01A	3D644EAF-82FC-4BC7-93B7-3E600E8C6511	Primary Tumor	Illumina HiSeq	586abfdd-f50a-4834-8143-3bda5638ea60	Bladder	74.0	B02C03B6-24AA-42D3-9310-741DE1EF0D30	D7EFF32B-E9EB-4891-93D7-4C3D10BE21EA	TCGA-GV-A3JW-01A-11D-A210-26	HG19_Broad_variant	TCGA-GV-A3JW	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T2	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2738	58cfa832e4b0c9d6adf6d020	TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted.filtered.	WGS	TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted	TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted.bam	63.92		0.14	58cfa832e4b0c9d6adf6d020	TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JZ-01A	9CC92795-7A24-4875-87F0-3EFCCBFCC970	Primary Tumor	Illumina HiSeq	d4d5d34c-9665-4291-a3d6-14bc9b48f2fa	Bladder	55.0	449E18FB-CBC0-4365-AEEC-EDC6A6B276BD	5A651606-6D92-445B-AA0B-B73CC9329402	TCGA-GV-A3JZ-01A-11D-A21C-26	HG19_Broad_variant	TCGA-GV-A3JZ	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T4a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2847	58cfa82ee4b0c9d6adf6ab22	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.filtered.	WGS	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.bam	85.12	1.95	0.08	58cfa82ee4b0c9d6adf6ab22	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A6-01A	9C274536-3CA1-4F0E-93A8-1688074D862F	Primary Tumor	Illumina HiSeq	694693d8-dc04-4516-bc18-e8a9ccb24d28	Bladder	53.0	7AD1CD01-0EA2-4FA4-9B05-C280BD256546	DF8A913C-5160-4FC5-950D-7C890E24E820	TCGA-DK-A1A6-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A6	TCGA-BLCA		Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2849	58cfa82ee4b0c9d6adf6a90a	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.filtered.	WGS	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.bam	47.84		0.08	58cfa82ee4b0c9d6adf6a90a	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N6-01A	8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567	Primary Tumor	Illumina HiSeq	d881868c-a616-4a4c-bbb7-4fbda95e1323	Bladder	43.0	6CD6D1F4-D8E4-47F9-812F-EB7FEC925F8D	D4615CA0-B5C7-4A5C-8593-BD50034A78AE	TCGA-FD-A3N6-01A-11D-A21A-08	HG19_Broad_variant	TCGA-FD-A3N6	TCGA-BLCA		Broad Institute of MIT and Harvard	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2853	58cfa82ee4b0c9d6adf6aa60	G32464.TCGA-BT-A20P-11A-11D-A14W-08.1.filtered.	WGS	G32464.TCGA-BT-A20P-11A-11D-A14W-08.1	G32464.TCGA-BT-A20P-11A-11D-A14W-08.1.bam	11.99	2.03	0.08	58cfa82ee4b0c9d6adf6aa60	G32464.TCGA-BT-A20P-11A-11D-A14W-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20P-11A	F48937ED-E294-41F0-8872-7010391167A9	Solid Tissue Normal	Illumina HiSeq	4f4ba732-c57e-421a-a421-532a1ce76f5d	Bladder	81.0	2A07DBF4-D44C-4643-8A37-80E013DBE20B	DD05D620-285E-4734-924B-C16361749FA4	TCGA-BT-A20P-11A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20P	TCGA-BLCA	544.0	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2858	58cfa831e4b0c9d6adf6c47a	TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted	TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted.bam	57.66		0.17	58cfa831e4b0c9d6adf6c47a	TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PK-01A	73041FCF-F3B6-4851-B34D-1D62A1FCF6FE	Primary Tumor	Illumina HiSeq	637e8bd5-61ee-4d45-8cc5-e3b89950d020	Bladder	80.0	F09E1EEB-BCD5-4DBA-92F0-7D4B34B81CE7	EE975BE9-76BF-4B5A-BF4C-155750C168CD	TCGA-BT-A3PK-01A-21D-A221-26	HG19_Broad_variant	TCGA-BT-A3PK	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2859	58cfa830e4b0c9d6adf6c21e	TCGA-BT-A20P-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BT-A20P-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_4_rg.sorted	TCGA-BT-A20P-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_4_rg.sorted.bam	11.99	2.03	0.16	58cfa830e4b0c9d6adf6c21e	TCGA-BT-A20P-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_4_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20P-11A	F48937ED-E294-41F0-8872-7010391167A9	Solid Tissue Normal	Illumina HiSeq	84bd8301-5869-4245-a3cc-3781508f00c5	Bladder	81.0	2A07DBF4-D44C-4643-8A37-80E013DBE20B	327826B3-DDC6-4478-A28D-9688B58F279F	TCGA-BT-A20P-11A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20P	TCGA-BLCA	544.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2860	58cfa831e4b0c9d6adf6c42a	TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted	TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted.bam	80.43		0.15	58cfa831e4b0c9d6adf6c42a	TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LA-01A	797A71EE-372D-41E5-AEEE-5AB3C4661110	Primary Tumor	Illumina HiSeq	587f05f3-8e6a-4a97-b59b-29371f2f8b74	Bladder	54.0	6ED52558-8039-4658-A245-78A29968CE2F	D08FDC4F-83B0-4885-A8CF-45F72E5E6BD2	TCGA-BT-A2LA-01A-11D-A18D-02	HG19_Broad_variant	TCGA-BT-A2LA	TCGA-BLCA		Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2863	58cfa830e4b0c9d6adf6c24c	TCGA-BT-A20U-11A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BT-A20U-11A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_8_rg.sorted	TCGA-BT-A20U-11A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_8_rg.sorted.bam	50.51	2.1	0.16	58cfa830e4b0c9d6adf6c24c	TCGA-BT-A20U-11A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20U-11A	83B41D35-69B1-4218-BE1A-8821D8A6899C	Solid Tissue Normal	Illumina HiSeq	62a2b30e-c3e7-4831-8cda-b72f3d30157a	Bladder	70.0	996EE634-A7F1-4273-80D2-ADBD68D5A1CE	643C646C-1135-4636-9E12-67AED166780E	TCGA-BT-A20U-11A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20U	TCGA-BLCA	455.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2865	58cfa830e4b0c9d6adf6c234	TCGA-BT-A20R-11A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BT-A20R-11A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_4_rg.sorted	TCGA-BT-A20R-11A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_4_rg.sorted.bam	17.44	1.78	0.18	58cfa830e4b0c9d6adf6c234	TCGA-BT-A20R-11A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_4_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20R-11A	F8780A4B-7F55-41D1-BF92-8513955D150E	Solid Tissue Normal	Illumina HiSeq	81815e13-7a11-4252-9fea-8006d97d9a9b	Bladder	79.0	4F6353E2-FB61-48B7-B784-3C0D391D708B	B2AEED65-1A63-4712-A8E1-22C91A2C690B	TCGA-BT-A20R-11A-11D-A16N-02	HG19_Broad_variant	TCGA-BT-A20R	TCGA-BLCA	154.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2866	58cfa830e4b0c9d6adf6c248	TCGA-BT-A2LA-11A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BT-A2LA-11A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_4_rg.sorted	TCGA-BT-A2LA-11A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_4_rg.sorted.bam	9.14		0.16	58cfa830e4b0c9d6adf6c248	TCGA-BT-A2LA-11A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LA-11A	797A71EE-372D-41E5-AEEE-5AB3C4661110	Solid Tissue Normal	Illumina HiSeq	ee7f989e-a375-4956-a120-aab1394e350f	Bladder	54.0	F12723EF-51A8-4071-B612-B47A14C2B459	BA6BC788-FE48-412B-B303-B45370501109	TCGA-BT-A2LA-11A-11D-A18D-02	HG19_Broad_variant	TCGA-BT-A2LA	TCGA-BLCA		Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2867	58cfa830e4b0c9d6adf6c1de	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.bam	62.34	1.97	0.15	58cfa830e4b0c9d6adf6c1de	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A0YX-01A	22473AD4-DF39-4716-B558-3C1409D5FA0E	Primary Tumor	Illumina HiSeq	71886c7b-a73b-4c00-9555-5fd61b5e1347	Bladder	70.0	DA614214-F84C-43AB-983C-D9D76CF2D6AE	DC052DFC-26A8-4393-8849-FA954913C622	TCGA-BT-A0YX-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BT-A0YX	TCGA-BLCA		Harvard Medical School	University of Pittsburgh	None	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2868	58cfa830e4b0c9d6adf6c2b4	TCGA-BT-A2LB-11A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BT-A2LB-11A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_8_rg.sorted	TCGA-BT-A2LB-11A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_8_rg.sorted.bam	7.56		0.18	58cfa830e4b0c9d6adf6c2b4	TCGA-BT-A2LB-11A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LB-11A	D17A5AB1-3789-4652-AFF5-D8F4F2291F9C	Solid Tissue Normal	Illumina HiSeq	c3d22884-08fb-4b8d-a589-f0ba4184d031	Bladder	73.0	085DA7A1-E01D-4273-B5F2-7AAB5D4D942A	00BA084F-E60A-41ED-BA1A-E1A07C85478E	TCGA-BT-A2LB-11A-11D-A18D-02	HG19_Broad_variant	TCGA-BT-A2LB	TCGA-BLCA		Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2870	58cfa830e4b0c9d6adf6c1f8	TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted	TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted.bam	10.21	1.76	0.18	58cfa830e4b0c9d6adf6c1f8	TCGA-BT-A20T-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20T-11A	096B4F32-10C1-4737-A0DD-CAE04C54EE33	Solid Tissue Normal	Illumina HiSeq	7205e655-2448-4a14-8a14-2a8a6a97c6ee	Bladder	63.0	27461A27-26EB-4C2C-9C54-E16FBD32C615	FF148CF3-AFB7-42F1-A137-AD7D6CB889C1	TCGA-BT-A20T-11A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20T	TCGA-BLCA	453.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2871	58cfa831e4b0c9d6adf6c420	TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted	TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted.bam	59.68	2.07	0.17	58cfa831e4b0c9d6adf6c420	TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20T-01A	096B4F32-10C1-4737-A0DD-CAE04C54EE33	Primary Tumor	Illumina HiSeq	e605a62d-c633-415e-bba0-2174fd3ad94e	Bladder	63.0	52F538EF-B05D-4C76-9976-CE6D49158016	3929BC99-B4FC-4EB9-BDEA-1986EA49AF2A	TCGA-BT-A20T-01A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20T	TCGA-BLCA	453.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2872	58cfa831e4b0c9d6adf6c4a4	TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted	TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted.bam	37.6	2.0	0.16	58cfa831e4b0c9d6adf6c4a4	TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A1HR-01A	39EA19E1-4959-4F1B-9934-54BDAF766842	Primary Tumor	Illumina HiSeq	65dee943-f41b-4f59-a5bb-2477053d1079	Bladder	62.0	6E77AB45-9C53-4A74-9581-043005C3E685	B048E28D-38FC-4E37-9C54-9C56526AD0E3	TCGA-CF-A1HR-01A-11D-A13U-02	HG19_Broad_variant	TCGA-CF-A1HR	TCGA-BLCA		Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2873	58cfa830e4b0c9d6adf6c31e	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.bam	67.64	2.28	0.18	58cfa830e4b0c9d6adf6c31e	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A27C-01A	7FEE9D6F-C0EA-43C2-89C2-66D965A077A8	Primary Tumor	Illumina HiSeq	ecc65751-9b59-49c3-a142-7a4c61174649	Bladder	52.0	EAD6792B-4E52-4C28-891C-6D8696873A13	1E553EB3-8C42-48A1-87A7-BFA8541CE568	TCGA-CF-A27C-01A-11D-A16N-02	HG19_Broad_variant	TCGA-CF-A27C	TCGA-BLCA		Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2874	58cfa831e4b0c9d6adf6c4ac	TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted	TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted.bam	63.16		0.15	58cfa831e4b0c9d6adf6c4ac	TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MH-01A	B8A8D2FC-421B-4393-8D5A-946CF72CB496	Primary Tumor	Illumina HiSeq	f82c1606-fe81-428d-9889-58cafa1f29e4	Bladder	75.0	8CF68BB1-5966-40CD-A038-E9E91E608766	463978F0-D37A-4035-9D1C-8C0E7B0F721C	TCGA-CF-A3MH-01A-11D-A210-26	HG19_Broad_variant	TCGA-CF-A3MH	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2875	58cfa830e4b0c9d6adf6c2c6	TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted	TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted.bam	42.45	1.95	0.16	58cfa830e4b0c9d6adf6c2c6	TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A1HS-01A	A73C0842-39C5-4C2C-AA6A-F31341A4F36E	Primary Tumor	Illumina HiSeq	ed90abf4-1d04-41ce-9de3-9dcf24c1e375	Bladder	75.0	0A01E5BA-5549-4027-9E84-1BBB163A8F07	B8F18CDA-053F-4E40-8978-7524A4C0B49A	TCGA-CF-A1HS-01A-11D-A13U-02	HG19_Broad_variant	TCGA-CF-A1HS	TCGA-BLCA		Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2880	58cfa831e4b0c9d6adf6c673	TCGA-CU-A0YR-11A-13D-A10R_120920_SN1222_0150_AC1927ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CU-A0YR-11A-13D-A10R_120920_SN1222_0150_AC1927ACXX_s_5_rg.sorted	TCGA-CU-A0YR-11A-13D-A10R_120920_SN1222_0150_AC1927ACXX_s_5_rg.sorted.bam	21.05	2.03	0.16	58cfa831e4b0c9d6adf6c673	TCGA-CU-A0YR-11A-13D-A10R_120920_SN1222_0150_AC1927ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YR-11A	811B3950-36E7-485F-BC48-ACA1EEE2DDEF	Solid Tissue Normal	Illumina HiSeq	1efc9ebb-a445-4460-9053-367c5b4daaf5	Bladder	83.0	C60912E4-2F70-4C1E-91BD-F2F5548E532B	4A3BA06D-AE96-4194-AC33-2133D7C5074A	TCGA-CU-A0YR-11A-13D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YR	TCGA-BLCA		Harvard Medical School	UNC	United States	NO	T2	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2882	58cfa831e4b0c9d6adf6c8ba	TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted	TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted.bam	26.41		0.15	58cfa831e4b0c9d6adf6c8ba	TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IM-01A	41B59716-116F-4942-8B63-409870A87E26	Primary Tumor	Illumina HiSeq	27ca0d22-3ef8-4c3c-814a-94dfb76c3289	Bladder	76.0	7A37AE7C-6B46-410D-AE2B-12FD868C25B3	CDAC6FE7-FB06-4F9A-86D0-DF0DF26FD558	TCGA-DK-A3IM-01A-11D-A210-26	HG19_Broad_variant	TCGA-DK-A3IM	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2884	58cfa831e4b0c9d6adf6c93f	TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted	TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted.bam	61.12	1.95	0.15	58cfa831e4b0c9d6adf6c93f	TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AC-01A	36C14E9D-1863-4C55-BBBB-F8C9DD418932	Primary Tumor	Illumina HiSeq	befc5d25-55df-4a22-b4e4-25508f3935c9	Bladder	72.0	CD2FB6B8-5DB9-42B4-A407-A5B6F7B8665F	221E5DDE-BAB0-456C-87BE-DB54998FE197	TCGA-DK-A1AC-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AC	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2885	58cfa831e4b0c9d6adf6c9a8	TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted	TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted.bam	70.38	1.89	0.17	58cfa831e4b0c9d6adf6c9a8	TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AG-01A	F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5	Primary Tumor	Illumina HiSeq	4043eef2-fcc6-411c-a6a3-ddd71f3852d8	Bladder	65.0	64668AA0-DDE5-4534-8CD0-378881E4A4E4	69A3B1DB-3463-456C-B3D1-6BE1FD7EE1D9	TCGA-DK-A1AG-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AG	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2887	58cfa831e4b0c9d6adf6c958	TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted	TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted.bam	35.88		0.16	58cfa831e4b0c9d6adf6c958	TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IK-01A	3F0A0748-9ACC-4D0B-BA18-7C08BD183F86	Primary Tumor	Illumina HiSeq	6c286798-955c-487f-b541-72f253866ada	Bladder	87.0	4FF20C48-29EE-4101-B409-C4573E38CF92	B13B80DE-1722-44D3-888D-EEE8677F205C	TCGA-DK-A3IK-01A-32D-A21C-26	HG19_Broad_variant	TCGA-DK-A3IK	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2889	58cfa831e4b0c9d6adf6ca7f	TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted	TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted.bam	59.04	1.91	0.16	58cfa831e4b0c9d6adf6ca7f	TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A5-01A	904A8757-E0C5-41EF-B583-C8F170CAAAC1	Primary Tumor	Illumina HiSeq	3aa26bad-446a-4391-a584-27b78fc638e8	Bladder	79.0	A9EF3EC5-B1C1-481F-89CF-1729FAB50173	C4A751AF-E8CC-452A-9B5B-99D4B0AC585D	TCGA-DK-A1A5-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1A5	TCGA-BLCA	65.0	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2890	58cfa831e4b0c9d6adf6ca5a	TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted	TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted.bam	36.12		0.15	58cfa831e4b0c9d6adf6ca5a	TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IN-01A	FC0032DB-B6D8-4DA3-BD1B-BEEC4196ABF0	Primary Tumor	Illumina HiSeq	ff3d1235-2aed-4091-a8a2-72340b403e05	Bladder	72.0	F8C14183-3982-44E5-967E-03967EAA8123	11901B8B-BE4C-4914-8D50-06EA0128EB39	TCGA-DK-A3IN-01A-11D-A210-26	HG19_Broad_variant	TCGA-DK-A3IN	TCGA-BLCA	250.0	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2892	58cfa831e4b0c9d6adf6c976	TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted	TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted.bam	85.12	1.95	0.15	58cfa831e4b0c9d6adf6c976	TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A6-01A	9C274536-3CA1-4F0E-93A8-1688074D862F	Primary Tumor	Illumina HiSeq	66e30a9a-052c-40b8-ac7c-a241a6b87d6e	Bladder	53.0	7AD1CD01-0EA2-4FA4-9B05-C280BD256546	CACE3242-E727-4E1F-9427-B952E10C9B12	TCGA-DK-A1A6-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1A6	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2894	58cfa831e4b0c9d6adf6c9d5	TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted	TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted.bam	22.29		0.16	58cfa831e4b0c9d6adf6c9d5	TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IQ-01A	E44F60EC-66C4-45A2-A003-0A1FAF1D6E03	Primary Tumor	Illumina HiSeq	edc43d06-7118-46e7-894e-d40138b6d69c	Bladder	74.0	1E375786-DB8F-4A8C-BA1C-C6DD7DE1A9BE	DB940CE0-2357-4E83-AA19-AEA672A121D9	TCGA-DK-A3IQ-01A-31D-A210-26	HG19_Broad_variant	TCGA-DK-A3IQ	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2895	58cfa831e4b0c9d6adf6c9ce	TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted	TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted.bam	13.9		0.15	58cfa831e4b0c9d6adf6c9ce	TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3WY-01A	9BB5D187-033E-4E86-A76E-E1A6D20488F7	Primary Tumor	Illumina HiSeq	ae1b3911-b342-4886-b75a-3e9be21dae41	Bladder	67.0	33D579B3-198D-46CA-B2CF-574A0673E26F	ABA3AF01-2CBD-4450-9CCB-698DF8982E91	TCGA-DK-A3WY-01A-11D-A233-26	HG19_Broad_variant	TCGA-DK-A3WY	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2899	58cfa831e4b0c9d6adf6c99c	TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted	TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted.bam	36.57		0.16	58cfa831e4b0c9d6adf6c99c	TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3WX-01A	D63C186D-ADD6-492E-8250-E83F46D39D00	Primary Tumor	Illumina HiSeq	12365344-0a7a-4ef2-a651-2f1f3a15f6a1	Bladder	67.0	FED73C89-75F1-45C9-B14B-7840C52C305F	A6D2A8FB-6A01-4625-AEB9-FFA9476B658E	TCGA-DK-A3WX-01A-22D-A233-26	HG19_Broad_variant	TCGA-DK-A3WX	TCGA-BLCA	321.0	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2901	58cfa832e4b0c9d6adf6ce9c	TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted	TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted.bam	28.25		0.16	58cfa832e4b0c9d6adf6ce9c	TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B7-01A	EF5DD4B3-B77A-444A-B5B0-C999A5A3D129	Primary Tumor	Illumina HiSeq	4a37fdf6-816c-46ca-b703-cf3d58b32149	Bladder	66.0	A307CA46-3A09-4F0C-84AB-9A9E8954DE38	6014D6A8-5495-4D71-AB6E-622E3E6C4DC6	TCGA-FD-A3B7-01A-31D-A210-26	HG19_Broad_variant	TCGA-FD-A3B7	TCGA-BLCA	122.0	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2903	58cfa831e4b0c9d6adf6cd7c	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.bam	42.39		0.15	58cfa831e4b0c9d6adf6cd7c	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B3-01A	4B5D873B-BFDA-482E-92A0-BF84C0F9032A	Primary Tumor	Illumina HiSeq	6b702a7f-ff83-4ff2-96a8-9da2f015ebcc	Bladder	74.0	769EE027-5ED7-4EC2-86B5-FE40F9D6FB5A	57731F40-BBEF-4C7B-BFDC-CE75DA6EB1EB	TCGA-FD-A3B3-01A-12D-A204-02	HG19_Broad_variant	TCGA-FD-A3B3	TCGA-BLCA		Harvard Medical School	BLN - University Of Chicago	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2907	58cfa832e4b0c9d6adf6ce0e	TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted	TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted.bam	30.45		0.15	58cfa832e4b0c9d6adf6ce0e	TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N5-01A	A658BECF-3934-49F2-9E74-291DCA61D4BB	Primary Tumor	Illumina HiSeq	b9214ac8-956d-471d-8cad-a44ddc8825e8	Bladder	69.0	66559B5F-AB2F-406B-9EDB-0F5085EEC7C5	BA548041-624F-4357-A9F9-3BE29A3FF4FD	TCGA-FD-A3N5-01A-11D-A21C-26	HG19_Broad_variant	TCGA-FD-A3N5	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2909	58cfa831e4b0c9d6adf6cd12	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.bam	30.78		0.17	58cfa831e4b0c9d6adf6cd12	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SJ-01A	6D8D8169-0C1A-4CDB-BE6F-9761C981A369	Primary Tumor	Illumina HiSeq	2635ae0a-878a-4237-ad5c-5f0092134ee3	Bladder	59.0	491A8898-7CC5-45D9-9502-FD24399C239D	E9F8EE08-E951-41A8-88AB-E7A98618EECC	TCGA-FD-A3SJ-01A-12D-A233-26	HG19_Broad_variant	TCGA-FD-A3SJ	TCGA-BLCA	739.0	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2911	58cfa831e4b0c9d6adf6cdc5	TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted	TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted.bam	39.92		0.14	58cfa831e4b0c9d6adf6cdc5	TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SO-01A	94809FBF-4895-42C0-A7C6-F39EE1A41F1A	Primary Tumor	Illumina HiSeq	6b296020-484a-4cc2-a114-6c8a34ed5712	Bladder	68.0	869E3D55-CAD8-436E-B6A8-7ED90AD0A535	3D37A593-EFD7-4250-961D-D914E0AB8C13	TCGA-FD-A3SO-01A-11D-A233-26	HG19_Broad_variant	TCGA-FD-A3SO	TCGA-BLCA	168.0	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2913	58cfa832e4b0c9d6adf6d018	TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted	TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted.bam	35.79		0.15	58cfa832e4b0c9d6adf6d018	TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FT-A3EE-01A	CCE62116-3DCD-400D-ADA0-9839CA02466E	Primary Tumor	Illumina HiSeq	7bd31003-35c9-4165-b964-e3d1e803dbe9	Bladder	80.0	2356F78C-0653-468F-83DB-6CF6107BD259	0C871E11-F5FB-4B9E-B286-163187A68992	TCGA-FT-A3EE-01A-11D-A204-02	HG19_Broad_variant	TCGA-FT-A3EE	TCGA-BLCA	99.0	Harvard Medical School	BLN - University of Miami	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s2914	58cfa832e4b0c9d6adf6d134	TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted.filtered.	WGS	TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted	TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted.bam	27.44		0.15	58cfa832e4b0c9d6adf6d134	TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A3VY-01A	CD50C69F-0F45-4C57-B61A-8C6B41AB4F7E	Primary Tumor	Illumina HiSeq	fc9767fe-ddfb-4540-b151-0a80300c0a1d	Bladder	66.0	5A66149F-8FB0-41BC-880C-56D5541E3D94	8263C8A3-7CE5-4487-B8A1-29CE9417D1E3	TCGA-G2-A3VY-01A-11D-A233-26	HG19_Broad_variant	TCGA-G2-A3VY	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	MD Anderson	United States	NO	Not available	Not available	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2917	58cfa832e4b0c9d6adf6d128	TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted	TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted.bam	48.07		0.15	58cfa832e4b0c9d6adf6d128	TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A3IE-01A	C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB	Primary Tumor	Illumina HiSeq	171a2a97-43d5-41cc-a9ae-2f685c3ed80f	Bladder	51.0	FC529667-D055-4FC3-806D-C0431D9A6CFF	5C93720D-56AA-4324-8543-9B37351BC9B6	TCGA-G2-A3IE-01A-11D-A210-26	HG19_Broad_variant	TCGA-G2-A3IE	TCGA-BLCA	612.0	MD Anderson - Institute for Applied Cancer Science	MD Anderson	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2919	58cfa832e4b0c9d6adf6d114	TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted.filtered.	WGS	TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted	TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted.bam	46.96		0.16	58cfa832e4b0c9d6adf6d114	TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2ES-01A	72D8EAE8-9EFB-45B2-ACBD-82C6B5732E38	Primary Tumor	Illumina HiSeq	5922785f-2336-403c-9cb6-0843df3383b5	Bladder	85.0	C2288290-F17A-435C-90E7-5A4913F0C076	52FA3B0A-B5C7-4A74-A798-0DB359029147	TCGA-G2-A2ES-01A-11D-A17R-02	HG19_Broad_variant	TCGA-G2-A2ES	TCGA-BLCA		Harvard Medical School	MD Anderson	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2920	58cfa832e4b0c9d6adf6d044	TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted.filtered.	WGS	TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted	TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted.bam	40.79		0.16	58cfa832e4b0c9d6adf6d044	TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A2C5-01A	5D54C742-5A8E-4C40-8D62-95E75E210AB8	Primary Tumor	Illumina HiSeq	27e88ee3-dcb4-43c4-9653-c55aa1851cb1	Bladder	53.0	2CD62676-762C-461D-B111-1F81E7CD5877	EEB315EA-D1B6-4F92-91B0-9AAAC7083D68	TCGA-GD-A2C5-01A-12D-A17R-02	HG19_Broad_variant	TCGA-GD-A2C5	TCGA-BLCA		Harvard Medical School	ABS - IUPUI	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2921	58cfa832e4b0c9d6adf6cf70	TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted.filtered.	WGS	TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted	TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted.bam	8.9		0.14	58cfa832e4b0c9d6adf6cf70	TCGA-GD-A3OP-11A-11D-A221_120902_SN1222_0147_AC195DACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A3OP-11A	31DA07BB-6752-49A3-A7EA-5427C04A9458	Solid Tissue Normal	Illumina HiSeq	cec19b51-29ce-4b48-81a6-7f61054cc053	Bladder	84.0	22340B82-9219-49C6-B511-FDA79F24F36E	120EE6C1-48C4-42BB-97F2-BFFD79B35FF9	TCGA-GD-A3OP-11A-11D-A221-26	HG19_Broad_variant	TCGA-GD-A3OP	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2922	58cfa832e4b0c9d6adf6cff0	TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted.filtered.	WGS	TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted	TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted.bam	37.3		0.14	58cfa832e4b0c9d6adf6cff0	TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A3OS-01A	2A41B7D4-132F-4FB6-87B5-487C445379C7	Primary Tumor	Illumina HiSeq	2a801113-8404-4c17-9d60-508761ec1659	Bladder	54.0	C629CD55-54D7-4E31-AB90-955EBFF0B20A	80DBF776-1B0B-454C-9DA6-9688816A294D	TCGA-GD-A3OS-01A-12D-A221-26	HG19_Broad_variant	TCGA-GD-A3OS	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2923	58cfa832e4b0c9d6adf6d026	TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted.filtered.	WGS	TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted	TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted.bam	40.42		0.15	58cfa832e4b0c9d6adf6d026	TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A3OQ-01A	2E85C30C-C4C4-4096-9EEF-4EB2C7D991A3	Primary Tumor	Illumina HiSeq	a07d0456-032d-409c-af8d-c4d6349ef4db	Bladder	48.0	E3D22638-C0AE-48AA-A523-8C9A6CFBF063	F77305E9-430E-4E7D-97A6-C97FFDDC3B65	TCGA-GD-A3OQ-01A-32D-A221-26	HG19_Broad_variant	TCGA-GD-A3OQ	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	T4a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2924	58cfa832e4b0c9d6adf6d024	TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted.filtered.	WGS	TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted	TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted.bam	51.48		0.15	58cfa832e4b0c9d6adf6d024	TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3BM-01A	7840AEA9-40C4-473E-BE33-8FA0B9F332C9	Primary Tumor	Illumina HiSeq	1901f2a9-837a-482c-8073-472f3c4d9ba1	Bladder	70.0	5C631CE8-F96A-4C35-A459-556FC4AB21E1	5FE3FF9D-CCF4-4C76-820D-26FD5D1FCD15	TCGA-GC-A3BM-01A-11D-A23Q-26	HG19_Broad_variant	TCGA-GC-A3BM	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2926	58cfa832e4b0c9d6adf6cff8	TCGA-GD-A2C5-11A-11D-A17R_120927_SN208_0432_AC188LACXX_s_8_rg.sorted.filtered.	WGS	TCGA-GD-A2C5-11A-11D-A17R_120927_SN208_0432_AC188LACXX_s_8_rg.sorted	TCGA-GD-A2C5-11A-11D-A17R_120927_SN208_0432_AC188LACXX_s_8_rg.sorted.bam	18.62		0.15	58cfa832e4b0c9d6adf6cff8	TCGA-GD-A2C5-11A-11D-A17R_120927_SN208_0432_AC188LACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A2C5-11A	5D54C742-5A8E-4C40-8D62-95E75E210AB8	Solid Tissue Normal	Illumina HiSeq	d56808f7-e6d9-4234-b65c-7ff6bad653f8	Bladder	53.0	892EB338-9C49-4378-A934-623F4EDACF7D	C0270E61-DE9A-4A93-941F-74A9E15BE419	TCGA-GD-A2C5-11A-11D-A17R-02	HG19_Broad_variant	TCGA-GD-A2C5	TCGA-BLCA		Harvard Medical School	ABS - IUPUI	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2927	58cfa832e4b0c9d6adf6cf66	TCGA-GD-A3OQ-11A-21D-A221_120902_SN1222_0147_AC195DACXX_s_5_rg.sorted.filtered.	WGS	TCGA-GD-A3OQ-11A-21D-A221_120902_SN1222_0147_AC195DACXX_s_5_rg.sorted	TCGA-GD-A3OQ-11A-21D-A221_120902_SN1222_0147_AC195DACXX_s_5_rg.sorted.bam	14.6		0.15	58cfa832e4b0c9d6adf6cf66	TCGA-GD-A3OQ-11A-21D-A221_120902_SN1222_0147_AC195DACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A3OQ-11A	2E85C30C-C4C4-4096-9EEF-4EB2C7D991A3	Solid Tissue Normal	Illumina HiSeq	b206c126-8a3d-4051-89bb-086c3e66ed39	Bladder	48.0	FA1B5772-8254-49BA-A385-AF8C9AC7FA4F	478C5567-E4F7-4155-A9DC-6B0B135A1758	TCGA-GD-A3OQ-11A-21D-A221-26	HG19_Broad_variant	TCGA-GD-A3OQ	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	T4a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2931	58cfa832e4b0c9d6adf6ce60	TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted	TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted.bam	21.58		0.16	58cfa832e4b0c9d6adf6ce60	TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3QF-01A	47990D5E-A0E1-4752-86F5-4F5B84E219DF	Primary Tumor	Illumina HiSeq	bcac19c7-1e8c-40ba-a577-39fce12db063	Bladder	79.0	6647C98E-7AA1-49E4-A067-D53AEBACFF9C	F7B433D0-F5DA-4E9C-9C32-A614FB4F614C	TCGA-GV-A3QF-01A-31D-A233-26	HG19_Broad_variant	TCGA-GV-A3QF	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s2937	58cfa832e4b0c9d6adf6d196	TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted.filtered.	WGS	TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted	TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted.bam	33.77		0.15	58cfa832e4b0c9d6adf6d196	TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-K4-A3WV-01A	D53EADE8-A845-4252-AECE-92F3573486A7	Primary Tumor	Illumina HiSeq	ca7a6b06-a6fa-4314-80ef-725b81781598	Bladder	77.0	3ADFA409-A9F8-4EDB-AAF7-C5285AE5F895	9A7CA3A1-631F-41BA-A490-04D470C4AF8E	TCGA-K4-A3WV-01A-11D-A23Q-26	HG19_Broad_variant	TCGA-K4-A3WV	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ABS - Lahey Clinic	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s2938	58cfa832e4b0c9d6adf6d258	TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted.filtered.	WGS	TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted	TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted.bam	14.71		0.15	58cfa832e4b0c9d6adf6d258	TCGA-K4-A3WV-11A-21D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-K4-A3WV-11A	D53EADE8-A845-4252-AECE-92F3573486A7	Solid Tissue Normal	Illumina HiSeq	3dc4b7a1-75cf-4f52-b921-7d6dcb7d1046	Bladder	77.0	C8B4ED6D-69C0-4052-BEC2-9FE6A3CFC481	30325C24-68C0-40DD-987B-DF84C4B5FBEA	TCGA-K4-A3WV-11A-21D-A23Q-26	HG19_Broad_variant	TCGA-K4-A3WV	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ABS - Lahey Clinic	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3065	58cfa82ee4b0c9d6adf6ab0a	G32451.TCGA-BT-A20T-11A-11D-A14W-08.1.filtered.	WGS	G32451.TCGA-BT-A20T-11A-11D-A14W-08.1	G32451.TCGA-BT-A20T-11A-11D-A14W-08.1.bam	10.21	1.76	0.09	58cfa82ee4b0c9d6adf6ab0a	G32451.TCGA-BT-A20T-11A-11D-A14W-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20T-11A	096B4F32-10C1-4737-A0DD-CAE04C54EE33	Solid Tissue Normal	Illumina HiSeq	1f33179c-e661-4003-9bb0-d0f222368c02	Bladder	63.0	27461A27-26EB-4C2C-9C54-E16FBD32C615	E0FCCAF5-925A-41F9-B87C-CD5EE4AECB59	TCGA-BT-A20T-11A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20T	TCGA-BLCA	453.0	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3066	58cfa82ee4b0c9d6adf6abaa	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.filtered.	WGS	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.bam	59.04	1.91	0.08	58cfa82ee4b0c9d6adf6abaa	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A5-01A	904A8757-E0C5-41EF-B583-C8F170CAAAC1	Primary Tumor	Illumina HiSeq	f0ccddad-f1d5-4cd3-bad7-f9710dba4127	Bladder	79.0	A9EF3EC5-B1C1-481F-89CF-1729FAB50173	448FE471-3F4E-4DC8-A4E0-6F147DC93ABE	TCGA-DK-A1A5-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A5	TCGA-BLCA	65.0	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3070	58cfa82ee4b0c9d6adf6a974	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.filtered.	WGS	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.bam	35.04	2.0	0.07	58cfa82ee4b0c9d6adf6a974	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A7-01A	3ED614E7-F356-4D87-985B-D3BBBAE3BB40	Primary Tumor	Illumina HiSeq	7a0d461d-525e-4b3a-86d1-d6d3306fb405	Bladder	67.0	D68D16F7-6117-4D3D-8347-CF5CD3F23AE4	91F458E6-64B7-454D-A542-B0AA23638FD8	TCGA-DK-A1A7-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A7	TCGA-BLCA		Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3072	58cfa82ee4b0c9d6adf6ab72	G32465.TCGA-BT-A20Q-11A-11D-A14W-08.1.filtered.	WGS	G32465.TCGA-BT-A20Q-11A-11D-A14W-08.1	G32465.TCGA-BT-A20Q-11A-11D-A14W-08.1.bam	7.0	1.89	0.07	58cfa82ee4b0c9d6adf6ab72	G32465.TCGA-BT-A20Q-11A-11D-A14W-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20Q-11A	419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F	Solid Tissue Normal	Illumina HiSeq	c4e57539-5d0e-43ce-87df-73ae5c8e8738	Bladder	73.0	DF346965-B972-445D-9AAC-35605B908F4D	21D0907A-AC47-4A72-8F6C-74D25949FE11	TCGA-BT-A20Q-11A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20Q	TCGA-BLCA	593.0	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3080	58cfa830e4b0c9d6adf6be6c	TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted	TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted.bam	57.46	1.9	0.15	58cfa830e4b0c9d6adf6be6c	TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A13J-01A	556FCBC8-172A-4AF1-8822-AE036E8D68E8	Primary Tumor	Illumina HiSeq	58daf5d5-0c54-4a8c-b756-35565cdc9671	Bladder	65.0	CF23846D-A7D2-40A9-8B51-49A27967D101	782CEFE1-C28F-40BA-93A2-66279184EEF6	TCGA-BL-A13J-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BL-A13J	TCGA-BLCA	81.0	Harvard Medical School	Christiana Healthcare	United States	NO	T4	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3081	58cfa830e4b0c9d6adf6becf	TCGA-BL-A13J-11A-13D-A10R_120920_SN1222_0151_BD1D5CACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BL-A13J-11A-13D-A10R_120920_SN1222_0151_BD1D5CACXX_s_2_rg.sorted	TCGA-BL-A13J-11A-13D-A10R_120920_SN1222_0151_BD1D5CACXX_s_2_rg.sorted.bam	13.33	1.94	0.14	58cfa830e4b0c9d6adf6becf	TCGA-BL-A13J-11A-13D-A10R_120920_SN1222_0151_BD1D5CACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A13J-11A	556FCBC8-172A-4AF1-8822-AE036E8D68E8	Solid Tissue Normal	Illumina HiSeq	477877cc-b9b8-4869-b082-7dc505705bcd	Bladder	65.0	2A834A44-9490-4C60-B587-EBE890C3FB0A	9B4FFD23-8B53-4DFC-A98E-E4C70F7680F0	TCGA-BL-A13J-11A-13D-A10R-02	HG19_Broad_variant	TCGA-BL-A13J	TCGA-BLCA	81.0	Harvard Medical School	Christiana Healthcare	United States	NO	T4	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3082	58cfa830e4b0c9d6adf6be94	TCGA-BL-A13I-11A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BL-A13I-11A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_5_rg.sorted	TCGA-BL-A13I-11A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_5_rg.sorted.bam	9.8	1.98	0.16	58cfa830e4b0c9d6adf6be94	TCGA-BL-A13I-11A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A13I-11A	EBC094A6-CDC9-4C02-B8EC-A181B25A364D	Solid Tissue Normal	Illumina HiSeq	18c5e150-2417-4ca7-88c8-d147dfb43853	Bladder	57.0	DD38F3F6-5A39-41B7-B2EA-8917298E76D2	325DC686-E598-42C6-B2E7-3AE19B1EA4F9	TCGA-BL-A13I-11A-11D-A13U-02	HG19_Broad_variant	TCGA-BL-A13I	TCGA-BLCA	223.0	Harvard Medical School	Christiana Healthcare	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3083	58cfa831e4b0c9d6adf6c3c2	TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted	TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted.bam	56.34	2.11	0.15	58cfa831e4b0c9d6adf6c3c2	TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20Q-01A	419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F	Primary Tumor	Illumina HiSeq	9d2dc2d3-8995-42b8-9bee-010c8bce06e0	Bladder	73.0	F3906CD4-31C7-48A8-935B-5B7FAFEC1AE7	72AF980B-98A8-4572-8AF9-EFD4294700F9	TCGA-BT-A20Q-01A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20Q	TCGA-BLCA	593.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3085	58cfa830e4b0c9d6adf6c206	TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted	TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted.bam	77.69	1.98	0.17	58cfa830e4b0c9d6adf6c206	TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20W-01A	4DC5CFFE-ED8C-47AB-B5FC-F9615B5414F7	Primary Tumor	Illumina HiSeq	a817f2b5-a06a-422e-869a-694baf6bb127	Bladder	71.0	CA14F475-1BE4-450C-80C3-7094D23D0B3D	A32E59E0-242F-465D-8277-E0FE26124091	TCGA-BT-A20W-01A-21D-A14U-02	HG19_Broad_variant	TCGA-BT-A20W	TCGA-BLCA	254.0	Harvard Medical School	University of Pittsburgh	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3086	58cfa830e4b0c9d6adf6c216	TCGA-BT-A20O-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BT-A20O-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_4_rg.sorted	TCGA-BT-A20O-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_4_rg.sorted.bam	10.13	1.84	0.17	58cfa830e4b0c9d6adf6c216	TCGA-BT-A20O-11A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20O-11A	C0E7FBE7-B9CB-4E65-941B-CD7D581C54EC	Solid Tissue Normal	Illumina HiSeq	d9764a1d-1e8f-47de-8916-e254751cd477	Bladder	75.0	F8846751-C6D7-4213-83BC-5A0382CBFFAE	F0DC405B-AFAB-4AE2-8585-295F6BC65243	TCGA-BT-A20O-11A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20O	TCGA-BLCA	370.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3087	58cfa830e4b0c9d6adf6c23c	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.bam	51.24		0.18	58cfa830e4b0c9d6adf6c23c	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LB-01A	D17A5AB1-3789-4652-AFF5-D8F4F2291F9C	Primary Tumor	Illumina HiSeq	de67212f-594e-409c-bd19-3d40f013b89a	Bladder	73.0	7C6178A6-6D4C-4DEF-B4AC-A064AB4A6C8A	FAD087E0-3752-4144-960B-659B59312C92	TCGA-BT-A2LB-01A-11D-A18D-02	HG19_Broad_variant	TCGA-BT-A2LB	TCGA-BLCA		Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3089	58cfa831e4b0c9d6adf6c42c	TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted	TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted.bam	16.84		0.18	58cfa831e4b0c9d6adf6c42c	TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LD-01A	9DD97821-7AFD-4982-8B1D-F14F845B79F7	Primary Tumor	Illumina HiSeq	205bfe9f-2bc9-4236-930c-a862874ad8e0	Bladder	78.0	AEB379D5-B157-4BCE-82C5-0CD0077DB01F	BF6A16B2-9DC9-4E9A-A810-2EBA7E9B56A1	TCGA-BT-A2LD-01A-12D-A210-26	HG19_Broad_variant	TCGA-BT-A2LD	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3090	58cfa831e4b0c9d6adf6c3c4	TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted	TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted.bam	63.78	1.88	0.16	58cfa831e4b0c9d6adf6c3c4	TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20O-01A	C0E7FBE7-B9CB-4E65-941B-CD7D581C54EC	Primary Tumor	Illumina HiSeq	c345a912-f3c8-4622-9793-88cf795fc964	Bladder	75.0	5ECD84AD-44FD-4599-BF3D-AB725E0404EC	13596E86-7CD8-4A07-941F-E936D0004F6B	TCGA-BT-A20O-01A-21D-A14U-02	HG19_Broad_variant	TCGA-BT-A20O	TCGA-BLCA	370.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3091	58cfa830e4b0c9d6adf6c218	TCGA-BT-A20X-11A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BT-A20X-11A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_6_rg.sorted	TCGA-BT-A20X-11A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_6_rg.sorted.bam	9.27	1.77	0.15	58cfa830e4b0c9d6adf6c218	TCGA-BT-A20X-11A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20X-11A	BE8B3F36-AAA1-4302-B28E-DE1996FACEAF	Solid Tissue Normal	Illumina HiSeq	85b68bda-849a-4597-8161-176a8ad06f09	Bladder	56.0	F949B635-1BF1-457F-B72A-02F59753E467	4200DE6A-AE4E-42DD-8AB5-1B78298A2A22	TCGA-BT-A20X-11A-12D-A16N-02	HG19_Broad_variant	TCGA-BT-A20X	TCGA-BLCA	251.0	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3092	58cfa831e4b0c9d6adf6c4d6	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.bam	55.07		0.16	58cfa831e4b0c9d6adf6c4d6	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MF-01A	1E308B12-0590-4DAE-94D0-A539FCF25DF7	Primary Tumor	Illumina HiSeq	57be2848-15e4-489c-b122-a660f03c68dd	Bladder	34.0	E9889071-4C6E-4761-9D65-06C6B5989FB7	6646401F-5235-4847-A4E6-006F98CAFE85	TCGA-CF-A3MF-01A-12D-A21C-26	HG19_Broad_variant	TCGA-CF-A3MF	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3095	58cfa831e4b0c9d6adf6c4d2	TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted	TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted.bam	66.73		0.14	58cfa831e4b0c9d6adf6c4d2	TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MG-01A	39EFA06A-FFE5-40B3-8F8A-A2D7071BC9E3	Primary Tumor	Illumina HiSeq	695ed631-423c-4381-ae8f-4a70fd6266b9	Bladder	48.0	1ACF91C8-4971-4893-AC27-64EA4A4C3023	99993BCD-8555-407A-A918-3F51D57BA720	TCGA-CF-A3MG-01A-11D-A210-26	HG19_Broad_variant	TCGA-CF-A3MG	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3096	58cfa831e4b0c9d6adf6c68a	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.bam	36.74	1.82	0.16	58cfa831e4b0c9d6adf6c68a	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YR-01A	811B3950-36E7-485F-BC48-ACA1EEE2DDEF	Primary Tumor	Illumina HiSeq	197d19a7-07c1-4cd3-b41d-a8233c9d8a42	Bladder	83.0	B362FCFA-4E31-4321-9E17-11A8BAE839C3	0CB51232-CFEA-4F4F-A26A-173B1094A64B	TCGA-CU-A0YR-01A-12D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YR	TCGA-BLCA		Harvard Medical School	UNC	United States	NO	T2	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3097	58cfa831e4b0c9d6adf6c688	TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted	TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted.bam	30.08	1.91	0.16	58cfa831e4b0c9d6adf6c688	TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YO-01A	4A9EF220-922C-49CF-BBED-D173B214ED31	Primary Tumor	Illumina HiSeq	98d555c2-93ae-4db5-9b19-43655d10609d	Bladder	84.0	9E190462-39FC-41B2-B1D6-2DA150412FCF	A407711E-26FF-4C0C-9391-326A51614BB7	TCGA-CU-A0YO-01A-11D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YO	TCGA-BLCA	149.0	Harvard Medical School	UNC	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3098	58cfa831e4b0c9d6adf6c6c8	TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted	TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted.bam	49.18		0.15	58cfa831e4b0c9d6adf6c6c8	TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A3KJ-01A	A75584BC-BEF7-48F6-B4B3-C1472A3AF768	Primary Tumor	Illumina HiSeq	6b7a9ee7-ee89-4473-9170-7372313595f7	Bladder	75.0	3D92F5A6-949A-4176-9309-4294CCA6FC25	25847D62-9932-4A04-9B00-378794D2CE72	TCGA-CU-A3KJ-01A-11D-A21C-26	HG19_Broad_variant	TCGA-CU-A3KJ	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	UNC	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3102	58cfa831e4b0c9d6adf6c9d3	TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted	TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted.bam	16.46	1.91	0.17	58cfa831e4b0c9d6adf6c9d3	TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A3-01A	C5B20CCC-523D-491C-8536-008E05C57212	Primary Tumor	Illumina HiSeq	0e78dec3-7b8b-425e-9cc5-489bf825e0ea	Bladder	60.0	954E46BA-514F-4708-AD3C-ECBF8CEF005A	DC0A234A-9177-4E2A-B218-212F1278B4A1	TCGA-DK-A1A3-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1A3	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3107	58cfa831e4b0c9d6adf6c914	TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted	TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted.bam	72.54	1.95	0.16	58cfa831e4b0c9d6adf6c914	TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AA-01A	56D8A1B8-1268-4362-A7F1-77B76FBF1B59	Primary Tumor	Illumina HiSeq	006c1498-f327-4fff-8936-7d7cb06639f4	Bladder	57.0	577700D1-C366-41EF-8A0D-E50DEEFB5E3C	6482BD80-A3F1-4169-A9F2-B45A9445035C	TCGA-DK-A1AA-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AA	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3108	58cfa831e4b0c9d6adf6c8e0	TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted	TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted.bam	71.23		0.16	58cfa831e4b0c9d6adf6c8e0	TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IV-01A	F953DC5D-58BF-4936-B9FE-74B45E8C00E5	Primary Tumor	Illumina HiSeq	5bf5cb9d-7592-4967-8440-fe80dfe9c2a6	Bladder	60.0	BC065247-1179-4FC2-B45C-8EFB13AADE65	62148C98-8E6F-4CA0-9EC6-C7FD7F96495D	TCGA-DK-A3IV-01A-22D-A21C-26	HG19_Broad_variant	TCGA-DK-A3IV	TCGA-BLCA	294.0	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3109	58cfa831e4b0c9d6adf6cb28	TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted	TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted.bam	43.56		0.17	58cfa831e4b0c9d6adf6cb28	TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E7-A3Y1-01A	F7C891EB-3B09-4E01-BB8A-53D570518CBE	Primary Tumor	Illumina HiSeq	aaeb4857-84bb-4a72-9e0d-81280de1ca61	Bladder	57.0	FABE5B98-4586-445D-9513-598BB7FD1909	46542747-5AF3-4F7E-AE97-7E0689976D0A	TCGA-E7-A3Y1-01A-11D-A233-26	HG19_Broad_variant	TCGA-E7-A3Y1	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	Asterand	Ukraine	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3111	58cfa832e4b0c9d6adf6ceba	TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted	TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted.bam	41.92		0.16	58cfa832e4b0c9d6adf6ceba	TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B4-01A	899F8D52-4C3A-4371-90EB-1F106001EDDC	Primary Tumor	Illumina HiSeq	54b70ff2-6c53-438c-934a-97fe2837620e	Bladder	55.0	6895A68F-0EFD-4B0E-8CF2-9195833DBBA1	7E975842-6EB5-4D66-A2F1-7EA7E8E989FC	TCGA-FD-A3B4-01A-12D-A204-02	HG19_Broad_variant	TCGA-FD-A3B4	TCGA-BLCA		Harvard Medical School	BLN - University Of Chicago	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3112	58cfa831e4b0c9d6adf6ccf8	TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted	TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted.bam	26.79		0.15	58cfa831e4b0c9d6adf6ccf8	TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SP-01A	5F99DCFF-D809-4C87-8024-C9B30BD565E9	Primary Tumor	Illumina HiSeq	2da38f98-8b94-404e-99e7-7a8d58aa25c1	Bladder	60.0	3592A9C5-124E-428F-B1F9-40429C591429	9BE9B27C-A33C-450E-806D-7C791472DAE6	TCGA-FD-A3SP-01A-31D-A233-26	HG19_Broad_variant	TCGA-FD-A3SP	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3114	58cfa832e4b0c9d6adf6ceac	TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted	TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted.bam	63.16		0.16	58cfa832e4b0c9d6adf6ceac	TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3NA-01A	14917461-DAE4-44CB-909D-42AC45AEF450	Primary Tumor	Illumina HiSeq	8c4c1672-fea7-4c17-a6d0-d4a0f3c04558	Bladder	60.0	7BD000AB-6F48-4A9E-98A4-EAF47D6E3C05	37789FCA-0C64-49B7-A704-572A19BD2645	TCGA-FD-A3NA-01A-11D-A21C-26	HG19_Broad_variant	TCGA-FD-A3NA	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3116	58cfa831e4b0c9d6adf6cd9c	TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted	TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted.bam	39.24		0.14	58cfa831e4b0c9d6adf6cd9c	TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SR-01A	72D6E9AA-4A99-4FC9-A67B-4631E95FB043	Primary Tumor	Illumina HiSeq	e8c95d25-27f4-4cba-b644-eb39019c6cc0	Bladder	68.0	8E9683F4-52B4-4646-921E-7BF89F56774A	93A2B3C4-915C-46BE-9D36-C244036B7A0C	TCGA-FD-A3SR-01A-11D-A233-26	HG19_Broad_variant	TCGA-FD-A3SR	TCGA-BLCA	602.0	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3118	58cfa832e4b0c9d6adf6ce97	TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted.filtered.	WGS	TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted	TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted.bam	40.86		0.15	58cfa832e4b0c9d6adf6ce97	TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EF-01A	2A142731-119C-495D-AD30-EB0B48BACB46	Primary Tumor	Illumina HiSeq	ac16538b-bd5d-496e-bccc-6f3374d226c6	Bladder	50.0	981F581E-32AF-486B-9B60-0C8F1047C879	CE2F4DE7-C8AE-4103-8084-5F783B1087A7	TCGA-G2-A2EF-01A-12D-A18D-02	HG19_Broad_variant	TCGA-G2-A2EF	TCGA-BLCA		Harvard Medical School	MD Anderson	United States	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3119	58cfa832e4b0c9d6adf6cff4	TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted.filtered.	WGS	TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted	TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted.bam	8.9		0.16	58cfa832e4b0c9d6adf6cff4	TCGA-G2-A2ES-11A-31D-A17R_120921_SN208_0430_AC18CWACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2ES-11A	72D8EAE8-9EFB-45B2-ACBD-82C6B5732E38	Solid Tissue Normal	Illumina HiSeq	f8583339-ea56-43ba-af11-e7b5945ecfb4	Bladder	85.0	F7D5544F-E86D-410F-995C-86A717742036	F310E6C4-B237-4EA0-A8A1-679B5B49C50D	TCGA-G2-A2ES-11A-31D-A17R-02	HG19_Broad_variant	TCGA-G2-A2ES	TCGA-BLCA		Harvard Medical School	MD Anderson	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3122	58cfa832e4b0c9d6adf6ce8a	TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted.filtered.	WGS	TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted	TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted.bam	27.96		0.16	58cfa832e4b0c9d6adf6ce8a	TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EL-01A	30C7445E-D0C4-4A0F-96A4-27E4259EE10B	Primary Tumor	Illumina HiSeq	15128dae-4500-4372-9676-d23d4c116527	Bladder	77.0	90F1D206-3E97-4C88-922C-FE4773C37CAA	D850DDCD-6E04-4EB4-887C-E1AE410C301C	TCGA-G2-A2EL-01A-12D-A18D-02	HG19_Broad_variant	TCGA-G2-A2EL	TCGA-BLCA	819.0	Harvard Medical School	MD Anderson	United States	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3123	58cfa832e4b0c9d6adf6cfe5	TCGA-GC-A3BM-11A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_5_rg.sorted.filtered.	WGS	TCGA-GC-A3BM-11A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_5_rg.sorted	TCGA-GC-A3BM-11A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_5_rg.sorted.bam	16.33		0.17	58cfa832e4b0c9d6adf6cfe5	TCGA-GC-A3BM-11A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3BM-11A	7840AEA9-40C4-473E-BE33-8FA0B9F332C9	Solid Tissue Normal	Illumina HiSeq	33f4607f-b43c-4a61-a3cf-ff21ad2e6d62	Bladder	70.0	BFBA8167-6ACC-47F8-B7AA-E9AB2B2F1005	93BD7C4E-CBF2-41B4-9B5B-C5426106C182	TCGA-GC-A3BM-11A-11D-A23Q-26	HG19_Broad_variant	TCGA-GC-A3BM	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3125	58cfa832e4b0c9d6adf6cf7f	TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted.filtered.	WGS	TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted	TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted.bam	15.89		0.17	58cfa832e4b0c9d6adf6cf7f	TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A3OP-01A	31DA07BB-6752-49A3-A7EA-5427C04A9458	Primary Tumor	Illumina HiSeq	e01f55a8-4fbe-4f9a-8617-ce0e6900f177	Bladder	84.0	C0773229-5A20-4451-9DB5-F757E34921AE	AB6D114E-DF58-4912-85F4-3C385CAA3749	TCGA-GD-A3OP-01A-21D-A221-26	HG19_Broad_variant	TCGA-GD-A3OP	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3126	58cfa832e4b0c9d6adf6d03a	TCGA-GC-A3WC-11A-11D-A233_120904_SN1120_0186_BC1911ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-GC-A3WC-11A-11D-A233_120904_SN1120_0186_BC1911ACXX_s_2_rg.sorted	TCGA-GC-A3WC-11A-11D-A233_120904_SN1120_0186_BC1911ACXX_s_2_rg.sorted.bam	10.9		0.17	58cfa832e4b0c9d6adf6d03a	TCGA-GC-A3WC-11A-11D-A233_120904_SN1120_0186_BC1911ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3WC-11A	DB52C68A-ED44-4EC4-9381-D75F9BCBC29A	Solid Tissue Normal	Illumina HiSeq	33924502-cf1d-4609-9e24-f717bcd9c439	Bladder	80.0	67ECDE91-9420-41F4-AE8A-5DA68D3EEABC	2058E8CF-4904-4A24-BCA5-3C5EB4D35A73	TCGA-GC-A3WC-11A-11D-A233-26	HG19_Broad_variant	TCGA-GC-A3WC	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3129	58cfa832e4b0c9d6adf6ce63	TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted.filtered.	WGS	TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted	TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted.bam	38.38		0.14	58cfa832e4b0c9d6adf6ce63	TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3QH-01A	33BC6A7C-9844-41E3-96B3-1E34BB3FEDD5	Primary Tumor	Illumina HiSeq	5672aee8-638c-45c6-af4f-0ccc5e2a1b45	Bladder	67.0	DEB7311F-E747-44EC-92C3-1E56CD5CACF2	B14D2F40-53F3-4A3A-8FA8-1BE7F102CA25	TCGA-GV-A3QH-01A-11D-A221-26	HG19_Broad_variant	TCGA-GV-A3QH	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3131	58cfa832e4b0c9d6adf6d269	TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted.filtered.	WGS	TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted	TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted.bam	18.56		0.16	58cfa832e4b0c9d6adf6d269	TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-K4-A3WS-01A	68ADACD1-A16E-4489-9E68-792A6BD8811C	Primary Tumor	Illumina HiSeq	891c215b-20ad-4eb3-9e53-87910b1d06f4	Bladder	66.0	54070AE0-0C10-4C10-B8BB-A7313B80A45F	F1840542-AEBE-4B4C-BA50-1686740847D4	TCGA-K4-A3WS-01A-11D-A23Q-26	HG19_Broad_variant	TCGA-K4-A3WS	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ABS - Lahey Clinic	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3250	58cfa82ee4b0c9d6adf6aaee	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.filtered.	WGS	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.bam	54.46		0.07	58cfa82ee4b0c9d6adf6aaee	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-H4-A2HQ-01A	CEDE5274-279D-4021-8ACA-5ECC4BF94D66	Primary Tumor	Illumina HiSeq	211fa39b-cffd-430e-b28a-b6624e81fb93	Bladder	64.0	CBEDC0DB-39FD-4661-9531-CC24D422FAC4	94108975-B7A0-40BA-AD39-E44CC62E8CC0	TCGA-H4-A2HQ-01A-11D-A17V-08	HG19_Broad_variant	TCGA-H4-A2HQ	TCGA-BLCA		Broad Institute of MIT and Harvard	Medical College of Georgia	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3254	58cfa82ee4b0c9d6adf6ab34	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.filtered.	WGS	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.bam	56.18		0.08	58cfa82ee4b0c9d6adf6ab34	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PH-01A	932BCDD4-5145-49E8-9A95-8A546396F572	Primary Tumor	Illumina HiSeq	6a3d1aec-7ab7-4703-b3f0-5ba3f396d70d	Bladder	76.0	33A83E54-3BE5-4A68-8AB0-D31D0BCD3B67	CDA1A403-16B6-487C-A82A-C377D1D0F89D	TCGA-BT-A3PH-01A-11D-A21Z-08	HG19_Broad_variant	TCGA-BT-A3PH	TCGA-BLCA	142.0	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3255	58cfa82ee4b0c9d6adf6aa1c	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.filtered.	WGS	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.bam	56.34	2.11	0.08	58cfa82ee4b0c9d6adf6aa1c	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20Q-01A	419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F	Primary Tumor	Illumina HiSeq	1e07bbf1-7f3c-4472-b21e-f9eaa7b11659	Bladder	73.0	F3906CD4-31C7-48A8-935B-5B7FAFEC1AE7	8C619CBC-9E91-4716-9711-5236E55D8F46	TCGA-BT-A20Q-01A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20Q	TCGA-BLCA	593.0	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3265	58cfa830e4b0c9d6adf6c24e	TCGA-BT-A20J-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BT-A20J-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_2_rg.sorted	TCGA-BT-A20J-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_2_rg.sorted.bam	14.88	1.95	0.16	58cfa830e4b0c9d6adf6c24e	TCGA-BT-A20J-11A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20J-11A	74B1E72D-FDD0-4D84-8858-3BB32D58FF7E	Solid Tissue Normal	Illumina HiSeq	da071b6a-1e54-41d9-86c9-47599382a770	Bladder	75.0	C53A13EF-44CD-49AF-B69C-82C5C11A3AB4	61898C3F-4C48-4E04-9B67-BE546BC7C662	TCGA-BT-A20J-11A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20J	TCGA-BLCA	579.0	Harvard Medical School	University of Pittsburgh	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3269	58cfa830e4b0c9d6adf6c22c	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.bam	12.85	1.87	0.15	58cfa830e4b0c9d6adf6c22c	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A0S7-01A	68BC786E-07C7-4964-BC88-5E2A8633626A	Primary Tumor	Illumina HiSeq	55a63ec5-a803-44ee-905f-c7bfff9162d6	Bladder	75.0	A9B73851-4609-4DF7-8EB8-45A56F4B2DD6	F415813D-F975-492B-9E4E-55CE47C967B9	TCGA-BT-A0S7-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BT-A0S7	TCGA-BLCA	200.0	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3270	58cfa831e4b0c9d6adf6c3a0	TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted	TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted.bam	68.38	1.71	0.17	58cfa831e4b0c9d6adf6c3a0	TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20U-01A	83B41D35-69B1-4218-BE1A-8821D8A6899C	Primary Tumor	Illumina HiSeq	9947c8cb-fa3d-4cc2-942e-b013f7a47faa	Bladder	70.0	D29E555F-8467-45C8-9124-0E6A757B1ADF	8D4442E9-3312-4607-A59F-49538B19FA71	TCGA-BT-A20U-01A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20U	TCGA-BLCA	455.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3272	58cfa830e4b0c9d6adf6c2e0	TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted	TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted.bam	75.72	2.03	0.15	58cfa830e4b0c9d6adf6c2e0	TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20P-01A	F48937ED-E294-41F0-8872-7010391167A9	Primary Tumor	Illumina HiSeq	814688fe-5071-40b6-bb89-643389543580	Bladder	81.0	6B43EEEC-4FEB-4062-827A-E63ED8CE3820	022AEFEC-CBAC-46C1-9F17-AC087BD7164E	TCGA-BT-A20P-01A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20P	TCGA-BLCA	544.0	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3273	58cfa831e4b0c9d6adf6c50c	TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted	TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted.bam	46.48		0.14	58cfa831e4b0c9d6adf6c50c	TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MI-01A	F1EBF96B-8DF9-4E59-ACEF-7AD433E40214	Primary Tumor	Illumina HiSeq	6559c325-d368-4f95-a2c0-df5efa895e3d	Bladder	62.0	A373568A-BBD3-4D67-92D6-96E8378065CF	86D4A4FB-47BB-4CD4-B481-CE9F815D38E6	TCGA-CF-A3MI-01A-11D-A210-26	HG19_Broad_variant	TCGA-CF-A3MI	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3274	58cfa831e4b0c9d6adf6c68f	TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted	TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted.bam	42.41		0.15	58cfa831e4b0c9d6adf6c68f	TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A3YL-01A	087A7F70-2FA8-4A16-B130-4DF10A70C662	Primary Tumor	Illumina HiSeq	8753d7f5-4d92-4781-8d19-d44710fa4f45	Bladder	67.0	F66AD788-E2D8-4688-820F-49A609701533	CAD008C4-3B53-4E9D-8730-9807E4753DDD	TCGA-CU-A3YL-01A-11D-A233-26	HG19_Broad_variant	TCGA-CU-A3YL	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	UNC	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3276	58cfa831e4b0c9d6adf6c66d	TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted	TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted.bam	82.02	2.0	0.16	58cfa831e4b0c9d6adf6c66d	TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YN-01A	679A6869-2CE9-4472-8DB1-8869E2C1A440	Primary Tumor	Illumina HiSeq	89fcc222-6a37-406f-a641-b3d857104f9f	Bladder	60.0	DBCC2FCB-A103-46DA-9893-6EC689D2F98E	98E994A3-9823-472B-AED1-38876DEA7F24	TCGA-CU-A0YN-01A-21D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YN	TCGA-BLCA	393.0	Harvard Medical School	UNC	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3277	58cfa831e4b0c9d6adf6c708	TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted	TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted.bam	8.8	2.09	0.14	58cfa831e4b0c9d6adf6c708	TCGA-CU-A0YN-11A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YN-11A	679A6869-2CE9-4472-8DB1-8869E2C1A440	Solid Tissue Normal	Illumina HiSeq	4f24b2d4-a63d-40e7-82c7-bc6e188fbb4a	Bladder	60.0	CAAC9355-9BAC-41D8-B7A7-8EEB775179FA	25F4133F-37D6-46DA-9405-03D506557044	TCGA-CU-A0YN-11A-11D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YN	TCGA-BLCA	393.0	Harvard Medical School	UNC	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3278	58cfa831e4b0c9d6adf6c6c3	TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted	TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted.bam	73.31		0.15	58cfa831e4b0c9d6adf6c6c3	TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A3QU-01A	AE6D853B-A7F0-4465-B7BF-5A45006AB3B3	Primary Tumor	Illumina HiSeq	c4c9ea17-be51-4e92-8cdc-0d5880def11c	Bladder	58.0	75448068-DED8-42F0-BB99-6D1C4B3FFA4E	98A4CFCF-34FE-433A-A598-4191742DC977	TCGA-CU-A3QU-01A-11D-A233-26	HG19_Broad_variant	TCGA-CU-A3QU	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	UNC	United States	NO	T2b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3280	58cfa831e4b0c9d6adf6c998	TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted	TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted.bam	35.04	2.0	0.15	58cfa831e4b0c9d6adf6c998	TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A7-01A	3ED614E7-F356-4D87-985B-D3BBBAE3BB40	Primary Tumor	Illumina HiSeq	4c14028a-f15d-42f9-ad5f-19f0dca3984e	Bladder	67.0	D68D16F7-6117-4D3D-8347-CF5CD3F23AE4	2DDD46A0-5304-4CA3-9AE3-AC3787D3C86A	TCGA-DK-A1A7-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1A7	TCGA-BLCA		Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3282	58cfa831e4b0c9d6adf6c8c2	TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted	TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted.bam	32.38		0.16	58cfa831e4b0c9d6adf6c8c2	TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IL-01A	178B28CD-99C3-48DC-8D09-1EF71B4CEE80	Primary Tumor	Illumina HiSeq	56a85daa-804e-4c68-b2be-c58cf3d5153e	Bladder	79.0	59D6683F-5EB7-493D-8E8E-78B88BE2CD70	F666A681-CA0D-4281-8E8A-156A24BBB63A	TCGA-DK-A3IL-01A-11D-A210-26	HG19_Broad_variant	TCGA-DK-A3IL	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3285	58cfa831e4b0c9d6adf6c9b5	TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted	TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted.bam	34.01		0.15	58cfa831e4b0c9d6adf6c9b5	TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IU-01A	F093F043-EFD4-4CBA-A87F-8CBB5C1ACD9E	Primary Tumor	Illumina HiSeq	346b87a3-0c3a-455c-b3c1-0fb96acd0f2f	Bladder	58.0	B9C39E8B-D689-499A-BC06-CE3BFFC9996C	8E8E8966-582A-45FF-96C2-EC0C1718C4F2	TCGA-DK-A3IU-01A-11D-A210-26	HG19_Broad_variant	TCGA-DK-A3IU	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3286	58cfa831e4b0c9d6adf6c9e6	TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted	TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted.bam	47.57		0.16	58cfa831e4b0c9d6adf6c9e6	TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3X1-01A	6BDDAFDE-7004-49B6-80CF-8081CD4B7D44	Primary Tumor	Illumina HiSeq	4c8de054-fd6d-4ebd-8a6e-b5061ef5913b	Bladder	78.0	3D440A83-214E-432F-89D2-B523BFE7C6EF	4A8B5117-AF70-40AB-9698-B736EF20F3DE	TCGA-DK-A3X1-01A-12D-A233-26	HG19_Broad_variant	TCGA-DK-A3X1	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3289	58cfa831e4b0c9d6adf6cb22	TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted.filtered.	WGS	TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted	TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted.bam	63.68		0.16	58cfa831e4b0c9d6adf6cb22	TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E5-A2PC-01A	4107AE6F-502C-4BDC-BF14-E4B3711CBA38	Primary Tumor	Illumina HiSeq	496052c5-5ab2-4852-88e1-348116a86746	Bladder	61.0	2195B75E-157F-4547-9705-1E7E75666CA8	FABA82E6-FF3D-468C-91EC-A88794619697	TCGA-E5-A2PC-01A-11D-A204-02	HG19_Broad_variant	TCGA-E5-A2PC	TCGA-BLCA		Harvard Medical School	Roswell Park	United States	NO	T2b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3291	58cfa831e4b0c9d6adf6cb1a	TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted.filtered.	WGS	TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted	TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted.bam	39.5		0.15	58cfa831e4b0c9d6adf6cb1a	TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E7-A3X6-01A	C871EA6B-FBD2-4E6F-AB29-F43F6E3DDCBB	Primary Tumor	Illumina HiSeq	548e206a-eaec-49d3-a405-664cf76d0e16	Bladder	70.0	554AE735-9991-4CB3-AFE8-4951490BD709	AE6DC0A6-7405-44C2-886F-E10BAD336295	TCGA-E7-A3X6-01A-12D-A233-26	HG19_Broad_variant	TCGA-E7-A3X6	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	Asterand	Ukraine	NO	T2	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3292	58cfa832e4b0c9d6adf6ce19	TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted	TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted.bam	47.84		0.16	58cfa832e4b0c9d6adf6ce19	TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N6-01A	8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567	Primary Tumor	Illumina HiSeq	2beb0463-75e7-4244-b88e-022e447445f2	Bladder	43.0	6CD6D1F4-D8E4-47F9-812F-EB7FEC925F8D	C218A6A8-78F5-472B-A1CA-886E2331A688	TCGA-FD-A3N6-01A-11D-A21C-26	HG19_Broad_variant	TCGA-FD-A3N6	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3295	58cfa831e4b0c9d6adf6cd50	TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted	TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted.bam	35.93		0.14	58cfa831e4b0c9d6adf6cd50	TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SQ-01A	3071CB51-DCF5-41F7-B047-AFC2DCBF0AAF	Primary Tumor	Illumina HiSeq	104a1ca4-a3b6-42e6-b6ba-1b0916160573	Bladder	62.0	A78A8C62-06ED-4562-B529-D30A5D1508E7	749C6741-66D9-4BEE-B5D6-7F6C4F9F0F88	TCGA-FD-A3SQ-01A-21D-A233-26	HG19_Broad_variant	TCGA-FD-A3SQ	TCGA-BLCA	1423.0	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3296	58cfa832e4b0c9d6adf6ce0f	TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted	TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted.bam	26.04		0.16	58cfa832e4b0c9d6adf6ce0f	TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B8-01A	537CA5D1-5B26-496F-B7B4-05FEA7B46353	Primary Tumor	Illumina HiSeq	c0aadcb9-2d54-45c7-9585-575ed21ea52f	Bladder	56.0	9A27AA84-D541-4FA3-A798-D7559A5AE70C	582B2439-02F1-4E2A-9A4E-771603658FB5	TCGA-FD-A3B8-01A-31D-A210-26	HG19_Broad_variant	TCGA-FD-A3B8	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3298	58cfa832e4b0c9d6adf6ce0c	TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted	TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted.bam	61.5		0.16	58cfa832e4b0c9d6adf6ce0c	TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B6-01A	36054200-3FA4-4541-A25C-47282E4EF88D	Primary Tumor	Illumina HiSeq	15aeae5e-1ef3-4574-a7af-025ac4d4be89	Bladder	75.0	D6818C85-5857-44B0-AD64-1EEB53B80606	D8D4A23A-F993-4A8F-9414-AD25149B4CB3	TCGA-FD-A3B6-01A-21D-A210-26	HG19_Broad_variant	TCGA-FD-A3B6	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3299	58cfa831e4b0c9d6adf6cc9c	TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted	TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted.bam	22.6		0.16	58cfa831e4b0c9d6adf6cc9c	TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SM-01A	474582F2-8DEC-4FBC-803F-4FD9BA2E0957	Primary Tumor	Illumina HiSeq	bacf3136-6605-4a66-a869-8d91e4003a0d	Bladder	70.0	5F7DE481-C011-43A8-844B-F47569499F0D	AF7DFCCA-999E-4EA2-A14B-1E923C2ECE38	TCGA-FD-A3SM-01A-11D-A233-26	HG19_Broad_variant	TCGA-FD-A3SM	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3302	58cfa831e4b0c9d6adf6cd64	TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted	TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted.bam	37.16		0.15	58cfa831e4b0c9d6adf6cd64	TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SS-01A	7B98B829-FDC7-4719-BEE9-C83F6154019C	Primary Tumor	Illumina HiSeq	23aab0ed-a2ae-43db-9050-527db1729aa5	Bladder	66.0	015E6B08-AB3C-4D1D-99E4-77B5E10BD7FC	315B09D3-D014-4EF1-9CAC-AD5F63F6024A	TCGA-FD-A3SS-01A-12D-A233-26	HG19_Broad_variant	TCGA-FD-A3SS	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T4	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3303	58cfa832e4b0c9d6adf6ce96	TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted.filtered.	WGS	TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted	TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted.bam	18.46		0.18	58cfa832e4b0c9d6adf6ce96	TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EC-01A	28E25FFB-8B0C-4839-A735-ED7B78E3213A	Primary Tumor	Illumina HiSeq	0d4b7559-34dc-4690-a8e9-144698537cdd	Bladder	58.0	2DA969E6-9A63-4C03-8347-01A51496C224	09ED2111-236D-47C1-A82D-7919C8EEA5B2	TCGA-G2-A2EC-01A-11D-A17R-02	HG19_Broad_variant	TCGA-G2-A2EC	TCGA-BLCA		Harvard Medical School	MD Anderson	United States	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3304	58cfa832e4b0c9d6adf6ce92	TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted	TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted.bam	36.89		0.16	58cfa832e4b0c9d6adf6ce92	TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EJ-01A	C6227D39-D9E8-4E28-9E70-D7F720AB25E4	Primary Tumor	Illumina HiSeq	18abb4d7-25d0-477e-bda6-011263e96364	Bladder	56.0	FBAD20BA-EE08-4D46-825B-870126AAD539	8D99E3A4-DECB-49D7-9727-C5D7606D60DF	TCGA-G2-A2EJ-01A-11D-A17R-02	HG19_Broad_variant	TCGA-G2-A2EJ	TCGA-BLCA		Harvard Medical School	MD Anderson	United States	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3306	58cfa832e4b0c9d6adf6cf6a	TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted.filtered.	WGS	TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted	TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted.bam	11.56		0.16	58cfa832e4b0c9d6adf6cf6a	TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3OO-01A	1FF60FD9-3CA3-43BE-92A8-8DBA2CD4D4DF	Primary Tumor	Illumina HiSeq	8c665767-edb1-4860-b26a-4171237962fa	Bladder	79.0	91E7F41C-17B3-4724-96EF-D3C207B964E1	67B2932F-8C9D-4D38-8791-D4D8AAB7F3B2	TCGA-GC-A3OO-01A-11D-A233-26	HG19_Broad_variant	TCGA-GC-A3OO	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II
s3307	58cfa832e4b0c9d6adf6cfe0	TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted	TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted.bam	23.27		0.17	58cfa832e4b0c9d6adf6cfe0	TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3WC-01A	DB52C68A-ED44-4EC4-9381-D75F9BCBC29A	Primary Tumor	Illumina HiSeq	5d982317-5753-41de-85ef-30ee85c56ba9	Bladder	80.0	24F9D01B-1210-4716-9466-8FE9F3612B8B	50E62704-6262-4426-BDAE-0490DC108B61	TCGA-GC-A3WC-01A-31D-A233-26	HG19_Broad_variant	TCGA-GC-A3WC	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s3308	58cfa832e4b0c9d6adf6cfa8	TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted.filtered.	WGS	TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted	TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted.bam	63.27		0.14	58cfa832e4b0c9d6adf6cfa8	TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JV-01A	01EE41EF-1894-4408-9E96-A22A1F068190	Primary Tumor	Illumina HiSeq	8f626567-33e0-4b6a-974f-6b41b341c60e	Bladder	66.0	55072935-CD20-4355-897B-F60F77A18847	E5863D29-E61D-4EE2-B04E-FE61C9B9CA5E	TCGA-GV-A3JV-01A-11D-A221-26	HG19_Broad_variant	TCGA-GV-A3JV	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3309	58cfa832e4b0c9d6adf6ce5a	TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted.filtered.	WGS	TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted	TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted.bam	32.14		0.15	58cfa832e4b0c9d6adf6ce5a	TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3QG-01A	79F23A0E-5AAE-4618-8191-7DD7C0552408	Primary Tumor	Illumina HiSeq	2102b9a0-6afe-47a9-89ae-9778452a6dcd	Bladder	65.0	FB9B1639-242F-4019-937F-DD13C40D9C2B	27EDCB5C-D1E4-4683-A967-A436E22D1958	TCGA-GV-A3QG-01A-11D-A221-26	HG19_Broad_variant	TCGA-GV-A3QG	TCGA-BLCA		MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T3a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV
s3395	58cfa830e4b0c9d6adf6be80	TCGA-BL-A3JM-11A-31D-A21C_120914_SN590_0180_BC19KDACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BL-A3JM-11A-31D-A21C_120914_SN590_0180_BC19KDACXX_s_4_rg.sorted	TCGA-BL-A3JM-11A-31D-A21C_120914_SN590_0180_BC19KDACXX_s_4_rg.sorted.bam	6.95		0.15	58cfa830e4b0c9d6adf6be80	TCGA-BL-A3JM-11A-31D-A21C_120914_SN590_0180_BC19KDACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A3JM-11A	0F4FB205-B13C-4A85-97B3-779429E6CCDD	Solid Tissue Normal	Illumina HiSeq	33f45265-9a07-4291-ad56-6a47f9838213	Bladder	62.0	4D4A9AB9-0FAE-4393-978D-612C22D5B393	C3DC6688-BCC8-4FF9-B396-778E160F57FD	TCGA-BL-A3JM-11A-31D-A21C-26	HG19_Broad_variant	TCGA-BL-A3JM	TCGA-BLCA	205.0	MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III
s5472	58cfa82de4b0c9d6adf6a496	112778209a264064ef4723c2643be148.filtered.	WGS	112778209a264064ef4723c2643be148	112778209a264064ef4723c2643be148.bam	23.1	1.93	0.08	58cfa82de4b0c9d6adf6a496	112778209a264064ef4723c2643be148.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A12H-10A	B5B99291-507E-4B68-A039-9A0F571F55DF	Blood Derived Normal	Illumina HiSeq	3acf783b-164a-4cee-bc63-deedb1ebc450	Breast	69.0	0B3F2524-3370-43E3-B1E4-07505A043165	15DD92B8-5AB6-4FF7-9244-951120EFF28D	TCGA-AO-A12H-10A-01D-A314-09	GRCh37-lite	TCGA-AO-A12H	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T2	N0 (i-)	Other  specify	Stage IIA
s5473	58cfa82de4b0c9d6adf6a4c2	12dd02ea14d0a87df23ce3bef406fe27.filtered.	WGS	12dd02ea14d0a87df23ce3bef406fe27	12dd02ea14d0a87df23ce3bef406fe27.bam	32.75		0.08	58cfa82de4b0c9d6adf6a4c2	12dd02ea14d0a87df23ce3bef406fe27.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I1-01A	5DD423E8-FEAA-4568-A750-500948C41D6C	Primary Tumor	Illumina HiSeq	30cac8b3-f09f-4eeb-8dff-e77e8b9c13fd	Breast	73.0	2A5F4696-6E02-4FE9-B66D-8C2AE93B7C2F	2290B078-6A5B-4C83-9DFB-B525BBF14E4E	TCGA-B6-A0I1-01A-11D-A21Q-09	GRCh37-lite	TCGA-B6-A0I1	TCGA-BRCA	2361.0	Washington University School of Medicine	Duke	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s5475	58cfa82de4b0c9d6adf6a55c	2b3e58fa7d731b844fe92dfbeb9a597e.filtered.	WGS	2b3e58fa7d731b844fe92dfbeb9a597e	2b3e58fa7d731b844fe92dfbeb9a597e.bam	38.4	1.33	0.07	58cfa82de4b0c9d6adf6a55c	2b3e58fa7d731b844fe92dfbeb9a597e.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DT-11A	74F31744-0AED-4633-BEEC-4E203315F0B7	Solid Tissue Normal	Illumina HiSeq	fafbdaae-4f36-4715-85b5-8cc9be96343c	Breast	41.0	A9CE148B-AD26-4257-8F5C-295FD2DCB1D7	03C623E2-04D7-43EA-ADE1-5F5A619CD5C8	TCGA-BH-A0DT-11A-12D-A12B-09	GRCh37-lite	TCGA-BH-A0DT	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s5476	58cfa82de4b0c9d6adf6a47e	2c5b37c2fff4a62ce10d93452de3771f.filtered.	WGS	2c5b37c2fff4a62ce10d93452de3771f	2c5b37c2fff4a62ce10d93452de3771f.bam	52.88	1.88	0.08	58cfa82de4b0c9d6adf6a47e	2c5b37c2fff4a62ce10d93452de3771f.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D1-01A	084C6AEC-94F7-4090-8F3F-59FA9E89721A	Primary Tumor	Illumina HiSeq	6d37aa75-54cd-423e-987a-342e9a2def7a	Breast	76.0	12ECE355-F1D0-446C-84E9-0AED3E6D29F8	E5593865-5F8E-4A4C-B36F-73FBE64D66DA	TCGA-A2-A0D1-01A-11D-A19H-09	GRCh37-lite	TCGA-A2-A0D1	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5477	58cfa82de4b0c9d6adf6a50e	29084d88d2f33ba899ea13cb6d938384.filtered.	WGS	29084d88d2f33ba899ea13cb6d938384	29084d88d2f33ba899ea13cb6d938384.bam	41.07	1.97	0.07	58cfa82de4b0c9d6adf6a50e	29084d88d2f33ba899ea13cb6d938384.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A0XR-01A	F51AF6DB-2655-47FB-9FFC-83A503A728EA	Primary Tumor	Illumina HiSeq	19e1e7d4-80dd-4107-98b2-6796fe22947f	Breast	55.0	6EDCDB8A-80E8-42A8-86FF-3950C1F3CB89	E7DC7492-3A84-49C7-8DEA-8F508B53DC40	TCGA-AN-A0XR-01A-11D-A10G-09	GRCh37-lite	TCGA-AN-A0XR	TCGA-BRCA		Washington University School of Medicine	Cureline	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage IIIA
s5478	58cfa82de4b0c9d6adf6a540	3673e63534c107f41189cc7b216ed30b.filtered.	WGS	3673e63534c107f41189cc7b216ed30b	3673e63534c107f41189cc7b216ed30b.bam	7.49	2.0	0.08	58cfa82de4b0c9d6adf6a540	3673e63534c107f41189cc7b216ed30b.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A0CE-10A	9D95A65B-E41D-4F93-92D4-99DCE29FF40D	Blood Derived Normal	Illumina HiSeq	2ff7263f-3be1-441e-a60d-2fb82d7e3478	Breast	57.0	AAC9A83D-4EE2-49A8-82DE-DEBDF3E6848C	5F750C41-AC61-4246-9224-E077B83D35F2	TCGA-A7-A0CE-10A-01D-A017-09	GRCh37-lite	TCGA-A7-A0CE	TCGA-BRCA		Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5480	58cfa82de4b0c9d6adf6a5f2	58c9640b867e208cc0db2f7a975b1c51.filtered.	WGS	58c9640b867e208cc0db2f7a975b1c51	58c9640b867e208cc0db2f7a975b1c51.bam	48.69	2.02	0.08	58cfa82de4b0c9d6adf6a5f2	58c9640b867e208cc0db2f7a975b1c51.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DT-01A	74F31744-0AED-4633-BEEC-4E203315F0B7	Primary Tumor	Illumina HiSeq	4ac2ec89-0e27-40ab-949e-6cb716b4d9e1	Breast	41.0	EB11D414-2F0E-44A1-843C-ECACC7212E91	30DBE353-86D5-40ED-84C2-DBDDF7BEB17B	TCGA-BH-A0DT-01A-21D-A12B-09	GRCh37-lite	TCGA-BH-A0DT	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s5481	58cfa82de4b0c9d6adf6a5b2	6822184f0a41bd067261cf1591f0dbf6.filtered.	WGS	6822184f0a41bd067261cf1591f0dbf6	6822184f0a41bd067261cf1591f0dbf6.bam	34.66	1.95	0.08	58cfa82de4b0c9d6adf6a5b2	6822184f0a41bd067261cf1591f0dbf6.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A12H-01A	B5B99291-507E-4B68-A039-9A0F571F55DF	Primary Tumor	Illumina HiSeq	55b85b3a-3eed-4a89-ab63-56b85e180571	Breast	69.0	D8AFCB32-81D0-43B3-AD5C-E8C735710624	5A535C49-D42E-43C6-9D32-DC76F28D4F0F	TCGA-AO-A12H-01A-11D-A10Y-09	GRCh37-lite	TCGA-AO-A12H	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T2	N0 (i-)	Other  specify	Stage IIA
s5482	58cfa82de4b0c9d6adf6a683	692c3778a86ca9872957c9a79f3cb1f1.filtered.	WGS	692c3778a86ca9872957c9a79f3cb1f1	692c3778a86ca9872957c9a79f3cb1f1.bam	54.86	1.92	0.09	58cfa82de4b0c9d6adf6a683	692c3778a86ca9872957c9a79f3cb1f1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A04D-10A	49717F75-0F2D-4E1C-9A12-F1CD7877B80A	Blood Derived Normal	Illumina HiSeq	4a1b29e7-a50b-4f6a-a8a5-0e1727c4647e	Breast	58.0	D3AACCDA-91D8-42D4-A1E6-1720F92214EC	03FE1DF5-EC6A-40E7-B609-A749B1AAFAD9	TCGA-AN-A04D-10A-01D-A314-09	GRCh37-lite	TCGA-AN-A04D	TCGA-BRCA		Washington University School of Medicine	Cureline	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB
s5483	58cfa82de4b0c9d6adf6a67a	5bb7debe47981e59cd82317bf4ef97fa.filtered.	WGS	5bb7debe47981e59cd82317bf4ef97fa	5bb7debe47981e59cd82317bf4ef97fa.bam	12.57		0.08	58cfa82de4b0c9d6adf6a67a	5bb7debe47981e59cd82317bf4ef97fa.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A2BK-11A	6FA2A667-9C36-4526-8A58-1975E863A806	Solid Tissue Normal	Illumina HiSeq	0cdbbe0e-0c6f-4320-a72f-e80cf5faeb8d	Breast	78.0	32A1654E-0650-4D90-98EE-B438B4005DF0	8F640FE4-AA25-444A-95B1-CA7A17BAEB52	TCGA-AC-A2BK-11A-13D-A21Q-09	GRCh37-lite	TCGA-AC-A2BK	TCGA-BRCA		Washington University School of Medicine	International Genomics Consortium	United States	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA
s5484	58cfa82de4b0c9d6adf6a644	7cc3dd16015812a7719ba947df5a6072.filtered.	WGS	7cc3dd16015812a7719ba947df5a6072	7cc3dd16015812a7719ba947df5a6072.bam	22.28		0.12	58cfa82de4b0c9d6adf6a644	7cc3dd16015812a7719ba947df5a6072.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GI-A2C9-11A	9F6BE944-83DE-42AB-8738-F0022F475E61	Solid Tissue Normal	Illumina HiSeq	70c562ea-b1bc-41ac-aa70-e3865fb5f03e	Breast	58.0	93B78420-ED0E-45D3-93F5-F60CE671A812	E0D54A00-8D0B-4A09-BF35-75183818D3ED	TCGA-GI-A2C9-11A-22D-A21Q-09	GRCh37-lite	TCGA-GI-A2C9	TCGA-BRCA		Washington University School of Medicine	ABS - IUPUI	United States	NO	T3	N0	Infiltrating Ductal Carcinoma	Stage IIB
s5485	58cfa82de4b0c9d6adf6a5ec	7584b2ea6ab67ca7411a7722eb44d8dd.filtered.	WGS	7584b2ea6ab67ca7411a7722eb44d8dd	7584b2ea6ab67ca7411a7722eb44d8dd.bam	30.18	2.08	0.08	58cfa82de4b0c9d6adf6a5ec	7584b2ea6ab67ca7411a7722eb44d8dd.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DG-11A	0BC5744C-5FA3-45BB-87D0-70A02068B392	Solid Tissue Normal	Illumina HiSeq	f5b1fe9e-b024-4845-a47a-42964a009d73	Breast	30.0	A3D00F8E-39C2-4E35-BC2F-DF9184B35670	D0D81468-73F6-4A8A-8F00-B99BD127C228	TCGA-BH-A0DG-11A-43D-A12Q-09	GRCh37-lite	TCGA-BH-A0DG	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s5486	58cfa82de4b0c9d6adf6a6ea	97d6377295cd0817733cb7c43c4ada7a.filtered.	WGS	97d6377295cd0817733cb7c43c4ada7a	97d6377295cd0817733cb7c43c4ada7a.bam	44.49	1.93	0.08	58cfa82de4b0c9d6adf6a6ea	97d6377295cd0817733cb7c43c4ada7a.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A18R-11A	F6E1EC78-5AD9-4879-9B7E-262D17B166AD	Solid Tissue Normal	Illumina HiSeq	6d0781dd-0e6b-44b9-bdba-469778ae2a04	Breast	50.0	3196C5F3-9227-4A9D-B87A-3E1F680A768C	2DC03379-AF51-45DE-8EE1-78687DA05313	TCGA-BH-A18R-11A-42D-A19H-09	GRCh37-lite	TCGA-BH-A18R	TCGA-BRCA	1142.0	Washington University School of Medicine	University of Pittsburgh	None	NO	T2b	N1	Infiltrating Ductal Carcinoma	Stage IIA
s5488	58cfa830e4b0c9d6adf6bbae	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	61.59	1.89	0.08	58cfa830e4b0c9d6adf6bbae	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D2-01A	99E32C59-AA73-43FA-88C9-399DDADB2C72	Primary Tumor	Illumina HiSeq	221d4b81-a70e-4647-8a9a-ce4866538392	Breast	45.0	72439E36-3C17-4A90-B3E1-8F6CCFD3DCD4	51A5A15A-1551-469F-A5B0-09581EC47975	TCGA-A2-A0D2-01A-21D-A128-09	GRCh37-lite	TCGA-A2-A0D2	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i+)	Infiltrating Ductal Carcinoma	Stage IIA
s5489	58cfa830e4b0c9d6adf6bbbc	TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted	TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted.bam	40.68	1.8	0.14	58cfa830e4b0c9d6adf6bbbc	TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0EU-01A	C0427237-B476-4AF4-B664-7BD479922EA5	Primary Tumor	Illumina HiSeq	f8f8a691-8930-46b3-9cd7-1b8ac6895baf	Breast	79.0	69DBB2AE-3F19-4C29-9C24-810AE60312F3	7F0FA628-7A18-4E52-81CC-3E213C431D3E	TCGA-A2-A0EU-01A-22D-A060-02	HG19_Broad_variant	TCGA-A2-A0EU	TCGA-BRCA		Harvard Medical School	Walter Reed	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s5490	58cfa82fe4b0c9d6adf6b8e0	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.filtered.	WGS	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.bam	40.39	1.89	0.07	58cfa82fe4b0c9d6adf6b8e0	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A0CE-01A	9D95A65B-E41D-4F93-92D4-99DCE29FF40D	Primary Tumor	Illumina HiSeq	d744c7c6-690c-4f5e-968e-532936b3696a	Breast	57.0	9DC315CE-3B76-4754-B103-2C2580CDE4AB	7B08E810-F3C9-4155-AC11-F45A3A4F8B41	TCGA-A7-A0CE-01A-11D-A12L-09	GRCh37-lite	TCGA-A7-A0CE	TCGA-BRCA		Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5491	58cfa830e4b0c9d6adf6bc46	TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted.filtered.	WGS	TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted	TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted.bam	16.97	1.91	0.13	58cfa830e4b0c9d6adf6bc46	TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JF-01A	F357FE19-5359-4662-8CE9-AA996132283B	Primary Tumor	Illumina HiSeq	031ab51d-07d0-4afe-a9dd-222889f5c32b	Breast	68.0	DDEE0B07-2771-40C7-BDDA-C1100958F0D8	BDAA1600-1B4F-4BBA-B4D6-A4D169B029D6	TCGA-AO-A0JF-01A-11D-A060-02	HG19_Broad_variant	TCGA-AO-A0JF	TCGA-BRCA		Harvard Medical School	MSKCC	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s5492	58cfa830e4b0c9d6adf6bdc8	TCGA-BH-A0BM-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BH-A0BM-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_4_rg.sorted	TCGA-BH-A0BM-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_4_rg.sorted.bam	10.8	1.92	0.15	58cfa830e4b0c9d6adf6bdc8	TCGA-BH-A0BM-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BM-10A	C2AEEE6C-BA10-4CF9-B560-C739580F7BF3	Blood Derived Normal	Illumina HiSeq	dfd425ac-1f68-4ee1-b9cb-983f4bc32371	Breast	54.0	3F8B9139-A283-42B3-ACCB-AB8CF047B8AA	D770733C-EE28-4D36-845F-FD51C1F72666	TCGA-BH-A0BM-10A-01D-A060-02	HG19_Broad_variant	TCGA-BH-A0BM	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s5493	58cfa830e4b0c9d6adf6bded	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.bam	43.73	2.05	0.16	58cfa830e4b0c9d6adf6bded	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DK-01A	F2BBFA9D-9A9D-4F46-9FDE-378E4C44E2AD	Primary Tumor	Illumina HiSeq	71acb20b-f186-44d4-a92e-a2751f845fe3	Breast	49.0	1ACAE6E0-3100-4DE8-A436-E15CDBE1322B	92245807-8B1B-4E96-8567-6CFE5E70ADE4	TCGA-BH-A0DK-01A-21D-A060-02	HG19_Broad_variant	TCGA-BH-A0DK	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5620	58cfa83ce4b0c9d6adf7314c	ad2e11dd12a22954808bf04bdec0d080.filtered.	WGS	ad2e11dd12a22954808bf04bdec0d080	ad2e11dd12a22954808bf04bdec0d080.bam	8.82	2.06	0.07	58cfa83ce4b0c9d6adf7314c	ad2e11dd12a22954808bf04bdec0d080.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H0-10A	96457EBF-AE88-41F4-97E5-CDC3163418AA	Blood Derived Normal	Illumina HiSeq	45b4fccd-bfa3-497e-a46a-b39a2b2d1263	Breast	69.0	3EB88A9F-AEC6-438B-82AD-620D248D9AB9	782B1013-EEB6-47CF-B7F1-536AC6D15F16	TCGA-BH-A0H0-10A-01D-A314-09	GRCh37-lite	TCGA-BH-A0H0	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s5622	58cfa83ce4b0c9d6adf72ea2	c365daeccf937ff8ec5b164169f4beb6.filtered.	WGS	c365daeccf937ff8ec5b164169f4beb6	c365daeccf937ff8ec5b164169f4beb6.bam	32.61		0.08	58cfa83ce4b0c9d6adf72ea2	c365daeccf937ff8ec5b164169f4beb6.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3XX-01A	53886143-C1C6-40E9-88E6-E4E5E0271FC8	Primary Tumor	Illumina HiSeq	c11a6c92-3f76-42d3-aa9d-e1e4c34f7cf5	Breast	49.0	0A1F4A81-38C6-407A-A33B-716A0F9A6B4D	C67409B2-AC25-42A0-8543-4636EF132FE4	TCGA-A2-A3XX-01A-21D-A23C-09	GRCh37-lite	TCGA-A2-A3XX	TCGA-BRCA		Washington University School of Medicine	Walter Reed	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s5623	58cfa83ce4b0c9d6adf72edf	e4a6e1d5b4230f26d94ced982fad1af3.filtered.	WGS	e4a6e1d5b4230f26d94ced982fad1af3	e4a6e1d5b4230f26d94ced982fad1af3.bam	94.6	1.95	0.08	58cfa83ce4b0c9d6adf72edf	e4a6e1d5b4230f26d94ced982fad1af3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A109-01A	F0787165-6F58-4D67-B510-928EEA2C4882	Primary Tumor	Illumina HiSeq	33884ffd-f43a-4cb9-beb0-9c0a7d6f3f31	Breast	64.0	710EAE35-A21D-4939-8414-D2AF4EA02FDD	3585E133-B3C1-4D90-B5F2-2B867E0AE0EC	TCGA-E2-A109-01A-11D-A10M-09	GRCh37-lite	TCGA-E2-A109	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5624	58cfa83ce4b0c9d6adf73100	e3a0c3d9d276b4fdb43b9746cfe85567.filtered.	WGS	e3a0c3d9d276b4fdb43b9746cfe85567	e3a0c3d9d276b4fdb43b9746cfe85567.bam	18.64	2.08	0.08	58cfa83ce4b0c9d6adf73100	e3a0c3d9d276b4fdb43b9746cfe85567.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H6-10A	AEB6A3A6-B57A-4C53-90E6-E833777DD2A1	Blood Derived Normal	Illumina HiSeq	9327706b-160e-4773-95f1-a875f0a92f60	Breast	82.0	9269A6CA-6D25-4815-8BB2-6AB526262266	E38A0342-1A02-478F-B61E-435D11BE797E	TCGA-BH-A0H6-10A-01D-A314-09	GRCh37-lite	TCGA-BH-A0H6	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1b	NX	Infiltrating Ductal Carcinoma	Stage I
s5625	58cfa83ce4b0c9d6adf7305a	f472a73249d16757bc8ffa8cace69db6.filtered.	WGS	f472a73249d16757bc8ffa8cace69db6	f472a73249d16757bc8ffa8cace69db6.bam	20.48	1.95	0.08	58cfa83ce4b0c9d6adf7305a	f472a73249d16757bc8ffa8cace69db6.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IJ-10A	2C86C3EA-D926-4D39-A5AE-39ECE4774287	Blood Derived Normal	Illumina HiSeq	b5a04a08-cf8c-4237-bb3b-d8fb7674c945	Breast	42.0	0985C5F5-C459-4AB1-90FA-D6BB6F9B23E6	53CB363B-46B5-49FA-8868-82D5957DA566	TCGA-B6-A0IJ-10A-01D-A128-09	GRCh37-lite	TCGA-B6-A0IJ	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB
s5626	58cfa82de4b0c9d6adf6a4b8	0f22f8fd9ef38ba084e8f5d882a18e4d.filtered.	WGS	0f22f8fd9ef38ba084e8f5d882a18e4d	0f22f8fd9ef38ba084e8f5d882a18e4d.bam	39.65	2.05	0.08	58cfa82de4b0c9d6adf6a4b8	0f22f8fd9ef38ba084e8f5d882a18e4d.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A0CE-11A	9D95A65B-E41D-4F93-92D4-99DCE29FF40D	Solid Tissue Normal	Illumina HiSeq	6cc44144-a33a-4a8c-a7a5-6ca9a0d019d4	Breast	57.0	139C8065-F56A-45F6-BC7E-7841F85A31AE	EFCAB56B-6F30-4443-801D-4BB8E30CCAD5	TCGA-A7-A0CE-11A-21D-A12L-09	GRCh37-lite	TCGA-A7-A0CE	TCGA-BRCA		Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5627	58cfa82de4b0c9d6adf6a56a	2be207283820c51539ebdfde69ab84ca.filtered.	WGS	2be207283820c51539ebdfde69ab84ca	2be207283820c51539ebdfde69ab84ca.bam	58.3	1.95	0.08	58cfa82de4b0c9d6adf6a56a	2be207283820c51539ebdfde69ab84ca.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1P8-01A	359F12F9-5C41-48A4-85BC-FD7E307BF7D8	Primary Tumor	Illumina HiSeq	3a2f0cf6-0405-4ef6-be7e-75054acf1343	Breast	58.0	BF055644-7BCA-43B6-8F5A-E21C42F7CF88	E55F338F-97E2-4394-AE23-C92606069485	TCGA-EW-A1P8-01A-11D-A142-09	GRCh37-lite	TCGA-EW-A1P8	TCGA-BRCA	239.0	Washington University School of Medicine	University of Miami	United States	NO	T2	N3b	Infiltrating Ductal Carcinoma	Stage IIIC
s5630	58cfa82de4b0c9d6adf6a5bc	7312d5e6ae948c9c6485d394dd643d43.filtered.	WGS	7312d5e6ae948c9c6485d394dd643d43	7312d5e6ae948c9c6485d394dd643d43.bam	71.04	1.87	0.09	58cfa82de4b0c9d6adf6a5bc	7312d5e6ae948c9c6485d394dd643d43.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PB-10A	88DB1340-E4BF-451A-87C0-6E9168296F5E	Blood Derived Normal	Illumina HiSeq	46b06dbe-5f5d-4733-8c98-f4a3fdf451c4	Breast	70.0	1D1C9067-00BF-4513-9A9D-217CBE35202A	26AA0F07-C813-4659-88FA-FDBAE73A937E	TCGA-EW-A1PB-10A-01D-A142-09	GRCh37-lite	TCGA-EW-A1PB	TCGA-BRCA		Washington University School of Medicine	University of Miami	United States	NO	T3	N1a	Infiltrating Ductal Carcinoma	Stage IIIA
s5631	58cfa82de4b0c9d6adf6a66e	7b7def1e9078a8087bb1b2791f5c4d57.filtered.	WGS	7b7def1e9078a8087bb1b2791f5c4d57	7b7def1e9078a8087bb1b2791f5c4d57.bam	75.7	2.0	0.08	58cfa82de4b0c9d6adf6a66e	7b7def1e9078a8087bb1b2791f5c4d57.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15E-06A	0A2A3529-F645-4967-9A58-89EE20B8BB62	Metastatic	Illumina HiSeq	40ec35c7-b205-4778-a319-2be1d3eee9be	Breast	40.0	28462438-FE47-4880-82D9-EE43D534D8A3	DABB5A94-9706-4429-8DB0-C328E2004340	TCGA-E2-A15E-06A-11D-A19H-09	GRCh37-lite	TCGA-E2-A15E	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s5635	58cfa82de4b0c9d6adf6a6fa	9ae1429cc5f7f8e4692281baf49e4ff5.filtered.	WGS	9ae1429cc5f7f8e4692281baf49e4ff5	9ae1429cc5f7f8e4692281baf49e4ff5.bam	55.4	1.9	0.08	58cfa82de4b0c9d6adf6a6fa	9ae1429cc5f7f8e4692281baf49e4ff5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RT-01A	4BF50455-9AB7-4521-A791-089F66D3B877	Primary Tumor	Illumina HiSeq	0058348e-638c-426a-9fba-b26a3143c45b	Breast	39.0	C2300B5B-43A7-43B8-8CD1-22FF7E89A21A	1BB3A1C7-4D7B-4FB6-B54D-E94CBD0E32AA	TCGA-B6-A0RT-01A-21D-A128-09	GRCh37-lite	TCGA-B6-A0RT	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	T3	N1	Infiltrating Ductal Carcinoma	Stage IIIA
s5636	58cfa830e4b0c9d6adf6bb92	TCGA-A2-A0D0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A0D0-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A0D0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	24.18	1.95	0.08	58cfa830e4b0c9d6adf6bb92	TCGA-A2-A0D0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D0-10A	324BCBA2-F6A4-45A6-807C-215BDFFCCA21	Blood Derived Normal	Illumina HiSeq	d5cf3968-3a25-4d98-9af5-206f96cce6db	Breast	60.0	8CAB86C8-E392-4387-ACEA-23B02BAF79AA	780A0702-3E17-4768-BD37-77F09E427673	TCGA-A2-A0D0-10A-01D-A128-09	GRCh37-lite	TCGA-A2-A0D0	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5637	58cfa82fe4b0c9d6adf6b948	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	91.2	1.92	0.08	58cfa82fe4b0c9d6adf6b948	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04T-01A	B58AD350-5140-4FA8-BC2C-24BCA8395F3A	Primary Tumor	Illumina HiSeq	6dd42df3-896f-418a-9f13-468ac66d69bc	Breast	62.0	6DD4870F-1EC2-484B-8703-6397D8E67DAA	B752B444-F033-4BE4-9D24-E5E80B4181AF	TCGA-A2-A04T-01A-21D-A128-09	GRCh37-lite	TCGA-A2-A04T	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5638	58cfa82fe4b0c9d6adf6b8de	TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted.filtered.	WGS	TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted	TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted.bam	59.5	2.02	0.17	58cfa82fe4b0c9d6adf6b8de	TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A0D9-01A	17BAEF7C-D97D-4B98-AB53-503EF856523D	Primary Tumor	Illumina HiSeq	43dc32db-2202-486d-82f4-388e37224379	Breast	37.0	C144AE50-ED29-4E27-BBEE-FA81E79AC7DB	7CD9AC40-F6B5-4C68-9D9A-D57845B812DB	TCGA-A7-A0D9-01A-31D-A060-02	HG19_Broad_variant	TCGA-A7-A0D9	TCGA-BRCA		Harvard Medical School	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5639	58cfa830e4b0c9d6adf6bc7a	TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted	TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted.bam	48.13	1.89	0.13	58cfa830e4b0c9d6adf6bc7a	TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JL-01A	D5D8E76E-2F2A-49BC-BA0A-D51283611B16	Primary Tumor	Illumina HiSeq	b39a31b9-dd85-403d-ac11-d7b6dd2703a6	Breast	59.0	834D2E25-DA72-413B-BB0E-3BEB24D46472	A34C3F47-AD37-4777-A733-07AE8F4B4BFF	TCGA-AO-A0JL-01A-11D-A060-02	HG19_Broad_variant	TCGA-AO-A0JL	TCGA-BRCA		Harvard Medical School	MSKCC	None	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA
s5640	58cfa830e4b0c9d6adf6c134	TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted	TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted.bam	40.26	2.11	0.15	58cfa830e4b0c9d6adf6c134	TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RG-01A	9B13927C-7357-44FD-8385-92AE6A656B7D	Primary Tumor	Illumina HiSeq	b38ff19d-a769-4388-81e2-03263bba7985	Breast	26.0	B98AA84F-5144-4062-BADC-32E89368D684	E71ED8ED-7371-4423-83C8-6075A6FC7C39	TCGA-B6-A0RG-01A-11D-A060-02	HG19_Broad_variant	TCGA-B6-A0RG	TCGA-BRCA		Harvard Medical School	Duke	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB
s5641	58cfa830e4b0c9d6adf6be28	TCGA-BH-A0W5-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BH-A0W5-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_4_rg.sorted	TCGA-BH-A0W5-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_4_rg.sorted.bam	17.76	2.22	0.16	58cfa830e4b0c9d6adf6be28	TCGA-BH-A0W5-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0W5-10A	DA9C10EA-C13F-4D88-8B94-A0CBC106D036	Blood Derived Normal	Illumina HiSeq	b768a52b-e629-46df-b042-fa815cb7ce57	Breast	77.0	B49CDE05-00A3-4B24-A1B9-64E300CF63E0	154C09B7-C645-497A-9B14-655DB46CD990	TCGA-BH-A0W5-10A-01D-A106-02	HG19_Broad_variant	TCGA-BH-A0W5	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s5642	58cfa830e4b0c9d6adf6c16a	TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted	TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted.bam	22.97	1.94	0.13	58cfa830e4b0c9d6adf6c16a	TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HK-01A	24334AC1-28A3-4B61-B590-3F51E375B247	Primary Tumor	Illumina HiSeq	c4f3a9e0-4b45-4e06-9320-171c27d9e28d	Breast	81.0	8835B20E-9343-4266-A356-E0343C657130	B96AE5EC-0139-4B8D-8136-B5BFA7AF8987	TCGA-BH-A0HK-01A-11D-A060-02	HG19_Broad_variant	TCGA-BH-A0HK	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB
s5778	58cfa83ce4b0c9d6adf72f34	b25a9036b8fc3d068adceca9887e9a8f.filtered.	WGS	b25a9036b8fc3d068adceca9887e9a8f	b25a9036b8fc3d068adceca9887e9a8f.bam	85.7	1.92	0.09	58cfa83ce4b0c9d6adf72f34	b25a9036b8fc3d068adceca9887e9a8f.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A26G-10A	5ED024E8-D05E-4C65-9441-EDA9930CCC82	Blood Derived Normal	Illumina HiSeq	b1afd1ab-e46c-4616-8f8e-70509f3f1c32	Breast	50.0	227A21EF-33D5-4981-9F0F-B48C75B090C8	337F54B9-3DC4-47CD-9E63-075EDD482454	TCGA-A7-A26G-10A-01D-A314-09	GRCh37-lite	TCGA-A7-A26G	TCGA-BRCA		Washington University School of Medicine	Christiana Healthcare	United States	NO	T2	N0 (i+)	Other  specify	Stage IIA
s5779	58cfa83ce4b0c9d6adf72ef9	ba1be52c7e1ba54b9239744965b4af57.filtered.	WGS	ba1be52c7e1ba54b9239744965b4af57	ba1be52c7e1ba54b9239744965b4af57.bam	27.82	1.95	0.07	58cfa83ce4b0c9d6adf72ef9	ba1be52c7e1ba54b9239744965b4af57.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IQ-10A	01EEF340-598C-4205-A990-CEC190AC2CA5	Blood Derived Normal	Illumina HiSeq	11ba6141-baa1-4403-beb6-4c5aa4dff23f	Breast	40.0	459247DB-4FC3-4415-9A9C-ED7B9B2AD95D	22A79ED6-A633-4BB0-9D33-F508ED2F2C69	TCGA-B6-A0IQ-10A-01D-A128-09	GRCh37-lite	TCGA-B6-A0IQ	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	T3	N1b	Infiltrating Ductal Carcinoma	Stage IIIA
s5780	58cfa83ce4b0c9d6adf72e98	c7785537c59d3349dd69e0f8e87266b7.filtered.	WGS	c7785537c59d3349dd69e0f8e87266b7	c7785537c59d3349dd69e0f8e87266b7.bam	27.86	1.93	0.08	58cfa83ce4b0c9d6adf72e98	c7785537c59d3349dd69e0f8e87266b7.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LL-01A	2A84997D-CCEE-4F46-BEA2-752534F26416	Primary Tumor	Illumina HiSeq	85360168-d41d-4201-8416-2cb4b45fca0f	Breast	73.0	E57574E4-7E01-4E61-BD29-EE4EC63DDDD6	47312F61-5EF4-4F25-9320-8FBB4758790E	TCGA-E2-A1LL-01A-11D-A142-09	GRCh37-lite	TCGA-E2-A1LL	TCGA-BRCA		Washington University School of Medicine	Roswell Park	United States	NO	T3	N2a	Infiltrating Ductal Carcinoma	Stage IIIA
s5782	58cfa83ce4b0c9d6adf72ebb	dd2257dc20b7a6b5bba5e609faa08f25.filtered.	WGS	dd2257dc20b7a6b5bba5e609faa08f25	dd2257dc20b7a6b5bba5e609faa08f25.bam	10.7	1.86	0.08	58cfa83ce4b0c9d6adf72ebb	dd2257dc20b7a6b5bba5e609faa08f25.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0EA-10A	1F601832-EEE3-48FB-ACF5-80C4A454F26E	Blood Derived Normal	Illumina HiSeq	9a8c10ef-1524-476d-aede-92a75cf6f28b	Breast	72.0	9A6C71A6-82CD-42B1-A93F-F569370848D6	CFBD5476-E83A-401D-9F9A-639C73A0E35B	TCGA-BH-A0EA-10A-01D-A110-09	GRCh37-lite	TCGA-BH-A0EA	TCGA-BRCA	991.0	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s5783	58cfa83ce4b0c9d6adf73098	f232a415b12a85ec04ceb082509958cc.filtered.	WGS	f232a415b12a85ec04ceb082509958cc	f232a415b12a85ec04ceb082509958cc.bam	9.27	2.06	0.08	58cfa83ce4b0c9d6adf73098	f232a415b12a85ec04ceb082509958cc.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LK-11A	1D27253F-B036-44E7-A04D-8DA5BBF57419	Solid Tissue Normal	Illumina HiSeq	32766841-2370-4aad-b93e-8d5e8b002229	Breast	84.0	FA69FFB2-A9F4-4D89-9C15-43988A9852EF	D21604F4-6D60-4EEA-BD42-F6AB6C19CAB8	TCGA-E2-A1LK-11A-12D-A314-09	GRCh37-lite	TCGA-E2-A1LK	TCGA-BRCA	266.0	Washington University School of Medicine	Roswell Park	United States	NO	T4b	N3a	Infiltrating Ductal Carcinoma	Stage IIIC
s5785	58cfa82de4b0c9d6adf6a52e	103f34ff20cea99f215bfb7393f043b8.filtered.	WGS	103f34ff20cea99f215bfb7393f043b8	103f34ff20cea99f215bfb7393f043b8.bam	45.75	2.0	0.09	58cfa82de4b0c9d6adf6a52e	103f34ff20cea99f215bfb7393f043b8.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A259-01A	3FC3755D-A3F8-4E2C-813F-FF124F2A75C1	Primary Tumor	Illumina HiSeq	767c5435-e3e1-4cdb-92e0-2b0961610118	Breast	70.0	EB2DE640-6C2A-4C8A-87C3-80F9FBDC3D9B	13D05F7A-E16A-40EF-9A15-21257DA2CF89	TCGA-A2-A259-01A-11D-A314-09	GRCh37-lite	TCGA-A2-A259	TCGA-BRCA		Washington University School of Medicine	Walter Reed	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I
s5786	58cfa82de4b0c9d6adf6a574	2cf824ff67beaee254d0025b0c57ecfb.filtered.	WGS	2cf824ff67beaee254d0025b0c57ecfb	2cf824ff67beaee254d0025b0c57ecfb.bam	23.2	1.82	0.08	58cfa82de4b0c9d6adf6a574	2cf824ff67beaee254d0025b0c57ecfb.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A27H-01A	0DCA98B0-F43E-45B6-9A02-00092C78678C	Primary Tumor	Illumina HiSeq	bdde252c-e43c-448b-8e22-1ff90c7c957b	Breast	72.0	B7542984-1410-45E6-B936-8333FF902EB4	6764E0A2-7A78-45C1-9189-6001C6518CE4	TCGA-D8-A27H-01A-11D-A314-09	GRCh37-lite	TCGA-D8-A27H	TCGA-BRCA		Washington University School of Medicine	Greater Poland Cancer Center	Poland	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s5788	58cfa82de4b0c9d6adf6a580	2db39072c0d1914dea2d317877070812.filtered.	WGS	2db39072c0d1914dea2d317877070812	2db39072c0d1914dea2d317877070812.bam	81.48	1.85	0.08	58cfa82de4b0c9d6adf6a580	2db39072c0d1914dea2d317877070812.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I2-01A	328DFCB0-B5AE-43F2-BC87-DAD0AB3DF9E7	Primary Tumor	Illumina HiSeq	1f31bdc1-69ef-49bf-8200-d73661b23c67	Breast	45.0	47436CE0-438F-475B-AC0D-1972D0C5285E	A2D9325E-DA9D-42F1-A360-328D17ED492B	TCGA-B6-A0I2-01A-11D-A12L-09	GRCh37-lite	TCGA-B6-A0I2	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s5789	58cfa82de4b0c9d6adf6a63e	4904c28d460c5452fabb15e54e66ee71.filtered.	WGS	4904c28d460c5452fabb15e54e66ee71	4904c28d460c5452fabb15e54e66ee71.bam	73.92		0.09	58cfa82de4b0c9d6adf6a63e	4904c28d460c5452fabb15e54e66ee71.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PC-01B	F45210D3-9E66-4F5E-BEF1-5EE5547CC893	Primary Tumor	Illumina HiSeq	4ded0771-e685-45fb-99f1-4dc1212cc9fc	Breast	66.0	FB635F1D-5EE1-4E58-86EA-B1AADA2DE4BA	1C0E384F-7254-4AFE-93C0-B3FC6C6A7894	TCGA-EW-A1PC-01B-11D-A21Q-09	GRCh37-lite	TCGA-EW-A1PC	TCGA-BRCA		Washington University School of Medicine	University of Miami	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB
s5790	58cfa82de4b0c9d6adf6a61c	5f651cb67a58c86e824c7bc365100295.filtered.	WGS	5f651cb67a58c86e824c7bc365100295	5f651cb67a58c86e824c7bc365100295.bam	17.77		0.08	58cfa82de4b0c9d6adf6a61c	5f651cb67a58c86e824c7bc365100295.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A3XL-10A	65CAC997-4D39-4501-85EC-4FCB328A8EB5	Blood Derived Normal	Illumina HiSeq	1c380c75-c405-42a9-8984-c87a63cc94a2	Breast	49.0	86BDDEDB-0034-4A61-AF7E-F577454C9646	90469BFB-140C-4856-BE28-A9B04C183157	TCGA-GM-A3XL-10A-01D-A22X-09	GRCh37-lite	TCGA-GM-A3XL	TCGA-BRCA		Washington University School of Medicine	MD Anderson	United States	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5791	58cfa82de4b0c9d6adf6a630	75ee291068e5b81083484950ce18b4d8.filtered.	WGS	75ee291068e5b81083484950ce18b4d8	75ee291068e5b81083484950ce18b4d8.bam	21.82	2.0	0.08	58cfa82de4b0c9d6adf6a630	75ee291068e5b81083484950ce18b4d8.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A18U-11A	233B02F3-C4F0-4A67-9DB5-E68D5CDACCB6	Solid Tissue Normal	Illumina HiSeq	66d1645c-a6d2-4a4f-9150-78bd1f576ae2	Breast	72.0	0B290880-D67C-42B4-AA57-AFD3C3D09518	CC233ED9-C88F-4845-A458-8BFFC7EAF403	TCGA-BH-A18U-11A-23D-A19H-09	GRCh37-lite	TCGA-BH-A18U	TCGA-BRCA	1563.0	Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA
s5792	58cfa82de4b0c9d6adf6a69f	824558b943d0281e9fdc0f4e97a69b78.filtered.	WGS	824558b943d0281e9fdc0f4e97a69b78	824558b943d0281e9fdc0f4e97a69b78.bam	71.16	2.03	0.08	58cfa82de4b0c9d6adf6a69f	824558b943d0281e9fdc0f4e97a69b78.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H6-01A	AEB6A3A6-B57A-4C53-90E6-E833777DD2A1	Primary Tumor	Illumina HiSeq	8df89d9c-2eb9-459a-adf7-48c9867c9462	Breast	82.0	B2921C9D-C655-46F3-86E5-2FC2BED1ED33	AA58C09A-7799-4675-8310-D270224B163E	TCGA-BH-A0H6-01A-21D-A314-09	GRCh37-lite	TCGA-BH-A0H6	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1b	NX	Infiltrating Ductal Carcinoma	Stage I
s5793	58cfa82de4b0c9d6adf6a5da	72037429d860f22e2662003e14708cfe.filtered.	WGS	72037429d860f22e2662003e14708cfe	72037429d860f22e2662003e14708cfe.bam	9.19		0.08	58cfa82de4b0c9d6adf6a5da	72037429d860f22e2662003e14708cfe.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I1-10A	5DD423E8-FEAA-4568-A750-500948C41D6C	Blood Derived Normal	Illumina HiSeq	ad8ec5b0-99a1-493d-bd8d-9bb358f87991	Breast	73.0	59205671-D3D4-40B2-85C1-D9EABFCA089D	82B4B870-3CC6-429F-BB9A-D53757437517	TCGA-B6-A0I1-10A-01D-A21Q-09	GRCh37-lite	TCGA-B6-A0I1	TCGA-BRCA	2361.0	Washington University School of Medicine	Duke	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s5794	58cfa82de4b0c9d6adf6a704	994b896532e3794d4f63fb96973b2256.filtered.	WGS	994b896532e3794d4f63fb96973b2256	994b896532e3794d4f63fb96973b2256.bam	19.66	2.0	0.07	58cfa82de4b0c9d6adf6a704	994b896532e3794d4f63fb96973b2256.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15K-10A	17C1D42C-CB84-4655-A4CD-B54BAE17ECAF	Blood Derived Normal	Illumina HiSeq	8cdfd720-da4b-4c8d-a277-eca9d8f65307	Breast	58.0	15A0F69E-6BCB-4680-B4F4-36F03E58012B	6C7D0BEB-A20C-4CF8-8E52-2028A8620BB5	TCGA-E2-A15K-10A-01D-A12Q-09	GRCh37-lite	TCGA-E2-A15K	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s5796	58cfa830e4b0c9d6adf6bbb0	TCGA-A2-A04T-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A04T-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A04T-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	23.59	1.8	0.07	58cfa830e4b0c9d6adf6bbb0	TCGA-A2-A04T-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04T-10A	B58AD350-5140-4FA8-BC2C-24BCA8395F3A	Blood Derived Normal	Illumina HiSeq	f9051235-b44d-460e-91f0-71118754ad79	Breast	62.0	9340E34D-4ADB-4C90-B496-8FA592471340	705B3927-BBA2-4D67-BBE4-61BD1855EFE4	TCGA-A2-A04T-10A-01D-A128-09	GRCh37-lite	TCGA-A2-A04T	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5797	58cfa82fe4b0c9d6adf6b8dc	TCGA-A7-A0D9-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_6_rg.sorted.filtered.	WGS	TCGA-A7-A0D9-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_6_rg.sorted	TCGA-A7-A0D9-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_6_rg.sorted.bam	338.66	1.9	0.15	58cfa82fe4b0c9d6adf6b8dc	TCGA-A7-A0D9-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A0D9-10A	17BAEF7C-D97D-4B98-AB53-503EF856523D	Blood Derived Normal	Illumina HiSeq	4d84158c-282c-48bc-ae3d-55ada9b30f29	Breast	37.0	70B623D6-E6A5-4BB6-A1BE-62E8EF235FE5	34D29129-A82C-477F-8D08-DC972D08AC45	TCGA-A7-A0D9-10A-01D-A060-02	HG19_Broad_variant	TCGA-A7-A0D9	TCGA-BRCA		Harvard Medical School	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5798	58cfa830e4b0c9d6adf6c1ea	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	73.05	2.0	0.08	58cfa830e4b0c9d6adf6c1ea	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J6-01A	E9F4F373-37A5-48AD-A1A0-B0D47820111A	Primary Tumor	Illumina HiSeq	71b1d18c-e0ab-473a-b4ee-55ebb68cfda8	Breast	61.0	0C12EA89-EEB4-4865-91EB-10CF75884C21	F69E5057-EDA6-4391-BA9A-AEDBF6B572DA	TCGA-AO-A0J6-01A-11D-A128-09	GRCh37-lite	TCGA-AO-A0J6	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5799	58cfa830e4b0c9d6adf6bdbc	TCGA-AO-A0J6-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-AO-A0J6-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-AO-A0J6-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	57.92	1.8	0.08	58cfa830e4b0c9d6adf6bdbc	TCGA-AO-A0J6-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J6-10A	E9F4F373-37A5-48AD-A1A0-B0D47820111A	Blood Derived Normal	Illumina HiSeq	6de10403-e69b-4372-a6f5-e74b01a70129	Breast	61.0	DD87D6FA-B756-4C73-BF7E-FF325D364F30	65EFED79-CE4A-4318-B8CC-B542AF419B26	TCGA-AO-A0J6-10A-01D-A128-09	GRCh37-lite	TCGA-AO-A0J6	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5800	58cfa830e4b0c9d6adf6bde8	TCGA-BH-A0B3-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0B3-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0B3-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	16.52	1.94	0.07	58cfa830e4b0c9d6adf6bde8	TCGA-BH-A0B3-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0B3-10A	18EB4DFC-556F-4BF3-A411-4780209ED1E0	Blood Derived Normal	Illumina HiSeq	3e0ede40-674b-441b-9bb4-28f65ecb7d8c	Breast	53.0	156C15D8-5E27-49C1-AB20-77B60B4FC665	67D6596D-D6A8-4D16-A10B-C744B2DB8117	TCGA-BH-A0B3-10A-01D-A128-09	GRCh37-lite	TCGA-BH-A0B3	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s5801	58cfa831e4b0c9d6adf6c3b0	TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted	TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted.bam	20.53	2.0	0.15	58cfa831e4b0c9d6adf6c3b0	TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H7-01A	2021ED1F-DC75-4701-B8B8-1386466E4802	Primary Tumor	Illumina HiSeq	d5ab471a-88d1-4966-865a-f7fa29214fe4	Breast	65.0	69BFA6CE-ED46-4321-A107-347C49D68951	E0E60B71-1EFA-4896-B89F-D05974CDCF48	TCGA-BH-A0H7-01A-13D-A060-02	HG19_Broad_variant	TCGA-BH-A0H7	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T1c	N2a	Infiltrating Ductal Carcinoma	Stage IIIA
s5802	58cfa830e4b0c9d6adf6c1c4	TCGA-BH-A0B9-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0B9-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0B9-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	31.27	1.9	0.08	58cfa830e4b0c9d6adf6c1c4	TCGA-BH-A0B9-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0B9-10A	5A57DC25-D252-4B22-B192-4DE630D7002F	Blood Derived Normal	Illumina HiSeq	9822e8f0-c9dd-4681-a427-46ce76876761	Breast	44.0	2FD262A9-384B-4C29-9FA3-837C42D84010	544469B8-D513-45DF-9FE8-861FCB3B2EF1	TCGA-BH-A0B9-10A-01D-A128-09	GRCh37-lite	TCGA-BH-A0B9	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s5803	58cfa830e4b0c9d6adf6be13	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.bam	55.92	1.91	0.16	58cfa830e4b0c9d6adf6be13	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0W5-01A	DA9C10EA-C13F-4D88-8B94-A0CBC106D036	Primary Tumor	Illumina HiSeq	eeccc516-2d3d-4f41-a324-c90f92a6f944	Breast	77.0	050E66BB-438A-49D5-A005-7967A006B3F0	6C8B3A70-CD58-4BFC-9418-54182588CFCB	TCGA-BH-A0W5-01A-11D-A106-02	HG19_Broad_variant	TCGA-BH-A0W5	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s5804	58cfa830e4b0c9d6adf6bdd8	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	55.87	1.93	0.08	58cfa830e4b0c9d6adf6bdd8	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0E0-01A	20E8106B-1290-4735-ABE4-7621E08E3DC8	Primary Tumor	Illumina HiSeq	fc737335-21e7-4997-b267-04d3f91043f5	Breast	38.0	662CC11C-DA31-4E31-8E77-46011B38EA96	E8392F20-C9E3-4649-B64F-5B266C393A76	TCGA-BH-A0E0-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0E0	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T3	N3a	Infiltrating Ductal Carcinoma	Stage IIIC
s5942	58cfa83ce4b0c9d6adf72f9a	a246b48a0a312eda5cafb748151a117b.filtered.	WGS	a246b48a0a312eda5cafb748151a117b	a246b48a0a312eda5cafb748151a117b.bam	74.65	1.93	0.09	58cfa83ce4b0c9d6adf72f9a	a246b48a0a312eda5cafb748151a117b.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A24Z-01A	9FEFBE7C-F66A-4940-843E-285CB7B392C1	Primary Tumor	Illumina HiSeq	1251c29c-8d85-4187-80dd-c459542e3080	Breast	57.0	5CDD3886-898B-4861-A748-D4164CE14A07	6C65CB6D-8C50-4C7C-BC84-EEEBE09FBE01	TCGA-AR-A24Z-01A-11D-A314-09	GRCh37-lite	TCGA-AR-A24Z	TCGA-BRCA		Washington University School of Medicine	Mayo	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s5943	58cfa83ce4b0c9d6adf730ac	ac2e74d430052ab39f0e2d8a23113736.filtered.	WGS	ac2e74d430052ab39f0e2d8a23113736	ac2e74d430052ab39f0e2d8a23113736.bam	33.01		0.1	58cfa83ce4b0c9d6adf730ac	ac2e74d430052ab39f0e2d8a23113736.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GI-A2C9-01A	9F6BE944-83DE-42AB-8738-F0022F475E61	Primary Tumor	Illumina HiSeq	5f4a8fdf-00c0-4ab7-8323-d04f23a9e4a8	Breast	58.0	143FC27D-E119-48FF-A5EA-BD6AAFC0404E	5DBF3203-CE73-41E4-BF9A-32FC856F73F5	TCGA-GI-A2C9-01A-11D-A21Q-09	GRCh37-lite	TCGA-GI-A2C9	TCGA-BRCA		Washington University School of Medicine	ABS - IUPUI	United States	NO	T3	N0	Infiltrating Ductal Carcinoma	Stage IIB
s5944	58cfa83ce4b0c9d6adf7314e	b56e328d4f1f38dee893b6e4f51044ba.filtered.	WGS	b56e328d4f1f38dee893b6e4f51044ba	b56e328d4f1f38dee893b6e4f51044ba.bam	56.7	1.92	0.08	58cfa83ce4b0c9d6adf7314e	b56e328d4f1f38dee893b6e4f51044ba.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RT-10A	4BF50455-9AB7-4521-A791-089F66D3B877	Blood Derived Normal	Illumina HiSeq	75db9c75-640f-4ad6-9d97-a0cb485b35d8	Breast	39.0	5CFFE233-5B5F-47B3-9DD2-7F80E821E15E	BC3DDD6B-6378-48E3-A676-380C45BF213F	TCGA-B6-A0RT-10A-01D-A128-09	GRCh37-lite	TCGA-B6-A0RT	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	T3	N1	Infiltrating Ductal Carcinoma	Stage IIIA
s5945	58cfa83ce4b0c9d6adf7310e	c31801ffe0265e1332d28d053c9a4955.filtered.	WGS	c31801ffe0265e1332d28d053c9a4955	c31801ffe0265e1332d28d053c9a4955.bam	64.37	1.97	0.08	58cfa83ce4b0c9d6adf7310e	c31801ffe0265e1332d28d053c9a4955.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A12L-01A	441919EB-8C9F-478C-BDA3-8DE4F8295E8A	Primary Tumor	Illumina HiSeq	c12fbad8-2c66-4967-9bfe-6837f6d1e5d4	Breast	67.0	E3CF8F8C-8FE6-45E2-B786-7DB5590C08CB	D5372745-95CF-4572-A6E7-E7F5B796911A	TCGA-C8-A12L-01A-11D-A19H-09	GRCh37-lite	TCGA-C8-A12L	TCGA-BRCA		Washington University School of Medicine	ILSbio	Vietnam	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s5946	58cfa83ce4b0c9d6adf72edd	e43cb6521def509cf89cee162d20ca68.filtered.	WGS	e43cb6521def509cf89cee162d20ca68	e43cb6521def509cf89cee162d20ca68.bam	29.16	1.98	0.08	58cfa83ce4b0c9d6adf72edd	e43cb6521def509cf89cee162d20ca68.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0EY-10A	D67CD793-2931-429A-9084-2F3C4C8BE7AD	Blood Derived Normal	Illumina HiSeq	20d69bac-1191-4446-9c05-469bef595edd	Breast	62.0	724E1354-8CE6-4EE3-8971-2E411E2C7F78	503BAEB5-D5D6-46DF-8695-C5E0F274C49C	TCGA-A2-A0EY-10A-01D-A19H-09	GRCh37-lite	TCGA-A2-A0EY	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s5947	58cfa82de4b0c9d6adf6a49a	1d2f2091a246a644d3f997d0edfd860a.filtered.	WGS	1d2f2091a246a644d3f997d0edfd860a	1d2f2091a246a644d3f997d0edfd860a.bam	17.4	1.97	0.08	58cfa82de4b0c9d6adf6a49a	1d2f2091a246a644d3f997d0edfd860a.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0EY-01A	D67CD793-2931-429A-9084-2F3C4C8BE7AD	Primary Tumor	Illumina HiSeq	79cc669f-41ce-4384-ac00-fe94ad0c8cd5	Breast	62.0	2A3E4DBB-AAFF-4B14-BBED-F2D7CF0F8FA3	01658141-8398-4585-9F0F-8355DD9B0604	TCGA-A2-A0EY-01A-11D-A19H-09	GRCh37-lite	TCGA-A2-A0EY	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s5948	58cfa82de4b0c9d6adf6a5f5	51fb402ae50ce6ad975504649caad6ce.filtered.	WGS	51fb402ae50ce6ad975504649caad6ce	51fb402ae50ce6ad975504649caad6ce.bam	14.0		0.08	58cfa82de4b0c9d6adf6a5f5	51fb402ae50ce6ad975504649caad6ce.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3KC-10A	2D29A4AC-98E7-4663-9DD6-5681BC32AC2E	Blood Derived Normal	Illumina HiSeq	0dee69dc-a2f3-404c-b1d3-0155e3df4b39	Breast	55.0	4F91387A-8561-4A68-A814-BE41B4D8E6A2	ABBA0FE4-8C3B-4B8D-9B68-36708BA3A4EF	TCGA-A2-A3KC-10A-01D-A20S-09	GRCh37-lite	TCGA-A2-A3KC	TCGA-BRCA		Washington University School of Medicine	Walter Reed	United States	NO	T2	N1a	Infiltrating Lobular Carcinoma	Stage IIB
s5949	58cfa82de4b0c9d6adf6a591	682471ccf3c736af5187920ac83b2068.filtered.	WGS	682471ccf3c736af5187920ac83b2068	682471ccf3c736af5187920ac83b2068.bam	15.25	2.03	0.08	58cfa82de4b0c9d6adf6a591	682471ccf3c736af5187920ac83b2068.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0EA-01A	1F601832-EEE3-48FB-ACF5-80C4A454F26E	Primary Tumor	Illumina HiSeq	b1ff5cfd-0f6e-4211-a58a-81b120d0eb6d	Breast	72.0	7F791228-DD77-4AB0-8227-D784A4C7FEA1	EEF9DCE1-6BA6-432B-BBE2-53C7DBE64FE7	TCGA-BH-A0EA-01A-11D-A314-09	GRCh37-lite	TCGA-BH-A0EA	TCGA-BRCA	991.0	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s5950	58cfa82de4b0c9d6adf6a5dc	5c54cebf17d98a845d11ad5d5185f4a0.filtered.	WGS	5c54cebf17d98a845d11ad5d5185f4a0	5c54cebf17d98a845d11ad5d5185f4a0.bam	37.22	1.8	0.07	58cfa82de4b0c9d6adf6a5dc	5c54cebf17d98a845d11ad5d5185f4a0.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RU-01A	6956473B-92E5-4069-A26B-B48E280E76F2	Primary Tumor	Illumina HiSeq	2efc5248-9be4-4e98-a400-f2ee744ac29d	Breast	40.0	C94232F8-2E37-46D0-B12A-B8E920E659D9	97064332-1D4F-4571-93FF-354FFE6D7DF9	TCGA-B6-A0RU-01A-11D-A12L-09	GRCh37-lite	TCGA-B6-A0RU	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	T1c	N0 (i-)	Other  specify	Stage IA
s5952	58cfa82de4b0c9d6adf6a656	801434f25120f36fe582c7906500e08e.filtered.	WGS	801434f25120f36fe582c7906500e08e	801434f25120f36fe582c7906500e08e.bam	21.21		0.08	58cfa82de4b0c9d6adf6a656	801434f25120f36fe582c7906500e08e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3KC-01A	2D29A4AC-98E7-4663-9DD6-5681BC32AC2E	Primary Tumor	Illumina HiSeq	449d2c68-674e-4e86-89ff-574170845aa1	Breast	55.0	8318A9A4-E78E-4DB8-97C7-2CC733D0C512	F9F04E42-63A2-4EE1-ADE4-9E5BB5C20CDD	TCGA-A2-A3KC-01A-11D-A20S-09	GRCh37-lite	TCGA-A2-A3KC	TCGA-BRCA		Washington University School of Medicine	Walter Reed	United States	NO	T2	N1a	Infiltrating Lobular Carcinoma	Stage IIB
s5954	58cfa82de4b0c9d6adf6a61a	77181bb00b006255840c66efcab8d16e.filtered.	WGS	77181bb00b006255840c66efcab8d16e	77181bb00b006255840c66efcab8d16e.bam	15.6	1.92	0.08	58cfa82de4b0c9d6adf6a61a	77181bb00b006255840c66efcab8d16e.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0E0-11A	20E8106B-1290-4735-ABE4-7621E08E3DC8	Solid Tissue Normal	Illumina HiSeq	ba938f20-4549-47f9-929c-3351cd03e1ce	Breast	38.0	90FB06A9-35BE-44B0-9F5B-EB270898AABE	8A1636AA-6B9B-42CB-8F0D-C8529ADB2C63	TCGA-BH-A0E0-11A-13D-A128-09	GRCh37-lite	TCGA-BH-A0E0	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T3	N3a	Infiltrating Ductal Carcinoma	Stage IIIC
s5955	58cfa82de4b0c9d6adf6a6fc	9ca76c5419b7c28caff81be798afdf6d.filtered.	WGS	9ca76c5419b7c28caff81be798afdf6d	9ca76c5419b7c28caff81be798afdf6d.bam	17.89	1.98	0.08	58cfa82de4b0c9d6adf6a6fc	9ca76c5419b7c28caff81be798afdf6d.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15E-10A	0A2A3529-F645-4967-9A58-89EE20B8BB62	Blood Derived Normal	Illumina HiSeq	9ed4cd7a-c9d6-47d6-8258-def05e151530	Breast	40.0	0927DA66-1240-460C-96C4-9EA25A71F94A	F99107DC-06E1-495F-83C9-3E17DC858FE5	TCGA-E2-A15E-10A-01D-A19H-09	GRCh37-lite	TCGA-E2-A15E	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s5956	58cfa82de4b0c9d6adf6a702	9bc66de4dce9c72e3a48ab48eebc3e7b.filtered.	WGS	9bc66de4dce9c72e3a48ab48eebc3e7b	9bc66de4dce9c72e3a48ab48eebc3e7b.bam	73.3	1.83	0.08	58cfa82de4b0c9d6adf6a702	9bc66de4dce9c72e3a48ab48eebc3e7b.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1P8-10A	359F12F9-5C41-48A4-85BC-FD7E307BF7D8	Blood Derived Normal	Illumina HiSeq	ab0a625b-6478-4d76-8b3e-b3e479e4242e	Breast	58.0	1EE2800D-4897-4990-B292-F7F8A04EEB6B	E52DD335-3B9A-4E3E-BA2E-F125611ECD09	TCGA-EW-A1P8-10A-01D-A314-09	GRCh37-lite	TCGA-EW-A1P8	TCGA-BRCA	239.0	Washington University School of Medicine	University of Miami	United States	NO	T2	N3b	Infiltrating Ductal Carcinoma	Stage IIIC
s5957	58cfa830e4b0c9d6adf6bb9e	TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	24.55	1.83	0.07	58cfa830e4b0c9d6adf6bb9e	TCGA-A2-A04P-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04P-10A	CCD4A24B-D8CC-4686-9DEE-C98B0C5A8D21	Blood Derived Normal	Illumina HiSeq	38b3f71f-fbf5-46cd-91b9-a6233ac79a89	Breast	36.0	C8A2B99E-2188-43E4-A7CB-3DD57D4E7662	07F6C203-D1CF-4C40-B181-B717D327DADE	TCGA-A2-A04P-10A-01D-A128-09	GRCh37-lite	TCGA-A2-A04P	TCGA-BRCA	548.0	Washington University School of Medicine	Walter Reed	None	NO	T2	N3c	Infiltrating Ductal Carcinoma	Stage IIIC
s5958	58cfa830e4b0c9d6adf6ba6a	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.bam	66.09	2.03	0.08	58cfa830e4b0c9d6adf6ba6a	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04P-01A	CCD4A24B-D8CC-4686-9DEE-C98B0C5A8D21	Primary Tumor	Illumina HiSeq	680a94d4-95ae-4e50-b380-28f9f3c3be71	Breast	36.0	E4DEE88B-58D0-4953-AD4A-A2DF876F3C95	A85CF239-FF51-46E7-9B88-4C2CB49C66B9	TCGA-A2-A04P-01A-31D-A128-09	GRCh37-lite	TCGA-A2-A04P	TCGA-BRCA	548.0	Washington University School of Medicine	Walter Reed	None	NO	T2	N3c	Infiltrating Ductal Carcinoma	Stage IIIC
s5959	58cfa830e4b0c9d6adf6bc48	TCGA-AO-A0JJ-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_4_rg.sorted.filtered.	WGS	TCGA-AO-A0JJ-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_4_rg.sorted	TCGA-AO-A0JJ-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_4_rg.sorted.bam	96.1	1.71	0.17	58cfa830e4b0c9d6adf6bc48	TCGA-AO-A0JJ-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JJ-10A	BEF7B135-A727-45E8-850A-CC4CD56C49AA	Blood Derived Normal	Illumina HiSeq	335753c7-066c-41ad-8616-f9ec5f6b22e8	Breast	54.0	57F491FB-7CAD-4BC8-B55B-2231AD16A9E3	8A9F1058-6930-4942-879D-6633DB1848E0	TCGA-AO-A0JJ-10A-01D-A060-02	HG19_Broad_variant	TCGA-AO-A0JJ	TCGA-BRCA		Harvard Medical School	MSKCC	None	NO	T2	N1a	Infiltrating Lobular Carcinoma	Stage IIB
s5960	58cfa830e4b0c9d6adf6bc2c	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	78.64	1.86	0.08	58cfa830e4b0c9d6adf6bc2c	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J4-01A	A9B7D7FE-BE31-4F71-AFEE-C1BFDF511888	Primary Tumor	Illumina HiSeq	b518df9f-2eae-4c82-92e3-3eb196cdd3a5	Breast	41.0	CF11642A-EB96-4B37-B914-371C71F8E0CA	110B5F05-DED7-45EC-B0F6-A941C92D77DD	TCGA-AO-A0J4-01A-11D-A128-09	GRCh37-lite	TCGA-AO-A0J4	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s5961	58cfa830e4b0c9d6adf6bc3f	TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	111.5	1.95	0.08	58cfa830e4b0c9d6adf6bc3f	TCGA-AO-A0J4-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J4-10A	A9B7D7FE-BE31-4F71-AFEE-C1BFDF511888	Blood Derived Normal	Illumina HiSeq	4d68d5de-7417-49a8-adf6-12b3ccc612c0	Breast	41.0	82BB4CE9-08E3-4EAE-83B6-268225097575	F146C30D-FCE0-49BC-B684-8AD9CCACA7CF	TCGA-AO-A0J4-10A-01D-A128-09	GRCh37-lite	TCGA-AO-A0J4	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s5962	58cfa830e4b0c9d6adf6be20	TCGA-B6-A0RG-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_4_rg.sorted.filtered.	WGS	TCGA-B6-A0RG-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_4_rg.sorted	TCGA-B6-A0RG-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_4_rg.sorted.bam	7.45	2.0	0.15	58cfa830e4b0c9d6adf6be20	TCGA-B6-A0RG-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RG-10A	9B13927C-7357-44FD-8385-92AE6A656B7D	Blood Derived Normal	Illumina HiSeq	5ad51bb7-5bcd-42bc-b3ad-64bb242f91b3	Breast	26.0	3EBECB70-9957-4BFB-8E69-DC6F157C3F08	6F602AEF-51FE-40AD-9984-0F95D27A4078	TCGA-B6-A0RG-10A-01D-A060-02	HG19_Broad_variant	TCGA-B6-A0RG	TCGA-BRCA		Harvard Medical School	Duke	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB
s5963	58cfa830e4b0c9d6adf6bdcc	TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted	TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted.bam	71.16	2.03	0.15	58cfa830e4b0c9d6adf6bdcc	TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H6-01A	AEB6A3A6-B57A-4C53-90E6-E833777DD2A1	Primary Tumor	Illumina HiSeq	9c69c17b-33de-4bb8-be9f-7e0dcde9db0a	Breast	82.0	B2921C9D-C655-46F3-86E5-2FC2BED1ED33	57D73BC9-950E-42A3-B9FB-6045117112B7	TCGA-BH-A0H6-01A-21D-A060-02	HG19_Broad_variant	TCGA-BH-A0H6	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T1b	NX	Infiltrating Ductal Carcinoma	Stage I
s6102	58cfa83ce4b0c9d6adf730ed	b2e10818826b4072c8f92e5b678b4332.filtered.	WGS	b2e10818826b4072c8f92e5b678b4332	b2e10818826b4072c8f92e5b678b4332.bam	76.73	1.92	0.08	58cfa83ce4b0c9d6adf730ed	b2e10818826b4072c8f92e5b678b4332.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IQ-01A	01EEF340-598C-4205-A990-CEC190AC2CA5	Primary Tumor	Illumina HiSeq	7f45dc68-74e8-4953-8221-00c2ba51dee4	Breast	40.0	183A47B2-1B00-4A72-ADEB-F35B55692EE1	8956D73D-7E36-4129-8A3E-D4F3B43BAF0B	TCGA-B6-A0IQ-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0IQ	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	T3	N1b	Infiltrating Ductal Carcinoma	Stage IIIA
s6103	58cfa83ce4b0c9d6adf7320a	b4fb6f3c8975390c84c136ba9b277834.filtered.	WGS	b4fb6f3c8975390c84c136ba9b277834	b4fb6f3c8975390c84c136ba9b277834.bam	21.02	1.97	0.07	58cfa83ce4b0c9d6adf7320a	b4fb6f3c8975390c84c136ba9b277834.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A109-10A	F0787165-6F58-4D67-B510-928EEA2C4882	Blood Derived Normal	Illumina HiSeq	bd77a131-48d3-4950-992a-ace47923f7ae	Breast	64.0	A0549DF7-5945-4355-81F3-58B896BA5B93	7826A2E6-30AE-460B-AB97-2986F1D76D4B	TCGA-E2-A109-10A-01D-A10M-09	GRCh37-lite	TCGA-E2-A109	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6104	58cfa83ce4b0c9d6adf72f12	c535b5e8e14454d2fb5975ead8bd9321.filtered.	WGS	c535b5e8e14454d2fb5975ead8bd9321	c535b5e8e14454d2fb5975ead8bd9321.bam	22.35	1.97	0.08	58cfa83ce4b0c9d6adf72f12	c535b5e8e14454d2fb5975ead8bd9321.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D4-10A	75113445-D2D6-44A0-866C-C9175E6D214B	Blood Derived Normal	Illumina HiSeq	231cf234-5a6f-486a-805f-8e2f12139cb6	Breast	37.0	138745F8-F15E-486B-A7DA-B835C1D7A67E	C462D06F-679D-451B-9BB9-0DA8E349A49B	TCGA-A2-A0D4-10A-01D-A314-09	GRCh37-lite	TCGA-A2-A0D4	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6105	58cfa83ce4b0c9d6adf72f04	da60919696928e24aa5fcbb89cc8bfa3.filtered.	WGS	da60919696928e24aa5fcbb89cc8bfa3	da60919696928e24aa5fcbb89cc8bfa3.bam	8.55	1.95	0.08	58cfa83ce4b0c9d6adf72f04	da60919696928e24aa5fcbb89cc8bfa3.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LL-11A	2A84997D-CCEE-4F46-BEA2-752534F26416	Solid Tissue Normal	Illumina HiSeq	f2fe81a1-3e80-4b03-9699-eaa8a4652be5	Breast	73.0	A172AEF1-943F-4423-8EA0-FEEC5EBF1958	63DC530D-0968-45A2-BA97-BFFF1EF2E5CD	TCGA-E2-A1LL-11A-21D-A314-09	GRCh37-lite	TCGA-E2-A1LL	TCGA-BRCA		Washington University School of Medicine	Roswell Park	United States	NO	T3	N2a	Infiltrating Ductal Carcinoma	Stage IIIA
s6106	58cfa83ce4b0c9d6adf73166	d79ab9e1fbdab9baa35cf4fcd55ea0da.filtered.	WGS	d79ab9e1fbdab9baa35cf4fcd55ea0da	d79ab9e1fbdab9baa35cf4fcd55ea0da.bam	76.81	1.95	0.08	58cfa83ce4b0c9d6adf73166	d79ab9e1fbdab9baa35cf4fcd55ea0da.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15K-06A	17C1D42C-CB84-4655-A4CD-B54BAE17ECAF	Metastatic	Illumina HiSeq	94369066-1292-427f-a441-6eddcd074492	Breast	58.0	4FCF4AFE-40BE-40EB-95CB-5B172ED83D11	F39CC911-36A7-4C06-9E91-4AD86281DB3D	TCGA-E2-A15K-06A-11D-A12Q-09	GRCh37-lite	TCGA-E2-A15K	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6107	58cfa83ce4b0c9d6adf7310c	e197a935bf028894f9cec5ec9a249bf2.filtered.	WGS	e197a935bf028894f9cec5ec9a249bf2	e197a935bf028894f9cec5ec9a249bf2.bam	6.0	1.59	0.08	58cfa83ce4b0c9d6adf7310c	e197a935bf028894f9cec5ec9a249bf2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I2-10B	328DFCB0-B5AE-43F2-BC87-DAD0AB3DF9E7	Blood Derived Normal	Illumina HiSeq	32d9eca6-d09e-458e-8564-2f50ca1eb655	Breast	45.0	99C37035-A40A-458C-868B-B0D3B64720F8	20641853-1373-4304-A795-5C8F45459B27	TCGA-B6-A0I2-10B-01D-A12L-09	GRCh37-lite	TCGA-B6-A0I2	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s6108	58cfa83ce4b0c9d6adf73074	f69f0ef802b7feefa79f55fe3e188902.filtered.	WGS	f69f0ef802b7feefa79f55fe3e188902	f69f0ef802b7feefa79f55fe3e188902.bam	35.42	1.97	0.08	58cfa83ce4b0c9d6adf73074	f69f0ef802b7feefa79f55fe3e188902.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A12Q-01A	A824B3BD-34D5-4CC1-A92F-F9D6AC0F1814	Primary Tumor	Illumina HiSeq	bb80680a-245c-421b-a3ef-198dc78bad1e	Breast	78.0	8867F07E-0993-4C9A-96DF-18E24801BA80	D8C6D4B8-F279-4EDC-AAA3-A1CC266AEC4D	TCGA-C8-A12Q-01A-11D-A19H-09	GRCh37-lite	TCGA-C8-A12Q	TCGA-BRCA		Washington University School of Medicine	ILSbio	None	NO	T1	N2	Infiltrating Ductal Carcinoma	Stage IIIA
s6109	58cfa83ce4b0c9d6adf730d4	fe7b56f09624164caf93abc1f8d3bdc7.filtered.	WGS	fe7b56f09624164caf93abc1f8d3bdc7	fe7b56f09624164caf93abc1f8d3bdc7.bam	34.51	1.9	0.08	58cfa83ce4b0c9d6adf730d4	fe7b56f09624164caf93abc1f8d3bdc7.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0WX-01A	A482FC4C-FF1D-46A0-A968-7DF06422CC4B	Primary Tumor	Illumina HiSeq	1d0beca4-681e-4dbe-a6cf-f6c492c370b2	Breast	40.0	7DAA9124-2878-4708-AE74-28B17EF4898C	47B5D831-5287-4F62-B17A-6E5EFF2E4184	TCGA-B6-A0WX-01A-11D-A10G-09	GRCh37-lite	TCGA-B6-A0WX	TCGA-BRCA	653.0	Washington University School of Medicine	Duke	United States	NO	T3	N1b	Other  specify	Stage IIIA
s6110	58cfa82de4b0c9d6adf6a48c	01e2ea9ed2554ea6df56ed963414b511.filtered.	WGS	01e2ea9ed2554ea6df56ed963414b511	01e2ea9ed2554ea6df56ed963414b511.bam	33.83	1.84	0.08	58cfa82de4b0c9d6adf6a48c	01e2ea9ed2554ea6df56ed963414b511.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A26G-01A	5ED024E8-D05E-4C65-9441-EDA9930CCC82	Primary Tumor	Illumina HiSeq	f7140aea-8ed7-4d5d-adfb-bd360e319805	Breast	50.0	F0CF4ACD-6B09-4538-B58C-E86C623B6C71	36D1A85E-A09B-4537-86E0-EAF1EB03AED8	TCGA-A7-A26G-01A-21D-A167-09	GRCh37-lite	TCGA-A7-A26G	TCGA-BRCA		Washington University School of Medicine	Christiana Healthcare	United States	NO	T2	N0 (i+)	Other  specify	Stage IIA
s6111	58cfa82de4b0c9d6adf6a572	29d8acadae6e2c6643400b1090ef29f2.filtered.	WGS	29d8acadae6e2c6643400b1090ef29f2	29d8acadae6e2c6643400b1090ef29f2.bam	61.59	1.88	0.08	58cfa82de4b0c9d6adf6a572	29d8acadae6e2c6643400b1090ef29f2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A1-A0SM-01A	784DE7AC-8424-42EB-83D4-A1BEBAA42B97	Primary Tumor	Illumina HiSeq	d1b482b0-0e66-4620-bc89-bfc93541735d	Breast	77.0	289F5433-4834-401F-9361-EFC8E883E630	546B982F-60D9-43DF-9761-09369AFBEE2D	TCGA-A1-A0SM-01A-11D-A19H-09	GRCh37-lite	TCGA-A1-A0SM	TCGA-BRCA		Washington University School of Medicine	UCSF	United States	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6112	58cfa82de4b0c9d6adf6a62a	58d251e38e74fbdfea909ba38fd6b2c4.filtered.	WGS	58d251e38e74fbdfea909ba38fd6b2c4	58d251e38e74fbdfea909ba38fd6b2c4.bam	30.09	1.89	0.09	58cfa82de4b0c9d6adf6a62a	58d251e38e74fbdfea909ba38fd6b2c4.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1FC-11A	B97BF89A-7A85-4EEF-AE7E-F787AEAD1F0A	Solid Tissue Normal	Illumina HiSeq	689d4e64-e8da-4e5d-8d57-fce960e4285a	Breast	78.0	A6916373-70F1-434C-910A-407609815556	00B14C77-845C-432E-923C-C2C412F5DF31	TCGA-BH-A1FC-11A-32D-A314-09	GRCh37-lite	TCGA-BH-A1FC	TCGA-BRCA	3472.0	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1b	Medullary Carcinoma	Stage IIA
s6113	58cfa82de4b0c9d6adf6a634	63fce88d543c8b969ca3171331e19211.filtered.	WGS	63fce88d543c8b969ca3171331e19211	63fce88d543c8b969ca3171331e19211.bam	14.72	1.91	0.08	58cfa82de4b0c9d6adf6a634	63fce88d543c8b969ca3171331e19211.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15K-11A	17C1D42C-CB84-4655-A4CD-B54BAE17ECAF	Solid Tissue Normal	Illumina HiSeq	4968e751-3f12-4e99-8228-6a58cbf1bca4	Breast	58.0	1EB11F10-2ACA-4CA1-B6FC-BBC97CC485FD	26163687-7EDE-43BE-AEB7-21AD33133D45	TCGA-E2-A15K-11A-13D-A12Q-09	GRCh37-lite	TCGA-E2-A15K	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6114	58cfa82de4b0c9d6adf6a686	666886d606520f78a6620cf9eb2e88cb.filtered.	WGS	666886d606520f78a6620cf9eb2e88cb	666886d606520f78a6620cf9eb2e88cb.bam	84.49	1.9	0.08	58cfa82de4b0c9d6adf6a686	666886d606520f78a6620cf9eb2e88cb.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J2-10A	D2F2560C-EC80-4FEA-9474-C47A2E85EA95	Blood Derived Normal	Illumina HiSeq	67104b13-f236-4501-aa7e-6a7eab9ec28e	Breast	41.0	7664E64F-BB15-4C10-B1C2-E2B85A512D58	5AFDC08C-4860-498E-8E4E-91D148812E62	TCGA-AO-A0J2-10A-01D-A19H-09	GRCh37-lite	TCGA-AO-A0J2	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s6115	58cfa82de4b0c9d6adf6a58f	5ef6a0389326d4bf5accd20037a358d3.filtered.	WGS	5ef6a0389326d4bf5accd20037a358d3	5ef6a0389326d4bf5accd20037a358d3.bam	42.25	2.0	0.08	58cfa82de4b0c9d6adf6a58f	5ef6a0389326d4bf5accd20037a358d3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AQ-A04J-01A	9938CE5C-E74E-446E-A932-F096F85CC3B1	Primary Tumor	Illumina HiSeq	c57fe789-7ef3-4dcb-bc21-b7ccb5ff208e	Breast	45.0	09D6F42C-5E9F-4ADC-BD8C-E5DCA597FC01	467EF778-F481-44F3-9768-B9900252D2BA	TCGA-AQ-A04J-01A-02D-A128-09	GRCh37-lite	TCGA-AQ-A04J	TCGA-BRCA		Washington University School of Medicine	Not available	United States	NO	T2	N0 (i+)	Infiltrating Ductal Carcinoma	Stage IIA
s6116	58cfa82de4b0c9d6adf6a5b8	61a02d82b4437f653c127eb3d3e0a78d.filtered.	WGS	61a02d82b4437f653c127eb3d3e0a78d	61a02d82b4437f653c127eb3d3e0a78d.bam	50.85	1.97	0.08	58cfa82de4b0c9d6adf6a5b8	61a02d82b4437f653c127eb3d3e0a78d.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A14X-01A	60DF7543-6DA5-4C75-943B-5800C1E08234	Primary Tumor	Illumina HiSeq	775348e1-91bf-4bf9-93e9-ff9f955b5a79	Breast	55.0	A7CC9298-D6F1-48EF-A93A-9C75FC0CB800	74039ACD-5ACA-4C65-818C-3B577D295BE0	TCGA-E2-A14X-01A-11D-A10Y-09	GRCh37-lite	TCGA-E2-A14X	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage IIIA
s6118	58cfa82de4b0c9d6adf6a6de	96494da11b3953fa17435019d7e9b926.filtered.	WGS	96494da11b3953fa17435019d7e9b926	96494da11b3953fa17435019d7e9b926.bam	12.32	2.0	0.07	58cfa82de4b0c9d6adf6a6de	96494da11b3953fa17435019d7e9b926.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A1-A0SM-10A	784DE7AC-8424-42EB-83D4-A1BEBAA42B97	Blood Derived Normal	Illumina HiSeq	96a41a4f-52b2-4699-9a58-6e8e2be5e409	Breast	77.0	58D5D36A-DAEC-449C-803C-13BDCDE876EE	F80D013A-BC2D-498D-898F-C25EFF8192A1	TCGA-A1-A0SM-10A-02D-A099-09	GRCh37-lite	TCGA-A1-A0SM	TCGA-BRCA		Washington University School of Medicine	UCSF	United States	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6119	58cfa82de4b0c9d6adf6a6f0	9802f275692b4130ed0848237ee1447e.filtered.	WGS	9802f275692b4130ed0848237ee1447e	9802f275692b4130ed0848237ee1447e.bam	49.14	1.91	0.07	58cfa82de4b0c9d6adf6a6f0	9802f275692b4130ed0848237ee1447e.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0X5-10A	4E6EDFE6-ADCB-4C12-8FF4-38A79F5887E8	Blood Derived Normal	Illumina HiSeq	1859efd4-29c0-48f0-9b0a-533ab337913a	Breast	61.0	003C8CFF-EC0E-4F7C-B38B-93575FD68A23	3FF1B637-7389-4E74-9E63-01642DF895F4	TCGA-B6-A0X5-10A-01D-A10G-09	GRCh37-lite	TCGA-B6-A0X5	TCGA-BRCA	2097.0	Washington University School of Medicine	Duke	United States	NO	T2	N1b	Infiltrating Ductal Carcinoma	Stage IIB
s6120	58cfa82de4b0c9d6adf6a6a8	951b84e6d6a0e3c96960a60e3291e860.filtered.	WGS	951b84e6d6a0e3c96960a60e3291e860	951b84e6d6a0e3c96960a60e3291e860.bam	22.18	1.95	0.07	58cfa82de4b0c9d6adf6a6a8	951b84e6d6a0e3c96960a60e3291e860.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A14X-10A	60DF7543-6DA5-4C75-943B-5800C1E08234	Blood Derived Normal	Illumina HiSeq	0a820852-4686-4bed-8995-35aba8b37368	Breast	55.0	8328302C-CFF7-46DA-9B14-9C55F6EE531C	6194BBB4-88AE-4DB8-86E1-99D4D2315E89	TCGA-E2-A14X-10A-01D-A314-09	GRCh37-lite	TCGA-E2-A14X	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage IIIA
s6121	58cfa82fe4b0c9d6adf6b8f4	TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted.filtered.	WGS	TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted	TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted.bam	6.58		0.15	58cfa82fe4b0c9d6adf6b8f4	TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A0DC-01B	CB9F5E50-F49D-4899-8895-9367AFCC1015	Primary Tumor	Illumina HiSeq	b8f1a569-bcd5-4da4-a1ea-ae76c98a5d91	Breast	63.0	00B54C99-C26D-423A-9871-2552C1603A9C	A253B105-73B8-4E33-8870-B31CCFB02847	TCGA-A7-A0DC-01B-04D-A22S-26	HG19_Broad_variant	TCGA-A7-A0DC	TCGA-BRCA		MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	None	YES	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s6122	58cfa830e4b0c9d6adf6becb	TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted.filtered.	WGS	TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted	TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted.bam	42.91	2.0	0.14	58cfa830e4b0c9d6adf6becb	TCGA-AO-A0JL-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JL-10A	D5D8E76E-2F2A-49BC-BA0A-D51283611B16	Blood Derived Normal	Illumina HiSeq	4db7f9bb-a3b8-4b87-b98c-8ba5be69963f	Breast	59.0	6F0C9CAE-2A0F-4512-9B36-E94917CF2561	5159552D-2BC4-4C78-A5FD-3B34084C6A4E	TCGA-AO-A0JL-10A-01D-A060-02	HG19_Broad_variant	TCGA-AO-A0JL	TCGA-BRCA		Harvard Medical School	MSKCC	None	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA
s6123	58cfa831e4b0c9d6adf6c3ae	TCGA-B6-A0X4-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_8_rg.sorted.filtered.	WGS	TCGA-B6-A0X4-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_8_rg.sorted	TCGA-B6-A0X4-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_8_rg.sorted.bam	56.99	1.97	0.14	58cfa831e4b0c9d6adf6c3ae	TCGA-B6-A0X4-10A-01D-A106_130719_SN1120_0270_AC2CVRACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0X4-10A	4E42FDC5-2A8B-49E9-87EF-6DB7A6692D08	Blood Derived Normal	Illumina HiSeq	b1fb31e5-69fe-4970-b9ab-98311778aa34	Breast	62.0	C437468C-9912-4AFB-99E6-1C9C7B566857	AB0347C3-AE35-4484-88A5-E545B27F5691	TCGA-B6-A0X4-10A-01D-A106-02	HG19_Broad_variant	TCGA-B6-A0X4	TCGA-BRCA	860.0	Harvard Medical School	Duke	United States	NO	T2	N1b	Infiltrating Ductal Carcinoma	Stage IIB
s6124	58cfa830e4b0c9d6adf6c256	TCGA-BH-A0HK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BH-A0HK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_2_rg.sorted	TCGA-BH-A0HK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_2_rg.sorted.bam	20.06	2.07	0.17	58cfa830e4b0c9d6adf6c256	TCGA-BH-A0HK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HK-10A	24334AC1-28A3-4B61-B590-3F51E375B247	Blood Derived Normal	Illumina HiSeq	c9ee059e-f157-47b4-a76b-64e57c14f01d	Breast	81.0	A67DC9C2-6D31-4B7D-99AD-C25CE2672E8C	AACC0421-E331-49E8-BA8F-AA7B091336C5	TCGA-BH-A0HK-10A-01D-A060-02	HG19_Broad_variant	TCGA-BH-A0HK	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB
s6125	58cfa830e4b0c9d6adf6bdce	TCGA-BH-A0H6-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BH-A0H6-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_2_rg.sorted	TCGA-BH-A0H6-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_2_rg.sorted.bam	18.64	2.08	0.16	58cfa830e4b0c9d6adf6bdce	TCGA-BH-A0H6-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H6-10A	AEB6A3A6-B57A-4C53-90E6-E833777DD2A1	Blood Derived Normal	Illumina HiSeq	f8cb702c-5eff-49df-98b0-e1404066dc8f	Breast	82.0	9269A6CA-6D25-4815-8BB2-6AB526262266	3DDCCFEC-A269-41AB-B274-31E992F98878	TCGA-BH-A0H6-10A-01D-A060-02	HG19_Broad_variant	TCGA-BH-A0H6	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T1b	NX	Infiltrating Ductal Carcinoma	Stage I
s6126	58cfa830e4b0c9d6adf6be10	TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted	TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted.bam	19.84	1.95	0.16	58cfa830e4b0c9d6adf6be10	TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HX-01A	3B01D064-8C00-4972-9F07-407EAC8E7534	Primary Tumor	Illumina HiSeq	06f7db86-540c-401d-bbd9-0b88698c5f36	Breast	54.0	989C2DF5-5183-4DAA-A8DA-FC9AB18A437C	11821020-0E93-4479-85F8-306976DE6722	TCGA-BH-A0HX-01A-21D-A060-02	HG19_Broad_variant	TCGA-BH-A0HX	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6250	58cfa83ce4b0c9d6adf72fbd	a765afe852088b93b14f4f8d87893494.filtered.	WGS	a765afe852088b93b14f4f8d87893494	a765afe852088b93b14f4f8d87893494.bam	49.61	2.14	0.08	58cfa83ce4b0c9d6adf72fbd	a765afe852088b93b14f4f8d87893494.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RE-01A	08DA7C4C-3067-4BCF-9D7A-78566DF72E69	Primary Tumor	Illumina HiSeq	6ed22fe1-529a-4ad1-8eb3-f50a383e4df4	Breast	61.0	270BE245-2239-4E96-A917-79CCA40868BA	1EB62ABC-7928-405B-84CC-F091CA5347B2	TCGA-B6-A0RE-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0RE	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	TX	N0 (i-)	Infiltrating Ductal Carcinoma	Stage X
s6251	58cfa83ce4b0c9d6adf73120	c4db7ecd250c14ade136a8948ac7149e.filtered.	WGS	c4db7ecd250c14ade136a8948ac7149e	c4db7ecd250c14ade136a8948ac7149e.bam	46.45	1.84	0.08	58cfa83ce4b0c9d6adf73120	c4db7ecd250c14ade136a8948ac7149e.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1J5-01A	5D8ED961-A012-4B6B-BFFB-9468D3953646	Primary Tumor	Illumina HiSeq	17593e20-8cc4-4961-8ff5-871806aeed93	Breast	59.0	BF42E8CE-CD3E-46C8-92F9-EA5CDA443A6F	98BB3025-0637-4106-8621-12DF7B5D662F	TCGA-EW-A1J5-01A-11D-A13L-09	GRCh37-lite	TCGA-EW-A1J5	TCGA-BRCA		Washington University School of Medicine	University of Miami	United States	NO	T3	N0 (i-)	Infiltrating Lobular Carcinoma	Stage IIB
s6253	58cfa83ce4b0c9d6adf7309a	be7bcf9d37d9e65a46acadb6e8e3450e.filtered.	WGS	be7bcf9d37d9e65a46acadb6e8e3450e	be7bcf9d37d9e65a46acadb6e8e3450e.bam	58.65	1.91	0.08	58cfa83ce4b0c9d6adf7309a	be7bcf9d37d9e65a46acadb6e8e3450e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BW-01A	5D1D00C6-FCAE-479E-AE1E-DE76EFD41D98	Primary Tumor	Illumina HiSeq	d87bcaa2-19f0-4c3b-8f85-8f47ed056ffc	Breast	71.0	DBEEDDC1-D149-46F7-91FF-D057F8C6BFFB	07B5141F-AC79-439B-883B-B0183BBE7FF5	TCGA-BH-A0BW-01A-11D-A10Y-09	GRCh37-lite	TCGA-BH-A0BW	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I
s6254	58cfa83ce4b0c9d6adf72e92	cb6b276f142f61c0948db2f9e3fc1a06.filtered.	WGS	cb6b276f142f61c0948db2f9e3fc1a06	cb6b276f142f61c0948db2f9e3fc1a06.bam	14.21		0.07	58cfa83ce4b0c9d6adf72e92	cb6b276f142f61c0948db2f9e3fc1a06.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3XX-10A	53886143-C1C6-40E9-88E6-E4E5E0271FC8	Blood Derived Normal	Illumina HiSeq	128df03c-0852-4e14-8f58-1c66046567fb	Breast	49.0	C6EB6218-AD71-40A6-88B7-A4F1A015B816	E96D5811-4736-40DD-966D-E0E172AEB0AF	TCGA-A2-A3XX-10A-01D-A23C-09	GRCh37-lite	TCGA-A2-A3XX	TCGA-BRCA		Washington University School of Medicine	Walter Reed	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s6255	58cfa83ce4b0c9d6adf72ec2	cf3a026c76b42c90171b25f03c7b18ad.filtered.	WGS	cf3a026c76b42c90171b25f03c7b18ad	cf3a026c76b42c90171b25f03c7b18ad.bam	68.2	1.89	0.07	58cfa83ce4b0c9d6adf72ec2	cf3a026c76b42c90171b25f03c7b18ad.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0CM-01A	EB2DBB4F-66B6-4525-8323-431970F7A64E	Primary Tumor	Illumina HiSeq	a6c27294-bf51-4eac-a2b6-885f5757b32b	Breast	40.0	EA7FB858-C17B-40D4-9A22-CBD9DA614B65	4B9CBBE5-CBD6-4CDE-853A-FA96A176E86D	TCGA-A2-A0CM-01A-31D-A128-09	GRCh37-lite	TCGA-A2-A0CM	TCGA-BRCA	754.0	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6256	58cfa83ce4b0c9d6adf72fe8	f316e3dff60e757701731d0c0cd94c3d.filtered.	WGS	f316e3dff60e757701731d0c0cd94c3d	f316e3dff60e757701731d0c0cd94c3d.bam	24.95	1.71	0.08	58cfa83ce4b0c9d6adf72fe8	f316e3dff60e757701731d0c0cd94c3d.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04Q-10A	B5FBA77B-1F50-4E71-95B2-566AFBA4BDD7	Blood Derived Normal	Illumina HiSeq	4f762d03-b511-4e74-a7af-6633100d33cd	Breast	48.0	5DFFF1AD-3046-4E43-8304-A8579A9F203B	BCC3DDC8-33E4-4F7C-81E6-8AD2480C62A7	TCGA-A2-A04Q-10A-01D-A128-09	GRCh37-lite	TCGA-A2-A04Q	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T1	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s6257	58cfa82de4b0c9d6adf6a453	0e568ec10e5985f96895830ea05ab7ea.filtered.	WGS	0e568ec10e5985f96895830ea05ab7ea	0e568ec10e5985f96895830ea05ab7ea.bam	26.04	1.95	0.08	58cfa82de4b0c9d6adf6a453	0e568ec10e5985f96895830ea05ab7ea.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D1-10A	084C6AEC-94F7-4090-8F3F-59FA9E89721A	Blood Derived Normal	Illumina HiSeq	a74be239-af6b-4564-9546-58302824434c	Breast	76.0	EAE92247-2372-4EC9-A140-57009E1D1BE5	C569741B-DAD3-4042-B1B0-45D62EB6A967	TCGA-A2-A0D1-10A-01D-A19H-09	GRCh37-lite	TCGA-A2-A0D1	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6258	58cfa82de4b0c9d6adf6a488	13cf3705382d9fa3718c1f9ee909853b.filtered.	WGS	13cf3705382d9fa3718c1f9ee909853b	13cf3705382d9fa3718c1f9ee909853b.bam	32.16	2.06	0.08	58cfa82de4b0c9d6adf6a488	13cf3705382d9fa3718c1f9ee909853b.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E9-A1NH-11A	B2AAC45B-2073-4C7A-ADB9-769A4FDCC111	Solid Tissue Normal	Illumina HiSeq	9ec85678-e1a8-44bd-9676-72b0d1b991d7	Breast	71.0	A646C533-70B4-43B7-B1B1-0D26509A13CC	0EE95056-A7CC-415C-A487-3AD08604DFC0	TCGA-E9-A1NH-11A-33D-A14G-09	GRCh37-lite	TCGA-E9-A1NH	TCGA-BRCA		Washington University School of Medicine	Asterand	Russia	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB
s6259	58cfa82de4b0c9d6adf6a46d	0434f7930c67bd9c412cb31f2ada0466.filtered.	WGS	0434f7930c67bd9c412cb31f2ada0466	0434f7930c67bd9c412cb31f2ada0466.bam	27.89	1.93	0.08	58cfa82de4b0c9d6adf6a46d	0434f7930c67bd9c412cb31f2ada0466.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A18R-01A	F6E1EC78-5AD9-4879-9B7E-262D17B166AD	Primary Tumor	Illumina HiSeq	14062e7f-b11d-44a9-ae98-3383c517bf91	Breast	50.0	518BE2C7-FBA5-47B1-8C8B-FEF812FA74A4	9C70688D-6E43-4520-9262-EAAE4E4D597D	TCGA-BH-A18R-01A-11D-A19H-09	GRCh37-lite	TCGA-BH-A18R	TCGA-BRCA	1142.0	Washington University School of Medicine	University of Pittsburgh	None	NO	T2b	N1	Infiltrating Ductal Carcinoma	Stage IIA
s6260	58cfa82de4b0c9d6adf6a567	05ac8012bd475ab2ce3d45b2e0e5864b.filtered.	WGS	05ac8012bd475ab2ce3d45b2e0e5864b	05ac8012bd475ab2ce3d45b2e0e5864b.bam	28.76	1.93	0.08	58cfa82de4b0c9d6adf6a567	05ac8012bd475ab2ce3d45b2e0e5864b.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0YG-10A	C0892598-1F7B-4F23-9CD8-731F797753D5	Blood Derived Normal	Illumina HiSeq	0fe624ef-b6b8-45dc-8e70-c51c6a2e31d7	Breast	63.0	FE03FD53-82B8-4C77-9644-1CB989873811	D1ED4413-2B27-4C4D-B1D0-14CFC39721DB	TCGA-A2-A0YG-10A-01D-A19H-09	GRCh37-lite	TCGA-A2-A0YG	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N3a	Infiltrating Ductal Carcinoma	Stage IIIC
s6261	58cfa82de4b0c9d6adf6a520	333fbe3c434cef7ad15ead3da2957f3d.filtered.	WGS	333fbe3c434cef7ad15ead3da2957f3d	333fbe3c434cef7ad15ead3da2957f3d.bam	50.51	2.08	0.08	58cfa82de4b0c9d6adf6a520	333fbe3c434cef7ad15ead3da2957f3d.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A27H-10A	0DCA98B0-F43E-45B6-9A02-00092C78678C	Blood Derived Normal	Illumina HiSeq	71bbc4fc-5b27-43d5-8475-9a1d1c744147	Breast	72.0	2A206224-13A9-44A4-926A-A80E61ADAEBC	0EE10097-FADC-4E57-A304-7A342CB44EDF	TCGA-D8-A27H-10A-01D-A17G-09	GRCh37-lite	TCGA-D8-A27H	TCGA-BRCA		Washington University School of Medicine	Greater Poland Cancer Center	Poland	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s6263	58cfa82de4b0c9d6adf6a595	5d0262da4025c9d30132153329060e06.filtered.	WGS	5d0262da4025c9d30132153329060e06	5d0262da4025c9d30132153329060e06.bam	32.74	2.0	0.07	58cfa82de4b0c9d6adf6a595	5d0262da4025c9d30132153329060e06.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A12Q-10A	A824B3BD-34D5-4CC1-A92F-F9D6AC0F1814	Blood Derived Normal	Illumina HiSeq	53c73214-7b73-4c24-9cae-1c11fcb39573	Breast	78.0	5766227F-4D93-4917-9D26-6A5685443047	C3591328-2299-4C71-976A-064724A24C86	TCGA-C8-A12Q-10A-01D-A19H-09	GRCh37-lite	TCGA-C8-A12Q	TCGA-BRCA		Washington University School of Medicine	ILSbio	None	NO	T1	N2	Infiltrating Ductal Carcinoma	Stage IIIA
s6264	58cfa82de4b0c9d6adf6a59b	63caf3c72c859d6a05579c2a05cead25.filtered.	WGS	63caf3c72c859d6a05579c2a05cead25	63caf3c72c859d6a05579c2a05cead25.bam	32.95		0.08	58cfa82de4b0c9d6adf6a59b	63caf3c72c859d6a05579c2a05cead25.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A3XL-01A	65CAC997-4D39-4501-85EC-4FCB328A8EB5	Primary Tumor	Illumina HiSeq	77d3443d-1bf9-4867-89a2-65cc8e10141b	Breast	49.0	FED3A891-21BE-4196-B9EF-0BF7C8F976AA	B27D75BA-5989-4200-BFE9-F1B7D7CF8008	TCGA-GM-A3XL-01A-11D-A22X-09	GRCh37-lite	TCGA-GM-A3XL	TCGA-BRCA		Washington University School of Medicine	MD Anderson	United States	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6265	58cfa82de4b0c9d6adf6a5c5	682d86f6440758f0452a9556d9b0d965.filtered.	WGS	682d86f6440758f0452a9556d9b0d965	682d86f6440758f0452a9556d9b0d965.bam	58.08	1.94	0.07	58cfa82de4b0c9d6adf6a5c5	682d86f6440758f0452a9556d9b0d965.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0WX-10A	A482FC4C-FF1D-46A0-A968-7DF06422CC4B	Blood Derived Normal	Illumina HiSeq	5df0fe6c-10bd-4c09-8766-283df19e6760	Breast	40.0	3D2E8C04-BFBF-471D-88A4-1A12B39A6298	57C92229-F196-429C-8C85-874E2906A3D4	TCGA-B6-A0WX-10A-01D-A10G-09	GRCh37-lite	TCGA-B6-A0WX	TCGA-BRCA	653.0	Washington University School of Medicine	Duke	United States	NO	T3	N1b	Other  specify	Stage IIIA
s6266	58cfa82de4b0c9d6adf6a5f4	6e6df6d5127aa75119a983f6e9554092.filtered.	WGS	6e6df6d5127aa75119a983f6e9554092	6e6df6d5127aa75119a983f6e9554092.bam	18.08	1.86	0.08	58cfa82de4b0c9d6adf6a5f4	6e6df6d5127aa75119a983f6e9554092.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RE-10A	08DA7C4C-3067-4BCF-9D7A-78566DF72E69	Blood Derived Normal	Illumina HiSeq	fb69f79f-0d25-4867-8a83-764167ccd5e0	Breast	61.0	B515904E-B78D-41BB-A960-D8B26A384B16	132C4EC7-509C-43C3-BE90-3A95170E31D5	TCGA-B6-A0RE-10A-01D-A128-09	GRCh37-lite	TCGA-B6-A0RE	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	TX	N0 (i-)	Infiltrating Ductal Carcinoma	Stage X
s6267	58cfa82de4b0c9d6adf6a688	760071f8e60ef39a6884464df08526f5.filtered.	WGS	760071f8e60ef39a6884464df08526f5	760071f8e60ef39a6884464df08526f5.bam	14.07	1.86	0.07	58cfa82de4b0c9d6adf6a688	760071f8e60ef39a6884464df08526f5.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BW-10A	5D1D00C6-FCAE-479E-AE1E-DE76EFD41D98	Blood Derived Normal	Illumina HiSeq	b2814a9e-e181-44be-8ac3-cea9313752a8	Breast	71.0	449E6D54-AD02-45E2-A3D2-A5DCA2C3BA14	ECDAC032-E125-4CD8-BA62-6265ECFFB3D7	TCGA-BH-A0BW-10A-01D-A314-09	GRCh37-lite	TCGA-BH-A0BW	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I
s6268	58cfa82de4b0c9d6adf6a696	8a3283276f7379064644ef8c36430362.filtered.	WGS	8a3283276f7379064644ef8c36430362	8a3283276f7379064644ef8c36430362.bam	20.65	1.74	0.06	58cfa82de4b0c9d6adf6a696	8a3283276f7379064644ef8c36430362.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A03N-10A	9435447E-D65F-408B-863B-6576B1D652DD	Blood Derived Normal	Illumina HiSeq	6299b302-ec55-4baf-a73d-0da84bb6b964	Breast	59.0	3053710D-5AFE-417C-B57B-C06AFCB5BF02	45671631-68EF-4375-8A47-22796365F9A1	TCGA-AO-A03N-10A-01D-A19H-09	GRCh37-lite	TCGA-AO-A03N	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6269	58cfa830e4b0c9d6adf6ba4e	TCGA-A2-A0D2-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A0D2-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A0D2-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	24.52	1.8	0.07	58cfa830e4b0c9d6adf6ba4e	TCGA-A2-A0D2-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D2-10A	99E32C59-AA73-43FA-88C9-399DDADB2C72	Blood Derived Normal	Illumina HiSeq	956f0d4d-6f36-47f6-b9b0-f418ba4544c5	Breast	45.0	4DD51CDC-2A9E-4A67-A506-E7CD39390AFC	1A1589CC-44A9-4C4F-A0AF-EF3FD3C8E1F2	TCGA-A2-A0D2-10A-01D-A128-09	GRCh37-lite	TCGA-A2-A0D2	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i+)	Infiltrating Ductal Carcinoma	Stage IIA
s6270	58cfa830e4b0c9d6adf6bb98	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	66.88	1.91	0.08	58cfa830e4b0c9d6adf6bb98	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D0-01A	324BCBA2-F6A4-45A6-807C-215BDFFCCA21	Primary Tumor	Illumina HiSeq	25ddf041-bc97-4ced-aa1a-cf0339d8c23b	Breast	60.0	7FD5702E-2D7B-4B79-B2D8-5CA4CA33CF65	71FDA5A9-7049-406F-9348-2C24F7DDF5F4	TCGA-A2-A0D0-01A-11D-A128-09	GRCh37-lite	TCGA-A2-A0D0	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6271	58cfa830e4b0c9d6adf6bd78	TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted.filtered.	WGS	TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted	TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted.bam	29.04	1.87	0.14	58cfa830e4b0c9d6adf6bd78	TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JJ-01A	BEF7B135-A727-45E8-850A-CC4CD56C49AA	Primary Tumor	Illumina HiSeq	6d955c96-b34d-4aea-961b-378e856ae8cb	Breast	54.0	008DAFDD-A3D1-4801-8C0A-8714E2B58E48	ED24B69D-599E-42ED-BBE3-5C4F59FABED4	TCGA-AO-A0JJ-01A-11D-A060-02	HG19_Broad_variant	TCGA-AO-A0JJ	TCGA-BRCA		Harvard Medical School	MSKCC	None	NO	T2	N1a	Infiltrating Lobular Carcinoma	Stage IIB
s6272	58cfa830e4b0c9d6adf6c12c	TCGA-B6-A0RE-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_8_rg.sorted.filtered.	WGS	TCGA-B6-A0RE-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_8_rg.sorted	TCGA-B6-A0RE-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_8_rg.sorted.bam	18.08	1.86	0.16	58cfa830e4b0c9d6adf6c12c	TCGA-B6-A0RE-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_8_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RE-10A	08DA7C4C-3067-4BCF-9D7A-78566DF72E69	Blood Derived Normal	Illumina HiSeq	67bd449b-7035-4a63-8e7e-e32f1f49e4f0	Breast	61.0	B515904E-B78D-41BB-A960-D8B26A384B16	F2DEE42D-9E1D-471D-BF3E-F1A0A27E16DF	TCGA-B6-A0RE-10A-01D-A060-02	HG19_Broad_variant	TCGA-B6-A0RE	TCGA-BRCA		Harvard Medical School	Duke	United States	NO	TX	N0 (i-)	Infiltrating Ductal Carcinoma	Stage X
s6273	58cfa830e4b0c9d6adf6c062	TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted.filtered.	WGS	TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted	TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted.bam	78.5	1.92	0.14	58cfa830e4b0c9d6adf6c062	TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RI-01A	BFD55808-DDDD-44C3-97D7-41600497B992	Primary Tumor	Illumina HiSeq	9283f68e-d261-4afd-b0eb-0a29fdda83ca	Breast	44.0	973EE776-E287-4568-A43D-7B16CC0094A9	71542129-1393-4608-B81C-1767A5051763	TCGA-B6-A0RI-01A-11D-A060-02	HG19_Broad_variant	TCGA-B6-A0RI	TCGA-BRCA		Harvard Medical School	Duke	United States	NO	T4b	N1b	Infiltrating Ductal Carcinoma	Stage IIIB
s6274	58cfa830e4b0c9d6adf6bdf0	TCGA-BH-A0B3-11B-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0B3-11B-21D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0B3-11B-21D-A128-09_IlluminaGA-DNASeq_whole.bam	47.07	2.0	0.08	58cfa830e4b0c9d6adf6bdf0	TCGA-BH-A0B3-11B-21D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0B3-11B	18EB4DFC-556F-4BF3-A411-4780209ED1E0	Solid Tissue Normal	Illumina HiSeq	29af0d77-d43d-4e85-9010-c496c956b250	Breast	53.0	9A81AF95-30F8-45B1-BBDA-CA5C7A91C5C5	CE23B4FB-A727-4CCB-B4D7-C2E8407ABD7E	TCGA-BH-A0B3-11B-21D-A128-09	GRCh37-lite	TCGA-BH-A0B3	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6275	58cfa830e4b0c9d6adf6c1a6	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.bam	58.9	2.0	0.14	58cfa830e4b0c9d6adf6c1a6	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HB-01A	0C1023C0-D2CE-4940-8047-7642F1DC3965	Primary Tumor	Illumina HiSeq	c9a434dc-8ce3-485f-88aa-a2373f6cdfac	Breast	55.0	19193B8F-1E1B-448C-B934-93F25E60D45B	49556237-D73F-4DE9-B5D9-7169DB7A53C5	TCGA-BH-A0HB-01A-11D-A060-02	HG19_Broad_variant	TCGA-BH-A0HB	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s6443	58cfa83ce4b0c9d6adf7307f	b58386e952752d807a06a013a922b7ae.filtered.	WGS	b58386e952752d807a06a013a922b7ae	b58386e952752d807a06a013a922b7ae.bam	17.96	1.86	0.07	58cfa83ce4b0c9d6adf7307f	b58386e952752d807a06a013a922b7ae.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A13D-01A	8785012F-F73E-4D68-87CF-1D804AF32782	Primary Tumor	Illumina HiSeq	3c8a206a-59d4-412a-97c1-9dd31cb9b7c0	Breast	46.0	79FC9ED3-4E96-4C0E-869E-1756CBDABB39	418E916B-7A4E-4FAB-8616-15DCEC4D79F8	TCGA-A7-A13D-01A-13D-A12Q-09	GRCh37-lite	TCGA-A7-A13D	TCGA-BRCA		Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6444	58cfa83ce4b0c9d6adf72fde	bb06d7ab408c6716e20c1e6607182a1c.filtered.	WGS	bb06d7ab408c6716e20c1e6607182a1c	bb06d7ab408c6716e20c1e6607182a1c.bam	26.22	1.73	0.09	58cfa83ce4b0c9d6adf72fde	bb06d7ab408c6716e20c1e6607182a1c.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A24Z-10A	9FEFBE7C-F66A-4940-843E-285CB7B392C1	Blood Derived Normal	Illumina HiSeq	832184fd-56a4-488a-a361-8fee484a5391	Breast	57.0	CCA6B801-F735-420C-9BF3-A11FA35E56B5	E7976863-3BBF-42AC-B272-CCD7CA5BF679	TCGA-AR-A24Z-10A-01D-A167-09	GRCh37-lite	TCGA-AR-A24Z	TCGA-BRCA		Washington University School of Medicine	Mayo	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s6445	58cfa83ce4b0c9d6adf731da	bfa1e20d9b7b963ef3b548bde1c4cf00.filtered.	WGS	bfa1e20d9b7b963ef3b548bde1c4cf00	bfa1e20d9b7b963ef3b548bde1c4cf00.bam	46.34	1.95	0.08	58cfa83ce4b0c9d6adf731da	bfa1e20d9b7b963ef3b548bde1c4cf00.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A13D-10A	8785012F-F73E-4D68-87CF-1D804AF32782	Blood Derived Normal	Illumina HiSeq	b80530e4-9ddc-40fa-a763-ea5010e21813	Breast	46.0	82C28BC5-DB37-4400-9A77-9D65F5071CE5	DBC462F5-F723-4CF7-A48D-84001D2D51E9	TCGA-A7-A13D-10A-02D-A12Q-09	GRCh37-lite	TCGA-A7-A13D	TCGA-BRCA		Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6448	58cfa83ce4b0c9d6adf72f6c	e869d292dcb3ead5c9128b76af2ac4bb.filtered.	WGS	e869d292dcb3ead5c9128b76af2ac4bb	e869d292dcb3ead5c9128b76af2ac4bb.bam	83.48	1.95	0.08	58cfa83ce4b0c9d6adf72f6c	e869d292dcb3ead5c9128b76af2ac4bb.bam	Dead	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A256-01A	D3D545B3-457F-4389-821F-704CB24AFF7F	Primary Tumor	Illumina HiSeq	83a38860-cf50-4344-8dbf-97d4cda96864	Breast	45.0	87676C70-E2AD-4103-8BC0-3D3C1E40A790	EA43434B-197E-48AC-AE2E-46BC7F3776DE	TCGA-AR-A256-01A-11D-A167-09	GRCh37-lite	TCGA-AR-A256	TCGA-BRCA	2854.0	Washington University School of Medicine	Mayo	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s6449	58cfa82de4b0c9d6adf6a44c	023c722ed278d2ab1cbbeef1bfee4130.filtered.	WGS	023c722ed278d2ab1cbbeef1bfee4130	023c722ed278d2ab1cbbeef1bfee4130.bam	45.87	1.86	0.08	58cfa82de4b0c9d6adf6a44c	023c722ed278d2ab1cbbeef1bfee4130.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E9-A1NH-01A	B2AAC45B-2073-4C7A-ADB9-769A4FDCC111	Primary Tumor	Illumina HiSeq	f57cf947-b314-4a64-a112-d09cc8045594	Breast	71.0	FB0B2D84-D982-4D3A-9803-36420F2E7E46	13C312EC-0ADD-4758-AB8D-C193E2E08C6D	TCGA-E9-A1NH-01A-11D-A14G-09	GRCh37-lite	TCGA-E9-A1NH	TCGA-BRCA		Washington University School of Medicine	Asterand	Russia	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB
s6450	58cfa82de4b0c9d6adf6a444	05b05a3f284cf713011e4bd81b09ab5e.filtered.	WGS	05b05a3f284cf713011e4bd81b09ab5e	05b05a3f284cf713011e4bd81b09ab5e.bam	26.91	1.86	0.07	58cfa82de4b0c9d6adf6a444	05b05a3f284cf713011e4bd81b09ab5e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0AV-01A	790FF5DB-B7F3-4946-AAED-305F66B1DD6A	Primary Tumor	Illumina HiSeq	b2a1b1a3-a780-4be9-9a65-8937ba5df3b0	Breast	52.0	DCE6CAC3-6C76-4574-B7A8-C7083B12F22E	9032B7FE-E38A-4641-A45E-67041668ADC4	TCGA-BH-A0AV-01A-31D-A10Y-09	GRCh37-lite	TCGA-BH-A0AV	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I
s6453	58cfa82de4b0c9d6adf6a4bc	11061be66fae71c16788fd9fc1a73afb.filtered.	WGS	11061be66fae71c16788fd9fc1a73afb	11061be66fae71c16788fd9fc1a73afb.bam	22.65	1.95	0.08	58cfa82de4b0c9d6adf6a4bc	11061be66fae71c16788fd9fc1a73afb.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A1AY-10A	5FD9552A-C742-4388-940D-295D1107AE00	Blood Derived Normal	Illumina HiSeq	08e07f8e-1ab8-4039-a26d-4a7e1fcb9d98	Breast	65.0	1A474269-BC7C-4490-A7AE-30EA51124792	1C6D0926-E635-4F26-97A6-642C012E930D	TCGA-AR-A1AY-10A-01D-A12Q-09	GRCh37-lite	TCGA-AR-A1AY	TCGA-BRCA		Washington University School of Medicine	Mayo	None	NO	T1	N0	Infiltrating Ductal Carcinoma	Stage I
s6454	58cfa82de4b0c9d6adf6a4a6	3a96e8c557be05593e3dbb1fccbb73d1.filtered.	WGS	3a96e8c557be05593e3dbb1fccbb73d1	3a96e8c557be05593e3dbb1fccbb73d1.bam	74.02	2.18	0.09	58cfa82de4b0c9d6adf6a4a6	3a96e8c557be05593e3dbb1fccbb73d1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PB-01A	88DB1340-E4BF-451A-87C0-6E9168296F5E	Primary Tumor	Illumina HiSeq	2ba1984b-043e-4cc5-8bc4-10b6c2915f61	Breast	70.0	DA9DC40B-0350-4B8C-8A7A-15100D5AEB90	9DDF2119-A222-4FA5-A9F3-0BEC7EEEA36B	TCGA-EW-A1PB-01A-11D-A142-09	GRCh37-lite	TCGA-EW-A1PB	TCGA-BRCA		Washington University School of Medicine	University of Miami	United States	NO	T3	N1a	Infiltrating Ductal Carcinoma	Stage IIIA
s6455	58cfa82de4b0c9d6adf6a522	2e173cba9eef7aec792a9b66d36c62fd.filtered.	WGS	2e173cba9eef7aec792a9b66d36c62fd	2e173cba9eef7aec792a9b66d36c62fd.bam	107.95	1.77	0.09	58cfa82de4b0c9d6adf6a522	2e173cba9eef7aec792a9b66d36c62fd.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1FC-01A	B97BF89A-7A85-4EEF-AE7E-F787AEAD1F0A	Primary Tumor	Illumina HiSeq	96f6b8e2-d4c6-44db-a8d4-3c7549e04038	Breast	78.0	3AD0093A-E57A-450A-B0EF-942C9B67A586	84C77098-03D0-4B22-AFB1-797703E85C6C	TCGA-BH-A1FC-01A-11D-A13L-09	GRCh37-lite	TCGA-BH-A1FC	TCGA-BRCA	3472.0	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1b	Medullary Carcinoma	Stage IIA
s6456	58cfa82de4b0c9d6adf6a638	4f775502d475a2bb06ef956ee457c09b.filtered.	WGS	4f775502d475a2bb06ef956ee457c09b	4f775502d475a2bb06ef956ee457c09b.bam	66.75	1.91	0.08	58cfa82de4b0c9d6adf6a638	4f775502d475a2bb06ef956ee457c09b.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PH-10A	4DA999A0-EF41-4A0B-B1D1-446B39CC855A	Blood Derived Normal	Illumina HiSeq	9bb03dd1-4a31-4ff3-930f-2ccf230339ae	Breast	52.0	2EDC0D6D-F928-45EC-AC6B-2CEE7B111A87	8F191915-D076-4C9E-95C7-1DE76EA96CC0	TCGA-EW-A1PH-10A-01D-A17G-09	GRCh37-lite	TCGA-EW-A1PH	TCGA-BRCA		Washington University School of Medicine	University of Miami	United States	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s6457	58cfa82de4b0c9d6adf6a5ba	6011eb0b47e84a64100b4ab1fb7890d4.filtered.	WGS	6011eb0b47e84a64100b4ab1fb7890d4	6011eb0b47e84a64100b4ab1fb7890d4.bam	17.14	1.93	0.08	58cfa82de4b0c9d6adf6a5ba	6011eb0b47e84a64100b4ab1fb7890d4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AQ-A04J-10A	9938CE5C-E74E-446E-A932-F096F85CC3B1	Blood Derived Normal	Illumina HiSeq	daa58157-819b-4aa9-b5f7-a7db1fb9acba	Breast	45.0	98EBBB82-4AFB-4BBD-B29C-03ADF2EDA305	5BF42CFB-BFE4-4666-9D7E-7D50500BDEBD	TCGA-AQ-A04J-10A-01D-A128-09	GRCh37-lite	TCGA-AQ-A04J	TCGA-BRCA		Washington University School of Medicine	Not available	United States	NO	T2	N0 (i+)	Infiltrating Ductal Carcinoma	Stage IIA
s6459	58cfa82de4b0c9d6adf6a5ee	6979f0583ba67718dda7c5ddb907abd8.filtered.	WGS	6979f0583ba67718dda7c5ddb907abd8	6979f0583ba67718dda7c5ddb907abd8.bam	77.7	2.03	0.08	58cfa82de4b0c9d6adf6a5ee	6979f0583ba67718dda7c5ddb907abd8.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J2-01A	D2F2560C-EC80-4FEA-9474-C47A2E85EA95	Primary Tumor	Illumina HiSeq	46cbf954-a4fb-4060-818c-a60666ae41d3	Breast	41.0	4F5E142F-D936-469D-ABAA-37BAF6F045AF	207F8A42-5B05-4876-B0AE-EBFAEEA27844	TCGA-AO-A0J2-01A-11D-A19H-09	GRCh37-lite	TCGA-AO-A0J2	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s6460	58cfa82de4b0c9d6adf6a6f6	985ebcb22e11e01fdcef2ea18860a936.filtered.	WGS	985ebcb22e11e01fdcef2ea18860a936	985ebcb22e11e01fdcef2ea18860a936.bam	7.45	1.92	0.07	58cfa82de4b0c9d6adf6a6f6	985ebcb22e11e01fdcef2ea18860a936.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0AV-10A	790FF5DB-B7F3-4946-AAED-305F66B1DD6A	Blood Derived Normal	Illumina HiSeq	d56f0f11-ae97-4969-a5f2-84945ca2c281	Breast	52.0	4FE385EA-0135-480C-84E0-4ED9F4B1BB7E	3AB50B2E-8B0C-4CCD-B6BF-D577F5E9FC94	TCGA-BH-A0AV-10A-01D-A110-09	GRCh37-lite	TCGA-BH-A0AV	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I
s6462	58cfa830e4b0c9d6adf6be2a	TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted.filtered.	WGS	TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted	TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted.bam	65.55	2.08	0.15	58cfa830e4b0c9d6adf6be2a	TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0X4-01A	4E42FDC5-2A8B-49E9-87EF-6DB7A6692D08	Primary Tumor	Illumina HiSeq	1973be6c-c5a9-40d1-bdd2-a752dd33d6d1	Breast	62.0	45C3BD72-D260-4663-9091-5058E58F352D	062A41CC-4B23-49E2-AFF8-3CFE34DE9A36	TCGA-B6-A0X4-01A-11D-A106-02	HG19_Broad_variant	TCGA-B6-A0X4	TCGA-BRCA	860.0	Harvard Medical School	Duke	United States	NO	T2	N1b	Infiltrating Ductal Carcinoma	Stage IIB
s6463	58cfa830e4b0c9d6adf6c0f8	TCGA-B6-A0RI-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_4_rg.sorted.filtered.	WGS	TCGA-B6-A0RI-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_4_rg.sorted	TCGA-B6-A0RI-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_4_rg.sorted.bam	46.43	1.78	0.15	58cfa830e4b0c9d6adf6c0f8	TCGA-B6-A0RI-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RI-10A	BFD55808-DDDD-44C3-97D7-41600497B992	Blood Derived Normal	Illumina HiSeq	a498f419-7468-4a58-8a82-6692d63a46df	Breast	44.0	4E128A37-BE58-477A-A01F-448179360B7C	C9478F7D-BFE3-4E80-8161-39B3D440FA16	TCGA-B6-A0RI-10A-01D-A060-02	HG19_Broad_variant	TCGA-B6-A0RI	TCGA-BRCA		Harvard Medical School	Duke	United States	NO	T4b	N1b	Infiltrating Ductal Carcinoma	Stage IIIB
s6464	58cfa830e4b0c9d6adf6bdc6	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	52.29	1.9	0.08	58cfa830e4b0c9d6adf6bdc6	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0B3-01A	18EB4DFC-556F-4BF3-A411-4780209ED1E0	Primary Tumor	Illumina HiSeq	82535082-739b-4a9b-8609-4724bbdd27ee	Breast	53.0	FC1F0AD4-8412-4143-8EBF-FA6592F396E9	43F7A2E0-FEC9-4E43-872D-18C6C946FA17	TCGA-BH-A0B3-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0B3	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6465	58cfa830e4b0c9d6adf6bdca	TCGA-BH-A0DK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BH-A0DK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_6_rg.sorted	TCGA-BH-A0DK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_6_rg.sorted.bam	14.3	1.95	0.15	58cfa830e4b0c9d6adf6bdca	TCGA-BH-A0DK-10A-01D-A060_130807_SN590_0236_BC291KACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DK-10A	F2BBFA9D-9A9D-4F46-9FDE-378E4C44E2AD	Blood Derived Normal	Illumina HiSeq	70caaa1c-198e-4a38-9d77-d97bb89f7c65	Breast	49.0	0FBA2EFB-9EDE-4FD2-ABED-F18275A076DD	1CC19E5F-922B-4878-A0E9-546A8C3FC949	TCGA-BH-A0DK-10A-01D-A060-02	HG19_Broad_variant	TCGA-BH-A0DK	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6466	58cfa830e4b0c9d6adf6c263	TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted	TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted.bam	7.54	2.03	0.13	58cfa830e4b0c9d6adf6c263	TCGA-BH-A0HX-10A-02D-A060_130807_SN590_0236_BC291KACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HX-10A	3B01D064-8C00-4972-9F07-407EAC8E7534	Blood Derived Normal	Illumina HiSeq	f43d0ad4-4ad4-4388-833e-94faf1db1598	Breast	54.0	B17B1EEF-04FD-4D51-B4AE-6E071AFBED16	39C48C76-B9AC-4485-A7C3-4729A56F830C	TCGA-BH-A0HX-10A-02D-A060-02	HG19_Broad_variant	TCGA-BH-A0HX	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6607	58cfa83ce4b0c9d6adf7312e	b9774dd35c320f70de8f2b81c15d5a98.filtered.	WGS	b9774dd35c320f70de8f2b81c15d5a98	b9774dd35c320f70de8f2b81c15d5a98.bam	29.12	1.95	0.08	58cfa83ce4b0c9d6adf7312e	b9774dd35c320f70de8f2b81c15d5a98.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A03L-10A	1174F6E4-FFBE-4E59-A000-8D861C968369	Blood Derived Normal	Illumina HiSeq	03cb8dc7-1f67-4e48-a45f-f95f827694cd	Breast	34.0	B51D49B7-1893-45E0-94FE-BA3D75616063	EA97B47F-1E01-42C0-AE0A-6E961E665C5E	TCGA-AO-A03L-10A-01D-A19H-09	GRCh37-lite	TCGA-AO-A03L	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T3	N2	Infiltrating Ductal Carcinoma	Stage IIIA
s6608	58cfa83ce4b0c9d6adf72e90	cee1724c461492416edf64ee160c4fc2.filtered.	WGS	cee1724c461492416edf64ee160c4fc2	cee1724c461492416edf64ee160c4fc2.bam	13.06		0.09	58cfa83ce4b0c9d6adf72e90	cee1724c461492416edf64ee160c4fc2.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3Y0-10A	174850B4-5EC2-462B-A890-89BD1716B3C2	Blood Derived Normal	Illumina HiSeq	2a32c16c-432c-401f-9725-63857230380b	Breast	57.0	7ECBCA0F-2185-4BFF-9B1C-13BCD82D749D	46E1FD58-C2EA-46EF-BFC9-26D61E7BE608	TCGA-A2-A3Y0-10A-01D-A23C-09	GRCh37-lite	TCGA-A2-A3Y0	TCGA-BRCA		Washington University School of Medicine	Walter Reed	United States	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6609	58cfa83ce4b0c9d6adf72eea	c418efb9913b78e45546dfb361a65778.filtered.	WGS	c418efb9913b78e45546dfb361a65778	c418efb9913b78e45546dfb361a65778.bam	15.02		0.08	58cfa83ce4b0c9d6adf72eea	c418efb9913b78e45546dfb361a65778.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A2DF-10C	D6F7AFC0-1558-43AD-ACB1-2B5311ED2264	Blood Derived Normal	Illumina HiSeq	26743711-c60e-43a7-899e-28535b3d3c27	Breast	53.0	66BB20B3-DEBB-4034-8E49-221C75AE7D22	12CA0B20-2F39-43DF-A572-28F4069502DE	TCGA-GM-A2DF-10C-01D-A17W-09	GRCh37-lite	TCGA-GM-A2DF	TCGA-BRCA		Washington University School of Medicine	MD Anderson	United States	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s6613	58cfa83ce4b0c9d6adf73116	e1fd0963f179515dbd7a5f7018b66fd9.filtered.	WGS	e1fd0963f179515dbd7a5f7018b66fd9	e1fd0963f179515dbd7a5f7018b66fd9.bam	55.79	2.17	0.08	58cfa83ce4b0c9d6adf73116	e1fd0963f179515dbd7a5f7018b66fd9.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BW-11A	5D1D00C6-FCAE-479E-AE1E-DE76EFD41D98	Solid Tissue Normal	Illumina HiSeq	190c051d-e6c9-4898-ae78-5946797b28ff	Breast	71.0	D03B3D7B-3629-4FDE-A47A-3184F67236EB	CA6B4239-5535-4790-A449-4B95E9395ADB	TCGA-BH-A0BW-11A-12D-A314-09	GRCh37-lite	TCGA-BH-A0BW	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I
s6614	58cfa83ce4b0c9d6adf730bc	fc5c85d8f5e38babc01190428928c325.filtered.	WGS	fc5c85d8f5e38babc01190428928c325	fc5c85d8f5e38babc01190428928c325.bam	23.53	2.0	0.09	58cfa83ce4b0c9d6adf730bc	fc5c85d8f5e38babc01190428928c325.bam	Dead	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A256-10A	D3D545B3-457F-4389-821F-704CB24AFF7F	Blood Derived Normal	Illumina HiSeq	3c6b93f3-c90a-4e23-9fdb-f7d1d3e89a82	Breast	45.0	DEC1A314-B7F4-4F86-83CB-A40E0B0994A2	09F34836-FC9A-4FF4-A0C9-FD93259E32F3	TCGA-AR-A256-10A-01D-A167-09	GRCh37-lite	TCGA-AR-A256	TCGA-BRCA	2854.0	Washington University School of Medicine	Mayo	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s6616	58cfa83ce4b0c9d6adf72f6e	e8ca1fee02c380bc36915df141c7889a.filtered.	WGS	e8ca1fee02c380bc36915df141c7889a	e8ca1fee02c380bc36915df141c7889a.bam	24.45	2.06	0.08	58cfa83ce4b0c9d6adf72f6e	e8ca1fee02c380bc36915df141c7889a.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A259-10A	3FC3755D-A3F8-4E2C-813F-FF124F2A75C1	Blood Derived Normal	Illumina HiSeq	d2a43dcc-9fe7-4ca8-9f36-dcffd1ac50b3	Breast	70.0	264CFFAA-EBCB-4FD0-A889-63374AFE7829	30CCA542-BE1F-4A2F-BE4C-D20F26D0F45A	TCGA-A2-A259-10A-01D-A17G-09	GRCh37-lite	TCGA-A2-A259	TCGA-BRCA		Washington University School of Medicine	Walter Reed	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I
s6617	58cfa82de4b0c9d6adf6a4ce	2258e57e8e0af9db6969a1da86177ca7.filtered.	WGS	2258e57e8e0af9db6969a1da86177ca7	2258e57e8e0af9db6969a1da86177ca7.bam	62.02	2.08	0.08	58cfa82de4b0c9d6adf6a4ce	2258e57e8e0af9db6969a1da86177ca7.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A03L-01A	1174F6E4-FFBE-4E59-A000-8D861C968369	Primary Tumor	Illumina HiSeq	e374014a-934d-4eee-b1e3-53ec285ea08e	Breast	34.0	00F81E98-E5C3-43B2-9757-F769EC17F3F8	8F558713-F32B-403B-AEDF-C79EFEB41C67	TCGA-AO-A03L-01A-41D-A19H-09	GRCh37-lite	TCGA-AO-A03L	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T3	N2	Infiltrating Ductal Carcinoma	Stage IIIA
s6619	58cfa82de4b0c9d6adf6a524	435533d16e831b2d6f6a0dc3bd50df1e.filtered.	WGS	435533d16e831b2d6f6a0dc3bd50df1e	435533d16e831b2d6f6a0dc3bd50df1e.bam	17.94		0.08	58cfa82de4b0c9d6adf6a524	435533d16e831b2d6f6a0dc3bd50df1e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PC-10A	F45210D3-9E66-4F5E-BEF1-5EE5547CC893	Blood Derived Normal	Illumina HiSeq	bbbfdc86-7d19-4c67-9a3f-c46da84f900d	Breast	66.0	EDED4CB4-F527-4FF6-A97D-2EC424B37ABE	58DDDDD4-CB14-4081-AC9F-C291DCDDC24D	TCGA-EW-A1PC-10A-01D-A21Q-09	GRCh37-lite	TCGA-EW-A1PC	TCGA-BRCA		Washington University School of Medicine	University of Miami	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB
s6621	58cfa82de4b0c9d6adf6a4ac	384e3a54d13c4da95f4e7a281f456d43.filtered.	WGS	384e3a54d13c4da95f4e7a281f456d43	384e3a54d13c4da95f4e7a281f456d43.bam	7.9	1.9	0.08	58cfa82de4b0c9d6adf6a4ac	384e3a54d13c4da95f4e7a281f456d43.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LG-11A	EF4CBD38-BC79-4D60-A715-647EDD2EBE9E	Solid Tissue Normal	Illumina HiSeq	6bd8c3ea-15b6-4d42-b4f1-bbfdacb145f8	Breast	50.0	54E5A437-3BC0-4D22-880C-926582B86BCB	583D989C-FA07-46F5-B463-6CE5A2744927	TCGA-E2-A1LG-11A-42D-A14K-09	GRCh37-lite	TCGA-E2-A1LG	TCGA-BRCA		Washington University School of Medicine	Roswell Park	United States	NO	T2	N0	Infiltrating Lobular Carcinoma	Stage IIA
s6622	58cfa82de4b0c9d6adf6a50c	437fd4c58a0c6f406413c5f2b3073d0a.filtered.	WGS	437fd4c58a0c6f406413c5f2b3073d0a	437fd4c58a0c6f406413c5f2b3073d0a.bam	63.5	1.98	0.08	58cfa82de4b0c9d6adf6a50c	437fd4c58a0c6f406413c5f2b3073d0a.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A156-01A	F05D314C-5EC5-4E2A-B785-9A702716F111	Primary Tumor	Illumina HiSeq	3d9a2788-2bc3-4df9-bae7-fef37f6096b8	Breast	61.0	9D39F2CF-84B5-45BA-8C40-0A42D8F303B7	2DA2B745-068D-408C-9163-3B3A78D4AAED	TCGA-E2-A156-01A-11D-A314-09	GRCh37-lite	TCGA-E2-A156	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I
s6623	58cfa82de4b0c9d6adf6a59f	4cc480609f127baaadd7eaeae13f96df.filtered.	WGS	4cc480609f127baaadd7eaeae13f96df	4cc480609f127baaadd7eaeae13f96df.bam	22.91	1.97	0.07	58cfa82de4b0c9d6adf6a59f	4cc480609f127baaadd7eaeae13f96df.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A152-10A	A8015490-9740-45C9-8BD2-EB6D1BEEFC2E	Blood Derived Normal	Illumina HiSeq	a5f27034-eded-4286-bf8f-965029909919	Breast	56.0	A66F19A5-BF40-47D5-99CF-C79283D011D1	236FD25D-CAE3-4ACF-AEF7-7DEF6042F30A	TCGA-E2-A152-10A-01D-A19H-09	GRCh37-lite	TCGA-E2-A152	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I
s6624	58cfa82de4b0c9d6adf6a535	4d34550076e0e5e5f628e1f2d531963f.filtered.	WGS	4d34550076e0e5e5f628e1f2d531963f	4d34550076e0e5e5f628e1f2d531963f.bam	58.16	2.0	0.07	58cfa82de4b0c9d6adf6a535	4d34550076e0e5e5f628e1f2d531963f.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D4-01A	75113445-D2D6-44A0-866C-C9175E6D214B	Primary Tumor	Illumina HiSeq	ac8422e5-dfeb-40c6-ab1f-dddd9f7fb015	Breast	37.0	ACE39EF3-1B5E-4AD2-A20D-62957E524281	2B000AF3-2C9D-4EAA-AF3F-8101B7425C37	TCGA-A2-A0D4-01A-11D-A314-09	GRCh37-lite	TCGA-A2-A0D4	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6625	58cfa82de4b0c9d6adf6a670	584d3eda47ec27e5fcabcd9551aaad55.filtered.	WGS	584d3eda47ec27e5fcabcd9551aaad55	584d3eda47ec27e5fcabcd9551aaad55.bam	24.26	1.79	0.07	58cfa82de4b0c9d6adf6a670	584d3eda47ec27e5fcabcd9551aaad55.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04X-10A	733A2A0F-B37A-4B81-B49E-3C0F30D1EB37	Blood Derived Normal	Illumina HiSeq	c942bc80-18ce-4573-869b-4fc96677f775	Breast	34.0	BAB345A6-97F2-4963-A696-2A4393C9C7BF	79ADE75E-AD86-436D-B2E0-0B5100B472C9	TCGA-A2-A04X-10A-01D-A19H-09	GRCh37-lite	TCGA-A2-A04X	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6626	58cfa82de4b0c9d6adf6a5e6	68643203aa5b5cbe3d40a15c06570987.filtered.	WGS	68643203aa5b5cbe3d40a15c06570987	68643203aa5b5cbe3d40a15c06570987.bam	18.94	2.03	0.07	58cfa82de4b0c9d6adf6a5e6	68643203aa5b5cbe3d40a15c06570987.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A14P-10A	E4FC0909-F284-4471-866D-D8967B6ADCBC	Blood Derived Normal	Illumina HiSeq	a639fa8f-f8d6-4d5c-85bf-5a37c02258d4	Breast	79.0	B41594A0-5892-4AE6-A354-DDF09A7772A0	45561DA8-6073-4F1D-9CFC-B627516D1242	TCGA-E2-A14P-10A-01D-A19H-09	GRCh37-lite	TCGA-E2-A14P	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T2	N3	Infiltrating Ductal Carcinoma	Stage IIIC
s6627	58cfa82de4b0c9d6adf6a5cb	6d7e6efd259f6da22588aaacd73c3c0e.filtered.	WGS	6d7e6efd259f6da22588aaacd73c3c0e	6d7e6efd259f6da22588aaacd73c3c0e.bam	46.27	1.72	0.09	58cfa82de4b0c9d6adf6a5cb	6d7e6efd259f6da22588aaacd73c3c0e.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1J5-10A	5D8ED961-A012-4B6B-BFFB-9468D3953646	Blood Derived Normal	Illumina HiSeq	ce79ca01-0c22-4e25-a5da-fd9438299f91	Breast	59.0	75B94F6E-1011-4106-9D9E-3B6E5573C3E8	D0C5457B-7BA5-4482-ACC8-EDC375E0E121	TCGA-EW-A1J5-10A-01D-A13O-09	GRCh37-lite	TCGA-EW-A1J5	TCGA-BRCA		Washington University School of Medicine	University of Miami	United States	NO	T3	N0 (i-)	Infiltrating Lobular Carcinoma	Stage IIB
s6628	58cfa82de4b0c9d6adf6a6b4	94b51555d1de0d10503b34342b586c3b.filtered.	WGS	94b51555d1de0d10503b34342b586c3b	94b51555d1de0d10503b34342b586c3b.bam	54.48	2.0	0.08	58cfa82de4b0c9d6adf6a6b4	94b51555d1de0d10503b34342b586c3b.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A130-10A	8CF54607-01CE-42B0-9BD9-8627EDD9F3B7	Blood Derived Normal	Illumina HiSeq	44978a5f-a9ce-40ac-8b2e-3ade35e32525	Breast	52.0	4D3B8AD8-94CE-49A7-A7AF-F56AC17891F6	D141E42E-AA3B-46ED-815F-3192B1959BF4	TCGA-C8-A130-10A-01D-A19H-09	GRCh37-lite	TCGA-C8-A130	TCGA-BRCA		Washington University School of Medicine	ILSbio	Vietnam	NO	T3	N2	Infiltrating Ductal Carcinoma	Stage IIIA
s6629	58cfa830e4b0c9d6adf6bc44	TCGA-AO-A0JF-10A-01D-A060_130719_SN1120_0270_AC2CVRACXX_s_2_rg.sorted.filtered.	WGS	TCGA-AO-A0JF-10A-01D-A060_130719_SN1120_0270_AC2CVRACXX_s_2_rg.sorted	TCGA-AO-A0JF-10A-01D-A060_130719_SN1120_0270_AC2CVRACXX_s_2_rg.sorted.bam	33.53	1.83	0.13	58cfa830e4b0c9d6adf6bc44	TCGA-AO-A0JF-10A-01D-A060_130719_SN1120_0270_AC2CVRACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JF-10A	F357FE19-5359-4662-8CE9-AA996132283B	Blood Derived Normal	Illumina HiSeq	ecbc57df-ef58-47a5-9ae5-83e394d14191	Breast	68.0	DA127378-BDD7-4D9E-AD83-D2C223B4A40E	85F3A9D5-E0B8-47B2-B525-5C8177F22C46	TCGA-AO-A0JF-10A-01D-A060-02	HG19_Broad_variant	TCGA-AO-A0JF	TCGA-BRCA		Harvard Medical School	MSKCC	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s6631	58cfa830e4b0c9d6adf6be26	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	63.5	1.95	0.07	58cfa830e4b0c9d6adf6be26	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0WA-01A	786E8DBE-442E-4551-87B3-B4C333B04DD4	Primary Tumor	Illumina HiSeq	1671f5e8-9bbd-41c1-803e-c518d5ba004f	Breast	82.0	8EF7AD6F-A6E4-405C-B20E-D547985BD9D6	EDDFBFB9-3AE8-449B-B870-46062A2571C1	TCGA-BH-A0WA-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0WA	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0 (i-)	Not available	Stage I
s6745	58cfa83ce4b0c9d6adf73187	a40573206785187a19235a673ae4ab01.filtered.	WGS	a40573206785187a19235a673ae4ab01	a40573206785187a19235a673ae4ab01.bam	55.76	1.97	0.08	58cfa83ce4b0c9d6adf73187	a40573206785187a19235a673ae4ab01.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A12L-10A	441919EB-8C9F-478C-BDA3-8DE4F8295E8A	Blood Derived Normal	Illumina HiSeq	1961adaf-b22b-4091-b508-99f711a4eaf1	Breast	67.0	C3BA3FE2-7B85-44A0-B0C7-55669601D97A	5C18404D-8918-4A84-B1C2-AE7D7731C213	TCGA-C8-A12L-10A-01D-A19H-09	GRCh37-lite	TCGA-C8-A12L	TCGA-BRCA		Washington University School of Medicine	ILSbio	Vietnam	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6746	58cfa83ce4b0c9d6adf72fb2	a71534313dd3551e1b02d0eed8d54add.filtered.	WGS	a71534313dd3551e1b02d0eed8d54add	a71534313dd3551e1b02d0eed8d54add.bam	55.26		0.08	58cfa83ce4b0c9d6adf72fb2	a71534313dd3551e1b02d0eed8d54add.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A2LK-01A	1B703058-E596-45BC-80FE-8B98D545C2E2	Primary Tumor	Illumina HiSeq	452eb1a3-2221-409b-a97e-f3266c5737cd	Breast	62.0	D6F5C34A-0F5C-4AED-977A-74A1E5D50915	7B0B60C7-5FA0-440E-937F-8D82119330D6	TCGA-AR-A2LK-01A-11D-A17W-09	GRCh37-lite	TCGA-AR-A2LK	TCGA-BRCA		Washington University School of Medicine	Mayo	United States	NO	T3	N2	Infiltrating Lobular Carcinoma	Stage III
s6747	58cfa83ce4b0c9d6adf73060	a3d780740258da56025b3a939d1ea7d5.filtered.	WGS	a3d780740258da56025b3a939d1ea7d5	a3d780740258da56025b3a939d1ea7d5.bam	57.22	2.05	0.08	58cfa83ce4b0c9d6adf73060	a3d780740258da56025b3a939d1ea7d5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0YG-01A	C0892598-1F7B-4F23-9CD8-731F797753D5	Primary Tumor	Illumina HiSeq	64d3bdd6-809b-4c4e-bb57-71f60383b777	Breast	63.0	5006C942-BC9A-41CB-8674-2341B4E66230	4D409156-3A36-4C63-9AD6-B6AF34F27B06	TCGA-A2-A0YG-01A-21D-A19H-09	GRCh37-lite	TCGA-A2-A0YG	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N3a	Infiltrating Ductal Carcinoma	Stage IIIC
s6748	58cfa83ce4b0c9d6adf72eee	ab46e9105ac4921cb2875cf654f76114.filtered.	WGS	ab46e9105ac4921cb2875cf654f76114	ab46e9105ac4921cb2875cf654f76114.bam	19.93	1.98	0.08	58cfa83ce4b0c9d6adf72eee	ab46e9105ac4921cb2875cf654f76114.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A156-10A	F05D314C-5EC5-4E2A-B785-9A702716F111	Blood Derived Normal	Illumina HiSeq	d87cfc01-42b6-4dc0-9403-d2daee055209	Breast	61.0	C1010EA5-926A-42AF-8E7A-B22BB368CE1B	F4F71B7E-B3E2-4573-8F78-EC9FC7F2D6E0	TCGA-E2-A156-10A-01D-A314-09	GRCh37-lite	TCGA-E2-A156	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I
s6749	58cfa83ce4b0c9d6adf72f19	ccd535b1664251ecbc0fb70ec7dee554.filtered.	WGS	ccd535b1664251ecbc0fb70ec7dee554	ccd535b1664251ecbc0fb70ec7dee554.bam	17.51	1.95	0.07	58cfa83ce4b0c9d6adf72f19	ccd535b1664251ecbc0fb70ec7dee554.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A03N-01B	9435447E-D65F-408B-863B-6576B1D652DD	Primary Tumor	Illumina HiSeq	a198d001-d09b-4a43-9704-060db667151f	Breast	59.0	06B3E3CA-24B9-4E19-9E59-B51CC6D6735B	F8F749B7-547D-49FA-9DA2-44EED962B6FD	TCGA-AO-A03N-01B-11D-A19H-09	GRCh37-lite	TCGA-AO-A03N	TCGA-BRCA		Washington University School of Medicine	MSKCC	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6750	58cfa83ce4b0c9d6adf72ef8	d9a4fed4943a3f61117cf771e1db8985.filtered.	WGS	d9a4fed4943a3f61117cf771e1db8985	d9a4fed4943a3f61117cf771e1db8985.bam	57.99		0.08	58cfa83ce4b0c9d6adf72ef8	d9a4fed4943a3f61117cf771e1db8985.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A2BK-01A	6FA2A667-9C36-4526-8A58-1975E863A806	Primary Tumor	Illumina HiSeq	53c5c882-8386-48e7-b7dd-8815bcf6b316	Breast	78.0	B85BE663-EDBA-4E1E-A10C-D0297744A0E9	8E03E773-5557-4E78-889B-4710C515378F	TCGA-AC-A2BK-01A-11D-A314-09	GRCh37-lite	TCGA-AC-A2BK	TCGA-BRCA		Washington University School of Medicine	International Genomics Consortium	United States	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA
s6751	58cfa83ce4b0c9d6adf72f73	f0f3dfb66995edcb514e1ccebc2c7e4d.filtered.	WGS	f0f3dfb66995edcb514e1ccebc2c7e4d	f0f3dfb66995edcb514e1ccebc2c7e4d.bam	61.2	1.96	0.09	58cfa83ce4b0c9d6adf72f73	f0f3dfb66995edcb514e1ccebc2c7e4d.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A130-01A	8CF54607-01CE-42B0-9BD9-8627EDD9F3B7	Primary Tumor	Illumina HiSeq	e70e14f9-ea63-4038-8a0e-5526391ea4fe	Breast	52.0	3BEA8456-DA16-4691-A260-5C94A83E2860	27F87D1E-2C32-4BEB-9677-62F7A286673D	TCGA-C8-A130-01A-31D-A19H-09	GRCh37-lite	TCGA-C8-A130	TCGA-BRCA		Washington University School of Medicine	ILSbio	Vietnam	NO	T3	N2	Infiltrating Ductal Carcinoma	Stage IIIA
s6756	58cfa82de4b0c9d6adf6a480	1e6e9eda1facdcda16b8442c40fec9c7.filtered.	WGS	1e6e9eda1facdcda16b8442c40fec9c7	1e6e9eda1facdcda16b8442c40fec9c7.bam	29.77	1.86	0.08	58cfa82de4b0c9d6adf6a480	1e6e9eda1facdcda16b8442c40fec9c7.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I6-10A	045C13EF-3DB7-4ADF-B0A3-23338F0479F3	Blood Derived Normal	Illumina HiSeq	92e425cc-f200-440b-a6ad-71e6feae486b	Breast	49.0	DEB8DCFD-F24A-4CC3-BC21-CDCD50359D13	E582A24D-98BF-40D3-BBC8-E8823A28127F	TCGA-B6-A0I6-10A-01D-A128-09	GRCh37-lite	TCGA-B6-A0I6	TCGA-BRCA	991.0	Washington University School of Medicine	Duke	United States	NO	T1c	N1	Infiltrating Ductal Carcinoma	Stage IIA
s6757	58cfa82de4b0c9d6adf6a4a8	1460837133c752e48d8ded9f16cc5949.filtered.	WGS	1460837133c752e48d8ded9f16cc5949	1460837133c752e48d8ded9f16cc5949.bam	43.68	1.56	0.08	58cfa82de4b0c9d6adf6a4a8	1460837133c752e48d8ded9f16cc5949.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LK-01A	1D27253F-B036-44E7-A04D-8DA5BBF57419	Primary Tumor	Illumina HiSeq	cdbdb1d9-4c6d-4a22-8867-42722b596ae9	Breast	84.0	CC937913-802F-48CD-A490-E6B90F007C5D	4E84EED6-82A8-4E91-B0FD-61EC6EF69CE9	TCGA-E2-A1LK-01A-21D-A14G-09	GRCh37-lite	TCGA-E2-A1LK	TCGA-BRCA	266.0	Washington University School of Medicine	Roswell Park	United States	NO	T4b	N3a	Infiltrating Ductal Carcinoma	Stage IIIC
s6758	58cfa82de4b0c9d6adf6a4ee	2548c39fc92627580ce126914f9e541c.filtered.	WGS	2548c39fc92627580ce126914f9e541c	2548c39fc92627580ce126914f9e541c.bam	10.66	1.96	0.09	58cfa82de4b0c9d6adf6a4ee	2548c39fc92627580ce126914f9e541c.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RU-10B	6956473B-92E5-4069-A26B-B48E280E76F2	Blood Derived Normal	Illumina HiSeq	a29cdc57-52ec-48f1-87d6-5f2a56480a48	Breast	40.0	53CA1040-ECA4-4ACA-B437-EEDEB89062D3	B7759C1C-44BA-4C57-A975-C98EED1A9C76	TCGA-B6-A0RU-10B-01D-A12L-09	GRCh37-lite	TCGA-B6-A0RU	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	T1c	N0 (i-)	Other  specify	Stage IA
s6759	58cfa82de4b0c9d6adf6a4c0	19ada9681b4376a963a9b9e1b4877a12.filtered.	WGS	19ada9681b4376a963a9b9e1b4877a12	19ada9681b4376a963a9b9e1b4877a12.bam	18.03		0.08	58cfa82de4b0c9d6adf6a4c0	19ada9681b4376a963a9b9e1b4877a12.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A2LK-10A	1B703058-E596-45BC-80FE-8B98D545C2E2	Blood Derived Normal	Illumina HiSeq	2c451421-5276-4960-9791-c9d9c5a2b7ff	Breast	62.0	6EC8CCF0-4292-4ADD-9190-7339FFED7FFA	ADFEFA9C-2E3E-444D-8018-F364999F5F42	TCGA-AR-A2LK-10A-01D-A17W-09	GRCh37-lite	TCGA-AR-A2LK	TCGA-BRCA		Washington University School of Medicine	Mayo	United States	NO	T3	N2	Infiltrating Lobular Carcinoma	Stage III
s6760	58cfa82de4b0c9d6adf6a4b2	1d839fbbdcb1971d9a0ef13b9f7a8b2e.filtered.	WGS	1d839fbbdcb1971d9a0ef13b9f7a8b2e	1d839fbbdcb1971d9a0ef13b9f7a8b2e.bam	69.79	1.98	0.08	58cfa82de4b0c9d6adf6a4b2	1d839fbbdcb1971d9a0ef13b9f7a8b2e.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A0AT-01A	05506F4C-E701-4A9D-AE06-97F066AADE43	Primary Tumor	Illumina HiSeq	5285cd99-09bc-48e5-abcb-11230d5f40f0	Breast	62.0	B2905A3F-810B-4E74-AF5C-42D513D91746	F848B66F-BD9E-4FBA-AFD4-EB58848D1EF4	TCGA-AN-A0AT-01A-11D-A045-09	GRCh37-lite	TCGA-AN-A0AT	TCGA-BRCA		Washington University School of Medicine	Cureline	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s6761	58cfa82de4b0c9d6adf6a53c	450a0ae734ab89c01b82ea2af8dacc92.filtered.	WGS	450a0ae734ab89c01b82ea2af8dacc92	450a0ae734ab89c01b82ea2af8dacc92.bam	75.68	1.83	0.09	58cfa82de4b0c9d6adf6a53c	450a0ae734ab89c01b82ea2af8dacc92.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A25B-01A	EADF8482-E60E-4307-ADB7-D5C3B9FA6CAE	Primary Tumor	Illumina HiSeq	372d2951-a381-41f0-88d7-72cc9da6b6db	Breast	39.0	2C619641-7849-4837-AB92-0DA80342B3E9	6E839EAF-1DBB-43F5-8846-C980E05540C7	TCGA-A2-A25B-01A-11D-A167-09	GRCh37-lite	TCGA-A2-A25B	TCGA-BRCA		Washington University School of Medicine	Walter Reed	United States	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB
s6762	58cfa82de4b0c9d6adf6a44d	4844004286e9369557674738d9be6d4a.filtered.	WGS	4844004286e9369557674738d9be6d4a	4844004286e9369557674738d9be6d4a.bam	21.91	1.63	0.08	58cfa82de4b0c9d6adf6a44d	4844004286e9369557674738d9be6d4a.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A25B-10A	EADF8482-E60E-4307-ADB7-D5C3B9FA6CAE	Blood Derived Normal	Illumina HiSeq	639ddd7e-f28c-4b27-ae48-82d236b2f872	Breast	39.0	8A33780A-F820-46A6-8830-E0D32581DBBC	C16CF182-B4B2-42C0-A2B1-CE071638DE2F	TCGA-A2-A25B-10A-01D-A167-09	GRCh37-lite	TCGA-A2-A25B	TCGA-BRCA		Washington University School of Medicine	Walter Reed	United States	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB
s6763	58cfa82de4b0c9d6adf6a614	511a3675203dfa8034f97dbe11cc6195.filtered.	WGS	511a3675203dfa8034f97dbe11cc6195	511a3675203dfa8034f97dbe11cc6195.bam	35.64		0.08	58cfa82de4b0c9d6adf6a614	511a3675203dfa8034f97dbe11cc6195.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A2DF-01A	D6F7AFC0-1558-43AD-ACB1-2B5311ED2264	Primary Tumor	Illumina HiSeq	f577059e-baa8-4030-9baa-5857d30fbfec	Breast	53.0	66760E17-251D-4981-BB02-82C29B315080	7456ABD5-303E-4E6F-BF4E-47EFEFC7310F	TCGA-GM-A2DF-01A-11D-A17W-09	GRCh37-lite	TCGA-GM-A2DF	TCGA-BRCA		Washington University School of Medicine	MD Anderson	United States	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA
s6766	58cfa82de4b0c9d6adf6a5d1	5e03deaed4f9d67805b748d70f393b0c.filtered.	WGS	5e03deaed4f9d67805b748d70f393b0c	5e03deaed4f9d67805b748d70f393b0c.bam	80.13	1.91	0.07	58cfa82de4b0c9d6adf6a5d1	5e03deaed4f9d67805b748d70f393b0c.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A0XR-10A	F51AF6DB-2655-47FB-9FFC-83A503A728EA	Blood Derived Normal	Illumina HiSeq	5820a5ab-6b80-4a87-8140-d96b70cd48d4	Breast	55.0	AD969C08-88A4-4421-8CE9-606F67C4891E	4066FC82-49BA-4A54-A81C-768AE25E2741	TCGA-AN-A0XR-10A-01D-A10G-09	GRCh37-lite	TCGA-AN-A0XR	TCGA-BRCA		Washington University School of Medicine	Cureline	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage IIIA
s6767	58cfa82de4b0c9d6adf6a6e0	8acca8432df87fc66fbf834556f68a20.filtered.	WGS	8acca8432df87fc66fbf834556f68a20	8acca8432df87fc66fbf834556f68a20.bam	92.82	1.95	0.08	58cfa82de4b0c9d6adf6a6e0	8acca8432df87fc66fbf834556f68a20.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04X-01A	733A2A0F-B37A-4B81-B49E-3C0F30D1EB37	Primary Tumor	Illumina HiSeq	055e605f-56b9-4ca6-8856-1f32ab8e34a6	Breast	34.0	ABFF5667-7EF4-46C1-AD34-CEABC27E7992	41F140B8-72B9-4AE3-8B25-6144D9F94D0F	TCGA-A2-A04X-01A-21D-A19H-09	GRCh37-lite	TCGA-A2-A04X	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
s6768	58cfa830e4b0c9d6adf6bbb6	TCGA-A2-A0EU-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_2_rg.sorted.filtered.	WGS	TCGA-A2-A0EU-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_2_rg.sorted	TCGA-A2-A0EU-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_2_rg.sorted.bam	21.31	1.91	0.13	58cfa830e4b0c9d6adf6bbb6	TCGA-A2-A0EU-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0EU-10A	C0427237-B476-4AF4-B664-7BD479922EA5	Blood Derived Normal	Illumina HiSeq	bbc2932c-4507-4111-a367-ba914dfe257b	Breast	79.0	7B9319B5-3093-4E22-94B2-E7A956BDC271	11E97514-242B-4CE1-99EA-3830E6902EE3	TCGA-A2-A0EU-10A-01D-A060-02	HG19_Broad_variant	TCGA-A2-A0EU	TCGA-BRCA		Harvard Medical School	Walter Reed	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s6769	58cfa830e4b0c9d6adf6c128	TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted	TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted.bam	49.61	2.14	0.16	58cfa830e4b0c9d6adf6c128	TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RE-01A	08DA7C4C-3067-4BCF-9D7A-78566DF72E69	Primary Tumor	Illumina HiSeq	f7dd44eb-562f-4d27-8c45-5ec7fbf49448	Breast	61.0	270BE245-2239-4E96-A917-79CCA40868BA	D5CE279A-3A7F-43E7-894C-265E9504C3FD	TCGA-B6-A0RE-01A-11D-A060-02	HG19_Broad_variant	TCGA-B6-A0RE	TCGA-BRCA		Harvard Medical School	Duke	United States	NO	TX	N0 (i-)	Infiltrating Ductal Carcinoma	Stage X
s6770	58cfa830e4b0c9d6adf6bdea	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	73.41	1.97	0.07	58cfa830e4b0c9d6adf6bdea	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0B9-01A	5A57DC25-D252-4B22-B192-4DE630D7002F	Primary Tumor	Illumina HiSeq	1a49cb56-547c-4a77-84e6-116bc406ba19	Breast	44.0	8137FFEE-BB4F-4E5F-B831-ACFC9C5585A8	CF599959-6AAF-48EA-8A15-8EF09163BAD7	TCGA-BH-A0B9-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0B9	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s6771	58cfa830e4b0c9d6adf6c298	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.bam	48.65	2.08	0.16	58cfa830e4b0c9d6adf6c298	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0GY-01A	7D9D3522-EC3B-4EFE-8C8E-C0E675276EF5	Primary Tumor	Illumina HiSeq	bcac7e1b-ddeb-43d6-ba44-db40336bf564	Breast	67.0	A7E71EAC-1768-4FC2-8EBA-1576D22E0F43	F5C72179-9BDA-4BC6-B006-93EB616804BC	TCGA-BH-A0GY-01A-11D-A060-02	HG19_Broad_variant	TCGA-BH-A0GY	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIA
s6772	58cfa830e4b0c9d6adf6bdd4	TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted	TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted.bam	18.62	1.9	0.15	58cfa830e4b0c9d6adf6bdd4	TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BM-01A	C2AEEE6C-BA10-4CF9-B560-C739580F7BF3	Primary Tumor	Illumina HiSeq	46f039c4-a705-4933-bf85-0e96e80e5024	Breast	54.0	5423B7F8-D2BB-47C8-9AF8-3D3E1276888C	FA99DD38-37F1-4B24-960E-617F92CDADD0	TCGA-BH-A0BM-01A-11D-A060-02	HG19_Broad_variant	TCGA-BH-A0BM	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6773	58cfa830e4b0c9d6adf6c197	TCGA-BH-A0H7-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BH-A0H7-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_8_rg.sorted	TCGA-BH-A0H7-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_8_rg.sorted.bam	6.8	1.96	0.17	58cfa830e4b0c9d6adf6c197	TCGA-BH-A0H7-10A-01D-A060_130725_SN590_0233_AD2B3HACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H7-10A	2021ED1F-DC75-4701-B8B8-1386466E4802	Blood Derived Normal	Illumina HiSeq	a267b823-747c-4258-b5e8-9cb33834ff6a	Breast	65.0	F104689E-1DC6-412D-BFAA-D3203EAF095C	AA3E5150-7EFF-4837-9946-EFECBEE42E92	TCGA-BH-A0H7-10A-01D-A060-02	HG19_Broad_variant	TCGA-BH-A0H7	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T1c	N2a	Infiltrating Ductal Carcinoma	Stage IIIA
s6774	58cfa830e4b0c9d6adf6bdd2	TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	12.94	2.03	0.08	58cfa830e4b0c9d6adf6bdd2	TCGA-BH-A0E0-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0E0-10A	20E8106B-1290-4735-ABE4-7621E08E3DC8	Blood Derived Normal	Illumina HiSeq	48d26da8-f7ee-4828-890b-be10385c1187	Breast	38.0	FE4E376B-7C87-4ED1-8994-7C8A8DAF402B	3448B251-9EE2-413B-8A08-F0160CEDEBA0	TCGA-BH-A0E0-10A-01D-A128-09	GRCh37-lite	TCGA-BH-A0E0	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T3	N3a	Infiltrating Ductal Carcinoma	Stage IIIC
s6775	58cfa830e4b0c9d6adf6be2c	TCGA-BH-A0WA-10A-01D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0WA-10A-01D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0WA-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	13.39	2.5	0.07	58cfa830e4b0c9d6adf6be2c	TCGA-BH-A0WA-10A-01D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0WA-10A	786E8DBE-442E-4551-87B3-B4C333B04DD4	Blood Derived Normal	Illumina HiSeq	8ed08a9b-096c-47fc-85fe-61038535e131	Breast	82.0	081B3B50-1CEE-40B5-8795-2266874673F8	BBA9F20C-543F-4473-86B5-423C6FC22594	TCGA-BH-A0WA-10A-01D-A128-09	GRCh37-lite	TCGA-BH-A0WA	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0 (i-)	Not available	Stage I
s6903	58cfa83ce4b0c9d6adf730fa	c03fa22a7c8629afd7ba660ae443cddc.filtered.	WGS	c03fa22a7c8629afd7ba660ae443cddc	c03fa22a7c8629afd7ba660ae443cddc.bam	74.86	1.88	0.08	58cfa83ce4b0c9d6adf730fa	c03fa22a7c8629afd7ba660ae443cddc.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04Q-01A	B5FBA77B-1F50-4E71-95B2-566AFBA4BDD7	Primary Tumor	Illumina HiSeq	77a8d1fa-9421-4333-b128-8a4b8fddfc6f	Breast	48.0	E17E273D-6F53-4419-9F0C-1E4E667C5257	03B8122D-02D9-4AD0-96ED-001C0D100DE0	TCGA-A2-A04Q-01A-21D-A128-09	GRCh37-lite	TCGA-A2-A04Q	TCGA-BRCA		Washington University School of Medicine	Walter Reed	None	NO	T1	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s6905	58cfa83ce4b0c9d6adf72f7d	e82f5efc1a18908b7a00b45b9bfd5e18.filtered.	WGS	e82f5efc1a18908b7a00b45b9bfd5e18	e82f5efc1a18908b7a00b45b9bfd5e18.bam	48.87	1.91	0.08	58cfa83ce4b0c9d6adf72f7d	e82f5efc1a18908b7a00b45b9bfd5e18.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A1AY-01A	5FD9552A-C742-4388-940D-295D1107AE00	Primary Tumor	Illumina HiSeq	45a65b22-252b-4f92-bd7b-16a76d26c165	Breast	65.0	81FC993E-8F5A-4B3B-BEA3-4C4C2F5E4EF2	15F90EF0-831B-40A3-98BD-EC226A9E8B26	TCGA-AR-A1AY-01A-21D-A12Q-09	GRCh37-lite	TCGA-AR-A1AY	TCGA-BRCA		Washington University School of Medicine	Mayo	None	NO	T1	N0	Infiltrating Ductal Carcinoma	Stage I
s6907	58cfa83ce4b0c9d6adf730b4	fae749c6bcfc193aa1b9126628a2cf23.filtered.	WGS	fae749c6bcfc193aa1b9126628a2cf23	fae749c6bcfc193aa1b9126628a2cf23.bam	116.59	1.95	0.07	58cfa83ce4b0c9d6adf730b4	fae749c6bcfc193aa1b9126628a2cf23.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IJ-01A	2C86C3EA-D926-4D39-A5AE-39ECE4774287	Primary Tumor	Illumina HiSeq	b665cc0b-5952-419e-87a4-d97d3298f607	Breast	42.0	9EF8142A-8627-4DCF-8C87-15B1BC2BFEA2	B7FAC67C-EB7A-485C-A9B3-3E36388D02B1	TCGA-B6-A0IJ-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0IJ	TCGA-BRCA		Washington University School of Medicine	Duke	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB
s6908	58cfa83ce4b0c9d6adf730cb	fa894126e254827396a4f68e2b369bc2.filtered.	WGS	fa894126e254827396a4f68e2b369bc2	fa894126e254827396a4f68e2b369bc2.bam	34.01	1.86	0.08	58cfa83ce4b0c9d6adf730cb	fa894126e254827396a4f68e2b369bc2.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DG-01A	0BC5744C-5FA3-45BB-87D0-70A02068B392	Primary Tumor	Illumina HiSeq	d1c980ac-6070-4a3b-8ff8-208b0f7897cf	Breast	30.0	3F104CF7-8DE8-4E77-8BAA-BAD1BBB493AC	EC4D4CBC-D5D1-418D-A292-CAD9576624FD	TCGA-BH-A0DG-01A-21D-A12Q-09	GRCh37-lite	TCGA-BH-A0DG	TCGA-BRCA		Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA
s6910	58cfa82de4b0c9d6adf6a4ea	282e52fc396cb531fa21b3436906608f.filtered.	WGS	282e52fc396cb531fa21b3436906608f	282e52fc396cb531fa21b3436906608f.bam	35.31		0.08	58cfa82de4b0c9d6adf6a4ea	282e52fc396cb531fa21b3436906608f.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3Y0-01A	174850B4-5EC2-462B-A890-89BD1716B3C2	Primary Tumor	Illumina HiSeq	f1452ca5-f44b-4f35-a5eb-a8b1f9c44ef7	Breast	57.0	CAA2D510-9024-4D7D-B0EF-80FA4BE1E2EE	D8FBB398-D1DA-4444-984A-22C8523625DA	TCGA-A2-A3Y0-01A-11D-A23C-09	GRCh37-lite	TCGA-A2-A3Y0	TCGA-BRCA		Washington University School of Medicine	Walter Reed	United States	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB
s6911	58cfa82de4b0c9d6adf6a4cc	1e9af460376762c5d489a2b820834e3f.filtered.	WGS	1e9af460376762c5d489a2b820834e3f	1e9af460376762c5d489a2b820834e3f.bam	15.12	1.95	0.08	58cfa82de4b0c9d6adf6a4cc	1e9af460376762c5d489a2b820834e3f.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15H-10A	5580B21A-2CDB-4777-AD79-6E06654144F5	Blood Derived Normal	Illumina HiSeq	b2b05078-b11f-488e-afc8-2d70b062609e	Breast	38.0	09644A32-44EA-4FAC-AFB9-448810B90EED	CCC8619F-C4AC-4CD9-9DAB-83FAAA59AFC5	TCGA-E2-A15H-10A-01D-A19H-09	GRCh37-lite	TCGA-E2-A15H	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T1c	N1mi	Infiltrating Ductal Carcinoma	Stage IIA
s6912	58cfa82de4b0c9d6adf6a51c	3016434d8255a1fb2b32ae1ae47ef1ec.filtered.	WGS	3016434d8255a1fb2b32ae1ae47ef1ec	3016434d8255a1fb2b32ae1ae47ef1ec.bam	57.13	1.93	0.08	58cfa82de4b0c9d6adf6a51c	3016434d8255a1fb2b32ae1ae47ef1ec.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A18U-01A	233B02F3-C4F0-4A67-9DB5-E68D5CDACCB6	Primary Tumor	Illumina HiSeq	8797ff7d-3b2a-4ac8-b8a3-375982e8413e	Breast	72.0	79763193-268D-49E7-B94C-5CB95F7271B6	FB9135D9-2ACF-41DD-8552-359E6B8C9470	TCGA-BH-A18U-01A-21D-A19H-09	GRCh37-lite	TCGA-BH-A18U	TCGA-BRCA	1563.0	Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA
s6915	58cfa82de4b0c9d6adf6a5d4	5b90de51bbfaf67cf060a869713e0324.filtered.	WGS	5b90de51bbfaf67cf060a869713e0324	5b90de51bbfaf67cf060a869713e0324.bam	56.64	1.95	0.08	58cfa82de4b0c9d6adf6a5d4	5b90de51bbfaf67cf060a869713e0324.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A152-01A	A8015490-9740-45C9-8BD2-EB6D1BEEFC2E	Primary Tumor	Illumina HiSeq	fe904377-4375-437b-8774-c80f11c6e0ff	Breast	56.0	0EF32921-BB7A-4055-A6ED-E8CED5F824E4	8691C87F-2468-44BB-A670-3DCCD6DA33C6	TCGA-E2-A152-01A-11D-A19H-09	GRCh37-lite	TCGA-E2-A152	TCGA-BRCA		Washington University School of Medicine	Roswell Park	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I
s6916	58cfa82fe4b0c9d6adf6b8e2	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.filtered.	WGS	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.bam	8.32		0.14	58cfa82fe4b0c9d6adf6b8e2	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A26F-01B	3B7B9C1E-A84C-47ED-983C-9E4B00CBF01A	Primary Tumor	Illumina HiSeq	4925c013-4605-47d0-9c97-2e8a69233aa4	Breast	55.0	29619D1E-E8B4-411E-BBBA-07F2CFB69E8A	A723DE1E-A9E0-487D-8D86-7AA4A062A1C2	TCGA-A7-A26F-01B-04D-A22S-26	HG19_Broad_variant	TCGA-A7-A26F	TCGA-BRCA		MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	United States	YES	T1	N0	Other  specify	Stage IA
s6917	58cfa830e4b0c9d6adf6c286	TCGA-BH-A0HB-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BH-A0HB-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_6_rg.sorted	TCGA-BH-A0HB-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_6_rg.sorted.bam	10.32	1.88	0.16	58cfa830e4b0c9d6adf6c286	TCGA-BH-A0HB-10A-01D-A060_130725_SN590_0234_BC29HAACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HB-10A	0C1023C0-D2CE-4940-8047-7642F1DC3965	Blood Derived Normal	Illumina HiSeq	6c213158-4cff-4e3f-a2fe-79b1eb8349dc	Breast	55.0	12ED991B-96F2-4A0E-AA8B-8345573A8E57	3F02CEB5-9B6C-453C-8A81-00D2B609B742	TCGA-BH-A0HB-10A-01D-A060-02	HG19_Broad_variant	TCGA-BH-A0HB	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA
s6918	58cfa830e4b0c9d6adf6bdd0	TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted	TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted.bam	8.18	2.06	0.13	58cfa830e4b0c9d6adf6bdd0	TCGA-BH-A0GY-10A-01D-A060_130807_SN590_0235_AC29RAACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0GY-10A	7D9D3522-EC3B-4EFE-8C8E-C0E675276EF5	Blood Derived Normal	Illumina HiSeq	2e13622c-8cd4-44aa-a010-0de1e4dbcbee	Breast	67.0	CD531C9F-A0E9-498A-9032-42040EC975DE	A9C89A38-C132-4BA7-A2D4-26B3184AA047	TCGA-BH-A0GY-10A-01D-A060-02	HG19_Broad_variant	TCGA-BH-A0GY	TCGA-BRCA		Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIA
s6966	58cfa83ce4b0c9d6adf73182	afadeaa36fa98e1d8bb84a2932ffc28f.filtered.	WGS	afadeaa36fa98e1d8bb84a2932ffc28f	afadeaa36fa98e1d8bb84a2932ffc28f.bam	25.12	2.03	0.08	58cfa83ce4b0c9d6adf73182	afadeaa36fa98e1d8bb84a2932ffc28f.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0CM-10A	EB2DBB4F-66B6-4525-8323-431970F7A64E	Blood Derived Normal	Illumina HiSeq	5aa2407a-3abf-42c8-817f-5de4731a1bc7	Breast	40.0	FC7033BB-1A9D-488D-AE8D-ECB67F179700	23CE62FF-753C-4A79-ADCC-2C39ED96D012	TCGA-A2-A0CM-10A-01D-A128-09	GRCh37-lite	TCGA-A2-A0CM	TCGA-BRCA	754.0	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA
